<HTML><HEAD><TITLE>Gene Ontology Results</TITLE></HEAD><BODY>
<H1>Gene Ontology Enrichment Results</H1>
<A HREF="homerResults.html">Homer <i>de novo</i> Motif Enrichment Results</A><BR/>
<A HREF="knownResults.html">Known Motif Enrichment Results</A><BR/>
<H4>Text file version of complete results (i.e. open with Excel)
<UL>
<LI><A HREF="biological_process.txt">biological process</A>: Functional groupings of proteins (<A HREF="http://www.geneontology.org">Gene Ontology</A>)</LI>
<LI><A HREF="molecular_function.txt">molecular function</A>: Mechanistic actions of proteins (<A HREF="http://www.geneontology.org">Gene Ontology</A>)</LI>
<LI><A HREF="cellular_component.txt">cellular component</A>: Protein localization (<A HREF="http://www.geneontology.org">Gene Ontology</A>)</LI>
<LI><A HREF="chromosome.txt">chromosome location</A>: Genes with similar chromosome localization (<A HREF="http://www.ncbi.nlm.nih.gov/gene">NCBI Gene</A>)</LI>
<LI><A HREF="kegg.txt">KEGG pathways</A>: Groups of proteins in the same pathways (<A HREF="http://www.genome.jp/kegg/pathway.html">KEGG</A>)</LI>
<LI><A HREF="interactions.txt">protein interactions</A>: "Proteins interacting with a common protein (BIND, EcoCyc, HPRD)" (<A HREF="http://www.ncbi.nlm.nih.gov/gene">NCBI Gene</A>)</LI>
<LI><A HREF="interpro.txt">interpro domains</A>: Proteins with similar domains and features (<A HREF="http://www.ebi.ac.uk/interpro/">Interpro</A>)</LI>
<LI><A HREF="pfam.txt">pfam domains</A>: Proteins with similar domains and features (<A HREF="http://www.sanger.ac.uk/Software/Pfam/">Pfam</A>)</LI>
<LI><A HREF="smart.txt">smart domains</A>: Proteins with similar domains and features (<A HREF="http://smart.embl-heidelberg.de/">SMART</A>)</LI>
<LI><A HREF="gene3d.txt">gene3d domains</A>: Proteins with similar domains and features (<A HREF="http://cathwww.biochem.ucl.ac.uk:8080/Gene3D">Gene3D</A>)</LI>
<LI><A HREF="prosite.txt">prosite domains</A>: Proteins with similar domains and features (<A HREF="http://ca.expasy.org/prosite/">Prosite</A>)</LI>
<LI><A HREF="prints.txt">prints domains</A>: Proteins with similar domains and features (<A HREF="http://www.bioinf.manchester.ac.uk/dbbrowser/PRINTS/">PRINTS</A>)</LI>
<LI><A HREF="msigdb.txt">MSigDB lists</A>: "Genes sets for pathways, factor/miRNA target predictions, expression patterns, etc." (<A HREF="http://www.broadinstitute.org/gsea/msigdb/index.jsp">MSigDB</A>)</LI>
<LI><A HREF="biocyc.txt">BIOCYC pathways</A>: Groups of proteins in the same pathways (<A HREF="http://biocyc.org/">BIOCYC</A>)</LI>
<LI><A HREF="cosmic.txt">COSMIC cancer mutations</A>: Genes mutated in similar cancers (<A HREF="http://cancer.sanger.ac.uk/cancergenome/projects/cosmic/">COSMIC</A>)</LI>
<LI><A HREF="gwas.txt">GWAS genes</A>: Genes mutated in similar diseases (<A HREF="http://www.genome.gov/26525384">GWAS Catalog</A>)</LI>
<LI><A HREF="lipidmaps.txt">Lipid Maps pathways</A>: Groups of proteins in the same lipid pathways (<A HREF="http://www.ncbi.nlm.nih.gov/biosystems/">Lipid Maps/Biosystems</A>)</LI>
<LI><A HREF="pathwayInteractionDB.txt">Pathway Interaction DB</A>: Groups of proteins in the same pathways (<A HREF="http://pid.nci.nih.gov/">Pathway Interaction Database</A>)</LI>
<LI><A HREF="reactome.txt">REACTOME pathways</A>: Groups of proteins in the same pathways (<A HREF="http://www.reactome.org/PathwayBrowser/">REACTOME</A>)</LI>
<LI><A HREF="smpdb.txt">SMPDB pathways</A>: Groups of proteins in the same pathways (<A HREF="http://www.smpdb.ca/">SMPDB</A>)</LI>
<LI><A HREF="wikipathways.txt">WikiPathways</A>: Groups of proteins in the same pathways (<A HREF="http://www.wikipathways.org/index.php/Special:BrowsePathwaysPage">Wikipathways</A>)</LI>
</UL>
<H2>Enriched Categories</H2>
<TABLE border="1" cellpading="0" cellspacing="0">
<TR><TH>P-value</TH><TD>ln(P)</TD><TD>Term</TD><TD>GO Tree</TD><TD>GO ID</TD><TD># of Genes in Term</TD><TD># of Target Genes in Term</TD><TD># of Total Genes</TD><TD># of Target Genes</TD><TD>Common Genes</TD></TR>
<TR><TD>9.666e-06</TD><TD>-11.55</TD><TD>GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP</TD><TD>MSigDB lists</TD><TD>GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP</TD><TD>191</TD><TD>8</TD><TD>17621</TD><TD>96</TD>
<TD>HEXA,UBE3A,ADAR,TPM4,EPAS1,EEF1A1,ENC1,TP53BP2</TD></TR>
<TR><TD>2.112e-05</TD><TD>-10.77</TD><TD>GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_2H_ACT_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_2H_ACT_CD4_TCELL_DN</TD><TD>154</TD><TD>7</TD><TD>17621</TD><TD>96</TD>
<TD>MAFF,FBXO31,KCNA2,RBKS,ENC1,KCNG3,RFX2</TD></TR>
<TR><TD>2.969e-05</TD><TD>-10.42</TD><TD>GO_IRON_ION_HOMEOSTASIS</TD><TD>MSigDB lists</TD><TD>GO_IRON_ION_HOMEOSTASIS</TD><TD>66</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>EPAS1,SLC40A1,FTL,ALAS2,FTH1</TD></TR>
<TR><TD>3.019e-05</TD><TD>-10.41</TD><TD>ferritin complex</TD><TD>cellular component</TD><TD>GO:0070288</TD><TD>2</TD><TD>2</TD><TD>17744</TD><TD>98</TD>
<TD>FTL,FTH1</TD></TR>
<TR><TD>3.019e-05</TD><TD>-10.41</TD><TD>intracellular ferritin complex</TD><TD>cellular component</TD><TD>GO:0008043</TD><TD>2</TD><TD>2</TD><TD>17744</TD><TD>98</TD>
<TD>FTL,FTH1</TD></TR>
<TR><TD>3.059e-05</TD><TD>-10.39</TD><TD>positive regulation of ubiquitin-specific protease activity</TD><TD>biological process</TD><TD>GO:2000158</TD><TD>2</TD><TD>2</TD><TD>16543</TD><TD>92</TD>
<TD>VCP,TANK</TD></TR>
<TR><TD>3.094e-05</TD><TD>-10.38</TD><TD>FERRITIN_1</TD><TD>prosite domains</TD><TD>PS00540</TD><TD>2</TD><TD>2</TD><TD>11955</TD><TD>67</TD>
<TD>FTH1,FTL</TD></TR>
<TR><TD>3.153e-05</TD><TD>-10.36</TD><TD>deubiquitinase activator activity</TD><TD>molecular function</TD><TD>GO:0035800</TD><TD>2</TD><TD>2</TD><TD>16652</TD><TD>94</TD>
<TD>TANK,VCP</TD></TR>
<TR><TD>3.984e-05</TD><TD>-10.13</TD><TD>GO_HOMEOSTASIS_OF_NUMBER_OF_CELLS</TD><TD>MSigDB lists</TD><TD>GO_HOMEOSTASIS_OF_NUMBER_OF_CELLS</TD><TD>170</TD><TD>7</TD><TD>17621</TD><TD>96</TD>
<TD>EPAS1,GAPT,SLC40A1,EMX1,ADAR,ALAS2,JAK2</TD></TR>
<TR><TD>4.338e-05</TD><TD>-10.05</TD><TD>iron ion homeostasis</TD><TD>biological process</TD><TD>GO:0055072</TD><TD>70</TD><TD>5</TD><TD>16543</TD><TD>92</TD>
<TD>SLC40A1,FTH1,FTL,ALAS2,EPAS1</TD></TR>
<TR><TD>6.809e-05</TD><TD>-9.59</TD><TD>GSE8678_IL7R_LOW_VS_HIGH_EFF_CD8_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE8678_IL7R_LOW_VS_HIGH_EFF_CD8_TCELL_DN</TD><TD>185</TD><TD>7</TD><TD>17621</TD><TD>96</TD>
<TD>ZFYVE1,ADAR,DTD1,ADI1,SCARB2,PTPN3,TACC2</TD></TR>
<TR><TD>8.216e-05</TD><TD>-9.41</TD><TD>homeostasis of number of cells</TD><TD>biological process</TD><TD>GO:0048872</TD><TD>187</TD><TD>7</TD><TD>16543</TD><TD>92</TD>
<TD>ALAS2,GAPT,JAK2,SLC40A1,EMX1,ADAR,EPAS1</TD></TR>
<TR><TD>9.502e-05</TD><TD>-9.26</TD><TD>GO_CELLULAR_IRON_ION_HOMEOSTASIS</TD><TD>MSigDB lists</TD><TD>GO_CELLULAR_IRON_ION_HOMEOSTASIS</TD><TD>44</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>FTH1,FTL,ALAS2,SLC40A1</TD></TR>
<TR><TD>1.198e-04</TD><TD>-9.03</TD><TD>autophagosome</TD><TD>cellular component</TD><TD>GO:0005776</TD><TD>87</TD><TD>5</TD><TD>17744</TD><TD>98</TD>
<TD>ZFYVE1,MAP1LC3B,OSBPL7,FTH1,FTL</TD></TR>
<TR><TD>1.331e-04</TD><TD>-8.92</TD><TD>cellular iron ion homeostasis</TD><TD>biological process</TD><TD>GO:0006879</TD><TD>47</TD><TD>4</TD><TD>16543</TD><TD>92</TD>
<TD>FTL,ALAS2,SLC40A1,FTH1</TD></TR>
<TR><TD>1.368e-04</TD><TD>-8.90</TD><TD>PPP1CC (protein phosphatase 1 catalytic subunit gamma)</TD><TD>protein interactions</TD><TD>5501</TD><TD>278</TD><TD>8</TD><TD>16330</TD><TD>89</TD>
<TD>TACC2,JAK2,VCP,TP53BP2,FTL,PPP1R32,PPP1R3F,TPM4</TD></TR>
<TR><TD>1.670e-04</TD><TD>-8.70</TD><TD>TIAN_TNF_SIGNALING_NOT_VIA_NFKB</TD><TD>MSigDB lists</TD><TD>TIAN_TNF_SIGNALING_NOT_VIA_NFKB</TD><TD>20</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>NR4A1,MAFF,FOSB</TD></TR>
<TR><TD>1.694e-04</TD><TD>-8.68</TD><TD>GTF3C3 (general transcription factor IIIC subunit 3)</TD><TD>protein interactions</TD><TD>9330</TD><TD>51</TD><TD>4</TD><TD>16330</TD><TD>89</TD>
<TD>VCP,SMARCA4,NANOG,EPAS1</TD></TR>
<TR><TD>1.822e-04</TD><TD>-8.61</TD><TD>regulation of ubiquitin-specific protease activity</TD><TD>biological process</TD><TD>GO:2000152</TD><TD>4</TD><TD>2</TD><TD>16543</TD><TD>92</TD>
<TD>TANK,VCP</TD></TR>
<TR><TD>1.822e-04</TD><TD>-8.61</TD><TD>positive regulation of protein deubiquitination</TD><TD>biological process</TD><TD>GO:1903003</TD><TD>4</TD><TD>2</TD><TD>16543</TD><TD>92</TD>
<TD>VCP,TANK</TD></TR>
<TR><TD>1.843e-04</TD><TD>-8.60</TD><TD>Ferritin_DPS_dom</TD><TD>interpro domains</TD><TD>IPR008331</TD><TD>4</TD><TD>2</TD><TD>18428</TD><TD>103</TD>
<TD>FTH1,FTL</TD></TR>
<TR><TD>1.843e-04</TD><TD>-8.60</TD><TD>Ferritin_CS</TD><TD>interpro domains</TD><TD>IPR014034</TD><TD>4</TD><TD>2</TD><TD>18428</TD><TD>103</TD>
<TD>FTL,FTH1</TD></TR>
<TR><TD>1.843e-04</TD><TD>-8.60</TD><TD>Ferritin-like_diiron</TD><TD>interpro domains</TD><TD>IPR009040</TD><TD>4</TD><TD>2</TD><TD>18428</TD><TD>103</TD>
<TD>FTH1,FTL</TD></TR>
<TR><TD>1.843e-04</TD><TD>-8.60</TD><TD>Ferritin</TD><TD>interpro domains</TD><TD>IPR001519</TD><TD>4</TD><TD>2</TD><TD>18428</TD><TD>103</TD>
<TD>FTL,FTH1</TD></TR>
<TR><TD>1.843e-04</TD><TD>-8.60</TD><TD>FERRITIN_2</TD><TD>prosite domains</TD><TD>PS00204</TD><TD>4</TD><TD>2</TD><TD>11955</TD><TD>67</TD>
<TD>FTL,FTH1</TD></TR>
<TR><TD>1.843e-04</TD><TD>-8.60</TD><TD>FERRITIN_LIKE</TD><TD>prosite domains</TD><TD>PS50905</TD><TD>4</TD><TD>2</TD><TD>11955</TD><TD>67</TD>
<TD>FTL,FTH1</TD></TR>
<TR><TD>1.957e-04</TD><TD>-8.54</TD><TD>Ferritin</TD><TD>pfam domains</TD><TD>PF00210</TD><TD>4</TD><TD>2</TD><TD>16832</TD><TD>97</TD>
<TD>FTH1,FTL</TD></TR>
<TR><TD>2.393e-04</TD><TD>-8.34</TD><TD>CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3</TD><TD>MSigDB lists</TD><TD>CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3</TD><TD>659</TD><TD>12</TD><TD>17621</TD><TD>96</TD>
<TD>AUTS2,EPAS1,KCNG3,MAP1LC3B,C14orf159,RBKS,PTPN3,FTH1,TACC2,ENC1,MFSD6,TANK</TD></TR>
<TR><TD>2.482e-04</TD><TD>-8.30</TD><TD>GO_TRANSITION_METAL_ION_HOMEOSTASIS</TD><TD>MSigDB lists</TD><TD>GO_TRANSITION_METAL_ION_HOMEOSTASIS</TD><TD>103</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>SLC40A1,EPAS1,FTH1,FTL,ALAS2</TD></TR>
<TR><TD>2.747e-04</TD><TD>-8.20</TD><TD>IKBKG (inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma)</TD><TD>protein interactions</TD><TD>8517</TD><TD>308</TD><TD>8</TD><TD>16330</TD><TD>89</TD>
<TD>TANK,MED7,JAK2,CASP6,COMMD7,LGALS2,EEF1A1,MAP3K7</TD></TR>
<TR><TD>2.794e-04</TD><TD>-8.18</TD><TD>ADD1 (adducin 1)</TD><TD>protein interactions</TD><TD>118</TD><TD>58</TD><TD>4</TD><TD>16330</TD><TD>89</TD>
<TD>VCP,TPM4,MAP1LC3B,SMARCA4</TD></TR>
<TR><TD>3.026e-04</TD><TD>-8.10</TD><TD>sequestering of iron ion</TD><TD>biological process</TD><TD>GO:0097577</TD><TD>5</TD><TD>2</TD><TD>16543</TD><TD>92</TD>
<TD>FTL,FTH1</TD></TR>
<TR><TD>3.026e-04</TD><TD>-8.10</TD><TD>intracellular sequestering of iron ion</TD><TD>biological process</TD><TD>GO:0006880</TD><TD>5</TD><TD>2</TD><TD>16543</TD><TD>92</TD>
<TD>FTH1,FTL</TD></TR>
<TR><TD>3.060e-04</TD><TD>-8.09</TD><TD>Ferritin-rel</TD><TD>interpro domains</TD><TD>IPR012347</TD><TD>5</TD><TD>2</TD><TD>18428</TD><TD>103</TD>
<TD>FTL,FTH1</TD></TR>
<TR><TD>3.185e-04</TD><TD>-8.05</TD><TD>STAM2 (signal transducing adaptor molecule 2)</TD><TD>protein interactions</TD><TD>10254</TD><TD>60</TD><TD>4</TD><TD>16330</TD><TD>89</TD>
<TD>JAK2,VCP,USP8,TP53BP2</TD></TR>
<TR><TD>3.242e-04</TD><TD>-8.03</TD><TD>transition metal ion homeostasis</TD><TD>biological process</TD><TD>GO:0055076</TD><TD>107</TD><TD>5</TD><TD>16543</TD><TD>92</TD>
<TD>EPAS1,ALAS2,FTL,SLC40A1,FTH1</TD></TR>
<TR><TD>3.401e-04</TD><TD>-7.99</TD><TD>-</TD><TD>gene3d domains</TD><TD>1.20.1260.10</TD><TD>5</TD><TD>2</TD><TD>10485</TD><TD>62</TD>
<TD>FTH1,FTL</TD></TR>
<TR><TD>4.093e-04</TD><TD>-7.80</TD><TD>GACAGGG,MIR-339</TD><TD>MSigDB lists</TD><TD>GACAGGG,MIR-339</TD><TD>64</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>USP8,MAP3K7,VCP,UBE3A</TD></TR>
<TR><TD>4.653e-04</TD><TD>-7.67</TD><TD>binding</TD><TD>molecular function</TD><TD>GO:0005488</TD><TD>14028</TD><TD>90</TD><TD>16652</TD><TD>94</TD>
<TD>PLK5,PTPN3,RBKS,KCNA2,ADAMTSL2,CHODL,RAB17,FOSB,MAFF,HSPB6,ADAR,POM121C,MYPN,GCSAM,JAK2,EEF1A1,TP53BP2,ARPC1B,DTD1,SHB,TACC2,RNASEH2A,VCP,AURKAIP1,TSFM,EHMT1,TANK,ARIH2,ERN2,CHID1,EMX1,GART,TPM4,USF3,LGALS2,OTUD7B,SLC27A6,MAP1LC3B,ZNF683,SLC40A1,MAP3K7,NGDN,NUP37,SLC52A2,ENC1,USP8,RMDN3,VARS2,AP1G1,F10,OSBPL7,RFX2,BNC1,ZFYVE1,GPRASP2,ONECUT3,FTL,NANOG,COQ8A,CDH7,ATP2B4,PXYLP1,CHL1,PPP1R32,MED7,JOSD1,KDM2A,KCNG3,ADI1,CASP6,SMARCA4,ALAS2,AUTS2,OVOL1,KNTC1,UBE3A,FGD5,HEXA,HEATR6,SCARB2,FBXO31,C14orf159,IFT27,EPAS1,FTH1,PPP1R3F,COMMD7,NR4A1,UGT1A6,MNX1</TD></TR>
<TR><TD>4.665e-04</TD><TD>-7.67</TD><TD>GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_45MIN_UP</TD><TD>MSigDB lists</TD><TD>GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_45MIN_UP</TD><TD>181</TD><TD>6</TD><TD>17621</TD><TD>96</TD>
<TD>NGDN,EPAS1,SCARB2,ADI1,FTL,VCP</TD></TR>
<TR><TD>4.967e-04</TD><TD>-7.61</TD><TD>BENPORATH_NANOG_TARGETS</TD><TD>MSigDB lists</TD><TD>BENPORATH_NANOG_TARGETS</TD><TD>930</TD><TD>14</TD><TD>17621</TD><TD>96</TD>
<TD>IFT27,COMMD7,AP1G1,FBXO31,OTUD7B,JOSD1,NANOG,RAB17,ADAR,SLC40A1,MAP1LC3B,GART,KDM2A,KNTC1</TD></TR>
<TR><TD>5.088e-04</TD><TD>-7.58</TD><TD>GSE4142_PLASMA_CELL_VS_GC_BCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE4142_PLASMA_CELL_VS_GC_BCELL_DN</TD><TD>184</TD><TD>6</TD><TD>17621</TD><TD>96</TD>
<TD>CDH7,FBXO31,NUP37,AURKAIP1,ADI1,DTD1</TD></TR>
<TR><TD>5.088e-04</TD><TD>-7.58</TD><TD>GSE43700_UNTREATED_VS_IL10_TREATED_PBMC_UP</TD><TD>MSigDB lists</TD><TD>GSE43700_UNTREATED_VS_IL10_TREATED_PBMC_UP</TD><TD>184</TD><TD>6</TD><TD>17621</TD><TD>96</TD>
<TD>ENC1,NGDN,GART,ALAS2,DTD1,NR4A1</TD></TR>
<TR><TD>5.253e-04</TD><TD>-7.55</TD><TD>erythrocyte differentiation</TD><TD>biological process</TD><TD>GO:0030218</TD><TD>67</TD><TD>4</TD><TD>16543</TD><TD>92</TD>
<TD>ADAR,EPAS1,JAK2,ALAS2</TD></TR>
<TR><TD>5.387e-04</TD><TD>-7.53</TD><TD>GSE9037_CTRL_VS_LPS_1H_STIM_BMDM_DN</TD><TD>MSigDB lists</TD><TD>GSE9037_CTRL_VS_LPS_1H_STIM_BMDM_DN</TD><TD>186</TD><TD>6</TD><TD>17621</TD><TD>96</TD>
<TD>MAFF,JAK2,ARIH2,GART,C14orf159,ERN2</TD></TR>
<TR><TD>5.712e-04</TD><TD>-7.47</TD><TD>STMN2 (stathmin 2)</TD><TD>protein interactions</TD><TD>11075</TD><TD>30</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>SMARCA4,GPRASP2,EEF1A1</TD></TR>
<TR><TD>5.761e-04</TD><TD>-7.46</TD><TD>GO_ERYTHROCYTE_HOMEOSTASIS</TD><TD>MSigDB lists</TD><TD>GO_ERYTHROCYTE_HOMEOSTASIS</TD><TD>70</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>EPAS1,ADAR,JAK2,ALAS2</TD></TR>
<TR><TD>6.026e-04</TD><TD>-7.41</TD><TD>GO_NEGATIVE_REGULATION_OF_MITOTIC_CELL_CYCLE</TD><TD>MSigDB lists</TD><TD>GO_NEGATIVE_REGULATION_OF_MITOTIC_CELL_CYCLE</TD><TD>190</TD><TD>6</TD><TD>17621</TD><TD>96</TD>
<TD>PTPN3,KNTC1,AURKAIP1,FBXO31,OVOL1,SMARCA4</TD></TR>
<TR><TD>6.059e-04</TD><TD>-7.41</TD><TD>TPM3P4 (tropomyosin 3 pseudogene 4)</TD><TD>protein interactions</TD><TD>402643</TD><TD>7</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>TPM4,VCP</TD></TR>
<TR><TD>6.194e-04</TD><TD>-7.39</TD><TD>GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH1_DN</TD><TD>MSigDB lists</TD><TD>GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH1_DN</TD><TD>191</TD><TD>6</TD><TD>17621</TD><TD>96</TD>
<TD>KNTC1,NGDN,VCP,JOSD1,RNASEH2A,FTH1</TD></TR>
<TR><TD>6.379e-04</TD><TD>-7.36</TD><TD>Ferritin-like_SF</TD><TD>interpro domains</TD><TD>IPR009078</TD><TD>7</TD><TD>2</TD><TD>18428</TD><TD>103</TD>
<TD>FTH1,FTL</TD></TR>
<TR><TD>6.721e-04</TD><TD>-7.31</TD><TD>KAECH_DAY15_EFF_VS_MEMORY_CD8_TCELL_DN</TD><TD>MSigDB lists</TD><TD>KAECH_DAY15_EFF_VS_MEMORY_CD8_TCELL_DN</TD><TD>194</TD><TD>6</TD><TD>17621</TD><TD>96</TD>
<TD>FTL,HEXA,NGDN,FOSB,SCARB2,GART</TD></TR>
<TR><TD>7.001e-04</TD><TD>-7.26</TD><TD>cytoplasm</TD><TD>cellular component</TD><TD>GO:0005737</TD><TD>10583</TD><TD>74</TD><TD>17744</TD><TD>98</TD>
<TD>KNTC1,C14orf159,USF3,HSPB6,GJB2,ALAS2,ARIH2,MYPN,VARS2,PTPN3,NR4A1,RFX2,COMMD7,RNASEH2A,TANK,EEF1A1,KCNA2,ARPC1B,BNC1,RGSL1,F10,HEXA,GART,MNX1,SHB,AURKAIP1,EMX1,JOSD1,FGD5,TMEM198,USP8,UGT1A6,COQ8A,OSBPL7,SLC40A1,ENC1,NUP37,SCARB2,CHODL,FTL,MAP3K7,POM121C,ADI1,ADAR,RMDN3,CASP6,TACC2,FBXO31,PXYLP1,MAP1LC3B,GCSAM,CHID1,VCP,RAB17,TSFM,DTD1,OTUD7B,RBKS,UBE3A,ATP2B4,JAK2,SERPINB10,TPM4,NGDN,AP1G1,TP53BP2,ZFYVE1,KCNG3,EPAS1,MAFF,GPRASP2,FTH1,ERN2,PLK5</TD></TR>
<TR><TD>7.198e-04</TD><TD>-7.24</TD><TD>SUPT16H (SPT16 homolog, facilitates chromatin remodeling subunit)</TD><TD>protein interactions</TD><TD>11198</TD><TD>130</TD><TD>5</TD><TD>16330</TD><TD>89</TD>
<TD>EEF1A1,FTH1,VCP,MAFF,NANOG</TD></TR>
<TR><TD>7.391e-04</TD><TD>-7.21</TD><TD>LINDGREN_BLADDER_CANCER_CLUSTER_1_DN</TD><TD>MSigDB lists</TD><TD>LINDGREN_BLADDER_CANCER_CLUSTER_1_DN</TD><TD>357</TD><TD>8</TD><TD>17621</TD><TD>96</TD>
<TD>MNX1,TTC39A,CASP6,NR4A1,SMARCA4,LGALS2,RNASEH2A,RAB17</TD></TR>
<TR><TD>7.480e-04</TD><TD>-7.20</TD><TD>GO_CELLULAR_TRANSITION_METAL_ION_HOMEOSTASIS</TD><TD>MSigDB lists</TD><TD>GO_CELLULAR_TRANSITION_METAL_ION_HOMEOSTASIS</TD><TD>75</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>SLC40A1,FTL,ALAS2,FTH1</TD></TR>
<TR><TD>7.897e-04</TD><TD>-7.14</TD><TD>adrenal_cortical_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>adrenal_cortical_carcinoma</TD><TD>2326</TD><TD>24</TD><TD>17630</TD><TD>93</TD>
<TD>KCNA2,KNTC1,OTUD7B,BNC1,VCP,OSBPL7,AUTS2,SMARCA4,DTD1,EHMT1,RBKS,MFSD6,PTPN3,FGD5,RGSL1,GART,ENC1,CHL1,TANK,C14orf159,ALAS2,ADAR,NR4A1,JAK2</TD></TR>
<TR><TD>8.050e-04</TD><TD>-7.12</TD><TD>ARNTL2 (aryl hydrocarbon receptor nuclear translocator like 2)</TD><TD>protein interactions</TD><TD>56938</TD><TD>8</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>EPAS1,UBE3A</TD></TR>
<TR><TD>8.053e-04</TD><TD>-7.12</TD><TD>erythrocyte homeostasis</TD><TD>biological process</TD><TD>GO:0034101</TD><TD>75</TD><TD>4</TD><TD>16543</TD><TD>92</TD>
<TD>ADAR,EPAS1,ALAS2,JAK2</TD></TR>
<TR><TD>8.382e-04</TD><TD>-7.08</TD><TD>regulation of protein deubiquitination</TD><TD>biological process</TD><TD>GO:0090085</TD><TD>8</TD><TD>2</TD><TD>16543</TD><TD>92</TD>
<TD>VCP,TANK</TD></TR>
<TR><TD>9.332e-04</TD><TD>-6.98</TD><TD>cellular transition metal ion homeostasis</TD><TD>biological process</TD><TD>GO:0046916</TD><TD>78</TD><TD>4</TD><TD>16543</TD><TD>92</TD>
<TD>FTH1,SLC40A1,ALAS2,FTL</TD></TR>
<TR><TD>9.810e-04</TD><TD>-6.93</TD><TD>DR1 (down-regulator of transcription 1)</TD><TD>protein interactions</TD><TD>1810</TD><TD>36</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>UBE3A,ARPC1B,MAP3K7</TD></TR>
<TR><TD>9.821e-04</TD><TD>-6.93</TD><TD>REACTOME_IRON_UPTAKE_AND_TRANSPORT</TD><TD>MSigDB lists</TD><TD>REACTOME_IRON_UPTAKE_AND_TRANSPORT</TD><TD>36</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>SLC40A1,FTH1,FTL</TD></TR>
<TR><TD>1.001e-03</TD><TD>-6.91</TD><TD>human chr18q22.1</TD><TD>chromosome location</TD><TD>human chr18q22.1</TD><TD>12</TD><TD>2</TD><TD>26234</TD><TD>104</TD>
<TD>CDH7,SERPINB10</TD></TR>
<TR><TD>1.031e-03</TD><TD>-6.88</TD><TD>MTRNR2L1 (MT-RNR2-like 1)</TD><TD>protein interactions</TD><TD>100462977</TD><TD>9</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>TSFM,EEF1A1</TD></TR>
<TR><TD>1.031e-03</TD><TD>-6.88</TD><TD>GO_AMINOACYL_TRNA_EDITING_ACTIVITY</TD><TD>MSigDB lists</TD><TD>GO_AMINOACYL_TRNA_EDITING_ACTIVITY</TD><TD>9</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>DTD1,VARS2</TD></TR>
<TR><TD>1.035e-03</TD><TD>-6.87</TD><TD>thiol-dependent ubiquitin-specific protease activity</TD><TD>molecular function</TD><TD>GO:0004843</TD><TD>79</TD><TD>4</TD><TD>16652</TD><TD>94</TD>
<TD>JOSD1,OTUD7B,TANK,USP8</TD></TR>
<TR><TD>1.060e-03</TD><TD>-6.85</TD><TD>autolysosome</TD><TD>cellular component</TD><TD>GO:0044754</TD><TD>9</TD><TD>2</TD><TD>17744</TD><TD>98</TD>
<TD>FTL,FTH1</TD></TR>
<TR><TD>1.069e-03</TD><TD>-6.84</TD><TD>ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF</TD><TD>MSigDB lists</TD><TD>ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF</TD><TD>471</TD><TD>9</TD><TD>17621</TD><TD>96</TD>
<TD>TPM4,UBE3A,FBXO31,MFSD6,EEF1A1,SHB,GAPT,BNC1,ADAMTSL2</TD></TR>
<TR><TD>1.106e-03</TD><TD>-6.81</TD><TD>ferric iron binding</TD><TD>molecular function</TD><TD>GO:0008199</TD><TD>9</TD><TD>2</TD><TD>16652</TD><TD>94</TD>
<TD>FTL,FTH1</TD></TR>
<TR><TD>1.118e-03</TD><TD>-6.80</TD><TD>TTTTGAG,MIR-373</TD><TD>MSigDB lists</TD><TD>TTTTGAG,MIR-373</TD><TD>214</TD><TD>6</TD><TD>17621</TD><TD>96</TD>
<TD>EEF1A1,AP1G1,JAK2,ATP2B4,VCP,UBE3A</TD></TR>
<TR><TD>1.122e-03</TD><TD>-6.79</TD><TD>negative regulation of mitotic cell cycle</TD><TD>biological process</TD><TD>GO:0045930</TD><TD>210</TD><TD>6</TD><TD>16543</TD><TD>92</TD>
<TD>AURKAIP1,FBXO31,SMARCA4,KNTC1,PTPN3,OVOL1</TD></TR>
<TR><TD>1.135e-03</TD><TD>-6.78</TD><TD>negative regulation of cell cycle</TD><TD>biological process</TD><TD>GO:0045786</TD><TD>466</TD><TD>9</TD><TD>16543</TD><TD>92</TD>
<TD>KNTC1,AURKAIP1,OVOL1,PTPN3,SMARCA4,TP53BP2,FBXO31,NR4A1,PLK5</TD></TR>
<TR><TD>1.150e-03</TD><TD>-6.77</TD><TD>ARID1B (AT-rich interaction domain 1B)</TD><TD>protein interactions</TD><TD>57492</TD><TD>38</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>SMARCA4,EPAS1,NANOG</TD></TR>
<TR><TD>1.150e-03</TD><TD>-6.77</TD><TD>PRKAB1 (protein kinase AMP-activated non-catalytic subunit beta 1)</TD><TD>protein interactions</TD><TD>5564</TD><TD>38</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>AP1G1,MAP3K7,F10</TD></TR>
<TR><TD>1.195e-03</TD><TD>-6.73</TD><TD>GO_MYELOID_CELL_HOMEOSTASIS</TD><TD>MSigDB lists</TD><TD>GO_MYELOID_CELL_HOMEOSTASIS</TD><TD>85</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>EPAS1,ALAS2,JAK2,ADAR</TD></TR>
<TR><TD>1.438e-03</TD><TD>-6.54</TD><TD>KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM</TD><TD>MSigDB lists</TD><TD>KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM</TD><TD>41</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>UGT1A6,ALAS2,FTH1</TD></TR>
<TR><TD>1.474e-03</TD><TD>-6.52</TD><TD>SPP1 (secreted phosphoprotein 1)</TD><TD>protein interactions</TD><TD>6696</TD><TD>90</TD><TD>4</TD><TD>16330</TD><TD>89</TD>
<TD>FTH1,USP8,EEF1A1,EPAS1</TD></TR>
<TR><TD>1.503e-03</TD><TD>-6.50</TD><TD>PML (promyelocytic leukemia)</TD><TD>protein interactions</TD><TD>5371</TD><TD>227</TD><TD>6</TD><TD>16330</TD><TD>89</TD>
<TD>NR4A1,SMARCA4,MED7,MAP1LC3B,ARIH2,UBE3A</TD></TR>
<TR><TD>1.565e-03</TD><TD>-6.46</TD><TD>ZNF609 (zinc finger protein 609)</TD><TD>protein interactions</TD><TD>23060</TD><TD>11</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>NANOG,AUTS2</TD></TR>
<TR><TD>1.565e-03</TD><TD>-6.46</TD><TD>NEU1 (neuraminidase 1)</TD><TD>protein interactions</TD><TD>4758</TD><TD>11</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>EEF1A1,KCNA2</TD></TR>
<TR><TD>1.678e-03</TD><TD>-6.39</TD><TD>aminoacyl-tRNA editing activity</TD><TD>molecular function</TD><TD>GO:0002161</TD><TD>11</TD><TD>2</TD><TD>16652</TD><TD>94</TD>
<TD>VARS2,DTD1</TD></TR>
<TR><TD>1.730e-03</TD><TD>-6.36</TD><TD>HIST2H3C (histone cluster 2 H3 family member c)</TD><TD>protein interactions</TD><TD>126961</TD><TD>94</TD><TD>4</TD><TD>16330</TD><TD>89</TD>
<TD>KDM2A,JAK2,NANOG,SMARCA4</TD></TR>
<TR><TD>1.761e-03</TD><TD>-6.34</TD><TD>Cellular response to heat stress</TD><TD>REACTOME pathways</TD><TD>R-HSA-3371556</TD><TD>89</TD><TD>4</TD><TD>10293</TD><TD>60</TD>
<TD>POM121C,NUP37,EEF1A1,VCP</TD></TR>
<TR><TD>1.767e-03</TD><TD>-6.34</TD><TD>HIF1A (hypoxia inducible factor 1 alpha subunit)</TD><TD>protein interactions</TD><TD>3091</TD><TD>159</TD><TD>5</TD><TD>16330</TD><TD>89</TD>
<TD>NR4A1,SMARCA4,EPAS1,OTUD7B,VCP</TD></TR>
<TR><TD>1.793e-03</TD><TD>-6.32</TD><TD>myeloid cell homeostasis</TD><TD>biological process</TD><TD>GO:0002262</TD><TD>93</TD><TD>4</TD><TD>16543</TD><TD>92</TD>
<TD>ADAR,EPAS1,ALAS2,JAK2</TD></TR>
<TR><TD>1.824e-03</TD><TD>-6.31</TD><TD>CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP</TD><TD>MSigDB lists</TD><TD>CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP</TD><TD>160</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>AUTS2,ATP2B4,TANK,FOSB,MAP1LC3B</TD></TR>
<TR><TD>1.843e-03</TD><TD>-6.30</TD><TD>GO_NEGATIVE_REGULATION_OF_CELL_CYCLE</TD><TD>MSigDB lists</TD><TD>GO_NEGATIVE_REGULATION_OF_CELL_CYCLE</TD><TD>412</TD><TD>8</TD><TD>17621</TD><TD>96</TD>
<TD>TP53BP2,SMARCA4,NR4A1,AURKAIP1,KNTC1,PTPN3,OVOL1,FBXO31</TD></TR>
<TR><TD>1.871e-03</TD><TD>-6.28</TD><TD>AFTPH (aftiphilin)</TD><TD>protein interactions</TD><TD>54812</TD><TD>12</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>AP1G1,UBE3A</TD></TR>
<TR><TD>1.871e-03</TD><TD>-6.28</TD><TD>GSG2 (germ cell associated 2, haspin)</TD><TD>protein interactions</TD><TD>83903</TD><TD>12</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>EHMT1,NANOG</TD></TR>
<TR><TD>1.871e-03</TD><TD>-6.28</TD><TD>NEPRO (nucleolus and neural progenitor protein)</TD><TD>protein interactions</TD><TD>25871</TD><TD>12</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>VCP,GPRASP2</TD></TR>
<TR><TD>1.871e-03</TD><TD>-6.28</TD><TD>XU_RESPONSE_TO_TRETINOIN_DN</TD><TD>MSigDB lists</TD><TD>XU_RESPONSE_TO_TRETINOIN_DN</TD><TD>12</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>UBE3A,TPM4</TD></TR>
<TR><TD>2.032e-03</TD><TD>-6.20</TD><TD>GSE26928_EFF_MEM_VS_CENTR_MEM_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE26928_EFF_MEM_VS_CENTR_MEM_CD4_TCELL_UP</TD><TD>164</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>KCNA2,LGALS2,FBXO31,EPAS1,COMMD7</TD></TR>
<TR><TD>2.092e-03</TD><TD>-6.17</TD><TD>PTN (pleiotrophin)</TD><TD>protein interactions</TD><TD>5764</TD><TD>99</TD><TD>4</TD><TD>16330</TD><TD>89</TD>
<TD>TP53BP2,ARIH2,GPRASP2,FTL</TD></TR>
<TR><TD>2.092e-03</TD><TD>-6.17</TD><TD>HSF1 (heat shock transcription factor 1)</TD><TD>protein interactions</TD><TD>3297</TD><TD>99</TD><TD>4</TD><TD>16330</TD><TD>89</TD>
<TD>SMARCA4,ARPC1B,DTD1,UBE3A</TD></TR>
<TR><TD>2.104e-03</TD><TD>-6.16</TD><TD>Iron uptake and transport</TD><TD>REACTOME pathways</TD><TD>R-HSA-917937</TD><TD>44</TD><TD>3</TD><TD>10293</TD><TD>60</TD>
<TD>FTH1,SLC40A1,FTL</TD></TR>
<TR><TD>2.124e-03</TD><TD>-6.15</TD><TD>HSF1 activation</TD><TD>REACTOME pathways</TD><TD>R-HSA-3371511</TD><TD>12</TD><TD>2</TD><TD>10293</TD><TD>60</TD>
<TD>VCP,EEF1A1</TD></TR>
<TR><TD>2.124e-03</TD><TD>-6.15</TD><TD>Josephin domain DUBs</TD><TD>REACTOME pathways</TD><TD>R-HSA-5689877</TD><TD>12</TD><TD>2</TD><TD>10293</TD><TD>60</TD>
<TD>JOSD1,VCP</TD></TR>
<TR><TD>2.133e-03</TD><TD>-6.15</TD><TD>HTT (huntingtin)</TD><TD>protein interactions</TD><TD>3064</TD><TD>166</TD><TD>5</TD><TD>16330</TD><TD>89</TD>
<TD>USP8,VCP,CASP6,GPRASP2,FTL</TD></TR>
<TR><TD>2.134e-03</TD><TD>-6.15</TD><TD>MAP3K14 (mitogen-activated protein kinase kinase kinase 14)</TD><TD>protein interactions</TD><TD>9020</TD><TD>47</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>EEF1A1,MAP3K7,TANK</TD></TR>
<TR><TD>2.203e-03</TD><TD>-6.12</TD><TD>BBS10 (Bardet-Biedl syndrome 10)</TD><TD>protein interactions</TD><TD>79738</TD><TD>13</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>MAP3K7,NR4A1</TD></TR>
<TR><TD>2.203e-03</TD><TD>-6.12</TD><TD>SYF2 (SYF2 pre-mRNA splicing factor)</TD><TD>protein interactions</TD><TD>25949</TD><TD>13</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>VCP,NANOG</TD></TR>
<TR><TD>2.233e-03</TD><TD>-6.10</TD><TD>Iron metabolism in placenta</TD><TD>WikiPathways</TD><TD>WP2007</TD><TD>12</TD><TD>2</TD><TD>5314</TD><TD>32</TD>
<TD>FTH1,SLC40A1</TD></TR>
<TR><TD>2.256e-03</TD><TD>-6.09</TD><TD>GSE15330_MEGAKARYOCYTE_ERYTHROID_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP</TD><TD>MSigDB lists</TD><TD>GSE15330_MEGAKARYOCYTE_ERYTHROID_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP</TD><TD>168</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>MAP1LC3B,MED7,FTH1,NR4A1,ATP2B4</TD></TR>
<TR><TD>2.267e-03</TD><TD>-6.09</TD><TD>GHR (growth hormone receptor)</TD><TD>protein interactions</TD><TD>2690</TD><TD>48</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>PTPN3,FBXO31,JAK2</TD></TR>
<TR><TD>2.289e-03</TD><TD>-6.08</TD><TD>MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3</TD><TD>MSigDB lists</TD><TD>MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3</TD><TD>333</TD><TD>7</TD><TD>17621</TD><TD>96</TD>
<TD>OVOL1,BNC1,KCNG3,PLK5,GJB2,ONECUT3,EMX1</TD></TR>
<TR><TD>2.417e-03</TD><TD>-6.03</TD><TD>STAT5A (signal transducer and activator of transcription 5A)</TD><TD>protein interactions</TD><TD>6776</TD><TD>103</TD><TD>4</TD><TD>16330</TD><TD>89</TD>
<TD>JAK2,EPAS1,POM121C,SMARCA4</TD></TR>
<TR><TD>2.517e-03</TD><TD>-5.98</TD><TD>kidney-carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>kidney-carcinoma</TD><TD>3769</TD><TD>32</TD><TD>17630</TD><TD>93</TD>
<TD>HEATR6,KNTC1,NR4A1,PPP1R3F,TANK,FOSB,TACC2,HSPB6,PTPN3,CASP6,RAB17,USP8,KDM2A,EEF1A1,SERPINB10,FBXO31,SMARCA4,MAP3K7,VCP,UBE3A,TP53BP2,F10,NUP37,MAFF,JAK2,IFT27,FGD5,ENC1,TPM4,RGSL1,MNX1,EPAS1</TD></TR>
<TR><TD>2.552e-03</TD><TD>-5.97</TD><TD>REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS</TD><TD>MSigDB lists</TD><TD>REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS</TD><TD>50</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>AP1G1,FTL,FTH1</TD></TR>
<TR><TD>2.561e-03</TD><TD>-5.97</TD><TD>ARFGAP2 (ADP ribosylation factor GTPase activating protein 2)</TD><TD>protein interactions</TD><TD>84364</TD><TD>14</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>VCP,ADI1</TD></TR>
<TR><TD>2.561e-03</TD><TD>-5.97</TD><TD>BIK (BCL2 interacting killer)</TD><TD>protein interactions</TD><TD>638</TD><TD>14</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>BNC1,TANK</TD></TR>
<TR><TD>2.561e-03</TD><TD>-5.97</TD><TD>ITGB1BP1 (integrin subunit beta 1 binding protein 1)</TD><TD>protein interactions</TD><TD>9270</TD><TD>14</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>TANK,EEF1A1</TD></TR>
<TR><TD>2.561e-03</TD><TD>-5.97</TD><TD>GO_REGULATION_OF_TRANSLATIONAL_FIDELITY</TD><TD>MSigDB lists</TD><TD>GO_REGULATION_OF_TRANSLATIONAL_FIDELITY</TD><TD>14</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>VARS2,DTD1</TD></TR>
<TR><TD>2.561e-03</TD><TD>-5.97</TD><TD>HOWLIN_CITED1_TARGETS_2_UP</TD><TD>MSigDB lists</TD><TD>HOWLIN_CITED1_TARGETS_2_UP</TD><TD>14</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>MAP3K7,SMARCA4</TD></TR>
<TR><TD>2.562e-03</TD><TD>-5.97</TD><TD>GSE21033_CTRL_VS_POLYIC_STIM_DC_1H_UP</TD><TD>MSigDB lists</TD><TD>GSE21033_CTRL_VS_POLYIC_STIM_DC_1H_UP</TD><TD>173</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>AUTS2,TP53BP2,RFX2,PTPN3,FOSB</TD></TR>
<TR><TD>2.581e-03</TD><TD>-5.96</TD><TD>prostate-carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>prostate-carcinoma</TD><TD>9331</TD><TD>63</TD><TD>17630</TD><TD>93</TD>
<TD>TP53BP2,F10,RFX2,ADAR,ALAS2,JAK2,MYPN,FGD5,AP1G1,NANOG,ENC1,SLC40A1,RGSL1,MNX1,EPAS1,SLC35E4,ADAMTSL2,DTD1,RBKS,ATP2B4,FBXO31,UGT1A6,TSFM,AUTS2,MAP3K7,VCP,UBE3A,OSBPL7,BNC1,NR4A1,HEXA,GRAMD1B,ONECUT3,TANK,CHL1,FOSB,TACC2,SLC27A6,TMEM198,NGDN,PTPN3,RAB17,CASP6,KDM2A,ZFYVE1,GART,USP8,EEF1A1,MFSD6,SERPINB10,EHMT1,CHID1,HEATR6,JOSD1,RNASEH2A,SCARB2,TTC39A,SHB,VARS2,KNTC1,CDH7,KCNA2,OTUD7B</TD></TR>
<TR><TD>2.624e-03</TD><TD>-5.94</TD><TD>vacuole</TD><TD>cellular component</TD><TD>GO:0005773</TD><TD>634</TD><TD>10</TD><TD>17744</TD><TD>98</TD>
<TD>SCARB2,FTH1,OSBPL7,ZFYVE1,EEF1A1,FTL,CHID1,AP1G1,HEXA,MAP1LC3B</TD></TR>
<TR><TD>2.631e-03</TD><TD>-5.94</TD><TD>secondary lysosome</TD><TD>cellular component</TD><TD>GO:0005767</TD><TD>14</TD><TD>2</TD><TD>17744</TD><TD>98</TD>
<TD>FTL,FTH1</TD></TR>
<TR><TD>2.665e-03</TD><TD>-5.93</TD><TD>hematopoietic stem cell proliferation</TD><TD>biological process</TD><TD>GO:0071425</TD><TD>14</TD><TD>2</TD><TD>16543</TD><TD>92</TD>
<TD>SHB,ARIH2</TD></TR>
<TR><TD>2.665e-03</TD><TD>-5.93</TD><TD>sequestering of metal ion</TD><TD>biological process</TD><TD>GO:0051238</TD><TD>14</TD><TD>2</TD><TD>16543</TD><TD>92</TD>
<TD>FTH1,FTL</TD></TR>
<TR><TD>2.696e-03</TD><TD>-5.92</TD><TD>regulation of cellular macromolecule biosynthetic process</TD><TD>biological process</TD><TD>GO:2000112</TD><TD>3902</TD><TD>34</TD><TD>16543</TD><TD>92</TD>
<TD>JAK2,EEF1A1,KDM2A,SMARCA4,VARS2,AUTS2,MAFF,ZNF683,RFX2,ERN2,PXYLP1,MED7,UBE3A,ATP2B4,ADAR,NR4A1,ENC1,TSFM,NGDN,OTUD7B,BNC1,FOSB,OVOL1,MAP3K7,EHMT1,PPP1R3F,NANOG,COMMD7,EMX1,EPAS1,MNX1,DTD1,ONECUT3,SLC40A1</TD></TR>
<TR><TD>2.700e-03</TD><TD>-5.91</TD><TD>MARSON_FOXP3_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>MARSON_FOXP3_TARGETS_DN</TD><TD>51</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>ENC1,GRAMD1B,JAK2</TD></TR>
<TR><TD>2.818e-03</TD><TD>-5.87</TD><TD>KAAB_HEART_ATRIUM_VS_VENTRICLE_DN</TD><TD>MSigDB lists</TD><TD>KAAB_HEART_ATRIUM_VS_VENTRICLE_DN</TD><TD>257</TD><TD>6</TD><TD>17621</TD><TD>96</TD>
<TD>UBE3A,TSFM,ARIH2,GRAMD1B,PTPN3,HSPB6</TD></TR>
<TR><TD>2.819e-03</TD><TD>-5.87</TD><TD>Mineral absorption</TD><TD>KEGG pathways</TD><TD>hsa04978</TD><TD>52</TD><TD>3</TD><TD>7094</TD><TD>39</TD>
<TD>FTH1,FTL,SLC40A1</TD></TR>
<TR><TD>2.819e-03</TD><TD>-5.87</TD><TD>Mineral absorption</TD><TD>KEGG pathways</TD><TD>ko04978</TD><TD>52</TD><TD>3</TD><TD>7094</TD><TD>39</TD>
<TD>FTL,SLC40A1,FTH1</TD></TR>
<TR><TD>2.828e-03</TD><TD>-5.87</TD><TD>GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_UP</TD><TD>MSigDB lists</TD><TD>GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_UP</TD><TD>177</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>ATP2B4,JOSD1,FTH1,ZFYVE1,TANK</TD></TR>
<TR><TD>2.897e-03</TD><TD>-5.84</TD><TD>GSE12392_IFNAR_KO_VS_IFNB_KO_CD8_NEG_SPLEEN_DC_UP</TD><TD>MSigDB lists</TD><TD>GSE12392_IFNAR_KO_VS_IFNB_KO_CD8_NEG_SPLEEN_DC_UP</TD><TD>178</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>SHB,MYPN,MAP1LC3B,TANK,MAFF</TD></TR>
<TR><TD>2.915e-03</TD><TD>-5.84</TD><TD>GO_VACUOLE</TD><TD>MSigDB lists</TD><TD>GO_VACUOLE</TD><TD>1120</TD><TD>14</TD><TD>17621</TD><TD>96</TD>
<TD>MAP1LC3B,SCARB2,SLC40A1,JAK2,RAB17,HEXA,ZFYVE1,MAP3K7,AP1G1,OSBPL7,FGD5,EEF1A1,CHID1,USP8</TD></TR>
<TR><TD>2.945e-03</TD><TD>-5.83</TD><TD>LRIG1 (leucine rich repeats and immunoglobulin like domains 1)</TD><TD>protein interactions</TD><TD>26018</TD><TD>15</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>VCP,USP8</TD></TR>
<TR><TD>2.945e-03</TD><TD>-5.83</TD><TD>POLE4 (DNA polymerase epsilon 4, accessory subunit)</TD><TD>protein interactions</TD><TD>56655</TD><TD>15</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>MAP3K7,UBE3A</TD></TR>
<TR><TD>2.945e-03</TD><TD>-5.83</TD><TD>GO_SPERM_PRINCIPAL_PIECE</TD><TD>MSigDB lists</TD><TD>GO_SPERM_PRINCIPAL_PIECE</TD><TD>15</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>ATP2B4,IFT27</TD></TR>
<TR><TD>2.945e-03</TD><TD>-5.83</TD><TD>MODULE_227</TD><TD>MSigDB lists</TD><TD>MODULE_227</TD><TD>15</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>UGT1A6,ALAS2</TD></TR>
<TR><TD>2.964e-03</TD><TD>-5.82</TD><TD>TGGAAA_V$NFAT_Q4_01</TD><TD>MSigDB lists</TD><TD>TGGAAA_V$NFAT_Q4_01</TD><TD>1772</TD><TD>19</TD><TD>17621</TD><TD>96</TD>
<TD>TACC2,UGT1A6,FTH1,NR4A1,KCNA2,ATP2B4,CHODL,VCP,AUTS2,GAPT,EMX1,AP1G1,MAFF,CHL1,SERPINB10,RBKS,OTUD7B,ARIH2,OVOL1</TD></TR>
<TR><TD>3.040e-03</TD><TD>-5.80</TD><TD>GSE7509_UNSTIM_VS_TNFA_IL1B_IL6_PGE_STIM_DC_UP</TD><TD>MSigDB lists</TD><TD>GSE7509_UNSTIM_VS_TNFA_IL1B_IL6_PGE_STIM_DC_UP</TD><TD>180</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>VCP,FTH1,GART,ENC1,CHID1</TD></TR>
<TR><TD>3.067e-03</TD><TD>-5.79</TD><TD>SMARCB1 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1)</TD><TD>protein interactions</TD><TD>6598</TD><TD>110</TD><TD>4</TD><TD>16330</TD><TD>89</TD>
<TD>EPAS1,TACC2,SMARCA4,MAP1LC3B</TD></TR>
<TR><TD>3.179e-03</TD><TD>-5.75</TD><TD>GO_IRON_ION_TRANSPORT</TD><TD>MSigDB lists</TD><TD>GO_IRON_ION_TRANSPORT</TD><TD>54</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>SLC40A1,FTL,FTH1</TD></TR>
<TR><TD>3.187e-03</TD><TD>-5.75</TD><TD>GSE21546_WT_VS_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP</TD><TD>MSigDB lists</TD><TD>GSE21546_WT_VS_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP</TD><TD>182</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>FOSB,MAP1LC3B,TP53BP2,NR4A1,ADI1</TD></TR>
<TR><TD>3.187e-03</TD><TD>-5.75</TD><TD>GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_DN</TD><TD>MSigDB lists</TD><TD>GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_DN</TD><TD>182</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>RNASEH2A,CHID1,KNTC1,SLC35E4,C14orf159</TD></TR>
<TR><TD>3.263e-03</TD><TD>-5.73</TD><TD>GSE22103_UNSTIM_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_UP</TD><TD>MSigDB lists</TD><TD>GSE22103_UNSTIM_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_UP</TD><TD>183</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>ENC1,MED7,PTPN3,OTUD7B,FTH1</TD></TR>
<TR><TD>3.263e-03</TD><TD>-5.73</TD><TD>GSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_UP</TD><TD>MSigDB lists</TD><TD>GSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_UP</TD><TD>183</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>RNASEH2A,IFT27,MAP1LC3B,COMMD7,ENC1</TD></TR>
<TR><TD>3.340e-03</TD><TD>-5.70</TD><TD>GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_DN</TD><TD>184</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>KDM2A,MAFF,NR4A1,USP8,CHL1</TD></TR>
<TR><TD>3.354e-03</TD><TD>-5.70</TD><TD>COMMD6 (COMM domain containing 6)</TD><TD>protein interactions</TD><TD>170622</TD><TD>16</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>VCP,COMMD7</TD></TR>
<TR><TD>3.354e-03</TD><TD>-5.70</TD><TD>F7 (coagulation factor VII)</TD><TD>protein interactions</TD><TD>2155</TD><TD>16</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>VCP,F10</TD></TR>
<TR><TD>3.354e-03</TD><TD>-5.70</TD><TD>RNF19A (ring finger protein 19A, RBR E3 ubiquitin protein ligase)</TD><TD>protein interactions</TD><TD>25897</TD><TD>16</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>MAP3K7,VCP</TD></TR>
<TR><TD>3.382e-03</TD><TD>-5.69</TD><TD>AURKA (aurora kinase A)</TD><TD>protein interactions</TD><TD>6790</TD><TD>267</TD><TD>6</TD><TD>16330</TD><TD>89</TD>
<TD>OTUD7B,ARPC1B,EEF1A1,FTH1,FTL,AURKAIP1</TD></TR>
<TR><TD>3.386e-03</TD><TD>-5.69</TD><TD>WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP</TD><TD>MSigDB lists</TD><TD>WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP</TD><TD>113</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>NR4A1,LGALS2,FOSB,ENC1</TD></TR>
<TR><TD>3.390e-03</TD><TD>-5.69</TD><TD>single-organism developmental process</TD><TD>biological process</TD><TD>GO:0044767</TD><TD>5076</TD><TD>41</TD><TD>16543</TD><TD>92</TD>
<TD>TMEM198,GJB2,EHMT1,AP1G1,OVOL1,TPM4,BNC1,RAB17,SCARB2,MYPN,CASP6,IFT27,CHODL,CHL1,SLC40A1,ONECUT3,MNX1,PTPN3,EMX1,EPAS1,ARIH2,KCNA2,NANOG,RFX2,ZNF683,TACC2,MAFF,SHB,SMARCA4,RMDN3,JAK2,PLK5,ADAMTSL2,ENC1,NR4A1,ATP2B4,ADAR,GART,UBE3A,ALAS2,MED7</TD></TR>
<TR><TD>3.418e-03</TD><TD>-5.68</TD><TD>GSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_UP</TD><TD>185</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>JAK2,ADI1,JOSD1,FTH1,EPAS1</TD></TR>
<TR><TD>3.484e-03</TD><TD>-5.66</TD><TD>thiol-dependent ubiquitinyl hydrolase activity</TD><TD>molecular function</TD><TD>GO:0036459</TD><TD>110</TD><TD>4</TD><TD>16652</TD><TD>94</TD>
<TD>JOSD1,TANK,OTUD7B,USP8</TD></TR>
<TR><TD>3.484e-03</TD><TD>-5.66</TD><TD>ubiquitinyl hydrolase activity</TD><TD>molecular function</TD><TD>GO:0101005</TD><TD>110</TD><TD>4</TD><TD>16652</TD><TD>94</TD>
<TD>USP8,TANK,JOSD1,OTUD7B</TD></TR>
<TR><TD>3.497e-03</TD><TD>-5.66</TD><TD>GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP</TD><TD>MSigDB lists</TD><TD>GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP</TD><TD>186</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>TANK,VCP,ZFYVE1,FTH1,CDH7</TD></TR>
<TR><TD>3.497e-03</TD><TD>-5.66</TD><TD>GSE24634_TREG_VS_TCONV_POST_DAY3_IL4_CONVERSION_UP</TD><TD>MSigDB lists</TD><TD>GSE24634_TREG_VS_TCONV_POST_DAY3_IL4_CONVERSION_UP</TD><TD>186</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>GRAMD1B,NUP37,RNASEH2A,TSFM,KNTC1</TD></TR>
<TR><TD>3.525e-03</TD><TD>-5.65</TD><TD>JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP</TD><TD>MSigDB lists</TD><TD>JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP</TD><TD>56</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>TPM4,EEF1A1,FTL</TD></TR>
<TR><TD>3.525e-03</TD><TD>-5.65</TD><TD>NAGASHIMA_EGF_SIGNALING_UP</TD><TD>MSigDB lists</TD><TD>NAGASHIMA_EGF_SIGNALING_UP</TD><TD>56</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>FOSB,MAFF,NR4A1</TD></TR>
<TR><TD>3.531e-03</TD><TD>-5.65</TD><TD>functioning</TD><TD>COSMIC cancer mutations</TD><TD>functioning</TD><TD>1862</TD><TD>19</TD><TD>17630</TD><TD>93</TD>
<TD>TANK,C14orf159,ALAS2,ADAR,NR4A1,MFSD6,PTPN3,FGD5,GART,RGSL1,ENC1,AUTS2,SMARCA4,DTD1,EHMT1,RBKS,KCNA2,OTUD7B,OSBPL7</TD></TR>
<TR><TD>3.531e-03</TD><TD>-5.65</TD><TD>adrenal_gland-adrenal_gland-adrenal_cortical_carcinoma-functioning</TD><TD>COSMIC cancer mutations</TD><TD>adrenal_gland-adrenal_gland-adrenal_cortical_carcinoma-functioning</TD><TD>1862</TD><TD>19</TD><TD>17630</TD><TD>93</TD>
<TD>OSBPL7,OTUD7B,KCNA2,RBKS,EHMT1,DTD1,SMARCA4,AUTS2,ENC1,GART,RGSL1,FGD5,PTPN3,MFSD6,NR4A1,ADAR,ALAS2,C14orf159,TANK</TD></TR>
<TR><TD>3.578e-03</TD><TD>-5.63</TD><TD>GSE36826_WT_VS_IL1R_KO_SKIN_STAPH_AUREUS_INF_DN</TD><TD>MSigDB lists</TD><TD>GSE36826_WT_VS_IL1R_KO_SKIN_STAPH_AUREUS_INF_DN</TD><TD>187</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>CASP6,HEXA,TSFM,ATP2B4,ADAR</TD></TR>
<TR><TD>3.578e-03</TD><TD>-5.63</TD><TD>GSE3982_EOSINOPHIL_VS_NEUTROPHIL_UP</TD><TD>MSigDB lists</TD><TD>GSE3982_EOSINOPHIL_VS_NEUTROPHIL_UP</TD><TD>187</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>EPAS1,SMARCA4,ADI1,JOSD1,NUP37</TD></TR>
<TR><TD>3.578e-03</TD><TD>-5.63</TD><TD>GSE360_DC_VS_MAC_DN</TD><TD>MSigDB lists</TD><TD>GSE360_DC_VS_MAC_DN</TD><TD>187</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>TSFM,MAFF,RFX2,NGDN,SCARB2</TD></TR>
<TR><TD>3.661e-03</TD><TD>-5.61</TD><TD>GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_GATA1_AND_SATB1_TRANSDUCED_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_GATA1_AND_SATB1_TRANSDUCED_CD4_TCELL_DN</TD><TD>188</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>MFSD6,ENC1,TACC2,C14orf159,HEXA</TD></TR>
<TR><TD>3.661e-03</TD><TD>-5.61</TD><TD>GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY7_DN</TD><TD>MSigDB lists</TD><TD>GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY7_DN</TD><TD>188</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>HEXA,NR4A1,ARIH2,SLC35E4,MED7</TD></TR>
<TR><TD>3.706e-03</TD><TD>-5.60</TD><TD>REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING</TD><TD>MSigDB lists</TD><TD>REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING</TD><TD>57</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>AP1G1,FTH1,FTL</TD></TR>
<TR><TD>3.744e-03</TD><TD>-5.59</TD><TD>GSE3982_EOSINOPHIL_VS_TH1_DN</TD><TD>MSigDB lists</TD><TD>GSE3982_EOSINOPHIL_VS_TH1_DN</TD><TD>189</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>KNTC1,VCP,NUP37,RNASEH2A,SMARCA4</TD></TR>
<TR><TD>3.769e-03</TD><TD>-5.58</TD><TD>Myeloproliferative neoplasms(PMID:19287384)</TD><TD>GWAS genes</TD><TD>Myeloproliferative neoplasms(PMID:19287384)</TD><TD>1</TD><TD>1</TD><TD>2388</TD><TD>9</TD>
<TD>JAK2</TD></TR>
<TR><TD>3.769e-03</TD><TD>-5.58</TD><TD>Alcohol consumption(PMID:21471458)</TD><TD>GWAS genes</TD><TD>Alcohol consumption(PMID:21471458)</TD><TD>1</TD><TD>1</TD><TD>2388</TD><TD>9</TD>
<TD>AUTS2</TD></TR>
<TR><TD>3.787e-03</TD><TD>-5.58</TD><TD>BATF2 (basic leucine zipper ATF-like transcription factor 2)</TD><TD>protein interactions</TD><TD>116071</TD><TD>17</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>MAFF,EPAS1</TD></TR>
<TR><TD>3.787e-03</TD><TD>-5.58</TD><TD>BBS2 (Bardet-Biedl syndrome 2)</TD><TD>protein interactions</TD><TD>583</TD><TD>17</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>EEF1A1,EPAS1</TD></TR>
<TR><TD>3.787e-03</TD><TD>-5.58</TD><TD>MAN2B1 (mannosidase alpha class 2B member 1)</TD><TD>protein interactions</TD><TD>4125</TD><TD>17</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>DTD1,CHID1</TD></TR>
<TR><TD>3.787e-03</TD><TD>-5.58</TD><TD>GO_FILOPODIUM_ASSEMBLY</TD><TD>MSigDB lists</TD><TD>GO_FILOPODIUM_ASSEMBLY</TD><TD>17</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>FGD5,RAB17</TD></TR>
<TR><TD>3.827e-03</TD><TD>-5.57</TD><TD>SMARCC1 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1)</TD><TD>protein interactions</TD><TD>6599</TD><TD>117</TD><TD>4</TD><TD>16330</TD><TD>89</TD>
<TD>EPAS1,SMARCA4,NR4A1,VCP</TD></TR>
<TR><TD>3.829e-03</TD><TD>-5.57</TD><TD>GSE339_CD4POS_VS_CD4CD8DN_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE339_CD4POS_VS_CD4CD8DN_DC_DN</TD><TD>190</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>GJB2,FOSB,SLC35E4,TSFM,VCP</TD></TR>
<TR><TD>3.829e-03</TD><TD>-5.57</TD><TD>GSE3039_NKT_CELL_VS_ALPHABETA_CD8_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE3039_NKT_CELL_VS_ALPHABETA_CD8_TCELL_UP</TD><TD>190</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>SHB,FOSB,GART,SMARCA4,MAFF</TD></TR>
<TR><TD>3.859e-03</TD><TD>-5.56</TD><TD>ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP</TD><TD>MSigDB lists</TD><TD>ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP</TD><TD>274</TD><TD>6</TD><TD>17621</TD><TD>96</TD>
<TD>SLC40A1,ARPC1B,ENC1,VCP,CHL1,CHODL</TD></TR>
<TR><TD>3.889e-03</TD><TD>-5.55</TD><TD>TXN2 (thioredoxin 2)</TD><TD>protein interactions</TD><TD>25828</TD><TD>58</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>GPRASP2,VCP,TPM4</TD></TR>
<TR><TD>3.915e-03</TD><TD>-5.54</TD><TD>GSE11057_NAIVE_VS_MEMORY_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE11057_NAIVE_VS_MEMORY_CD4_TCELL_DN</TD><TD>191</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>AUTS2,ATP2B4,ARPC1B,TPM4,TANK</TD></TR>
<TR><TD>3.915e-03</TD><TD>-5.54</TD><TD>GSE24574_BCL6_HIGH_VS_LOW_TFH_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE24574_BCL6_HIGH_VS_LOW_TFH_CD4_TCELL_UP</TD><TD>191</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>KDM2A,ENC1,JOSD1,AUTS2,FTH1</TD></TR>
<TR><TD>3.915e-03</TD><TD>-5.54</TD><TD>GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN</TD><TD>MSigDB lists</TD><TD>GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN</TD><TD>191</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>GRAMD1B,NUP37,NANOG,TTC39A,MYPN</TD></TR>
<TR><TD>3.920e-03</TD><TD>-5.54</TD><TD>iron ion transport</TD><TD>biological process</TD><TD>GO:0006826</TD><TD>57</TD><TD>3</TD><TD>16543</TD><TD>92</TD>
<TD>FTL,FTH1,SLC40A1</TD></TR>
<TR><TD>3.941e-03</TD><TD>-5.54</TD><TD>filopodium assembly</TD><TD>biological process</TD><TD>GO:0046847</TD><TD>17</TD><TD>2</TD><TD>16543</TD><TD>92</TD>
<TD>FGD5,RAB17</TD></TR>
<TR><TD>3.941e-03</TD><TD>-5.54</TD><TD>regulation of translational fidelity</TD><TD>biological process</TD><TD>GO:0006450</TD><TD>17</TD><TD>2</TD><TD>16543</TD><TD>92</TD>
<TD>DTD1,VARS2</TD></TR>
<TR><TD>3.953e-03</TD><TD>-5.53</TD><TD>V$ATF6_01</TD><TD>MSigDB lists</TD><TD>V$ATF6_01</TD><TD>118</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>TPM4,NR4A1,VCP,JOSD1</TD></TR>
<TR><TD>3.964e-03</TD><TD>-5.53</TD><TD>human chr19p13.12-p13.11</TD><TD>chromosome location</TD><TD>human chr19p13.12-p13.11</TD><TD>1</TD><TD>1</TD><TD>26234</TD><TD>104</TD>
<TD>TPM4</TD></TR>
<TR><TD>4.003e-03</TD><TD>-5.52</TD><TD>GSE17721_LPS_VS_POLYIC_8H_BMDC_DN</TD><TD>MSigDB lists</TD><TD>GSE17721_LPS_VS_POLYIC_8H_BMDC_DN</TD><TD>192</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>SCARB2,ERN2,C14orf159,RBKS,NANOG</TD></TR>
<TR><TD>4.003e-03</TD><TD>-5.52</TD><TD>GSE42088_2H_VS_24H_LEISHMANIA_INF_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE42088_2H_VS_24H_LEISHMANIA_INF_DC_DN</TD><TD>192</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>TSFM,VCP,ADAMTSL2,F10,POM121C</TD></TR>
<TR><TD>4.058e-03</TD><TD>-5.51</TD><TD>human chr2q32.2</TD><TD>chromosome location</TD><TD>human chr2q32.2</TD><TD>24</TD><TD>2</TD><TD>26234</TD><TD>104</TD>
<TD>SLC40A1,MFSD6</TD></TR>
<TR><TD>4.092e-03</TD><TD>-5.50</TD><TD>GSE9650_EXHAUSTED_VS_MEMORY_CD8_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE9650_EXHAUSTED_VS_MEMORY_CD8_TCELL_DN</TD><TD>193</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>MAP1LC3B,NGDN,RNASEH2A,AURKAIP1,HEXA</TD></TR>
<TR><TD>4.092e-03</TD><TD>-5.50</TD><TD>GSE29949_CD8_POS_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_DN</TD><TD>MSigDB lists</TD><TD>GSE29949_CD8_POS_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_DN</TD><TD>193</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>MAP1LC3B,TP53BP2,BNC1,FTL,GRAMD1B</TD></TR>
<TR><TD>4.092e-03</TD><TD>-5.50</TD><TD>GSE9650_EFFECTOR_VS_MEMORY_CD8_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE9650_EFFECTOR_VS_MEMORY_CD8_TCELL_DN</TD><TD>193</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>ADI1,HEXA,BNC1,GART,FOSB</TD></TR>
<TR><TD>4.182e-03</TD><TD>-5.48</TD><TD>GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_12H_UP</TD><TD>MSigDB lists</TD><TD>GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_12H_UP</TD><TD>194</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>NR4A1,NUP37,AURKAIP1,HEXA,ADI1</TD></TR>
<TR><TD>4.244e-03</TD><TD>-5.46</TD><TD>cysteine-type peptidase activity</TD><TD>molecular function</TD><TD>GO:0008234</TD><TD>188</TD><TD>5</TD><TD>16652</TD><TD>94</TD>
<TD>TANK,OTUD7B,JOSD1,USP8,CASP6</TD></TR>
<TR><TD>4.246e-03</TD><TD>-5.46</TD><TD>TBC1D9B (TBC1 domain family member 9B)</TD><TD>protein interactions</TD><TD>23061</TD><TD>18</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>VCP,MAP1LC3B</TD></TR>
<TR><TD>4.246e-03</TD><TD>-5.46</TD><TD>KANG_CISPLATIN_RESISTANCE_UP</TD><TD>MSigDB lists</TD><TD>KANG_CISPLATIN_RESISTANCE_UP</TD><TD>18</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>FTH1,MAFF</TD></TR>
<TR><TD>4.246e-03</TD><TD>-5.46</TD><TD>YIH_RESPONSE_TO_ARSENITE_C2</TD><TD>MSigDB lists</TD><TD>YIH_RESPONSE_TO_ARSENITE_C2</TD><TD>18</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>USP8,TANK</TD></TR>
<TR><TD>4.280e-03</TD><TD>-5.45</TD><TD>DCAF7 (DDB1 and CUL4 associated factor 7)</TD><TD>protein interactions</TD><TD>10238</TD><TD>60</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>AUTS2,VCP,EPAS1</TD></TR>
<TR><TD>4.361e-03</TD><TD>-5.44</TD><TD>sperm principal piece</TD><TD>cellular component</TD><TD>GO:0097228</TD><TD>18</TD><TD>2</TD><TD>17744</TD><TD>98</TD>
<TD>ATP2B4,IFT27</TD></TR>
<TR><TD>4.407e-03</TD><TD>-5.42</TD><TD>Golgi Associated Vesicle Biogenesis</TD><TD>REACTOME pathways</TD><TD>R-HSA-432722</TD><TD>57</TD><TD>3</TD><TD>10293</TD><TD>60</TD>
<TD>AP1G1,FTH1,FTL</TD></TR>
<TR><TD>4.410e-03</TD><TD>-5.42</TD><TD>regulation of macromolecule biosynthetic process</TD><TD>biological process</TD><TD>GO:0010556</TD><TD>4016</TD><TD>34</TD><TD>16543</TD><TD>92</TD>
<TD>ENC1,TSFM,MED7,UBE3A,NR4A1,ATP2B4,ADAR,RFX2,ERN2,PXYLP1,ZNF683,JAK2,EEF1A1,KDM2A,MAFF,VARS2,SMARCA4,AUTS2,MNX1,ONECUT3,SLC40A1,DTD1,NANOG,COMMD7,EPAS1,EMX1,MAP3K7,OVOL1,PPP1R3F,EHMT1,NGDN,BNC1,OTUD7B,FOSB</TD></TR>
<TR><TD>4.419e-03</TD><TD>-5.42</TD><TD>human chr22q13.1</TD><TD>chromosome location</TD><TD>human chr22q13.1</TD><TD>83</TD><TD>3</TD><TD>26234</TD><TD>104</TD>
<TD>JOSD1,LGALS2,MAFF</TD></TR>
<TR><TD>4.451e-03</TD><TD>-5.41</TD><TD>GSE15624_CTRL_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE15624_CTRL_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_UP</TD><TD>122</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>OSBPL7,RFX2,PTPN3,KCNA2</TD></TR>
<TR><TD>4.484e-03</TD><TD>-5.41</TD><TD>CDC25A (cell division cycle 25A)</TD><TD>protein interactions</TD><TD>993</TD><TD>61</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>FTH1,EEF1A1,VCP</TD></TR>
<TR><TD>4.514e-03</TD><TD>-5.40</TD><TD>ACATTCC,MIR-1,MIR-206</TD><TD>MSigDB lists</TD><TD>ACATTCC,MIR-1,MIR-206</TD><TD>283</TD><TD>6</TD><TD>17621</TD><TD>96</TD>
<TD>OSBPL7,AP1G1,FOSB,SMARCA4,ADAR,JOSD1</TD></TR>
<TR><TD>4.532e-03</TD><TD>-5.40</TD><TD>upper_aerodigestive_tract-mouth-carcinoma-squamous_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>upper_aerodigestive_tract-mouth-carcinoma-squamous_cell_carcinoma</TD><TD>7213</TD><TD>51</TD><TD>17630</TD><TD>93</TD>
<TD>AP1G1,FGD5,SLC40A1,ENC1,RGSL1,EPAS1,COMMD7,F10,RFX2,ADAR,TP53BP2,JAK2,MED7,MYPN,VCP,UBE3A,OSBPL7,C2orf81,OVOL1,ADAMTSL2,RBKS,UGT1A6,AUTS2,GJB2,SMARCA4,MAP3K7,TMEM198,PTPN3,ZFYVE1,USP8,GART,NR4A1,HEXA,ZNF683,GRAMD1B,KCNG3,CHL1,TACC2,SLC27A6,SCARB2,VARS2,CDH7,KNTC1,CHODL,PLK5,OTUD7B,EHMT1,CHID1,HEATR6,JOSD1,GPRASP2</TD></TR>
<TR><TD>4.632e-03</TD><TD>-5.37</TD><TD>YWHAG (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma)</TD><TD>protein interactions</TD><TD>7532</TD><TD>379</TD><TD>7</TD><TD>16330</TD><TD>89</TD>
<TD>RMDN3,VCP,EEF1A1,USP8,TP53BP2,PTPN3,HSPB6</TD></TR>
<TR><TD>4.715e-03</TD><TD>-5.36</TD><TD>REACTOME_MEMBRANE_TRAFFICKING</TD><TD>MSigDB lists</TD><TD>REACTOME_MEMBRANE_TRAFFICKING</TD><TD>124</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>FTL,FTH1,AP1G1,GJB2</TD></TR>
<TR><TD>4.729e-03</TD><TD>-5.35</TD><TD>GO_TRANSLATION_ELONGATION_FACTOR_ACTIVITY</TD><TD>MSigDB lists</TD><TD>GO_TRANSLATION_ELONGATION_FACTOR_ACTIVITY</TD><TD>19</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>EEF1A1,TSFM</TD></TR>
<TR><TD>4.729e-03</TD><TD>-5.35</TD><TD>KIF20B (kinesin family member 20B)</TD><TD>protein interactions</TD><TD>9585</TD><TD>19</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>NANOG,KDM2A</TD></TR>
<TR><TD>4.729e-03</TD><TD>-5.35</TD><TD>PTPN3 (protein tyrosine phosphatase, non-receptor type 3)</TD><TD>protein interactions</TD><TD>5774</TD><TD>19</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>UBE3A,VCP</TD></TR>
<TR><TD>4.754e-03</TD><TD>-5.35</TD><TD>human chr16q24.2</TD><TD>chromosome location</TD><TD>human chr16q24.2</TD><TD>26</TD><TD>2</TD><TD>26234</TD><TD>104</TD>
<TD>MAP1LC3B,FBXO31</TD></TR>
<TR><TD>4.847e-03</TD><TD>-5.33</TD><TD>regulation of cellular biosynthetic process</TD><TD>biological process</TD><TD>GO:0031326</TD><TD>4197</TD><TD>35</TD><TD>16543</TD><TD>92</TD>
<TD>NGDN,BNC1,OTUD7B,FOSB,MAP3K7,OVOL1,PPP1R3F,EHMT1,NANOG,COMMD7,EMX1,EPAS1,VCP,MNX1,ONECUT3,SLC40A1,DTD1,EEF1A1,JAK2,KDM2A,MAFF,VARS2,AUTS2,SMARCA4,PXYLP1,ERN2,RFX2,ZNF683,MED7,UBE3A,NR4A1,ATP2B4,ADAR,ENC1,TSFM</TD></TR>
<TR><TD>4.892e-03</TD><TD>-5.32</TD><TD>ubiquitin-like protein-specific protease activity</TD><TD>molecular function</TD><TD>GO:0019783</TD><TD>121</TD><TD>4</TD><TD>16652</TD><TD>94</TD>
<TD>OTUD7B,JOSD1,TANK,USP8</TD></TR>
<TR><TD>4.909e-03</TD><TD>-5.32</TD><TD>PARD6A (par-6 family cell polarity regulator alpha)</TD><TD>protein interactions</TD><TD>50855</TD><TD>63</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>FBXO31,SMARCA4,TP53BP2</TD></TR>
<TR><TD>4.919e-03</TD><TD>-5.31</TD><TD>axon regeneration</TD><TD>biological process</TD><TD>GO:0031103</TD><TD>19</TD><TD>2</TD><TD>16543</TD><TD>92</TD>
<TD>CHL1,JAK2</TD></TR>
<TR><TD>4.958e-03</TD><TD>-5.31</TD><TD>developmental process</TD><TD>biological process</TD><TD>GO:0032502</TD><TD>5175</TD><TD>41</TD><TD>16543</TD><TD>92</TD>
<TD>TPM4,BNC1,RAB17,SCARB2,MYPN,GJB2,TMEM198,EHMT1,AP1G1,OVOL1,EPAS1,EMX1,ARIH2,KCNA2,NANOG,CASP6,IFT27,CHL1,CHODL,ONECUT3,SLC40A1,MNX1,PTPN3,MAFF,SMARCA4,SHB,RMDN3,JAK2,PLK5,RFX2,ZNF683,TACC2,NR4A1,ADAR,ATP2B4,GART,UBE3A,MED7,ALAS2,ADAMTSL2,ENC1</TD></TR>
<TR><TD>4.968e-03</TD><TD>-5.30</TD><TD>RELA (RELA proto-oncogene, NF-kB subunit)</TD><TD>protein interactions</TD><TD>5970</TD><TD>289</TD><TD>6</TD><TD>16330</TD><TD>89</TD>
<TD>MED7,KDM2A,MAP3K7,COMMD7,EHMT1,TP53BP2</TD></TR>
<TR><TD>5.065e-03</TD><TD>-5.29</TD><TD>translation elongation factor activity</TD><TD>molecular function</TD><TD>GO:0003746</TD><TD>19</TD><TD>2</TD><TD>16652</TD><TD>94</TD>
<TD>EEF1A1,TSFM</TD></TR>
<TR><TD>5.235e-03</TD><TD>-5.25</TD><TD>GESERICK_TERT_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>GESERICK_TERT_TARGETS_DN</TD><TD>20</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>NR4A1,FOSB</TD></TR>
<TR><TD>5.235e-03</TD><TD>-5.25</TD><TD>WELCH_GATA1_TARGETS</TD><TD>MSigDB lists</TD><TD>WELCH_GATA1_TARGETS</TD><TD>20</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>ALAS2,FTL</TD></TR>
<TR><TD>5.235e-03</TD><TD>-5.25</TD><TD>TRIM13 (tripartite motif containing 13)</TD><TD>protein interactions</TD><TD>10206</TD><TD>20</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>ZFYVE1,VCP</TD></TR>
<TR><TD>5.235e-03</TD><TD>-5.25</TD><TD>JARID2 (jumonji and AT-rich interaction domain containing 2)</TD><TD>protein interactions</TD><TD>3720</TD><TD>20</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>EHMT1,NANOG</TD></TR>
<TR><TD>5.235e-03</TD><TD>-5.25</TD><TD>BBS4 (Bardet-Biedl syndrome 4)</TD><TD>protein interactions</TD><TD>585</TD><TD>20</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>EEF1A1,EPAS1</TD></TR>
<TR><TD>5.237e-03</TD><TD>-5.25</TD><TD>EP300 (E1A binding protein p300)</TD><TD>protein interactions</TD><TD>2033</TD><TD>490</TD><TD>8</TD><TD>16330</TD><TD>89</TD>
<TD>EEF1A1,NANOG,EPAS1,TP53BP2,AUTS2,FOSB,TACC2,NR4A1</TD></TR>
<TR><TD>5.357e-03</TD><TD>-5.23</TD><TD>RPS6KA5 (ribosomal protein S6 kinase A5)</TD><TD>protein interactions</TD><TD>9252</TD><TD>65</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>NR4A1,GPRASP2,SMARCA4</TD></TR>
<TR><TD>5.361e-03</TD><TD>-5.23</TD><TD>Protein methylation</TD><TD>REACTOME pathways</TD><TD>R-HSA-8876725</TD><TD>19</TD><TD>2</TD><TD>10293</TD><TD>60</TD>
<TD>EEF1A1,VCP</TD></TR>
<TR><TD>5.362e-03</TD><TD>-5.23</TD><TD>GO_P53_BINDING</TD><TD>MSigDB lists</TD><TD>GO_P53_BINDING</TD><TD>65</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>EHMT1,SMARCA4,TP53BP2</TD></TR>
<TR><TD>5.379e-03</TD><TD>-5.23</TD><TD>Preimplantation Embryo</TD><TD>WikiPathways</TD><TD>WP3527</TD><TD>60</TD><TD>3</TD><TD>5314</TD><TD>32</TD>
<TD>NANOG,FOSB,SMARCA4</TD></TR>
<TR><TD>5.404e-03</TD><TD>-5.22</TD><TD>regulation of macromolecule metabolic process</TD><TD>biological process</TD><TD>GO:0060255</TD><TD>5699</TD><TD>44</TD><TD>16543</TD><TD>92</TD>
<TD>TANK,TSFM,AURKAIP1,ENC1,ATP2B4,ADAR,SERPINB10,NR4A1,UBE3A,MED7,ZNF683,ERN2,PXYLP1,RFX2,SMARCA4,SHB,VARS2,AUTS2,MAFF,KDM2A,JAK2,EEF1A1,OSBPL7,DTD1,ONECUT3,SLC40A1,PTPN3,MNX1,VCP,EPAS1,EMX1,COMMD7,ARIH2,NANOG,NUP37,EHMT1,PPP1R3F,OVOL1,MAP3K7,FOSB,POM121C,OTUD7B,BNC1,NGDN</TD></TR>
<TR><TD>5.410e-03</TD><TD>-5.22</TD><TD>biological regulation</TD><TD>biological process</TD><TD>GO:0065007</TD><TD>11242</TD><TD>74</TD><TD>16543</TD><TD>92</TD>
<TD>MAP3K7,RGSL1,PPP1R3F,KNTC1,EHMT1,AP1G1,SCARB2,NGDN,KCNG3,POM121C,FTH1,ONECUT3,SLC40A1,MNX1,PTPN3,ARPC1B,CASP6,FGD5,IFT27,CHODL,ZFYVE1,KCNA2,VCP,ERN2,ZNF683,CHID1,EEF1A1,MAFF,KDM2A,TSFM,ADAMTSL2,AURKAIP1,MED7,FBXO31,NR4A1,SERPINB10,OVOL1,USP8,HSPB6,TMEM198,NUP37,BNC1,OTUD7B,RAB17,GCSAM,TP53BP2,FOSB,DTD1,OSBPL7,CHL1,COMMD7,ARIH2,FTL,NANOG,EMX1,EPAS1,RFX2,PXYLP1,F10,MAP1LC3B,JAK2,PLK5,SMARCA4,AUTS2,VARS2,SHB,RMDN3,GAPT,ENC1,TANK,UBE3A,ALAS2,ADAR,ATP2B4</TD></TR>
<TR><TD>5.450e-03</TD><TD>-5.21</TD><TD>DDIAS (DNA damage induced apoptosis suppressor)</TD><TD>protein interactions</TD><TD>220042</TD><TD>1</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>VCP</TD></TR>
<TR><TD>5.450e-03</TD><TD>-5.21</TD><TD>Zpr1 (ZPR1 zinc finger)</TD><TD>protein interactions</TD><TD>22687</TD><TD>1</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>EEF1A1</TD></TR>
<TR><TD>5.450e-03</TD><TD>-5.21</TD><TD>COQ5 (2-hexaprenyl-6-methoxy-1,4-benzoquinone methyltransferase)</TD><TD>protein interactions</TD><TD>854930</TD><TD>1</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>COQ8A</TD></TR>
<TR><TD>5.450e-03</TD><TD>-5.21</TD><TD>Ifngr1 (interferon gamma receptor 1)</TD><TD>protein interactions</TD><TD>15979</TD><TD>1</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>JAK2</TD></TR>
<TR><TD>5.450e-03</TD><TD>-5.21</TD><TD>Cacna1b (calcium voltage-gated channel subunit alpha1 B)</TD><TD>protein interactions</TD><TD>257648</TD><TD>1</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>MAP1LC3B</TD></TR>
<TR><TD>5.450e-03</TD><TD>-5.21</TD><TD>HSP90B2P (heat shock protein 90 beta family member 2, pseudogene)</TD><TD>protein interactions</TD><TD>7190</TD><TD>1</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>VCP</TD></TR>
<TR><TD>5.450e-03</TD><TD>-5.21</TD><TD>CAT5 (putative monooxygenase CAT5)</TD><TD>protein interactions</TD><TD>854292</TD><TD>1</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>COQ8A</TD></TR>
<TR><TD>5.450e-03</TD><TD>-5.21</TD><TD>AP3S2 (adaptor-related protein complex 3, sigma 2 subunit)</TD><TD>protein interactions</TD><TD>100153862</TD><TD>1</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>SCARB2</TD></TR>
<TR><TD>5.450e-03</TD><TD>-5.21</TD><TD>COQ3 (hexaprenyldihydroxybenzoate methyltransferase)</TD><TD>protein interactions</TD><TD>854057</TD><TD>1</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>COQ8A</TD></TR>
<TR><TD>5.450e-03</TD><TD>-5.21</TD><TD>CIDEC (cell death inducing DFFA like effector c)</TD><TD>protein interactions</TD><TD>63924</TD><TD>1</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>VCP</TD></TR>
<TR><TD>5.450e-03</TD><TD>-5.21</TD><TD>YAP1 (Yes associated protein 1)</TD><TD>protein interactions</TD><TD>396171</TD><TD>1</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>TP53BP2</TD></TR>
<TR><TD>5.450e-03</TD><TD>-5.21</TD><TD>BPY2B (basic charge, Y-linked, 2B)</TD><TD>protein interactions</TD><TD>442867</TD><TD>1</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>UBE3A</TD></TR>
<TR><TD>5.450e-03</TD><TD>-5.21</TD><TD>LOC147791 (uncharacterized LOC147791)</TD><TD>protein interactions</TD><TD>147791</TD><TD>1</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>ARIH2</TD></TR>
<TR><TD>5.450e-03</TD><TD>-5.21</TD><TD>ABCC13 (ATP binding cassette subfamily C member 13 (pseudogene))</TD><TD>protein interactions</TD><TD>150000</TD><TD>1</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>NR4A1</TD></TR>
<TR><TD>5.450e-03</TD><TD>-5.21</TD><TD>COQ8 (protein kinase COQ8)</TD><TD>protein interactions</TD><TD>852758</TD><TD>1</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>COQ8A</TD></TR>
<TR><TD>5.450e-03</TD><TD>-5.21</TD><TD>Afti (Aftiphilin)</TD><TD>protein interactions</TD><TD>41744</TD><TD>1</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>AP1G1</TD></TR>
<TR><TD>5.450e-03</TD><TD>-5.21</TD><TD>DNER (delta/notch like EGF repeat containing)</TD><TD>protein interactions</TD><TD>92737</TD><TD>1</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>AP1G1</TD></TR>
<TR><TD>5.450e-03</TD><TD>-5.21</TD><TD>Nr1h4 (nuclear receptor subfamily 1, group H, member 4)</TD><TD>protein interactions</TD><TD>20186</TD><TD>1</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>SMARCA4</TD></TR>
<TR><TD>5.450e-03</TD><TD>-5.21</TD><TD>VRTN (vertebrae development associated)</TD><TD>protein interactions</TD><TD>55237</TD><TD>1</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>NANOG</TD></TR>
<TR><TD>5.450e-03</TD><TD>-5.21</TD><TD>COQ9 (ubiquinone biosynthesis protein COQ9)</TD><TD>protein interactions</TD><TD>850898</TD><TD>1</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>COQ8A</TD></TR>
<TR><TD>5.450e-03</TD><TD>-5.21</TD><TD>UFD2 (ubiquitin-ubiquitin ligase UFD2)</TD><TD>protein interactions</TD><TD>851337</TD><TD>1</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>VCP</TD></TR>
<TR><TD>5.450e-03</TD><TD>-5.21</TD><TD>Ap1g1 (adaptor-related protein complex 1, gamma 1 subunit)</TD><TD>protein interactions</TD><TD>171494</TD><TD>1</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>SCARB2</TD></TR>
<TR><TD>5.450e-03</TD><TD>-5.21</TD><TD>Arnt (aryl hydrocarbon receptor nuclear translocator)</TD><TD>protein interactions</TD><TD>11863</TD><TD>1</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>EPAS1</TD></TR>
<TR><TD>5.450e-03</TD><TD>-5.21</TD><TD>dvc-1 (SprT-like domain-containing protein Spartan)</TD><TD>protein interactions</TD><TD>179554</TD><TD>1</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>VCP</TD></TR>
<TR><TD>5.450e-03</TD><TD>-5.21</TD><TD>ATG3 (Atg3p)</TD><TD>protein interactions</TD><TD>855741</TD><TD>1</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>MAP1LC3B</TD></TR>
<TR><TD>5.450e-03</TD><TD>-5.21</TD><TD>PPM1L (protein phosphatase, Mg2+/Mn2+ dependent 1L)</TD><TD>protein interactions</TD><TD>151742</TD><TD>1</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>MAP3K7</TD></TR>
<TR><TD>5.450e-03</TD><TD>-5.21</TD><TD>IGDCC3 (immunoglobulin superfamily DCC subclass member 3)</TD><TD>protein interactions</TD><TD>9543</TD><TD>1</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>FTL</TD></TR>
<TR><TD>5.510e-03</TD><TD>-5.20</TD><TD>regulation of mitotic cell cycle</TD><TD>biological process</TD><TD>GO:0007346</TD><TD>484</TD><TD>8</TD><TD>16543</TD><TD>92</TD>
<TD>SMARCA4,SHB,FBXO31,PLK5,KNTC1,AURKAIP1,OVOL1,PTPN3</TD></TR>
<TR><TD>5.523e-03</TD><TD>-5.20</TD><TD>tubulobulbar complex</TD><TD>cellular component</TD><TD>GO:0036284</TD><TD>1</TD><TD>1</TD><TD>17744</TD><TD>98</TD>
<TD>ARPC1B</TD></TR>
<TR><TD>5.558e-03</TD><TD>-5.19</TD><TD>BSG (basigin (Ok blood group))</TD><TD>protein interactions</TD><TD>682</TD><TD>130</TD><TD>4</TD><TD>16330</TD><TD>89</TD>
<TD>HEATR6,KNTC1,VCP,ATP2B4</TD></TR>
<TR><TD>5.561e-03</TD><TD>-5.19</TD><TD>negative regulation of cellular amino acid biosynthetic process</TD><TD>biological process</TD><TD>GO:2000283</TD><TD>1</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ATP2B4</TD></TR>
<TR><TD>5.561e-03</TD><TD>-5.19</TD><TD>negative regulation of citrulline biosynthetic process</TD><TD>biological process</TD><TD>GO:1903249</TD><TD>1</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ATP2B4</TD></TR>
<TR><TD>5.561e-03</TD><TD>-5.19</TD><TD>negative regulation of cellular amine catabolic process</TD><TD>biological process</TD><TD>GO:0033242</TD><TD>1</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ATP2B4</TD></TR>
<TR><TD>5.561e-03</TD><TD>-5.19</TD><TD>cell cycle switching</TD><TD>biological process</TD><TD>GO:0060184</TD><TD>1</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>OVOL1</TD></TR>
<TR><TD>5.561e-03</TD><TD>-5.19</TD><TD>histone H3-Y41 phosphorylation</TD><TD>biological process</TD><TD>GO:0035409</TD><TD>1</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>JAK2</TD></TR>
<TR><TD>5.561e-03</TD><TD>-5.19</TD><TD>regulation of arginine catabolic process</TD><TD>biological process</TD><TD>GO:1900081</TD><TD>1</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ATP2B4</TD></TR>
<TR><TD>5.561e-03</TD><TD>-5.19</TD><TD>flavin adenine dinucleotide catabolic process</TD><TD>biological process</TD><TD>GO:0072389</TD><TD>1</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>VCP</TD></TR>
<TR><TD>5.561e-03</TD><TD>-5.19</TD><TD>regulation of citrulline biosynthetic process</TD><TD>biological process</TD><TD>GO:1903248</TD><TD>1</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ATP2B4</TD></TR>
<TR><TD>5.561e-03</TD><TD>-5.19</TD><TD>spleen trabecula formation</TD><TD>biological process</TD><TD>GO:0060345</TD><TD>1</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>SLC40A1</TD></TR>
<TR><TD>5.561e-03</TD><TD>-5.19</TD><TD>iron cation export</TD><TD>biological process</TD><TD>GO:1903414</TD><TD>1</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>SLC40A1</TD></TR>
<TR><TD>5.561e-03</TD><TD>-5.19</TD><TD>negative regulation of arginine catabolic process</TD><TD>biological process</TD><TD>GO:1900082</TD><TD>1</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ATP2B4</TD></TR>
<TR><TD>5.561e-03</TD><TD>-5.19</TD><TD>sperm entry</TD><TD>biological process</TD><TD>GO:0035037</TD><TD>1</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>UBE3A</TD></TR>
<TR><TD>5.561e-03</TD><TD>-5.19</TD><TD>positive regulation of Lys63-specific deubiquitinase activity</TD><TD>biological process</TD><TD>GO:1903007</TD><TD>1</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>VCP</TD></TR>
<TR><TD>5.561e-03</TD><TD>-5.19</TD><TD>positive regulation of protein K63-linked deubiquitination</TD><TD>biological process</TD><TD>GO:1903006</TD><TD>1</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>VCP</TD></TR>
<TR><TD>5.561e-03</TD><TD>-5.19</TD><TD>regulation of protein K63-linked deubiquitination</TD><TD>biological process</TD><TD>GO:1903004</TD><TD>1</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>VCP</TD></TR>
<TR><TD>5.561e-03</TD><TD>-5.19</TD><TD>regulation of cellular amine catabolic process</TD><TD>biological process</TD><TD>GO:0033241</TD><TD>1</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ATP2B4</TD></TR>
<TR><TD>5.561e-03</TD><TD>-5.19</TD><TD>negative regulation of the force of heart contraction</TD><TD>biological process</TD><TD>GO:0098736</TD><TD>1</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ATP2B4</TD></TR>
<TR><TD>5.561e-03</TD><TD>-5.19</TD><TD>ferrous iron export</TD><TD>biological process</TD><TD>GO:1903988</TD><TD>1</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>SLC40A1</TD></TR>
<TR><TD>5.561e-03</TD><TD>-5.19</TD><TD>germline cell cycle switching, mitotic to meiotic cell cycle</TD><TD>biological process</TD><TD>GO:0051729</TD><TD>1</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>OVOL1</TD></TR>
<TR><TD>5.561e-03</TD><TD>-5.19</TD><TD>histone-tyrosine phosphorylation</TD><TD>biological process</TD><TD>GO:0035406</TD><TD>1</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>JAK2</TD></TR>
<TR><TD>5.561e-03</TD><TD>-5.19</TD><TD>flavin-containing compound catabolic process</TD><TD>biological process</TD><TD>GO:0042728</TD><TD>1</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>VCP</TD></TR>
<TR><TD>5.561e-03</TD><TD>-5.19</TD><TD>regulation of lysosome organization</TD><TD>biological process</TD><TD>GO:1905671</TD><TD>1</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>SCARB2</TD></TR>
<TR><TD>5.561e-03</TD><TD>-5.19</TD><TD>cell cycle switching, mitotic to meiotic cell cycle</TD><TD>biological process</TD><TD>GO:0051728</TD><TD>1</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>OVOL1</TD></TR>
<TR><TD>5.589e-03</TD><TD>-5.19</TD><TD>K_chnl_volt-dep_Kv1</TD><TD>interpro domains</TD><TD>IPR004049</TD><TD>1</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>KCNA2</TD></TR>
<TR><TD>5.589e-03</TD><TD>-5.19</TD><TD>PPP1R32</TD><TD>interpro domains</TD><TD>IPR031410</TD><TD>1</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>PPP1R32</TD></TR>
<TR><TD>5.589e-03</TD><TD>-5.19</TD><TD>PRibGlycinamide_synth_N</TD><TD>interpro domains</TD><TD>IPR020562</TD><TD>1</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>GART</TD></TR>
<TR><TD>5.589e-03</TD><TD>-5.19</TD><TD>IRE2</TD><TD>interpro domains</TD><TD>IPR033523</TD><TD>1</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>ERN2</TD></TR>
<TR><TD>5.589e-03</TD><TD>-5.19</TD><TD>RNase_HII/HIII_dom</TD><TD>interpro domains</TD><TD>IPR024567</TD><TD>1</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>RNASEH2A</TD></TR>
<TR><TD>5.589e-03</TD><TD>-5.19</TD><TD>PRibGlycinamide_synth_CS</TD><TD>interpro domains</TD><TD>IPR020559</TD><TD>1</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>GART</TD></TR>
<TR><TD>5.589e-03</TD><TD>-5.19</TD><TD>UPF0317_mt</TD><TD>interpro domains</TD><TD>IPR017135</TD><TD>1</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>C14orf159</TD></TR>
<TR><TD>5.589e-03</TD><TD>-5.19</TD><TD>Ferroportin-1</TD><TD>interpro domains</TD><TD>IPR009716</TD><TD>1</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>SLC40A1</TD></TR>
<TR><TD>5.589e-03</TD><TD>-5.19</TD><TD>RNase_H2_suA</TD><TD>interpro domains</TD><TD>IPR004649</TD><TD>1</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>RNASEH2A</TD></TR>
<TR><TD>5.589e-03</TD><TD>-5.19</TD><TD>Transl_elong_Ts_CS</TD><TD>interpro domains</TD><TD>IPR018101</TD><TD>1</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>TSFM</TD></TR>
<TR><TD>5.589e-03</TD><TD>-5.19</TD><TD>DUF4639</TD><TD>interpro domains</TD><TD>IPR028042</TD><TD>1</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>C2orf81</TD></TR>
<TR><TD>5.589e-03</TD><TD>-5.19</TD><TD>PurN</TD><TD>interpro domains</TD><TD>IPR004607</TD><TD>1</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>GART</TD></TR>
<TR><TD>5.589e-03</TD><TD>-5.19</TD><TD>UBE3A</TD><TD>interpro domains</TD><TD>IPR017134</TD><TD>1</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>UBE3A</TD></TR>
<TR><TD>5.589e-03</TD><TD>-5.19</TD><TD>DUF4042</TD><TD>interpro domains</TD><TD>IPR025283</TD><TD>1</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>HEATR6</TD></TR>
<TR><TD>5.589e-03</TD><TD>-5.19</TD><TD>RNase_HII/HIII</TD><TD>interpro domains</TD><TD>IPR001352</TD><TD>1</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>RNASEH2A</TD></TR>
<TR><TD>5.589e-03</TD><TD>-5.19</TD><TD>ARD</TD><TD>interpro domains</TD><TD>IPR004313</TD><TD>1</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>ADI1</TD></TR>
<TR><TD>5.589e-03</TD><TD>-5.19</TD><TD>BRG1</TD><TD>interpro domains</TD><TD>IPR030100</TD><TD>1</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>SMARCA4</TD></TR>
<TR><TD>5.589e-03</TD><TD>-5.19</TD><TD>RZZ-complex_KNTC1/ROD_C</TD><TD>interpro domains</TD><TD>IPR019527</TD><TD>1</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>KNTC1</TD></TR>
<TR><TD>5.589e-03</TD><TD>-5.19</TD><TD>MAPKKK7</TD><TD>interpro domains</TD><TD>IPR017421</TD><TD>1</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>MAP3K7</TD></TR>
<TR><TD>5.589e-03</TD><TD>-5.19</TD><TD>Tyr_kinase_non-rcpt_Jak2</TD><TD>interpro domains</TD><TD>IPR020693</TD><TD>1</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>JAK2</TD></TR>
<TR><TD>5.589e-03</TD><TD>-5.19</TD><TD>MafF</TD><TD>interpro domains</TD><TD>IPR033531</TD><TD>1</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>MAFF</TD></TR>
<TR><TD>5.589e-03</TD><TD>-5.19</TD><TD>ARD_euk</TD><TD>interpro domains</TD><TD>IPR027496</TD><TD>1</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>ADI1</TD></TR>
<TR><TD>5.589e-03</TD><TD>-5.19</TD><TD>Transl_elong_EFTs/EF1B</TD><TD>interpro domains</TD><TD>IPR001816</TD><TD>1</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>TSFM</TD></TR>
<TR><TD>5.589e-03</TD><TD>-5.19</TD><TD>LimpII</TD><TD>interpro domains</TD><TD>IPR005429</TD><TD>1</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>SCARB2</TD></TR>
<TR><TD>5.589e-03</TD><TD>-5.19</TD><TD>PRibGlycinamide_synth</TD><TD>interpro domains</TD><TD>IPR000115</TD><TD>1</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>GART</TD></TR>
<TR><TD>5.589e-03</TD><TD>-5.19</TD><TD>AAA_ATPase_CDC48</TD><TD>interpro domains</TD><TD>IPR005938</TD><TD>1</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>VCP</TD></TR>
<TR><TD>5.589e-03</TD><TD>-5.19</TD><TD>Protein_GAPT</TD><TD>interpro domains</TD><TD>IPR021082</TD><TD>1</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>GAPT</TD></TR>
<TR><TD>5.589e-03</TD><TD>-5.19</TD><TD>AZUL</TD><TD>interpro domains</TD><TD>IPR032353</TD><TD>1</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>UBE3A</TD></TR>
<TR><TD>5.589e-03</TD><TD>-5.19</TD><TD>D_ribokin</TD><TD>interpro domains</TD><TD>IPR011877</TD><TD>1</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>RBKS</TD></TR>
<TR><TD>5.589e-03</TD><TD>-5.19</TD><TD>ARC1B</TD><TD>interpro domains</TD><TD>IPR030141</TD><TD>1</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>ARPC1B</TD></TR>
<TR><TD>5.589e-03</TD><TD>-5.19</TD><TD>DUF1445</TD><TD>interpro domains</TD><TD>IPR009906</TD><TD>1</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>C14orf159</TD></TR>
<TR><TD>5.589e-03</TD><TD>-5.19</TD><TD>FATP6</TD><TD>interpro domains</TD><TD>IPR030309</TD><TD>1</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>SLC27A6</TD></TR>
<TR><TD>5.589e-03</TD><TD>-5.19</TD><TD>RNase_HII_hlx-loop-hlx_cap_dom</TD><TD>interpro domains</TD><TD>IPR023160</TD><TD>1</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>RNASEH2A</TD></TR>
<TR><TD>5.589e-03</TD><TD>-5.19</TD><TD>Nuc_orp_HMR_rcpt</TD><TD>interpro domains</TD><TD>IPR003071</TD><TD>1</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>NR4A1</TD></TR>
<TR><TD>5.589e-03</TD><TD>-5.19</TD><TD>ENC1</TD><TD>interpro domains</TD><TD>IPR030562</TD><TD>1</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>ENC1</TD></TR>
<TR><TD>5.589e-03</TD><TD>-5.19</TD><TD>Connexin26</TD><TD>interpro domains</TD><TD>IPR002268</TD><TD>1</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>GJB2</TD></TR>
<TR><TD>5.589e-03</TD><TD>-5.19</TD><TD>Ribo/fructo_kinase</TD><TD>interpro domains</TD><TD>IPR002139</TD><TD>1</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>RBKS</TD></TR>
<TR><TD>5.589e-03</TD><TD>-5.19</TD><TD>Mediatior_Med7</TD><TD>interpro domains</TD><TD>IPR009244</TD><TD>1</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>MED7</TD></TR>
<TR><TD>5.589e-03</TD><TD>-5.19</TD><TD>PRibGlycinamide_synth_C-dom</TD><TD>interpro domains</TD><TD>IPR020560</TD><TD>1</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>GART</TD></TR>
<TR><TD>5.589e-03</TD><TD>-5.19</TD><TD>FBXO31</TD><TD>interpro domains</TD><TD>IPR026941</TD><TD>1</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>FBXO31</TD></TR>
<TR><TD>5.589e-03</TD><TD>-5.19</TD><TD>DUF4392</TD><TD>interpro domains</TD><TD>IPR025504</TD><TD>1</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>C14orf159</TD></TR>
<TR><TD>5.589e-03</TD><TD>-5.19</TD><TD>DUF1713</TD><TD>interpro domains</TD><TD>IPR013177</TD><TD>1</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>AURKAIP1</TD></TR>
<TR><TD>5.589e-03</TD><TD>-5.19</TD><TD>FosB</TD><TD>interpro domains</TD><TD>IPR029813</TD><TD>1</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>FOSB</TD></TR>
<TR><TD>5.589e-03</TD><TD>-5.19</TD><TD>PRibGlycinamid_synth_ATP-grasp</TD><TD>interpro domains</TD><TD>IPR020561</TD><TD>1</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>GART</TD></TR>
<TR><TD>5.589e-03</TD><TD>-5.19</TD><TD>PurM_cligase</TD><TD>interpro domains</TD><TD>IPR004733</TD><TD>1</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>GART</TD></TR>
<TR><TD>5.589e-03</TD><TD>-5.19</TD><TD>Transl_elong_EFTs/EF1B_dimer</TD><TD>interpro domains</TD><TD>IPR014039</TD><TD>1</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>TSFM</TD></TR>
<TR><TD>5.590e-03</TD><TD>-5.19</TD><TD>ARIH2 (ariadne RBR E3 ubiquitin protein ligase 2)</TD><TD>protein interactions</TD><TD>10425</TD><TD>66</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>EEF1A1,ARIH2,VCP</TD></TR>
<TR><TD>5.604e-03</TD><TD>-5.18</TD><TD>DRADA_REPEAT</TD><TD>prosite domains</TD><TD>PS50139</TD><TD>1</TD><TD>1</TD><TD>11955</TD><TD>67</TD>
<TD>ADAR</TD></TR>
<TR><TD>5.604e-03</TD><TD>-5.18</TD><TD>EF_TS_1</TD><TD>prosite domains</TD><TD>PS01126</TD><TD>1</TD><TD>1</TD><TD>11955</TD><TD>67</TD>
<TD>TSFM</TD></TR>
<TR><TD>5.604e-03</TD><TD>-5.18</TD><TD>EF_TS_2</TD><TD>prosite domains</TD><TD>PS01127</TD><TD>1</TD><TD>1</TD><TD>11955</TD><TD>67</TD>
<TD>TSFM</TD></TR>
<TR><TD>5.604e-03</TD><TD>-5.18</TD><TD>GARS</TD><TD>prosite domains</TD><TD>PS00184</TD><TD>1</TD><TD>1</TD><TD>11955</TD><TD>67</TD>
<TD>GART</TD></TR>
<TR><TD>5.645e-03</TD><TD>-5.18</TD><TD>iron channel activity</TD><TD>molecular function</TD><TD>GO:0097689</TD><TD>1</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>SLC40A1</TD></TR>
<TR><TD>5.645e-03</TD><TD>-5.18</TD><TD>acireductone dioxygenase [iron(II)-requiring] activity</TD><TD>molecular function</TD><TD>GO:0010309</TD><TD>1</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>ADI1</TD></TR>
<TR><TD>5.645e-03</TD><TD>-5.18</TD><TD>nitric-oxide synthase inhibitor activity</TD><TD>molecular function</TD><TD>GO:0036487</TD><TD>1</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>ATP2B4</TD></TR>
<TR><TD>5.645e-03</TD><TD>-5.18</TD><TD>phosphoribosylformylglycinamidine cyclo-ligase activity</TD><TD>molecular function</TD><TD>GO:0004641</TD><TD>1</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>GART</TD></TR>
<TR><TD>5.645e-03</TD><TD>-5.18</TD><TD>histone kinase activity (H3-Y41 specific)</TD><TD>molecular function</TD><TD>GO:0035401</TD><TD>1</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>JAK2</TD></TR>
<TR><TD>5.645e-03</TD><TD>-5.18</TD><TD>phosphoribosylglycinamide formyltransferase activity</TD><TD>molecular function</TD><TD>GO:0004644</TD><TD>1</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>GART</TD></TR>
<TR><TD>5.645e-03</TD><TD>-5.18</TD><TD>ribokinase activity</TD><TD>molecular function</TD><TD>GO:0004747</TD><TD>1</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>RBKS</TD></TR>
<TR><TD>5.645e-03</TD><TD>-5.18</TD><TD>phosphoribosylamine-glycine ligase activity</TD><TD>molecular function</TD><TD>GO:0004637</TD><TD>1</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>GART</TD></TR>
<TR><TD>5.645e-03</TD><TD>-5.18</TD><TD>histone tyrosine kinase activity</TD><TD>molecular function</TD><TD>GO:0035400</TD><TD>1</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>JAK2</TD></TR>
<TR><TD>5.696e-03</TD><TD>-5.17</TD><TD>GARS_C</TD><TD>smart domains</TD><TD>SM01210</TD><TD>1</TD><TD>1</TD><TD>9480</TD><TD>54</TD>
<TD>GART</TD></TR>
<TR><TD>5.696e-03</TD><TD>-5.17</TD><TD>DUF1713</TD><TD>smart domains</TD><TD>SM01155</TD><TD>1</TD><TD>1</TD><TD>9480</TD><TD>54</TD>
<TD>AURKAIP1</TD></TR>
<TR><TD>5.763e-03</TD><TD>-5.16</TD><TD>RNase_HII</TD><TD>pfam domains</TD><TD>PF01351</TD><TD>1</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>RNASEH2A</TD></TR>
<TR><TD>5.763e-03</TD><TD>-5.16</TD><TD>DUF4639</TD><TD>pfam domains</TD><TD>PF15479</TD><TD>1</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>C2orf81</TD></TR>
<TR><TD>5.763e-03</TD><TD>-5.16</TD><TD>Med7</TD><TD>pfam domains</TD><TD>PF05983</TD><TD>1</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>MED7</TD></TR>
<TR><TD>5.763e-03</TD><TD>-5.16</TD><TD>EF_TS</TD><TD>pfam domains</TD><TD>PF00889</TD><TD>1</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>TSFM</TD></TR>
<TR><TD>5.763e-03</TD><TD>-5.16</TD><TD>DUF4042</TD><TD>pfam domains</TD><TD>PF13251</TD><TD>1</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>HEATR6</TD></TR>
<TR><TD>5.763e-03</TD><TD>-5.16</TD><TD>DUF1445</TD><TD>pfam domains</TD><TD>PF07286</TD><TD>1</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>C14orf159</TD></TR>
<TR><TD>5.763e-03</TD><TD>-5.16</TD><TD>DUF1713</TD><TD>pfam domains</TD><TD>PF08213</TD><TD>1</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>AURKAIP1</TD></TR>
<TR><TD>5.763e-03</TD><TD>-5.16</TD><TD>PPP1R32</TD><TD>pfam domains</TD><TD>PF15691</TD><TD>1</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>PPP1R32</TD></TR>
<TR><TD>5.763e-03</TD><TD>-5.16</TD><TD>GARS_A</TD><TD>pfam domains</TD><TD>PF01071</TD><TD>1</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>GART</TD></TR>
<TR><TD>5.763e-03</TD><TD>-5.16</TD><TD>Rod_C</TD><TD>pfam domains</TD><TD>PF10493</TD><TD>1</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>KNTC1</TD></TR>
<TR><TD>5.763e-03</TD><TD>-5.16</TD><TD>GARS_C</TD><TD>pfam domains</TD><TD>PF02843</TD><TD>1</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>GART</TD></TR>
<TR><TD>5.763e-03</TD><TD>-5.16</TD><TD>GARS_N</TD><TD>pfam domains</TD><TD>PF02844</TD><TD>1</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>GART</TD></TR>
<TR><TD>5.763e-03</TD><TD>-5.16</TD><TD>AZUL</TD><TD>pfam domains</TD><TD>PF16558</TD><TD>1</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>UBE3A</TD></TR>
<TR><TD>5.763e-03</TD><TD>-5.16</TD><TD>DUF4392</TD><TD>pfam domains</TD><TD>PF14336</TD><TD>1</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>C14orf159</TD></TR>
<TR><TD>5.763e-03</TD><TD>-5.16</TD><TD>ARD</TD><TD>pfam domains</TD><TD>PF03079</TD><TD>1</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>ADI1</TD></TR>
<TR><TD>5.763e-03</TD><TD>-5.16</TD><TD>FPN1</TD><TD>pfam domains</TD><TD>PF06963</TD><TD>1</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>SLC40A1</TD></TR>
<TR><TD>5.763e-03</TD><TD>-5.16</TD><TD>GAPT</TD><TD>pfam domains</TD><TD>PF11770</TD><TD>1</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>GAPT</TD></TR>
<TR><TD>5.766e-03</TD><TD>-5.16</TD><TD>BBS1 (Bardet-Biedl syndrome 1)</TD><TD>protein interactions</TD><TD>582</TD><TD>21</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>EPAS1,EEF1A1</TD></TR>
<TR><TD>5.766e-03</TD><TD>-5.16</TD><TD>C11orf49 (chromosome 11 open reading frame 49)</TD><TD>protein interactions</TD><TD>79096</TD><TD>21</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>RAB17,UBE3A</TD></TR>
<TR><TD>5.766e-03</TD><TD>-5.16</TD><TD>BATF3 (basic leucine zipper ATF-like transcription factor 3)</TD><TD>protein interactions</TD><TD>55509</TD><TD>21</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>EPAS1,MAFF</TD></TR>
<TR><TD>5.830e-03</TD><TD>-5.14</TD><TD>AP1M1 (adaptor related protein complex 1 mu 1 subunit)</TD><TD>protein interactions</TD><TD>8907</TD><TD>67</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>AP1G1,GPRASP2,RNASEH2A</TD></TR>
<TR><TD>5.830e-03</TD><TD>-5.14</TD><TD>NFE2L2 (nuclear factor, erythroid 2 like 2)</TD><TD>protein interactions</TD><TD>4780</TD><TD>67</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>SMARCA4,MAFF,ENC1</TD></TR>
<TR><TD>5.832e-03</TD><TD>-5.14</TD><TD>ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF</TD><TD>MSigDB lists</TD><TD>ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF</TD><TD>210</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>MAFF,NR4A1,JOSD1,MYPN,FOSB</TD></TR>
<TR><TD>5.847e-03</TD><TD>-5.14</TD><TD>ACTB (actin beta)</TD><TD>protein interactions</TD><TD>60</TD><TD>299</TD><TD>6</TD><TD>16330</TD><TD>89</TD>
<TD>SMARCA4,ARPC1B,EEF1A1,UBE3A,ENC1,VCP</TD></TR>
<TR><TD>5.862e-03</TD><TD>-5.14</TD><TD>HSPB1 (heat shock protein family B (small) member 1)</TD><TD>protein interactions</TD><TD>3315</TD><TD>396</TD><TD>7</TD><TD>16330</TD><TD>89</TD>
<TD>MAP3K7,VCP,EEF1A1,FTH1,PTPN3,HSPB6,SMARCA4</TD></TR>
<TR><TD>5.899e-03</TD><TD>-5.13</TD><TD>regulation of biosynthetic process</TD><TD>biological process</TD><TD>GO:0009889</TD><TD>4246</TD><TD>35</TD><TD>16543</TD><TD>92</TD>
<TD>KDM2A,VARS2,SMARCA4,AUTS2,MAFF,EEF1A1,JAK2,ZNF683,PXYLP1,RFX2,ERN2,ATP2B4,ADAR,NR4A1,MED7,UBE3A,TSFM,ENC1,FOSB,NGDN,OTUD7B,BNC1,EHMT1,PPP1R3F,OVOL1,MAP3K7,EPAS1,EMX1,VCP,NANOG,COMMD7,MNX1,DTD1,ONECUT3,SLC40A1</TD></TR>
<TR><TD>5.913e-03</TD><TD>-5.13</TD><TD>-</TD><TD>gene3d domains</TD><TD>3.90.600.10</TD><TD>1</TD><TD>1</TD><TD>10485</TD><TD>62</TD>
<TD>GART</TD></TR>
<TR><TD>5.913e-03</TD><TD>-5.13</TD><TD>-</TD><TD>gene3d domains</TD><TD>3.30.479.20</TD><TD>1</TD><TD>1</TD><TD>10485</TD><TD>62</TD>
<TD>TSFM</TD></TR>
<TR><TD>5.913e-03</TD><TD>-5.13</TD><TD>-</TD><TD>gene3d domains</TD><TD>1.10.10.460</TD><TD>1</TD><TD>1</TD><TD>10485</TD><TD>62</TD>
<TD>RNASEH2A</TD></TR>
<TR><TD>5.971e-03</TD><TD>-5.12</TD><TD>JIANG_HYPOXIA_NORMAL</TD><TD>MSigDB lists</TD><TD>JIANG_HYPOXIA_NORMAL</TD><TD>300</TD><TD>6</TD><TD>17621</TD><TD>96</TD>
<TD>MAP1LC3B,RBKS,EEF1A1,FTH1,ARIH2,ADAR</TD></TR>
<TR><TD>6.082e-03</TD><TD>-5.10</TD><TD>adrenal_gland</TD><TD>COSMIC cancer mutations</TD><TD>adrenal_gland</TD><TD>2706</TD><TD>24</TD><TD>17630</TD><TD>93</TD>
<TD>CHL1,TANK,C14orf159,ALAS2,ADAR,NR4A1,JAK2,MFSD6,FGD5,PTPN3,RGSL1,GART,ENC1,AUTS2,SMARCA4,DTD1,EHMT1,RBKS,KCNA2,KNTC1,OTUD7B,BNC1,VCP,OSBPL7</TD></TR>
<TR><TD>6.138e-03</TD><TD>-5.09</TD><TD>CONNEXINB2</TD><TD>prints domains</TD><TD>PR01139</TD><TD>1</TD><TD>1</TD><TD>4725</TD><TD>29</TD>
<TD>GJB2</TD></TR>
<TR><TD>6.138e-03</TD><TD>-5.09</TD><TD>LIMPII</TD><TD>prints domains</TD><TD>PR01611</TD><TD>1</TD><TD>1</TD><TD>4725</TD><TD>29</TD>
<TD>SCARB2</TD></TR>
<TR><TD>6.138e-03</TD><TD>-5.09</TD><TD>HMRNUCRECPTR</TD><TD>prints domains</TD><TD>PR01285</TD><TD>1</TD><TD>1</TD><TD>4725</TD><TD>29</TD>
<TD>NR4A1</TD></TR>
<TR><TD>6.138e-03</TD><TD>-5.09</TD><TD>KV12CHANNEL</TD><TD>prints domains</TD><TD>PR01509</TD><TD>1</TD><TD>1</TD><TD>4725</TD><TD>29</TD>
<TD>KCNA2</TD></TR>
<TR><TD>6.138e-03</TD><TD>-5.09</TD><TD>PROTEINGAPT</TD><TD>prints domains</TD><TD>PR02077</TD><TD>1</TD><TD>1</TD><TD>4725</TD><TD>29</TD>
<TD>GAPT</TD></TR>
<TR><TD>6.138e-03</TD><TD>-5.09</TD><TD>RIBOKINASE</TD><TD>prints domains</TD><TD>PR00990</TD><TD>1</TD><TD>1</TD><TD>4725</TD><TD>29</TD>
<TD>RBKS</TD></TR>
<TR><TD>6.138e-03</TD><TD>-5.09</TD><TD>JANUSKINASE2</TD><TD>prints domains</TD><TD>PR01825</TD><TD>1</TD><TD>1</TD><TD>4725</TD><TD>29</TD>
<TD>JAK2</TD></TR>
<TR><TD>6.166e-03</TD><TD>-5.09</TD><TD>p53 binding</TD><TD>molecular function</TD><TD>GO:0002039</TD><TD>66</TD><TD>3</TD><TD>16652</TD><TD>94</TD>
<TD>EHMT1,SMARCA4,TP53BP2</TD></TR>
<TR><TD>6.193e-03</TD><TD>-5.08</TD><TD>AGGGCAG,MIR-18A</TD><TD>MSigDB lists</TD><TD>AGGGCAG,MIR-18A</TD><TD>134</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>EMX1,KDM2A,ENC1,ZFYVE1</TD></TR>
<TR><TD>6.298e-03</TD><TD>-5.07</TD><TD>human chr3q13.2</TD><TD>chromosome location</TD><TD>human chr3q13.2</TD><TD>30</TD><TD>2</TD><TD>26234</TD><TD>104</TD>
<TD>USF3,GCSAM</TD></TR>
<TR><TD>6.320e-03</TD><TD>-5.06</TD><TD>GO_AXON_REGENERATION</TD><TD>MSigDB lists</TD><TD>GO_AXON_REGENERATION</TD><TD>22</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>JAK2,CHL1</TD></TR>
<TR><TD>6.320e-03</TD><TD>-5.06</TD><TD>GO_REGULATION_OF_TRANSLATIONAL_ELONGATION</TD><TD>MSigDB lists</TD><TD>GO_REGULATION_OF_TRANSLATIONAL_ELONGATION</TD><TD>22</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>DTD1,VARS2</TD></TR>
<TR><TD>6.326e-03</TD><TD>-5.06</TD><TD>STAT6 (signal transducer and activator of transcription 6)</TD><TD>protein interactions</TD><TD>6778</TD><TD>69</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>USP8,EEF1A1,GART</TD></TR>
<TR><TD>6.326e-03</TD><TD>-5.06</TD><TD>NIPSNAP1 (nipsnap homolog 1)</TD><TD>protein interactions</TD><TD>8508</TD><TD>69</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>KNTC1,VCP,MAP1LC3B</TD></TR>
<TR><TD>6.509e-03</TD><TD>-5.03</TD><TD>SEM1 (SEM1, 26S proteasome complex subunit)</TD><TD>protein interactions</TD><TD>7979</TD><TD>136</TD><TD>4</TD><TD>16330</TD><TD>89</TD>
<TD>VCP,EEF1A1,UBE3A,MAP1LC3B</TD></TR>
<TR><TD>6.511e-03</TD><TD>-5.03</TD><TD>metal ion homeostasis</TD><TD>biological process</TD><TD>GO:0055065</TD><TD>498</TD><TD>8</TD><TD>16543</TD><TD>92</TD>
<TD>RMDN3,ATP2B4,EPAS1,JAK2,FTL,ALAS2,FTH1,SLC40A1</TD></TR>
<TR><TD>6.535e-03</TD><TD>-5.03</TD><TD>Scavenging by Class A Receptors</TD><TD>REACTOME pathways</TD><TD>R-HSA-3000480</TD><TD>21</TD><TD>2</TD><TD>10293</TD><TD>60</TD>
<TD>FTL,FTH1</TD></TR>
<TR><TD>6.637e-03</TD><TD>-5.02</TD><TD>5-aminoimidazole ribonucleotide biosynthesis I</TD><TD>BIOCYC pathways</TD><TD>META_PWY-6121</TD><TD>2</TD><TD>1</TD><TD>903</TD><TD>3</TD>
<TD>GART</TD></TR>
<TR><TD>6.637e-03</TD><TD>-5.02</TD><TD>tetrahydrofolate salvage from 5,10-methenyltetrahydrofolate</TD><TD>BIOCYC pathways</TD><TD>META_PWY-6613</TD><TD>2</TD><TD>1</TD><TD>903</TD><TD>3</TD>
<TD>GART</TD></TR>
<TR><TD>6.637e-03</TD><TD>-5.02</TD><TD>5-aminoimidazole ribonucleotide biosynthesis</TD><TD>BIOCYC pathways</TD><TD>HUMAN_PWY-6121</TD><TD>2</TD><TD>1</TD><TD>903</TD><TD>3</TD>
<TD>GART</TD></TR>
<TR><TD>6.637e-03</TD><TD>-5.02</TD><TD>tetrahydrofolate salvage from 5,10-methenyltetrahydrofolate</TD><TD>BIOCYC pathways</TD><TD>HUMAN_PWY-6613</TD><TD>2</TD><TD>1</TD><TD>903</TD><TD>3</TD>
<TD>GART</TD></TR>
<TR><TD>6.664e-03</TD><TD>-5.01</TD><TD>lung-carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>lung-carcinoma</TD><TD>4337</TD><TD>34</TD><TD>17630</TD><TD>93</TD>
<TD>MAP3K7,SMARCA4,FBXO31,UBE3A,VCP,NUP37,MAFF,JAK2,F10,TP53BP2,ALAS2,IFT27,ENC1,RGSL1,TPM4,FGD5,EPAS1,MNX1,GPRASP2,ARPC1B,HEATR6,KNTC1,PPP1R3F,FOSB,TACC2,TANK,CASP6,RAB17,KDM2A,USP8,HSPB6,PTPN3,EEF1A1,SERPINB10</TD></TR>
<TR><TD>6.750e-03</TD><TD>-5.00</TD><TD>GO_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_CONJUGATION_OR_REMOVAL</TD><TD>MSigDB lists</TD><TD>GO_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_CONJUGATION_OR_REMOVAL</TD><TD>855</TD><TD>11</TD><TD>17621</TD><TD>96</TD>
<TD>POM121C,FBXO31,UBE3A,OTUD7B,VCP,JOSD1,ARIH2,MED7,ENC1,NUP37,USP8</TD></TR>
<TR><TD>6.898e-03</TD><TD>-4.98</TD><TD>CSF3R (colony stimulating factor 3 receptor)</TD><TD>protein interactions</TD><TD>1441</TD><TD>23</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>FTH1,JAK2</TD></TR>
<TR><TD>7.045e-03</TD><TD>-4.96</TD><TD>neuroendocrine_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>neuroendocrine_carcinoma</TD><TD>24</TD><TD>2</TD><TD>17630</TD><TD>93</TD>
<TD>SMARCA4,JAK2</TD></TR>
<TR><TD>7.138e-03</TD><TD>-4.94</TD><TD>MDM2 (MDM2 proto-oncogene)</TD><TD>protein interactions</TD><TD>4193</TD><TD>411</TD><TD>7</TD><TD>16330</TD><TD>89</TD>
<TD>ARIH2,VCP,EHMT1,UBE3A,EEF1A1,FBXO31,SMARCA4</TD></TR>
<TR><TD>7.188e-03</TD><TD>-4.94</TD><TD>GO_REGULATION_OF_CELL_CYCLE_PHASE_TRANSITION</TD><TD>MSigDB lists</TD><TD>GO_REGULATION_OF_CELL_CYCLE_PHASE_TRANSITION</TD><TD>312</TD><TD>6</TD><TD>17621</TD><TD>96</TD>
<TD>KNTC1,PLK5,FBXO31,SMARCA4,OVOL1,ATP2B4</TD></TR>
<TR><TD>7.327e-03</TD><TD>-4.92</TD><TD>intracellular membrane-bounded organelle</TD><TD>cellular component</TD><TD>GO:0043231</TD><TD>10282</TD><TD>69</TD><TD>17744</TD><TD>98</TD>
<TD>C14orf159,KNTC1,USF3,MED7,HSPB6,GJB2,ALAS2,OVOL1,MYPN,ARIH2,VARS2,NR4A1,RFX2,COMMD7,RNASEH2A,EHMT1,KCNA2,EEF1A1,BNC1,FOSB,F10,ONECUT3,HEXA,MNX1,AURKAIP1,EMX1,FGD5,COQ8A,UGT1A6,NANOG,USP8,OSBPL7,NUP37,ENC1,SCARB2,MAP3K7,FTL,POM121C,ADAR,ADI1,CASP6,RMDN3,TACC2,PXYLP1,MAP1LC3B,ZNF683,VCP,CHID1,TSFM,DTD1,RBKS,OTUD7B,UBE3A,ATP2B4,JAK2,AP1G1,NGDN,SERPINB10,KDM2A,EPAS1,ZFYVE1,TP53BP2,KCNG3,SMARCA4,MAFF,FTH1,ERN2,AUTS2,PLK5</TD></TR>
<TR><TD>7.394e-03</TD><TD>-4.91</TD><TD>MED17 (mediator complex subunit 17)</TD><TD>protein interactions</TD><TD>9440</TD><TD>73</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>SMARCA4,MED7,EPAS1</TD></TR>
<TR><TD>7.394e-03</TD><TD>-4.91</TD><TD>GO_REGULATION_OF_CELL_CYCLE_G1_S_PHASE_TRANSITION</TD><TD>MSigDB lists</TD><TD>GO_REGULATION_OF_CELL_CYCLE_G1_S_PHASE_TRANSITION</TD><TD>141</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>FBXO31,SMARCA4,ATP2B4,PLK5</TD></TR>
<TR><TD>7.498e-03</TD><TD>-4.89</TD><TD>GO_PROTEIN_K48_LINKED_DEUBIQUITINATION</TD><TD>MSigDB lists</TD><TD>GO_PROTEIN_K48_LINKED_DEUBIQUITINATION</TD><TD>24</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>OTUD7B,USP8</TD></TR>
<TR><TD>7.499e-03</TD><TD>-4.89</TD><TD>IL4R (interleukin 4 receptor)</TD><TD>protein interactions</TD><TD>3566</TD><TD>24</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>JAK2,ARIH2</TD></TR>
<TR><TD>7.525e-03</TD><TD>-4.89</TD><TD>Renal cell carcinoma(PMID:21131975)</TD><TD>GWAS genes</TD><TD>Renal cell carcinoma(PMID:21131975)</TD><TD>2</TD><TD>1</TD><TD>2388</TD><TD>9</TD>
<TD>EPAS1</TD></TR>
<TR><TD>7.525e-03</TD><TD>-4.89</TD><TD>Optic disc size (disc)(PMID:20395239)</TD><TD>GWAS genes</TD><TD>Optic disc size (disc)(PMID:20395239)</TD><TD>2</TD><TD>1</TD><TD>2388</TD><TD>9</TD>
<TD>MYPN</TD></TR>
<TR><TD>7.544e-03</TD><TD>-4.89</TD><TD>single-organism cellular process</TD><TD>biological process</TD><TD>GO:0044763</TD><TD>9376</TD><TD>64</TD><TD>16543</TD><TD>92</TD>
<TD>HEXA,ADI1,ZNF683,ERN2,KDM2A,MAFF,AURKAIP1,ADAMTSL2,NR4A1,FBXO31,SLC27A6,AP1G1,KNTC1,UGT1A6,MAP3K7,TPM4,POM121C,KCNG3,SCARB2,CHODL,IFT27,FGD5,CASP6,ARPC1B,MNX1,FTH1,SLC40A1,ONECUT3,VCP,KCNA2,TACC2,PXYLP1,RFX2,RMDN3,SHB,VARS2,SMARCA4,PLK5,JAK2,USF3,ENC1,GAPT,ADAR,ATP2B4,ALAS2,GART,NUP37,TMEM198,GJB2,USP8,OVOL1,CDH7,TP53BP2,MYPN,RAB17,BNC1,CHL1,DTD1,EPAS1,EMX1,COQ8A,NANOG,FTL,ARIH2</TD></TR>
<TR><TD>7.577e-03</TD><TD>-4.88</TD><TD>GSE36891_UNSTIM_VS_POLYIC_TLR3_STIM_PERITONEAL_MACROPHAGE_UP</TD><TD>MSigDB lists</TD><TD>GSE36891_UNSTIM_VS_POLYIC_TLR3_STIM_PERITONEAL_MACROPHAGE_UP</TD><TD>142</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>MAFF,NR4A1,ENC1,FOSB</TD></TR>
<TR><TD>7.612e-03</TD><TD>-4.88</TD><TD>V$SOX9_B1</TD><TD>MSigDB lists</TD><TD>V$SOX9_B1</TD><TD>224</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>NR4A1,ZFYVE1,OTUD7B,CHL1,UBE3A</TD></TR>
<TR><TD>7.745e-03</TD><TD>-4.86</TD><TD>MULLIGHAN_NPM1_SIGNATURE_3_UP</TD><TD>MSigDB lists</TD><TD>MULLIGHAN_NPM1_SIGNATURE_3_UP</TD><TD>317</TD><TD>6</TD><TD>17621</TD><TD>96</TD>
<TD>TANK,RBKS,RGSL1,VCP,MAP3K7,ARIH2</TD></TR>
<TR><TD>7.758e-03</TD><TD>-4.86</TD><TD>protein binding</TD><TD>molecular function</TD><TD>GO:0005515</TD><TD>10733</TD><TD>72</TD><TD>16652</TD><TD>94</TD>
<TD>EEF1A1,JAK2,GCSAM,TACC2,ARPC1B,TP53BP2,SHB,MYPN,VCP,AURKAIP1,RBKS,KCNA2,RAB17,FOSB,ADAMTSL2,PTPN3,POM121C,ADAR,HSPB6,LGALS2,OTUD7B,MAP1LC3B,EMX1,EHMT1,CHID1,ARIH2,TANK,TPM4,USF3,NANOG,COQ8A,GPRASP2,ZFYVE1,FTL,CASP6,CHL1,PXYLP1,ATP2B4,KDM2A,KCNG3,ADI1,JOSD1,MED7,PPP1R32,NUP37,NGDN,SLC52A2,MAP3K7,SLC40A1,AP1G1,RMDN3,USP8,RFX2,F10,OSBPL7,ENC1,IFT27,C14orf159,EPAS1,UGT1A6,PPP1R3F,FTH1,NR4A1,COMMD7,ALAS2,SMARCA4,SCARB2,HEXA,FBXO31,UBE3A,KNTC1,FGD5</TD></TR>
<TR><TD>8.122e-03</TD><TD>-4.81</TD><TD>GO_EXTRINSIC_COMPONENT_OF_ORGANELLE_MEMBRANE</TD><TD>MSigDB lists</TD><TD>GO_EXTRINSIC_COMPONENT_OF_ORGANELLE_MEMBRANE</TD><TD>25</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>ZFYVE1,USP8</TD></TR>
<TR><TD>8.122e-03</TD><TD>-4.81</TD><TD>GTF2A1L (general transcription factor IIA subunit 1 like)</TD><TD>protein interactions</TD><TD>11036</TD><TD>25</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>EMX1,MAFF</TD></TR>
<TR><TD>8.122e-03</TD><TD>-4.81</TD><TD>BTF3L4 (basic transcription factor 3 like 4)</TD><TD>protein interactions</TD><TD>91408</TD><TD>25</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>UBE3A,ARPC1B</TD></TR>
<TR><TD>8.122e-03</TD><TD>-4.81</TD><TD>YOD1 (YOD1 deubiquitinase)</TD><TD>protein interactions</TD><TD>55432</TD><TD>25</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>VCP,UBE3A</TD></TR>
<TR><TD>8.122e-03</TD><TD>-4.81</TD><TD>UBE2G1 (ubiquitin conjugating enzyme E2 G1)</TD><TD>protein interactions</TD><TD>7326</TD><TD>25</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>UBE3A,USP8</TD></TR>
<TR><TD>8.145e-03</TD><TD>-4.81</TD><TD>GSE36891_POLYIC_TLR3_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_UP</TD><TD>MSigDB lists</TD><TD>GSE36891_POLYIC_TLR3_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_UP</TD><TD>145</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>NR4A1,MAFF,RBKS,FOSB</TD></TR>
<TR><TD>8.267e-03</TD><TD>-4.80</TD><TD>GO_AUTOPHAGOSOME</TD><TD>MSigDB lists</TD><TD>GO_AUTOPHAGOSOME</TD><TD>76</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>MAP1LC3B,OSBPL7,ZFYVE1</TD></TR>
<TR><TD>8.267e-03</TD><TD>-4.80</TD><TD>GO_THIOL_DEPENDENT_UBIQUITIN_SPECIFIC_PROTEASE_ACTIVITY</TD><TD>MSigDB lists</TD><TD>GO_THIOL_DEPENDENT_UBIQUITIN_SPECIFIC_PROTEASE_ACTIVITY</TD><TD>76</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>USP8,OTUD7B,JOSD1</TD></TR>
<TR><TD>8.333e-03</TD><TD>-4.79</TD><TD>intracellular part</TD><TD>cellular component</TD><TD>GO:0044424</TD><TD>13571</TD><TD>85</TD><TD>17744</TD><TD>98</TD>
<TD>MAP3K7,FTL,POM121C,CHODL,SLC40A1,ENC1,NUP37,SCARB2,OSBPL7,CHID1,VCP,TSFM,RAB17,MAP1LC3B,PXYLP1,ZNF683,GCSAM,RMDN3,CASP6,FBXO31,TACC2,ADAR,ADI1,SERPINB10,IFT27,AP1G1,TPM4,NGDN,KDM2A,JAK2,UBE3A,ATP2B4,DTD1,RBKS,OTUD7B,PLK5,AUTS2,ERN2,FTH1,TP53BP2,KCNG3,ZFYVE1,EPAS1,MAFF,SMARCA4,GPRASP2,ARIH2,MYPN,VARS2,ALAS2,OVOL1,HSPB6,MED7,GJB2,KNTC1,C14orf159,USF3,TANK,EEF1A1,KCNA2,ARPC1B,FOSB,BNC1,RNASEH2A,EHMT1,COMMD7,RFX2,PTPN3,NR4A1,MNX1,ONECUT3,HEXA,GART,RGSL1,F10,NANOG,USP8,UGT1A6,COQ8A,EMX1,JOSD1,FGD5,TMEM198,SHB,AURKAIP1</TD></TR>
<TR><TD>8.340e-03</TD><TD>-4.79</TD><TD>GSE41867_DAY8_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE41867_DAY8_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP</TD><TD>146</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>KCNA2,SLC27A6,CEACAM19,PLK5</TD></TR>
<TR><TD>8.445e-03</TD><TD>-4.77</TD><TD>protein K48-linked deubiquitination</TD><TD>biological process</TD><TD>GO:0071108</TD><TD>25</TD><TD>2</TD><TD>16543</TD><TD>92</TD>
<TD>OTUD7B,USP8</TD></TR>
<TR><TD>8.445e-03</TD><TD>-4.77</TD><TD>regulation of translational elongation</TD><TD>biological process</TD><TD>GO:0006448</TD><TD>25</TD><TD>2</TD><TD>16543</TD><TD>92</TD>
<TD>VARS2,DTD1</TD></TR>
<TR><TD>8.445e-03</TD><TD>-4.77</TD><TD>protein K63-linked deubiquitination</TD><TD>biological process</TD><TD>GO:0070536</TD><TD>25</TD><TD>2</TD><TD>16543</TD><TD>92</TD>
<TD>OTUD7B,USP8</TD></TR>
<TR><TD>8.632e-03</TD><TD>-4.75</TD><TD>V$CACBINDINGPROTEIN_Q6</TD><TD>MSigDB lists</TD><TD>V$CACBINDINGPROTEIN_Q6</TD><TD>231</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>CHL1,ZFYVE1,KNTC1,AP1G1,EEF1A1</TD></TR>
<TR><TD>8.768e-03</TD><TD>-4.74</TD><TD>UBE4A (ubiquitination factor E4A)</TD><TD>protein interactions</TD><TD>9354</TD><TD>26</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>VCP,CASP6</TD></TR>
<TR><TD>8.768e-03</TD><TD>-4.74</TD><TD>OSTF1 (osteoclast stimulating factor 1)</TD><TD>protein interactions</TD><TD>26578</TD><TD>26</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>TPM4,ADI1</TD></TR>
<TR><TD>8.771e-03</TD><TD>-4.74</TD><TD>trans-Golgi Network Vesicle Budding</TD><TD>REACTOME pathways</TD><TD>R-HSA-199992</TD><TD>73</TD><TD>3</TD><TD>10293</TD><TD>60</TD>
<TD>FTH1,FTL,AP1G1</TD></TR>
<TR><TD>8.771e-03</TD><TD>-4.74</TD><TD>Clathrin derived vesicle budding</TD><TD>REACTOME pathways</TD><TD>R-HSA-421837</TD><TD>73</TD><TD>3</TD><TD>10293</TD><TD>60</TD>
<TD>FTL,FTH1,AP1G1</TD></TR>
<TR><TD>8.869e-03</TD><TD>-4.73</TD><TD>MAGEA1 (MAGE family member A1)</TD><TD>protein interactions</TD><TD>4100</TD><TD>78</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>RAB17,EEF1A1,UBE3A</TD></TR>
<TR><TD>9.002e-03</TD><TD>-4.71</TD><TD>extrinsic component of organelle membrane</TD><TD>cellular component</TD><TD>GO:0031312</TD><TD>26</TD><TD>2</TD><TD>17744</TD><TD>98</TD>
<TD>USP8,ZFYVE1</TD></TR>
<TR><TD>9.131e-03</TD><TD>-4.70</TD><TD>regulation of cell cycle phase transition</TD><TD>biological process</TD><TD>GO:1901987</TD><TD>322</TD><TD>6</TD><TD>16543</TD><TD>92</TD>
<TD>PLK5,OVOL1,FBXO31,ATP2B4,SMARCA4,KNTC1</TD></TR>
<TR><TD>9.134e-03</TD><TD>-4.70</TD><TD>RAD23A (RAD23 homolog A, nucleotide excision repair protein)</TD><TD>protein interactions</TD><TD>5886</TD><TD>150</TD><TD>4</TD><TD>16330</TD><TD>89</TD>
<TD>EEF1A1,UBE3A,HEXA,VCP</TD></TR>
<TR><TD>9.142e-03</TD><TD>-4.69</TD><TD>regulation of cell cycle G1/S phase transition</TD><TD>biological process</TD><TD>GO:1902806</TD><TD>147</TD><TD>4</TD><TD>16543</TD><TD>92</TD>
<TD>PLK5,SMARCA4,FBXO31,ATP2B4</TD></TR>
<TR><TD>9.151e-03</TD><TD>-4.69</TD><TD>GO_PALLIUM_DEVELOPMENT</TD><TD>MSigDB lists</TD><TD>GO_PALLIUM_DEVELOPMENT</TD><TD>150</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>ATP2B4,TACC2,GART,EMX1</TD></TR>
<TR><TD>9.151e-03</TD><TD>-4.69</TD><TD>GSE37301_HEMATOPOIETIC_STEM_CELL_VS_GRAN_MONO_PROGENITOR_UP</TD><TD>MSigDB lists</TD><TD>GSE37301_HEMATOPOIETIC_STEM_CELL_VS_GRAN_MONO_PROGENITOR_UP</TD><TD>150</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>CASP6,NR4A1,ADAR,GRAMD1B</TD></TR>
<TR><TD>9.184e-03</TD><TD>-4.69</TD><TD>NSF (N-ethylmaleimide sensitive factor, vesicle fusing ATPase)</TD><TD>protein interactions</TD><TD>4905</TD><TD>79</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>RBKS,NANOG,VCP</TD></TR>
<TR><TD>9.207e-03</TD><TD>-4.69</TD><TD>MIKKELSEN_NPC_HCP_WITH_H3K27ME3</TD><TD>MSigDB lists</TD><TD>MIKKELSEN_NPC_HCP_WITH_H3K27ME3</TD><TD>329</TD><TD>6</TD><TD>17621</TD><TD>96</TD>
<TD>ONECUT3,EMX1,PLK5,GJB2,BNC1,OVOL1</TD></TR>
<TR><TD>9.436e-03</TD><TD>-4.66</TD><TD>REACTOME_TRANSPORT_OF_RIBONUCLEOPROTEINS_INTO_THE_HOST_NUCLEUS</TD><TD>MSigDB lists</TD><TD>REACTOME_TRANSPORT_OF_RIBONUCLEOPROTEINS_INTO_THE_HOST_NUCLEUS</TD><TD>27</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>POM121C,NUP37</TD></TR>
<TR><TD>9.436e-03</TD><TD>-4.66</TD><TD>REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN</TD><TD>MSigDB lists</TD><TD>REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN</TD><TD>27</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>NUP37,POM121C</TD></TR>
<TR><TD>9.436e-03</TD><TD>-4.66</TD><TD>REACTOME_NEP_NS2_INTERACTS_WITH_THE_CELLULAR_EXPORT_MACHINERY</TD><TD>MSigDB lists</TD><TD>REACTOME_NEP_NS2_INTERACTS_WITH_THE_CELLULAR_EXPORT_MACHINERY</TD><TD>27</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>POM121C,NUP37</TD></TR>
<TR><TD>9.436e-03</TD><TD>-4.66</TD><TD>PRC1 (protein regulator of cytokinesis 1)</TD><TD>protein interactions</TD><TD>9055</TD><TD>27</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>TACC2,NANOG</TD></TR>
<TR><TD>9.436e-03</TD><TD>-4.66</TD><TD>ARNTL (aryl hydrocarbon receptor nuclear translocator like)</TD><TD>protein interactions</TD><TD>406</TD><TD>27</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>UBE3A,EPAS1</TD></TR>
<TR><TD>9.436e-03</TD><TD>-4.66</TD><TD>MCPH1 (microcephalin 1)</TD><TD>protein interactions</TD><TD>79648</TD><TD>27</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>USP8,SMARCA4</TD></TR>
<TR><TD>9.501e-03</TD><TD>-4.66</TD><TD>GO_ENZYME_BINDING</TD><TD>MSigDB lists</TD><TD>GO_ENZYME_BINDING</TD><TD>1692</TD><TD>17</TD><TD>17621</TD><TD>96</TD>
<TD>ATP2B4,TANK,PPP1R32,FGD5,UGT1A6,VCP,JAK2,PTPN3,CHL1,SMARCA4,EEF1A1,AP1G1,ARIH2,SCARB2,MAP1LC3B,PPP1R3F,EPAS1</TD></TR>
<TR><TD>9.524e-03</TD><TD>-4.65</TD><TD>pleura-mesothelioma</TD><TD>COSMIC cancer mutations</TD><TD>pleura-mesothelioma</TD><TD>4267</TD><TD>33</TD><TD>17630</TD><TD>93</TD>
<TD>SERPINB10,EEF1A1,USP8,KDM2A,RAB17,CASP6,PTPN3,HSPB6,FOSB,TACC2,TANK,PPP1R3F,KNTC1,GPRASP2,HEATR6,EPAS1,MNX1,TPM4,RGSL1,ENC1,FGD5,IFT27,MAFF,JAK2,NUP37,ALAS2,F10,TP53BP2,UBE3A,VCP,SMARCA4,MAP3K7,FBXO31</TD></TR>
<TR><TD>9.750e-03</TD><TD>-4.63</TD><TD>regulation of metabolic process</TD><TD>biological process</TD><TD>GO:0019222</TD><TD>6040</TD><TD>45</TD><TD>16543</TD><TD>92</TD>
<TD>ENC1,TSFM,TANK,AURKAIP1,UBE3A,MED7,NR4A1,ADAR,SERPINB10,ATP2B4,ERN2,RFX2,PXYLP1,ZNF683,EEF1A1,JAK2,MAFF,AUTS2,SMARCA4,SHB,VARS2,KDM2A,ONECUT3,SLC40A1,DTD1,MNX1,PTPN3,OSBPL7,ARIH2,COMMD7,ZFYVE1,NANOG,VCP,EMX1,EPAS1,MAP3K7,OVOL1,PPP1R3F,EHMT1,NUP37,BNC1,OTUD7B,NGDN,FOSB,POM121C</TD></TR>
<TR><TD>9.792e-03</TD><TD>-4.63</TD><TD>REACTOME_INTERFERON_SIGNALING</TD><TD>MSigDB lists</TD><TD>REACTOME_INTERFERON_SIGNALING</TD><TD>153</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>NUP37,ADAR,JAK2,POM121C</TD></TR>
<TR><TD>9.792e-03</TD><TD>-4.63</TD><TD>GTGACTT,MIR-224</TD><TD>MSigDB lists</TD><TD>GTGACTT,MIR-224</TD><TD>153</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>FOSB,KDM2A,FTH1,NR4A1</TD></TR>
<TR><TD>9.810e-03</TD><TD>-4.62</TD><TD>neuron projection regeneration</TD><TD>biological process</TD><TD>GO:0031102</TD><TD>27</TD><TD>2</TD><TD>16543</TD><TD>92</TD>
<TD>CHL1,JAK2</TD></TR>
<TR><TD>9.832e-03</TD><TD>-4.62</TD><TD>SRSF11 (serine and arginine rich splicing factor 11)</TD><TD>protein interactions</TD><TD>9295</TD><TD>81</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>TANK,EEF1A1,VCP</TD></TR>
<TR><TD>9.842e-03</TD><TD>-4.62</TD><TD>GO_VACUOLAR_PART</TD><TD>MSigDB lists</TD><TD>GO_VACUOLAR_PART</TD><TD>660</TD><TD>9</TD><TD>17621</TD><TD>96</TD>
<TD>MAP3K7,HEXA,RAB17,JAK2,MAP1LC3B,SCARB2,USP8,EEF1A1,AP1G1</TD></TR>
<TR><TD>9.914e-03</TD><TD>-4.61</TD><TD>K_chnl_volt-dep_Kv</TD><TD>interpro domains</TD><TD>IPR003968</TD><TD>27</TD><TD>2</TD><TD>18428</TD><TD>103</TD>
<TD>KCNG3,KCNA2</TD></TR>
<TR><TD>9.926e-03</TD><TD>-4.61</TD><TD>TNFR1-induced NFkappaB signaling pathway</TD><TD>REACTOME pathways</TD><TD>R-HSA-5357956</TD><TD>26</TD><TD>2</TD><TD>10293</TD><TD>60</TD>
<TD>OTUD7B,MAP3K7</TD></TR>
<TR><TD>1.005e-02</TD><TD>-4.60</TD><TD>GO_MACROMOLECULE_CATABOLIC_PROCESS</TD><TD>MSigDB lists</TD><TD>GO_MACROMOLECULE_CATABOLIC_PROCESS</TD><TD>904</TD><TD>11</TD><TD>17621</TD><TD>96</TD>
<TD>USP8,ERN2,ENC1,CHID1,UBE3A,HEXA,VCP,OTUD7B,RNASEH2A,FBXO31,ARIH2</TD></TR>
<TR><TD>1.007e-02</TD><TD>-4.60</TD><TD>NRF2 pathway</TD><TD>WikiPathways</TD><TD>WP2884</TD><TD>143</TD><TD>4</TD><TD>5314</TD><TD>32</TD>
<TD>MAFF,FTH1,UGT1A6,FTL</TD></TR>
<TR><TD>1.013e-02</TD><TD>-4.59</TD><TD>GO_PROTEIN_K63_LINKED_DEUBIQUITINATION</TD><TD>MSigDB lists</TD><TD>GO_PROTEIN_K63_LINKED_DEUBIQUITINATION</TD><TD>28</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>USP8,OTUD7B</TD></TR>
<TR><TD>1.017e-02</TD><TD>-4.59</TD><TD>MODULE_204</TD><TD>MSigDB lists</TD><TD>MODULE_204</TD><TD>82</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>AUTS2,RNASEH2A,GART</TD></TR>
<TR><TD>1.022e-02</TD><TD>-4.58</TD><TD>FOS (Fos proto-oncogene, AP-1 transcription factor subunit)</TD><TD>protein interactions</TD><TD>2353</TD><TD>155</TD><TD>4</TD><TD>16330</TD><TD>89</TD>
<TD>MAFF,FOSB,MAP3K7,KDM2A</TD></TR>
<TR><TD>1.024e-02</TD><TD>-4.58</TD><TD>ACCATTT,MIR-522</TD><TD>MSigDB lists</TD><TD>ACCATTT,MIR-522</TD><TD>155</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>EHMT1,UBE3A,JOSD1,ENC1</TD></TR>
<TR><TD>1.030e-02</TD><TD>-4.58</TD><TD>renal_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>renal_cell_carcinoma</TD><TD>4627</TD><TD>35</TD><TD>17630</TD><TD>93</TD>
<TD>MNX1,EPAS1,FGD5,ENC1,TPM4,RGSL1,IFT27,F10,TP53BP2,ALAS2,NUP37,JAK2,MAFF,VCP,UBE3A,FBXO31,AUTS2,MAP3K7,SMARCA4,EEF1A1,SERPINB10,HSPB6,PTPN3,RAB17,CASP6,KDM2A,USP8,TANK,TACC2,FOSB,PPP1R3F,CDH7,KNTC1,HEATR6,GPRASP2</TD></TR>
<TR><TD>1.030e-02</TD><TD>-4.58</TD><TD>kidney-carcinoma-renal_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>kidney-carcinoma-renal_cell_carcinoma</TD><TD>4627</TD><TD>35</TD><TD>17630</TD><TD>93</TD>
<TD>UBE3A,VCP,SMARCA4,MAP3K7,FBXO31,AUTS2,EPAS1,MNX1,ENC1,TPM4,RGSL1,FGD5,IFT27,NUP37,JAK2,MAFF,TP53BP2,F10,ALAS2,CDH7,KNTC1,GPRASP2,HEATR6,EEF1A1,SERPINB10,RAB17,CASP6,KDM2A,USP8,HSPB6,PTPN3,TACC2,FOSB,TANK,PPP1R3F</TD></TR>
<TR><TD>1.031e-02</TD><TD>-4.58</TD><TD>protein modification by small protein conjugation or removal</TD><TD>biological process</TD><TD>GO:0070647</TD><TD>890</TD><TD>11</TD><TD>16543</TD><TD>92</TD>
<TD>MED7,ARIH2,UBE3A,OTUD7B,FBXO31,POM121C,VCP,USP8,ENC1,JOSD1,NUP37</TD></TR>
<TR><TD>1.051e-02</TD><TD>-4.56</TD><TD>MED12 (mediator complex subunit 12)</TD><TD>protein interactions</TD><TD>9968</TD><TD>83</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>MED7,EPAS1,NANOG</TD></TR>
<TR><TD>1.051e-02</TD><TD>-4.56</TD><TD>regulation of translation</TD><TD>biological process</TD><TD>GO:0006417</TD><TD>332</TD><TD>6</TD><TD>16543</TD><TD>92</TD>
<TD>DTD1,ENC1,NGDN,VARS2,TSFM,ADAR</TD></TR>
<TR><TD>1.053e-02</TD><TD>-4.55</TD><TD>regulation of natural killer cell activation</TD><TD>biological process</TD><TD>GO:0032814</TD><TD>28</TD><TD>2</TD><TD>16543</TD><TD>92</TD>
<TD>AP1G1,ZNF683</TD></TR>
<TR><TD>1.065e-02</TD><TD>-4.54</TD><TD>regulation of gene expression</TD><TD>biological process</TD><TD>GO:0010468</TD><TD>4241</TD><TD>34</TD><TD>16543</TD><TD>92</TD>
<TD>UBE3A,MED7,NR4A1,ATP2B4,ADAR,ENC1,TSFM,JAK2,EEF1A1,MAFF,SMARCA4,AUTS2,VARS2,KDM2A,RFX2,ERN2,ZNF683,COMMD7,NANOG,EMX1,EPAS1,SLC40A1,ONECUT3,DTD1,MNX1,BNC1,OTUD7B,NGDN,FOSB,POM121C,MAP3K7,OVOL1,EHMT1,NUP37</TD></TR>
<TR><TD>1.069e-02</TD><TD>-4.54</TD><TD>GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_UP</TD><TD>MSigDB lists</TD><TD>GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_UP</TD><TD>157</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>FGD5,FTH1,USP8,HEXA</TD></TR>
<TR><TD>1.076e-02</TD><TD>-4.53</TD><TD>lung-carcinoma-non_small_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>lung-carcinoma-non_small_cell_carcinoma</TD><TD>5329</TD><TD>39</TD><TD>17630</TD><TD>93</TD>
<TD>PTPN3,HSPB6,KDM2A,USP8,RAB17,CASP6,SERPINB10,EEF1A1,GRAMD1B,PPP1R3F,TANK,FOSB,TACC2,KNTC1,CDH7,HEATR6,GPRASP2,FGD5,AP1G1,TPM4,RGSL1,ENC1,MNX1,EPAS1,ALAS2,F10,TP53BP2,JAK2,MAFF,NUP37,IFT27,VCP,UBE3A,ADAMTSL2,AUTS2,UGT1A6,FBXO31,SMARCA4,MAP3K7</TD></TR>
<TR><TD>1.076e-02</TD><TD>-4.53</TD><TD>non_small_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>non_small_cell_carcinoma</TD><TD>5329</TD><TD>39</TD><TD>17630</TD><TD>93</TD>
<TD>KNTC1,CDH7,HEATR6,GPRASP2,SERPINB10,EEF1A1,PTPN3,HSPB6,KDM2A,USP8,RAB17,CASP6,TANK,TACC2,FOSB,GRAMD1B,PPP1R3F,VCP,UBE3A,AUTS2,UGT1A6,FBXO31,SMARCA4,MAP3K7,ADAMTSL2,MNX1,EPAS1,FGD5,AP1G1,RGSL1,TPM4,ENC1,IFT27,F10,ALAS2,TP53BP2,JAK2,MAFF,NUP37</TD></TR>
<TR><TD>1.077e-02</TD><TD>-4.53</TD><TD>regulation of cellular metabolic process</TD><TD>biological process</TD><TD>GO:0031323</TD><TD>5730</TD><TD>43</TD><TD>16543</TD><TD>92</TD>
<TD>KDM2A,SMARCA4,VARS2,SHB,AUTS2,MAFF,JAK2,EEF1A1,ZNF683,ERN2,PXYLP1,RFX2,ATP2B4,ADAR,SERPINB10,NR4A1,MED7,UBE3A,AURKAIP1,TANK,TSFM,ENC1,FOSB,NGDN,OTUD7B,BNC1,EHMT1,PPP1R3F,OVOL1,MAP3K7,EPAS1,EMX1,VCP,NANOG,ZFYVE1,COMMD7,ARIH2,OSBPL7,PTPN3,MNX1,DTD1,SLC40A1,ONECUT3</TD></TR>
<TR><TD>1.079e-02</TD><TD>-4.53</TD><TD>phosphatase binding</TD><TD>molecular function</TD><TD>GO:0019902</TD><TD>152</TD><TD>4</TD><TD>16652</TD><TD>94</TD>
<TD>PPP1R32,ATP2B4,PPP1R3F,VCP</TD></TR>
<TR><TD>1.080e-02</TD><TD>-4.53</TD><TD>cellular metal ion homeostasis</TD><TD>biological process</TD><TD>GO:0006875</TD><TD>436</TD><TD>7</TD><TD>16543</TD><TD>92</TD>
<TD>RMDN3,ATP2B4,FTL,ALAS2,SLC40A1,FTH1,JAK2</TD></TR>
<TR><TD>1.083e-02</TD><TD>-4.53</TD><TD>NF-kappaB binding</TD><TD>molecular function</TD><TD>GO:0051059</TD><TD>28</TD><TD>2</TD><TD>16652</TD><TD>94</TD>
<TD>TP53BP2,COMMD7</TD></TR>
<TR><TD>1.084e-02</TD><TD>-4.52</TD><TD>GO_NF_KAPPAB_BINDING</TD><TD>MSigDB lists</TD><TD>GO_NF_KAPPAB_BINDING</TD><TD>29</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>TP53BP2,COMMD7</TD></TR>
<TR><TD>1.084e-02</TD><TD>-4.52</TD><TD>CNOT10 (CCR4-NOT transcription complex subunit 10)</TD><TD>protein interactions</TD><TD>25904</TD><TD>29</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>VCP,EPAS1</TD></TR>
<TR><TD>1.084e-02</TD><TD>-4.52</TD><TD>FBXO2 (F-box protein 2)</TD><TD>protein interactions</TD><TD>26232</TD><TD>29</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>GJB2,VCP</TD></TR>
<TR><TD>1.084e-02</TD><TD>-4.52</TD><TD>MAP2K6 (mitogen-activated protein kinase kinase 6)</TD><TD>protein interactions</TD><TD>5608</TD><TD>29</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>FBXO31,MAP3K7</TD></TR>
<TR><TD>1.084e-02</TD><TD>-4.52</TD><TD>PAPSS1 (3'-phosphoadenosine 5'-phosphosulfate synthase 1)</TD><TD>protein interactions</TD><TD>9061</TD><TD>29</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>EEF1A1,RNASEH2A</TD></TR>
<TR><TD>1.084e-02</TD><TD>-4.52</TD><TD>BCL7C (BCL tumor suppressor 7C)</TD><TD>protein interactions</TD><TD>9274</TD><TD>29</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>SMARCA4,EPAS1</TD></TR>
<TR><TD>1.085e-02</TD><TD>-4.52</TD><TD>TRIM21 (tripartite motif containing 21)</TD><TD>protein interactions</TD><TD>6737</TD><TD>84</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>NANOG,VCP,MAP1LC3B</TD></TR>
<TR><TD>1.087e-02</TD><TD>-4.52</TD><TD>US2 (possibly envelope-associated; interacts with cytokeratin 18)</TD><TD>protein interactions</TD><TD>2703399</TD><TD>2</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>VCP</TD></TR>
<TR><TD>1.087e-02</TD><TD>-4.52</TD><TD>ZNF608 (zinc finger protein 608)</TD><TD>protein interactions</TD><TD>57507</TD><TD>2</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>AUTS2</TD></TR>
<TR><TD>1.087e-02</TD><TD>-4.52</TD><TD>DGAT2 (diacylglycerol O-acyltransferase 2)</TD><TD>protein interactions</TD><TD>84649</TD><TD>2</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>VCP</TD></TR>
<TR><TD>1.087e-02</TD><TD>-4.52</TD><TD>OTU1 (ubiquitin-specific protease OTU1)</TD><TD>protein interactions</TD><TD>850500</TD><TD>2</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>VCP</TD></TR>
<TR><TD>1.087e-02</TD><TD>-4.52</TD><TD>GJB6 (gap junction protein beta 6)</TD><TD>protein interactions</TD><TD>10804</TD><TD>2</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>GJB2</TD></TR>
<TR><TD>1.087e-02</TD><TD>-4.52</TD><TD>Cacnb3 (calcium voltage-gated channel auxiliary subunit beta 3)</TD><TD>protein interactions</TD><TD>25297</TD><TD>2</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>MAP1LC3B</TD></TR>
<TR><TD>1.087e-02</TD><TD>-4.52</TD><TD>NEB (nebulin)</TD><TD>protein interactions</TD><TD>100328572</TD><TD>2</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>MYPN</TD></TR>
<TR><TD>1.087e-02</TD><TD>-4.52</TD><TD>BPY2C (basic charge, Y-linked, 2C)</TD><TD>protein interactions</TD><TD>442868</TD><TD>2</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>UBE3A</TD></TR>
<TR><TD>1.087e-02</TD><TD>-4.52</TD><TD>BPY2 (basic charge, Y-linked, 2)</TD><TD>protein interactions</TD><TD>9083</TD><TD>2</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>UBE3A</TD></TR>
<TR><TD>1.087e-02</TD><TD>-4.52</TD><TD>Rasgrf1 (RAS protein-specific guanine nucleotide-releasing factor 1)</TD><TD>protein interactions</TD><TD>19417</TD><TD>2</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>USP8</TD></TR>
<TR><TD>1.087e-02</TD><TD>-4.52</TD><TD>Tardbp (TAR DNA binding protein)</TD><TD>protein interactions</TD><TD>230908</TD><TD>2</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>VCP</TD></TR>
<TR><TD>1.087e-02</TD><TD>-4.52</TD><TD>ABCA5 (ATP binding cassette subfamily A member 5)</TD><TD>protein interactions</TD><TD>23461</TD><TD>2</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>NR4A1</TD></TR>
<TR><TD>1.087e-02</TD><TD>-4.52</TD><TD>Su(var)205 (Suppressor of variegation 205)</TD><TD>protein interactions</TD><TD>34119</TD><TD>2</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>SMARCA4</TD></TR>
<TR><TD>1.087e-02</TD><TD>-4.52</TD><TD>IL17RD (interleukin 17 receptor D)</TD><TD>protein interactions</TD><TD>54756</TD><TD>2</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>MAP3K7</TD></TR>
<TR><TD>1.087e-02</TD><TD>-4.52</TD><TD>Dlg2 (discs large MAGUK scaffold protein 2)</TD><TD>protein interactions</TD><TD>64053</TD><TD>2</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>ATP2B4</TD></TR>
<TR><TD>1.087e-02</TD><TD>-4.52</TD><TD>SLC1A6 (solute carrier family 1 member 6)</TD><TD>protein interactions</TD><TD>6511</TD><TD>2</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>ARIH2</TD></TR>
<TR><TD>1.087e-02</TD><TD>-4.52</TD><TD>CFAP65 (cilia and flagella associated protein 65)</TD><TD>protein interactions</TD><TD>255101</TD><TD>2</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>GART</TD></TR>
<TR><TD>1.087e-02</TD><TD>-4.52</TD><TD>HRH2 (histamine receptor H2)</TD><TD>protein interactions</TD><TD>3274</TD><TD>2</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>GPRASP2</TD></TR>
<TR><TD>1.087e-02</TD><TD>-4.52</TD><TD>N6AMT1 (N-6 adenine-specific DNA methyltransferase 1 (putative))</TD><TD>protein interactions</TD><TD>29104</TD><TD>2</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>RNASEH2A</TD></TR>
<TR><TD>1.087e-02</TD><TD>-4.52</TD><TD>Mbd3 (methyl-CpG binding domain protein 3)</TD><TD>protein interactions</TD><TD>17192</TD><TD>2</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>SMARCA4</TD></TR>
<TR><TD>1.087e-02</TD><TD>-4.52</TD><TD>PDE1B (phosphodiesterase 1B)</TD><TD>protein interactions</TD><TD>5153</TD><TD>2</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>UBE3A</TD></TR>
<TR><TD>1.087e-02</TD><TD>-4.52</TD><TD>AFG3L1P (AFG3 like matrix AAA peptidase subunit 1, pseudogene)</TD><TD>protein interactions</TD><TD>172</TD><TD>2</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>UBE3A</TD></TR>
<TR><TD>1.087e-02</TD><TD>-4.52</TD><TD>ANKRD23 (ankyrin repeat domain 23)</TD><TD>protein interactions</TD><TD>200539</TD><TD>2</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>MYPN</TD></TR>
<TR><TD>1.087e-02</TD><TD>-4.52</TD><TD>RPL6P1 (ribosomal protein L6 pseudogene 1)</TD><TD>protein interactions</TD><TD>440587</TD><TD>2</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>USP8</TD></TR>
<TR><TD>1.087e-02</TD><TD>-4.52</TD><TD>PCDH15 (protocadherin related 15)</TD><TD>protein interactions</TD><TD>65217</TD><TD>2</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>NANOG</TD></TR>
<TR><TD>1.087e-02</TD><TD>-4.52</TD><TD>ZNF778 (zinc finger protein 778)</TD><TD>protein interactions</TD><TD>197320</TD><TD>2</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>VCP</TD></TR>
<TR><TD>1.087e-02</TD><TD>-4.52</TD><TD>CDH12 (cadherin 12)</TD><TD>protein interactions</TD><TD>1010</TD><TD>2</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>CDH7</TD></TR>
<TR><TD>1.090e-02</TD><TD>-4.52</TD><TD>RBX1 (ring-box 1)</TD><TD>protein interactions</TD><TD>9978</TD><TD>158</TD><TD>4</TD><TD>16330</TD><TD>89</TD>
<TD>FBXO31,MAP3K7,ENC1,EEF1A1</TD></TR>
<TR><TD>1.102e-02</TD><TD>-4.51</TD><TD>VCP-NSFL1C complex</TD><TD>cellular component</TD><TD>GO:1990730</TD><TD>2</TD><TD>1</TD><TD>17744</TD><TD>98</TD>
<TD>VCP</TD></TR>
<TR><TD>1.103e-02</TD><TD>-4.51</TD><TD>GO_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER</TD><TD>MSigDB lists</TD><TD>GO_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER</TD><TD>1719</TD><TD>17</TD><TD>17621</TD><TD>96</TD>
<TD>ATP2B4,NR4A1,EHMT1,FOSB,MNX1,AUTS2,UBE3A,ONECUT3,SMARCA4,MAFF,RFX2,MED7,OVOL1,OTUD7B,NANOG,EPAS1,SLC40A1</TD></TR>
<TR><TD>1.109e-02</TD><TD>-4.50</TD><TD>divalent metal ion export</TD><TD>biological process</TD><TD>GO:0070839</TD><TD>2</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>SLC40A1</TD></TR>
<TR><TD>1.109e-02</TD><TD>-4.50</TD><TD>regulation of extrathymic T cell differentiation</TD><TD>biological process</TD><TD>GO:0033082</TD><TD>2</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ZNF683</TD></TR>
<TR><TD>1.109e-02</TD><TD>-4.50</TD><TD>optic nerve structural organization</TD><TD>biological process</TD><TD>GO:0021633</TD><TD>2</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>KCNA2</TD></TR>
<TR><TD>1.109e-02</TD><TD>-4.50</TD><TD>flavin adenine dinucleotide metabolic process</TD><TD>biological process</TD><TD>GO:0072387</TD><TD>2</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>VCP</TD></TR>
<TR><TD>1.109e-02</TD><TD>-4.50</TD><TD>positive regulation of histone H4-K16 acetylation</TD><TD>biological process</TD><TD>GO:2000620</TD><TD>2</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>AUTS2</TD></TR>
<TR><TD>1.109e-02</TD><TD>-4.50</TD><TD>negative regulation of RNA interference</TD><TD>biological process</TD><TD>GO:1900369</TD><TD>2</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ADAR</TD></TR>
<TR><TD>1.109e-02</TD><TD>-4.50</TD><TD>immune response in mucosal-associated lymphoid tissue</TD><TD>biological process</TD><TD>GO:0002386</TD><TD>2</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>RAB17</TD></TR>
<TR><TD>1.109e-02</TD><TD>-4.50</TD><TD>negative regulation of adrenergic receptor signaling pathway involved in heart process</TD><TD>biological process</TD><TD>GO:1901205</TD><TD>2</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ATP2B4</TD></TR>
<TR><TD>1.109e-02</TD><TD>-4.50</TD><TD>regulation of transcription from RNA polymerase II promoter in response to iron</TD><TD>biological process</TD><TD>GO:0034395</TD><TD>2</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>SLC40A1</TD></TR>
<TR><TD>1.109e-02</TD><TD>-4.50</TD><TD>regulation of adrenergic receptor signaling pathway involved in heart process</TD><TD>biological process</TD><TD>GO:1901204</TD><TD>2</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ATP2B4</TD></TR>
<TR><TD>1.109e-02</TD><TD>-4.50</TD><TD>D-ribose catabolic process</TD><TD>biological process</TD><TD>GO:0019303</TD><TD>2</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>RBKS</TD></TR>
<TR><TD>1.109e-02</TD><TD>-4.50</TD><TD>positive regulation of growth factor dependent skeletal muscle satellite cell proliferation</TD><TD>biological process</TD><TD>GO:1902728</TD><TD>2</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>JAK2</TD></TR>
<TR><TD>1.109e-02</TD><TD>-4.50</TD><TD>positive regulation of natural killer cell degranulation</TD><TD>biological process</TD><TD>GO:0043323</TD><TD>2</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>AP1G1</TD></TR>
<TR><TD>1.109e-02</TD><TD>-4.50</TD><TD>defense response to tumor cell</TD><TD>biological process</TD><TD>GO:0002357</TD><TD>2</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>PLK5</TD></TR>
<TR><TD>1.109e-02</TD><TD>-4.50</TD><TD>regulation of arginine metabolic process</TD><TD>biological process</TD><TD>GO:0000821</TD><TD>2</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ATP2B4</TD></TR>
<TR><TD>1.109e-02</TD><TD>-4.50</TD><TD>innate vocalization behavior</TD><TD>biological process</TD><TD>GO:0098582</TD><TD>2</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>AUTS2</TD></TR>
<TR><TD>1.109e-02</TD><TD>-4.50</TD><TD>regulation of natural killer cell degranulation</TD><TD>biological process</TD><TD>GO:0043321</TD><TD>2</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>AP1G1</TD></TR>
<TR><TD>1.109e-02</TD><TD>-4.50</TD><TD>immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor</TD><TD>biological process</TD><TD>GO:0002415</TD><TD>2</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>RAB17</TD></TR>
<TR><TD>1.109e-02</TD><TD>-4.50</TD><TD>negative regulation of transcription from RNA polymerase II promoter during mitotic cell cycle</TD><TD>biological process</TD><TD>GO:0007070</TD><TD>2</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>SMARCA4</TD></TR>
<TR><TD>1.109e-02</TD><TD>-4.50</TD><TD>regulation of glucosylceramidase activity</TD><TD>biological process</TD><TD>GO:1905123</TD><TD>2</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>SCARB2</TD></TR>
<TR><TD>1.109e-02</TD><TD>-4.50</TD><TD>negative regulation of cellular amino acid metabolic process</TD><TD>biological process</TD><TD>GO:0045763</TD><TD>2</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ATP2B4</TD></TR>
<TR><TD>1.109e-02</TD><TD>-4.50</TD><TD>mineralocorticoid receptor signaling pathway</TD><TD>biological process</TD><TD>GO:0031959</TD><TD>2</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>JAK2</TD></TR>
<TR><TD>1.109e-02</TD><TD>-4.50</TD><TD>negative regulation of transcription during mitotic cell cycle</TD><TD>biological process</TD><TD>GO:0007068</TD><TD>2</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>SMARCA4</TD></TR>
<TR><TD>1.109e-02</TD><TD>-4.50</TD><TD>regulation of cellular amino acid biosynthetic process</TD><TD>biological process</TD><TD>GO:2000282</TD><TD>2</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ATP2B4</TD></TR>
<TR><TD>1.111e-02</TD><TD>-4.50</TD><TD>bone-rib-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour</TD><TD>COSMIC cancer mutations</TD><TD>bone-rib-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour</TD><TD>164</TD><TD>4</TD><TD>17630</TD><TD>93</TD>
<TD>FBXO31,RNASEH2A,GJB2,KDM2A</TD></TR>
<TR><TD>1.115e-02</TD><TD>-4.50</TD><TD>DTD-like_dom</TD><TD>interpro domains</TD><TD>IPR023509</TD><TD>2</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>DTD1</TD></TR>
<TR><TD>1.115e-02</TD><TD>-4.50</TD><TD>TTC39A/B</TD><TD>interpro domains</TD><TD>IPR030416</TD><TD>2</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>TTC39A</TD></TR>
<TR><TD>1.115e-02</TD><TD>-4.50</TD><TD>Cdc48_dom2</TD><TD>interpro domains</TD><TD>IPR004201</TD><TD>2</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>VCP</TD></TR>
<TR><TD>1.115e-02</TD><TD>-4.50</TD><TD>HIF-1_TAD_C</TD><TD>interpro domains</TD><TD>IPR014887</TD><TD>2</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>EPAS1</TD></TR>
<TR><TD>1.115e-02</TD><TD>-4.50</TD><TD>Chitobiase/Hex_dom_2-like</TD><TD>interpro domains</TD><TD>IPR029018</TD><TD>2</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>HEXA</TD></TR>
<TR><TD>1.115e-02</TD><TD>-4.50</TD><TD>AP1_complex_gsu</TD><TD>interpro domains</TD><TD>IPR017107</TD><TD>2</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>AP1G1</TD></TR>
<TR><TD>1.115e-02</TD><TD>-4.50</TD><TD>dsRNA_A_deaminase</TD><TD>interpro domains</TD><TD>IPR000607</TD><TD>2</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>ADAR</TD></TR>
<TR><TD>1.115e-02</TD><TD>-4.50</TD><TD>Anticodon_Ia_Val</TD><TD>interpro domains</TD><TD>IPR033705</TD><TD>2</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>VARS2</TD></TR>
<TR><TD>1.115e-02</TD><TD>-4.50</TD><TD>POM121</TD><TD>interpro domains</TD><TD>IPR026090</TD><TD>2</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>POM121C</TD></TR>
<TR><TD>1.115e-02</TD><TD>-4.50</TD><TD>SnAC</TD><TD>interpro domains</TD><TD>IPR029295</TD><TD>2</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>SMARCA4</TD></TR>
<TR><TD>1.115e-02</TD><TD>-4.50</TD><TD>5aminolev_synth_preseq</TD><TD>interpro domains</TD><TD>IPR015118</TD><TD>2</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>ALAS2</TD></TR>
<TR><TD>1.115e-02</TD><TD>-4.50</TD><TD>Tyr_Pase_non-rcpt_typ-3/4</TD><TD>interpro domains</TD><TD>IPR012151</TD><TD>2</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>PTPN3</TD></TR>
<TR><TD>1.115e-02</TD><TD>-4.50</TD><TD>Beta_hexosaminidase_sua/sub</TD><TD>interpro domains</TD><TD>IPR025705</TD><TD>2</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>HEXA</TD></TR>
<TR><TD>1.115e-02</TD><TD>-4.50</TD><TD>Cezanne-2</TD><TD>interpro domains</TD><TD>IPR033477</TD><TD>2</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>OTUD7B</TD></TR>
<TR><TD>1.115e-02</TD><TD>-4.50</TD><TD>XPG/Rad2_eukaryotes</TD><TD>interpro domains</TD><TD>IPR001044</TD><TD>2</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>BIVM-ERCC5</TD></TR>
<TR><TD>1.115e-02</TD><TD>-4.50</TD><TD>Carboh/pur_kinase_PfkB_CS</TD><TD>interpro domains</TD><TD>IPR002173</TD><TD>2</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>RBKS</TD></TR>
<TR><TD>1.115e-02</TD><TD>-4.50</TD><TD>Valyl-tRNA_ligase</TD><TD>interpro domains</TD><TD>IPR002303</TD><TD>2</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>VARS2</TD></TR>
<TR><TD>1.115e-02</TD><TD>-4.50</TD><TD>Gln-Leu-Gln_QLQ</TD><TD>interpro domains</TD><TD>IPR014978</TD><TD>2</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>SMARCA4</TD></TR>
<TR><TD>1.115e-02</TD><TD>-4.50</TD><TD>GC_assoc_lym</TD><TD>interpro domains</TD><TD>IPR031364</TD><TD>2</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>GCSAM</TD></TR>
<TR><TD>1.115e-02</TD><TD>-4.50</TD><TD>CDC4_N-term_subdom</TD><TD>interpro domains</TD><TD>IPR003338</TD><TD>2</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>VCP</TD></TR>
<TR><TD>1.115e-02</TD><TD>-4.50</TD><TD>HEX_eukaryotic_N</TD><TD>interpro domains</TD><TD>IPR029019</TD><TD>2</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>HEXA</TD></TR>
<TR><TD>1.115e-02</TD><TD>-4.50</TD><TD>4pyrrol_synth_NH2levulA_synth</TD><TD>interpro domains</TD><TD>IPR010961</TD><TD>2</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>ALAS2</TD></TR>
<TR><TD>1.115e-02</TD><TD>-4.50</TD><TD>DUF4203</TD><TD>interpro domains</TD><TD>IPR025256</TD><TD>2</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>TMEM198</TD></TR>
<TR><TD>1.115e-02</TD><TD>-4.50</TD><TD>Daa-tRNA_deacyls_DTD</TD><TD>interpro domains</TD><TD>IPR003732</TD><TD>2</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>DTD1</TD></TR>
<TR><TD>1.115e-02</TD><TD>-4.50</TD><TD>ATP2B1/4</TD><TD>interpro domains</TD><TD>IPR030319</TD><TD>2</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>ATP2B4</TD></TR>
<TR><TD>1.115e-02</TD><TD>-4.50</TD><TD>MFS_assoc_dom</TD><TD>interpro domains</TD><TD>IPR024989</TD><TD>2</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>MFSD6</TD></TR>
<TR><TD>1.115e-02</TD><TD>-4.50</TD><TD>Transl_elong_EF1A_euk/arc</TD><TD>interpro domains</TD><TD>IPR004539</TD><TD>2</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>EEF1A1</TD></TR>
<TR><TD>1.115e-02</TD><TD>-4.50</TD><TD>ARPC1</TD><TD>interpro domains</TD><TD>IPR017383</TD><TD>2</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>ARPC1B</TD></TR>
<TR><TD>1.116e-02</TD><TD>-4.50</TD><TD>GO_PHOSPHATASE_BINDING</TD><TD>MSigDB lists</TD><TD>GO_PHOSPHATASE_BINDING</TD><TD>159</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>PPP1R3F,PPP1R32,ATP2B4,VCP</TD></TR>
<TR><TD>1.118e-02</TD><TD>-4.49</TD><TD>PFKB_KINASES_2</TD><TD>prosite domains</TD><TD>PS00584</TD><TD>2</TD><TD>1</TD><TD>11955</TD><TD>67</TD>
<TD>RBKS</TD></TR>
<TR><TD>1.118e-02</TD><TD>-4.49</TD><TD>QLQ</TD><TD>prosite domains</TD><TD>PS51666</TD><TD>2</TD><TD>1</TD><TD>11955</TD><TD>67</TD>
<TD>SMARCA4</TD></TR>
<TR><TD>1.121e-02</TD><TD>-4.49</TD><TD>CDKN1B (cyclin dependent kinase inhibitor 1B)</TD><TD>protein interactions</TD><TD>1027</TD><TD>85</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>JAK2,VCP,UBE3A</TD></TR>
<TR><TD>1.126e-02</TD><TD>-4.49</TD><TD>D-aminoacyl-tRNA deacylase activity</TD><TD>molecular function</TD><TD>GO:0051499</TD><TD>2</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>DTD1</TD></TR>
<TR><TD>1.126e-02</TD><TD>-4.49</TD><TD>microfibril binding</TD><TD>molecular function</TD><TD>GO:0050436</TD><TD>2</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>ADAMTSL2</TD></TR>
<TR><TD>1.126e-02</TD><TD>-4.49</TD><TD>5-aminolevulinate synthase activity</TD><TD>molecular function</TD><TD>GO:0003870</TD><TD>2</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>ALAS2</TD></TR>
<TR><TD>1.126e-02</TD><TD>-4.49</TD><TD>D-tyrosyl-tRNA(Tyr) deacylase activity</TD><TD>molecular function</TD><TD>GO:0051500</TD><TD>2</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>DTD1</TD></TR>
<TR><TD>1.127e-02</TD><TD>-4.49</TD><TD>mucosal immune response</TD><TD>biological process</TD><TD>GO:0002385</TD><TD>29</TD><TD>2</TD><TD>16543</TD><TD>92</TD>
<TD>OTUD7B,RAB17</TD></TR>
<TR><TD>1.131e-02</TD><TD>-4.48</TD><TD>V$ATF_01</TD><TD>MSigDB lists</TD><TD>V$ATF_01</TD><TD>247</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>MAFF,JOSD1,GART,TPM4,FOSB</TD></TR>
<TR><TD>1.136e-02</TD><TD>-4.48</TD><TD>QLQ</TD><TD>smart domains</TD><TD>SM00951</TD><TD>2</TD><TD>1</TD><TD>9480</TD><TD>54</TD>
<TD>SMARCA4</TD></TR>
<TR><TD>1.136e-02</TD><TD>-4.48</TD><TD>SnAC</TD><TD>smart domains</TD><TD>SM01314</TD><TD>2</TD><TD>1</TD><TD>9480</TD><TD>54</TD>
<TD>SMARCA4</TD></TR>
<TR><TD>1.136e-02</TD><TD>-4.48</TD><TD>CDC48_2</TD><TD>smart domains</TD><TD>SM01072</TD><TD>2</TD><TD>1</TD><TD>9480</TD><TD>54</TD>
<TD>VCP</TD></TR>
<TR><TD>1.136e-02</TD><TD>-4.48</TD><TD>CDC48_N</TD><TD>smart domains</TD><TD>SM01073</TD><TD>2</TD><TD>1</TD><TD>9480</TD><TD>54</TD>
<TD>VCP</TD></TR>
<TR><TD>1.136e-02</TD><TD>-4.48</TD><TD>Zalpha</TD><TD>smart domains</TD><TD>SM00550</TD><TD>2</TD><TD>1</TD><TD>9480</TD><TD>54</TD>
<TD>ADAR</TD></TR>
<TR><TD>1.139e-02</TD><TD>-4.48</TD><TD>Znf_FYVE</TD><TD>interpro domains</TD><TD>IPR000306</TD><TD>29</TD><TD>2</TD><TD>18428</TD><TD>103</TD>
<TD>FGD5,ZFYVE1</TD></TR>
<TR><TD>1.140e-02</TD><TD>-4.47</TD><TD>GSE6566_STRONG_VS_WEAK_DC_STIMULATED_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE6566_STRONG_VS_WEAK_DC_STIMULATED_CD4_TCELL_UP</TD><TD>160</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>NR4A1,JAK2,PTPN3,CHID1</TD></TR>
<TR><TD>1.149e-02</TD><TD>-4.47</TD><TD>DUF4203</TD><TD>pfam domains</TD><TD>PF13886</TD><TD>2</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>TMEM198</TD></TR>
<TR><TD>1.149e-02</TD><TD>-4.47</TD><TD>CDC48_2</TD><TD>pfam domains</TD><TD>PF02933</TD><TD>2</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>VCP</TD></TR>
<TR><TD>1.149e-02</TD><TD>-4.47</TD><TD>QLQ</TD><TD>pfam domains</TD><TD>PF08880</TD><TD>2</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>SMARCA4</TD></TR>
<TR><TD>1.149e-02</TD><TD>-4.47</TD><TD>MFS_1_like</TD><TD>pfam domains</TD><TD>PF12832</TD><TD>2</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>MFSD6</TD></TR>
<TR><TD>1.149e-02</TD><TD>-4.47</TD><TD>Tyr_Deacylase</TD><TD>pfam domains</TD><TD>PF02580</TD><TD>2</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>DTD1</TD></TR>
<TR><TD>1.149e-02</TD><TD>-4.47</TD><TD>Glycohydro_20b2</TD><TD>pfam domains</TD><TD>PF14845</TD><TD>2</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>HEXA</TD></TR>
<TR><TD>1.149e-02</TD><TD>-4.47</TD><TD>z-alpha</TD><TD>pfam domains</TD><TD>PF02295</TD><TD>2</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>ADAR</TD></TR>
<TR><TD>1.149e-02</TD><TD>-4.47</TD><TD>HIF-1a_CTAD</TD><TD>pfam domains</TD><TD>PF08778</TD><TD>2</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>EPAS1</TD></TR>
<TR><TD>1.149e-02</TD><TD>-4.47</TD><TD>Preseq_ALAS</TD><TD>pfam domains</TD><TD>PF09029</TD><TD>2</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>ALAS2</TD></TR>
<TR><TD>1.149e-02</TD><TD>-4.47</TD><TD>HGAL</TD><TD>pfam domains</TD><TD>PF15666</TD><TD>2</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>GCSAM</TD></TR>
<TR><TD>1.149e-02</TD><TD>-4.47</TD><TD>CDC48_N</TD><TD>pfam domains</TD><TD>PF02359</TD><TD>2</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>VCP</TD></TR>
<TR><TD>1.149e-02</TD><TD>-4.47</TD><TD>SnAC</TD><TD>pfam domains</TD><TD>PF14619</TD><TD>2</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>SMARCA4</TD></TR>
<TR><TD>1.157e-02</TD><TD>-4.46</TD><TD>GO_ORGAN_OR_TISSUE_SPECIFIC_IMMUNE_RESPONSE</TD><TD>MSigDB lists</TD><TD>GO_ORGAN_OR_TISSUE_SPECIFIC_IMMUNE_RESPONSE</TD><TD>30</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>RAB17,OTUD7B</TD></TR>
<TR><TD>1.157e-02</TD><TD>-4.46</TD><TD>BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN</TD><TD>MSigDB lists</TD><TD>BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN</TD><TD>30</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>CHL1,FOSB</TD></TR>
<TR><TD>1.157e-02</TD><TD>-4.46</TD><TD>KIM_LRRC3B_TARGETS</TD><TD>MSigDB lists</TD><TD>KIM_LRRC3B_TARGETS</TD><TD>30</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>EEF1A1,FTH1</TD></TR>
<TR><TD>1.157e-02</TD><TD>-4.46</TD><TD>BIOCARTA_FAS_PATHWAY</TD><TD>MSigDB lists</TD><TD>BIOCARTA_FAS_PATHWAY</TD><TD>30</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>CASP6,MAP3K7</TD></TR>
<TR><TD>1.157e-02</TD><TD>-4.46</TD><TD>MODULE_524</TD><TD>MSigDB lists</TD><TD>MODULE_524</TD><TD>30</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>ENC1,TPM4</TD></TR>
<TR><TD>1.157e-02</TD><TD>-4.46</TD><TD>STAT2 (signal transducer and activator of transcription 2)</TD><TD>protein interactions</TD><TD>6773</TD><TD>30</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>JAK2,SMARCA4</TD></TR>
<TR><TD>1.157e-02</TD><TD>-4.46</TD><TD>MAP1A (microtubule associated protein 1A)</TD><TD>protein interactions</TD><TD>4130</TD><TD>30</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>MAP1LC3B,AP1G1</TD></TR>
<TR><TD>1.161e-02</TD><TD>-4.46</TD><TD>KVCHANNEL</TD><TD>prints domains</TD><TD>PR01491</TD><TD>27</TD><TD>2</TD><TD>4725</TD><TD>29</TD>
<TD>KCNA2,KCNG3</TD></TR>
<TR><TD>1.162e-02</TD><TD>-4.45</TD><TD>mRNA Editing: A to I Conversion</TD><TD>REACTOME pathways</TD><TD>R-HSA-75064</TD><TD>2</TD><TD>1</TD><TD>10293</TD><TD>60</TD>
<TD>ADAR</TD></TR>
<TR><TD>1.162e-02</TD><TD>-4.45</TD><TD>Transport of connexons to the plasma membrane</TD><TD>REACTOME pathways</TD><TD>R-HSA-190872</TD><TD>2</TD><TD>1</TD><TD>10293</TD><TD>60</TD>
<TD>GJB2</TD></TR>
<TR><TD>1.162e-02</TD><TD>-4.45</TD><TD>Formation of editosomes by ADAR proteins</TD><TD>REACTOME pathways</TD><TD>R-HSA-77042</TD><TD>2</TD><TD>1</TD><TD>10293</TD><TD>60</TD>
<TD>ADAR</TD></TR>
<TR><TD>1.162e-02</TD><TD>-4.45</TD><TD>C6 deamination of adenosine</TD><TD>REACTOME pathways</TD><TD>R-HSA-75102</TD><TD>2</TD><TD>1</TD><TD>10293</TD><TD>60</TD>
<TD>ADAR</TD></TR>
<TR><TD>1.163e-02</TD><TD>-4.45</TD><TD>macromolecule biosynthetic process</TD><TD>biological process</TD><TD>GO:0009059</TD><TD>3629</TD><TD>30</TD><TD>16543</TD><TD>92</TD>
<TD>VCP,NR4A1,EPAS1,COMMD7,MED7,NANOG,ALAS2,TSFM,AURKAIP1,ONECUT3,DTD1,MNX1,MAFF,SMARCA4,FOSB,VARS2,POM121C,KDM2A,USF3,BNC1,EEF1A1,RNASEH2A,NUP37,HEXA,RFX2,MAP3K7,ERN2,PXYLP1,ZNF683,OVOL1</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_DN</TD><TD>MSigDB lists</TD><TD>GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_DN</TD><TD>161</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>SERPINB10,ADI1,OTUD7B,TACC2</TD></TR>
<TR><TD>1.169e-02</TD><TD>-4.45</TD><TD>pallium development</TD><TD>biological process</TD><TD>GO:0021543</TD><TD>158</TD><TD>4</TD><TD>16543</TD><TD>92</TD>
<TD>GART,TACC2,ATP2B4,EMX1</TD></TR>
<TR><TD>1.172e-02</TD><TD>-4.45</TD><TD>FYVE</TD><TD>smart domains</TD><TD>SM00064</TD><TD>29</TD><TD>2</TD><TD>9480</TD><TD>54</TD>
<TD>ZFYVE1,FGD5</TD></TR>
<TR><TD>1.179e-02</TD><TD>-4.44</TD><TD>-</TD><TD>gene3d domains</TD><TD>3.50.80.10</TD><TD>2</TD><TD>1</TD><TD>10485</TD><TD>62</TD>
<TD>DTD1</TD></TR>
<TR><TD>1.179e-02</TD><TD>-4.44</TD><TD>-</TD><TD>gene3d domains</TD><TD>3.30.379.10</TD><TD>2</TD><TD>1</TD><TD>10485</TD><TD>62</TD>
<TD>HEXA</TD></TR>
<TR><TD>1.187e-02</TD><TD>-4.43</TD><TD>skin-head_neck-carcinoma-squamous_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-head_neck-carcinoma-squamous_cell_carcinoma</TD><TD>14793</TD><TD>86</TD><TD>17630</TD><TD>93</TD>
<TD>GPRASP2,JOSD1,ARPC1B,CHID1,CEACAM19,EHMT1,KCNA2,TTC39A,C14orf159,TACC2,KCNG3,ZNF683,GRAMD1B,ARIH2,MFSD6,KDM2A,CASP6,PTPN3,TMEM198,MAP3K7,GJB2,TSFM,UGT1A6,FBXO31,RBKS,DTD1,OVOL1,GAPT,C2orf81,BNC1,UBE3A,MYPN,NUP37,RFX2,RGSL1,NANOG,SLC40A1,ENC1,AP1G1,FGD5,RNASEH2A,HEATR6,FTL,OTUD7B,CHODL,KNTC1,CDH7,VARS2,SHB,SCARB2,POM121C,SLC27A6,FOSB,CHL1,MAP1LC3B,TANK,PPP1R3F,NR4A1,HEXA,SERPINB10,EEF1A1,USP8,ZFYVE1,GART,RAB17,NGDN,HSPB6,SMARCA4,AUTS2,ATP2B4,ADAMTSL2,ADI1,OSBPL7,VCP,AURKAIP1,MED7,IFT27,JAK2,TP53BP2,ALAS2,ADAR,F10,LGALS2,SLC35E4,EPAS1,MNX1</TD></TR>
<TR><TD>1.188e-02</TD><TD>-4.43</TD><TD>GO_REGULATION_OF_MITOTIC_CELL_CYCLE</TD><TD>MSigDB lists</TD><TD>GO_REGULATION_OF_MITOTIC_CELL_CYCLE</TD><TD>453</TD><TD>7</TD><TD>17621</TD><TD>96</TD>
<TD>OVOL1,SMARCA4,FBXO31,AURKAIP1,PLK5,KNTC1,PTPN3</TD></TR>
<TR><TD>1.189e-02</TD><TD>-4.43</TD><TD>GSE7348_UNSTIM_VS_LPS_STIM_MACROPHAGE_DN</TD><TD>MSigDB lists</TD><TD>GSE7348_UNSTIM_VS_LPS_STIM_MACROPHAGE_DN</TD><TD>162</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>JAK2,TANK,HEATR6,KCNG3</TD></TR>
<TR><TD>1.193e-02</TD><TD>-4.43</TD><TD>DLG1 (discs large MAGUK scaffold protein 1)</TD><TD>protein interactions</TD><TD>1739</TD><TD>87</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>UBE3A,ATP2B4,KCNA2</TD></TR>
<TR><TD>1.194e-02</TD><TD>-4.43</TD><TD>SASSON_RESPONSE_TO_FORSKOLIN_UP</TD><TD>MSigDB lists</TD><TD>SASSON_RESPONSE_TO_FORSKOLIN_UP</TD><TD>87</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>SMARCA4,MAP3K7,MAP1LC3B</TD></TR>
<TR><TD>1.205e-02</TD><TD>-4.42</TD><TD>cell differentiation</TD><TD>biological process</TD><TD>GO:0030154</TD><TD>3172</TD><TD>27</TD><TD>16543</TD><TD>92</TD>
<TD>TPM4,RMDN3,SHB,MAFF,PLK5,MYPN,JAK2,SCARB2,RAB17,BNC1,AP1G1,ZNF683,RFX2,ADAR,EMX1,EPAS1,NR4A1,NANOG,ALAS2,ARIH2,CHODL,CHL1,IFT27,CASP6,MNX1,ENC1,ONECUT3</TD></TR>
<TR><TD>1.206e-02</TD><TD>-4.42</TD><TD>FYVE</TD><TD>pfam domains</TD><TD>PF01363</TD><TD>29</TD><TD>2</TD><TD>16832</TD><TD>97</TD>
<TD>FGD5,ZFYVE1</TD></TR>
<TR><TD>1.214e-02</TD><TD>-4.41</TD><TD>GO_INTRACELLULAR_RECEPTOR_SIGNALING_PATHWAY</TD><TD>MSigDB lists</TD><TD>GO_INTRACELLULAR_RECEPTOR_SIGNALING_PATHWAY</TD><TD>163</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>NR4A1,MAP3K7,UBE3A,JAK2</TD></TR>
<TR><TD>1.219e-02</TD><TD>-4.41</TD><TD>hematopoietic or lymphoid organ development</TD><TD>biological process</TD><TD>GO:0048534</TD><TD>556</TD><TD>8</TD><TD>16543</TD><TD>92</TD>
<TD>SLC40A1,ZNF683,ARIH2,JAK2,ALAS2,SHB,ADAR,EPAS1</TD></TR>
<TR><TD>1.223e-02</TD><TD>-4.40</TD><TD>KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP</TD><TD>MSigDB lists</TD><TD>KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP</TD><TD>684</TD><TD>9</TD><TD>17621</TD><TD>96</TD>
<TD>TPM4,RBKS,MAP1LC3B,TANK,OSBPL7,MFSD6,EEF1A1,FTH1,MAFF</TD></TR>
<TR><TD>1.224e-02</TD><TD>-4.40</TD><TD>XRODRMPGMNTG</TD><TD>prints domains</TD><TD>PR00066</TD><TD>2</TD><TD>1</TD><TD>4725</TD><TD>29</TD>
<TD>BIVM-ERCC5</TD></TR>
<TR><TD>1.224e-02</TD><TD>-4.40</TD><TD>GLHYDRLASE20</TD><TD>prints domains</TD><TD>PR00738</TD><TD>2</TD><TD>1</TD><TD>4725</TD><TD>29</TD>
<TD>HEXA</TD></TR>
<TR><TD>1.224e-02</TD><TD>-4.40</TD><TD>TRNASYNTHVAL</TD><TD>prints domains</TD><TD>PR00986</TD><TD>2</TD><TD>1</TD><TD>4725</TD><TD>29</TD>
<TD>VARS2</TD></TR>
<TR><TD>1.232e-02</TD><TD>-4.40</TD><TD>GO_NUCLEOLUS</TD><TD>MSigDB lists</TD><TD>GO_NUCLEOLUS</TD><TD>806</TD><TD>10</TD><TD>17621</TD><TD>96</TD>
<TD>SMARCA4,MNX1,NGDN,EEF1A1,TACC2,ENC1,NANOG,ADAR,KDM2A,PLK5</TD></TR>
<TR><TD>1.233e-02</TD><TD>-4.40</TD><TD>AMIT_SERUM_RESPONSE_40_MCF10A</TD><TD>MSigDB lists</TD><TD>AMIT_SERUM_RESPONSE_40_MCF10A</TD><TD>31</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>FOSB,NR4A1</TD></TR>
<TR><TD>1.233e-02</TD><TD>-4.40</TD><TD>GROSS_ELK3_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>GROSS_ELK3_TARGETS_DN</TD><TD>31</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>MAFF,FTH1</TD></TR>
<TR><TD>1.233e-02</TD><TD>-4.40</TD><TD>GO_NEURON_PROJECTION_REGENERATION</TD><TD>MSigDB lists</TD><TD>GO_NEURON_PROJECTION_REGENERATION</TD><TD>31</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>CHL1,JAK2</TD></TR>
<TR><TD>1.233e-02</TD><TD>-4.40</TD><TD>NF1 (neurofibromin 1)</TD><TD>protein interactions</TD><TD>4763</TD><TD>31</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>VCP,SMARCA4</TD></TR>
<TR><TD>1.233e-02</TD><TD>-4.40</TD><TD>US3 (tegument protein; phosphorylates nuclear egress lamina protein; mediates phosphorylation of HDAC1 and HDAC2 and other cellular and viral proteins; involved in protein phosphorylation; involved in apoptosis; involved in nuclear egress)</TD><TD>protein interactions</TD><TD>2703401</TD><TD>31</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>VCP,EEF1A1</TD></TR>
<TR><TD>1.233e-02</TD><TD>-4.40</TD><TD>PDLIM1 (PDZ and LIM domain 1)</TD><TD>protein interactions</TD><TD>9124</TD><TD>31</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>ARIH2,FBXO31</TD></TR>
<TR><TD>1.233e-02</TD><TD>-4.40</TD><TD>ATG5 (autophagy related 5)</TD><TD>protein interactions</TD><TD>9474</TD><TD>31</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>VCP,MAP1LC3B</TD></TR>
<TR><TD>1.233e-02</TD><TD>-4.40</TD><TD>FBXO11 (F-box protein 11)</TD><TD>protein interactions</TD><TD>80204</TD><TD>31</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>HSPB6,NANOG</TD></TR>
<TR><TD>1.233e-02</TD><TD>-4.40</TD><TD>MED11 (mediator complex subunit 11)</TD><TD>protein interactions</TD><TD>400569</TD><TD>31</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>EPAS1,MED7</TD></TR>
<TR><TD>1.233e-02</TD><TD>-4.40</TD><TD>IL2RG (interleukin 2 receptor subunit gamma)</TD><TD>protein interactions</TD><TD>3561</TD><TD>31</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>SHB,JAK2</TD></TR>
<TR><TD>1.233e-02</TD><TD>-4.40</TD><TD>IL2RB (interleukin 2 receptor subunit beta)</TD><TD>protein interactions</TD><TD>3560</TD><TD>31</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>JAK2,SHB</TD></TR>
<TR><TD>1.233e-02</TD><TD>-4.40</TD><TD>EDF1 (endothelial differentiation related factor 1)</TD><TD>protein interactions</TD><TD>8721</TD><TD>31</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>RNASEH2A,NANOG</TD></TR>
<TR><TD>1.233e-02</TD><TD>-4.40</TD><TD>MED22 (mediator complex subunit 22)</TD><TD>protein interactions</TD><TD>6837</TD><TD>31</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>MED7,EPAS1</TD></TR>
<TR><TD>1.243e-02</TD><TD>-4.39</TD><TD>skin-extremity-malignant_melanoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-extremity-malignant_melanoma</TD><TD>1948</TD><TD>18</TD><TD>17630</TD><TD>93</TD>
<TD>FBXO31,UGT1A6,HEATR6,BNC1,CHODL,OSBPL7,TTC39A,TACC2,POM121C,MYPN,PPP1R3F,MAFF,JAK2,SLC35E4,MFSD6,EEF1A1,NANOG,RGSL1</TD></TR>
<TR><TD>1.249e-02</TD><TD>-4.38</TD><TD>extremity</TD><TD>COSMIC cancer mutations</TD><TD>extremity</TD><TD>1949</TD><TD>18</TD><TD>17630</TD><TD>93</TD>
<TD>RGSL1,NANOG,MFSD6,EEF1A1,SLC35E4,MAFF,JAK2,PPP1R3F,MYPN,POM121C,TACC2,TTC39A,OSBPL7,CHODL,BNC1,HEATR6,UGT1A6,FBXO31</TD></TR>
<TR><TD>1.260e-02</TD><TD>-4.37</TD><TD>intracellular organelle</TD><TD>cellular component</TD><TD>GO:0043229</TD><TD>11832</TD><TD>76</TD><TD>17744</TD><TD>98</TD>
<TD>FTH1,KCNG3,ZFYVE1,TP53BP2,EPAS1,MAFF,SMARCA4,PLK5,AUTS2,ERN2,UBE3A,ATP2B4,DTD1,RBKS,OTUD7B,SERPINB10,IFT27,AP1G1,NGDN,TPM4,KDM2A,JAK2,RMDN3,CASP6,TACC2,ADI1,ADAR,CHID1,VCP,TSFM,RAB17,MAP1LC3B,PXYLP1,ZNF683,SLC40A1,NUP37,SCARB2,ENC1,OSBPL7,MAP3K7,FTL,POM121C,EMX1,TMEM198,FGD5,AURKAIP1,USP8,NANOG,COQ8A,UGT1A6,F10,MNX1,ONECUT3,HEXA,RFX2,COMMD7,PTPN3,NR4A1,EEF1A1,KCNA2,ARPC1B,BNC1,FOSB,RNASEH2A,EHMT1,MED7,HSPB6,GJB2,KNTC1,C14orf159,USF3,ARIH2,MYPN,VARS2,ALAS2,OVOL1</TD></TR>
<TR><TD>1.260e-02</TD><TD>-4.37</TD><TD>positive regulation of proteasomal protein catabolic process</TD><TD>biological process</TD><TD>GO:1901800</TD><TD>87</TD><TD>3</TD><TD>16543</TD><TD>92</TD>
<TD>OSBPL7,VCP,ARIH2</TD></TR>
<TR><TD>1.264e-02</TD><TD>-4.37</TD><TD>MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP</TD><TD>MSigDB lists</TD><TD>MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP</TD><TD>254</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>ARIH2,MAP3K7,RGSL1,VCP,TANK</TD></TR>
<TR><TD>1.264e-02</TD><TD>-4.37</TD><TD>V$CREB_Q2</TD><TD>MSigDB lists</TD><TD>V$CREB_Q2</TD><TD>254</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>JOSD1,MAFF,MAP3K7,TPM4,FOSB</TD></TR>
<TR><TD>1.281e-02</TD><TD>-4.36</TD><TD>organ or tissue specific immune response</TD><TD>biological process</TD><TD>GO:0002251</TD><TD>31</TD><TD>2</TD><TD>16543</TD><TD>92</TD>
<TD>RAB17,OTUD7B</TD></TR>
<TR><TD>1.283e-02</TD><TD>-4.36</TD><TD>GRB2 (growth factor receptor bound protein 2)</TD><TD>protein interactions</TD><TD>2885</TD><TD>573</TD><TD>8</TD><TD>16330</TD><TD>89</TD>
<TD>JAK2,TP53BP2,USP8,VCP,SHB,FTL,FTH1,ALAS2</TD></TR>
<TR><TD>1.291e-02</TD><TD>-4.35</TD><TD>GSE26928_EFF_MEMORY_VS_CXCR5_POS_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE26928_EFF_MEMORY_VS_CXCR5_POS_CD4_TCELL_UP</TD><TD>166</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>ENC1,EPAS1,ZFYVE1,TMEM198</TD></TR>
<TR><TD>1.298e-02</TD><TD>-4.34</TD><TD>MATSUDA_NATURAL_KILLER_DIFFERENTIATION</TD><TD>MSigDB lists</TD><TD>MATSUDA_NATURAL_KILLER_DIFFERENTIATION</TD><TD>461</TD><TD>7</TD><TD>17621</TD><TD>96</TD>
<TD>SLC40A1,ENC1,TACC2,VCP,HEXA,UBE3A,BNC1</TD></TR>
<TR><TD>1.310e-02</TD><TD>-4.34</TD><TD>REACTOME_TRANSPORT_OF_MATURE_MRNA_DERIVED_FROM_AN_INTRONLESS_TRANSCRIPT</TD><TD>MSigDB lists</TD><TD>REACTOME_TRANSPORT_OF_MATURE_MRNA_DERIVED_FROM_AN_INTRONLESS_TRANSCRIPT</TD><TD>32</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>NUP37,POM121C</TD></TR>
<TR><TD>1.310e-02</TD><TD>-4.34</TD><TD>chr6q14</TD><TD>MSigDB lists</TD><TD>chr6q14</TD><TD>32</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>MAP3K7,EEF1A1</TD></TR>
<TR><TD>1.310e-02</TD><TD>-4.34</TD><TD>GO_SODIUM_CHANNEL_REGULATOR_ACTIVITY</TD><TD>MSigDB lists</TD><TD>GO_SODIUM_CHANNEL_REGULATOR_ACTIVITY</TD><TD>32</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>PTPN3,ATP2B4</TD></TR>
<TR><TD>1.310e-02</TD><TD>-4.34</TD><TD>REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS</TD><TD>MSigDB lists</TD><TD>REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS</TD><TD>32</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>NUP37,POM121C</TD></TR>
<TR><TD>1.310e-02</TD><TD>-4.34</TD><TD>GO_TRNA_TRANSPORT</TD><TD>MSigDB lists</TD><TD>GO_TRNA_TRANSPORT</TD><TD>32</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>POM121C,NUP37</TD></TR>
<TR><TD>1.310e-02</TD><TD>-4.34</TD><TD>COQ8A (coenzyme Q8A)</TD><TD>protein interactions</TD><TD>56997</TD><TD>32</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>COQ8A,VCP</TD></TR>
<TR><TD>1.310e-02</TD><TD>-4.34</TD><TD>YEATS2 (YEATS domain containing 2)</TD><TD>protein interactions</TD><TD>55689</TD><TD>32</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>NANOG,MAP3K7</TD></TR>
<TR><TD>1.317e-02</TD><TD>-4.33</TD><TD>GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_48H_ACT_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_48H_ACT_CD4_TCELL_UP</TD><TD>167</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>PTPN3,SLC40A1,TP53BP2,AUTS2</TD></TR>
<TR><TD>1.318e-02</TD><TD>-4.33</TD><TD>NUYTTEN_EZH2_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>NUYTTEN_EZH2_TARGETS_DN</TD><TD>940</TD><TD>11</TD><TD>17621</TD><TD>96</TD>
<TD>RNASEH2A,VCP,EPAS1,SLC40A1,GART,KNTC1,IFT27,NUP37,CASP6,MED7,MFSD6</TD></TR>
<TR><TD>1.323e-02</TD><TD>-4.33</TD><TD>NS-malignant_melanoma</TD><TD>COSMIC cancer mutations</TD><TD>NS-malignant_melanoma</TD><TD>3529</TD><TD>28</TD><TD>17630</TD><TD>93</TD>
<TD>ADAMTSL2,SMARCA4,FTH1,AUTS2,SCARB2,SHB,BNC1,GAPT,KNTC1,CDH7,PPP1R3F,JAK2,ZNF683,RFX2,ADAR,GRAMD1B,ALAS2,TACC2,C14orf159,SLC27A6,POM121C,IFT27,GART,USP8,TMEM198,FGD5,EPAS1,SERPINB10</TD></TR>
<TR><TD>1.324e-02</TD><TD>-4.32</TD><TD>S-methyl-5-thio-alpha-D-ribose 1-phosphate degradation</TD><TD>BIOCYC pathways</TD><TD>HUMAN_PWY-6755</TD><TD>4</TD><TD>1</TD><TD>903</TD><TD>3</TD>
<TD>ADI1</TD></TR>
<TR><TD>1.324e-02</TD><TD>-4.32</TD><TD>S-methyl-5-thio-alpha-D-ribose 1-phosphate degradation</TD><TD>BIOCYC pathways</TD><TD>HUMAN_PWY-4361</TD><TD>4</TD><TD>1</TD><TD>903</TD><TD>3</TD>
<TD>ADI1</TD></TR>
<TR><TD>1.341e-02</TD><TD>-4.31</TD><TD>ADRB2 (adrenoceptor beta 2)</TD><TD>protein interactions</TD><TD>154</TD><TD>258</TD><TD>5</TD><TD>16330</TD><TD>89</TD>
<TD>ATP2B4,MAP1LC3B,VCP,EEF1A1,SLC52A2</TD></TR>
<TR><TD>1.343e-02</TD><TD>-4.31</TD><TD>GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_DC_UP</TD><TD>MSigDB lists</TD><TD>GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_DC_UP</TD><TD>168</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>GRAMD1B,NR4A1,ENC1,MFSD6</TD></TR>
<TR><TD>1.343e-02</TD><TD>-4.31</TD><TD>GSE40274_IRF4_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE40274_IRF4_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_UP</TD><TD>168</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>ADI1,JOSD1,GART,MAP1LC3B</TD></TR>
<TR><TD>1.347e-02</TD><TD>-4.31</TD><TD>NUP107 (nucleoporin 107)</TD><TD>protein interactions</TD><TD>57122</TD><TD>91</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>NUP37,POM121C,VCP</TD></TR>
<TR><TD>1.348e-02</TD><TD>-4.31</TD><TD>lymphoid_neoplasm</TD><TD>COSMIC cancer mutations</TD><TD>lymphoid_neoplasm</TD><TD>12762</TD><TD>77</TD><TD>17630</TD><TD>93</TD>
<TD>SLC35E4,EPAS1,COMMD7,MNX1,TPM4,AURKAIP1,JAK2,LGALS2,ALAS2,F10,TP53BP2,ADAR,VCP,SMARCA4,AUTS2,ATP2B4,ADAMTSL2,EEF1A1,SERPINB10,RAB17,ZFYVE1,USP8,GART,NGDN,FOSB,SLC27A6,POM121C,TANK,CHL1,PPP1R3F,HEXA,NR4A1,ONECUT3,OTUD7B,CDH7,KNTC1,CHODL,VARS2,SCARB2,SHB,RNASEH2A,FTH1,HEATR6,ENC1,SLC40A1,NANOG,RGSL1,AP1G1,FGD5,MYPN,NUP37,RFX2,C2orf81,BNC1,OVOL1,UBE3A,GJB2,MAP3K7,FBXO31,RBKS,DTD1,MFSD6,CASP6,KDM2A,TMEM198,PTPN3,TACC2,C14orf159,KCNG3,ARIH2,GRAMD1B,KCNA2,TTC39A,JOSD1,GPRASP2,CHID1,EHMT1</TD></TR>
<TR><TD>1.362e-02</TD><TD>-4.30</TD><TD>tRNA export from nucleus</TD><TD>biological process</TD><TD>GO:0006409</TD><TD>32</TD><TD>2</TD><TD>16543</TD><TD>92</TD>
<TD>NUP37,POM121C</TD></TR>
<TR><TD>1.362e-02</TD><TD>-4.30</TD><TD>tRNA-containing ribonucleoprotein complex export from nucleus</TD><TD>biological process</TD><TD>GO:0071431</TD><TD>32</TD><TD>2</TD><TD>16543</TD><TD>92</TD>
<TD>NUP37,POM121C</TD></TR>
<TR><TD>1.365e-02</TD><TD>-4.29</TD><TD>V$CREB_Q4</TD><TD>MSigDB lists</TD><TD>V$CREB_Q4</TD><TD>259</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>FOSB,TPM4,JOSD1,MAP3K7,MAFF</TD></TR>
<TR><TD>1.366e-02</TD><TD>-4.29</TD><TD>SMAD3 (SMAD family member 3)</TD><TD>protein interactions</TD><TD>4088</TD><TD>359</TD><TD>6</TD><TD>16330</TD><TD>89</TD>
<TD>MAP3K7,KDM2A,NR4A1,SMARCA4,EPAS1,TANK</TD></TR>
<TR><TD>1.380e-02</TD><TD>-4.28</TD><TD>intracellular receptor signaling pathway</TD><TD>biological process</TD><TD>GO:0030522</TD><TD>166</TD><TD>4</TD><TD>16543</TD><TD>92</TD>
<TD>MAP3K7,UBE3A,JAK2,NR4A1</TD></TR>
<TR><TD>1.387e-02</TD><TD>-4.28</TD><TD>SMAD7 (SMAD family member 7)</TD><TD>protein interactions</TD><TD>4092</TD><TD>92</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>NR4A1,KDM2A,MAP3K7</TD></TR>
<TR><TD>1.390e-02</TD><TD>-4.28</TD><TD>MODULE_419</TD><TD>MSigDB lists</TD><TD>MODULE_419</TD><TD>33</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>TPM4,ENC1</TD></TR>
<TR><TD>1.390e-02</TD><TD>-4.28</TD><TD>SSBP3 (single stranded DNA binding protein 3)</TD><TD>protein interactions</TD><TD>23648</TD><TD>33</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>NANOG,EPAS1</TD></TR>
<TR><TD>1.390e-02</TD><TD>-4.28</TD><TD>NBR1 (NBR1, autophagy cargo receptor)</TD><TD>protein interactions</TD><TD>4077</TD><TD>33</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>MAP1LC3B,USP8</TD></TR>
<TR><TD>1.390e-02</TD><TD>-4.28</TD><TD>GOLM1 (golgi membrane protein 1)</TD><TD>protein interactions</TD><TD>51280</TD><TD>33</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>FTH1,SLC40A1</TD></TR>
<TR><TD>1.394e-02</TD><TD>-4.27</TD><TD>Transport of Ribonucleoproteins into the Host Nucleus</TD><TD>REACTOME pathways</TD><TD>R-HSA-168271</TD><TD>31</TD><TD>2</TD><TD>10293</TD><TD>60</TD>
<TD>NUP37,POM121C</TD></TR>
<TR><TD>1.394e-02</TD><TD>-4.27</TD><TD>NEP/NS2 Interacts with the Cellular Export Machinery</TD><TD>REACTOME pathways</TD><TD>R-HSA-168333</TD><TD>31</TD><TD>2</TD><TD>10293</TD><TD>60</TD>
<TD>NUP37,POM121C</TD></TR>
<TR><TD>1.394e-02</TD><TD>-4.27</TD><TD>Regulation of Glucokinase by Glucokinase Regulatory Protein</TD><TD>REACTOME pathways</TD><TD>R-HSA-170822</TD><TD>31</TD><TD>2</TD><TD>10293</TD><TD>60</TD>
<TD>POM121C,NUP37</TD></TR>
<TR><TD>1.397e-02</TD><TD>-4.27</TD><TD>oesophagus-carcinoma-adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>oesophagus-carcinoma-adenocarcinoma</TD><TD>13662</TD><TD>81</TD><TD>17630</TD><TD>93</TD>
<TD>IFT27,AURKAIP1,LGALS2,TP53BP2,ADAR,ALAS2,F10,JAK2,MNX1,EPAS1,SLC35E4,COMMD7,EMX1,AUTS2,SMARCA4,ADI1,ADAMTSL2,ATP2B4,VCP,OSBPL7,MAP1LC3B,TANK,CHL1,POM121C,SLC27A6,HEXA,NR4A1,ONECUT3,PPP1R3F,EEF1A1,SERPINB10,HSPB6,NGDN,RAB17,GART,ZFYVE1,USP8,HEATR6,RNASEH2A,FTH1,CDH7,KNTC1,CHODL,PLK5,OTUD7B,SCARB2,SHB,VARS2,MYPN,RFX2,NUP37,FGD5,AP1G1,SLC40A1,RGSL1,FBXO31,TSFM,UGT1A6,MAP3K7,DTD1,RBKS,BNC1,UBE3A,KCNG3,TACC2,C14orf159,ARIH2,GRAMD1B,ZNF683,MFSD6,TMEM198,PTPN3,KDM2A,ARPC1B,JOSD1,GPRASP2,EHMT1,CEACAM19,CHID1,KCNA2,TTC39A</TD></TR>
<TR><TD>1.408e-02</TD><TD>-4.26</TD><TD>REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM</TD><TD>MSigDB lists</TD><TD>REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM</TD><TD>261</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>POM121C,JAK2,ADAR,NUP37,MAP3K7</TD></TR>
<TR><TD>1.425e-02</TD><TD>-4.25</TD><TD>positive regulation of proteolysis</TD><TD>biological process</TD><TD>GO:0045862</TD><TD>355</TD><TD>6</TD><TD>16543</TD><TD>92</TD>
<TD>JAK2,ARIH2,TANK,VCP,AURKAIP1,OSBPL7</TD></TR>
<TR><TD>1.425e-02</TD><TD>-4.25</TD><TD>GSE6259_CD4_TCELL_VS_CD8_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE6259_CD4_TCELL_VS_CD8_TCELL_UP</TD><TD>171</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>EPAS1,SHB,CHL1,ATP2B4</TD></TR>
<TR><TD>1.425e-02</TD><TD>-4.25</TD><TD>GSE13547_WT_VS_ZFX_KO_BCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE13547_WT_VS_ZFX_KO_BCELL_DN</TD><TD>171</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>EPAS1,MED7,FOSB,NR4A1</TD></TR>
<TR><TD>1.425e-02</TD><TD>-4.25</TD><TD>NAGASHIMA_NRG1_SIGNALING_UP</TD><TD>MSigDB lists</TD><TD>NAGASHIMA_NRG1_SIGNALING_UP</TD><TD>171</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>FOSB,NR4A1,MAFF,JOSD1</TD></TR>
<TR><TD>1.453e-02</TD><TD>-4.23</TD><TD>GSE18281_MEDULLARY_THYMOCYTE_VS_WHOLE_MEDULLA_THYMUS_DN</TD><TD>MSigDB lists</TD><TD>GSE18281_MEDULLARY_THYMOCYTE_VS_WHOLE_MEDULLA_THYMUS_DN</TD><TD>172</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>ADAR,SLC40A1,TANK,NGDN</TD></TR>
<TR><TD>1.453e-02</TD><TD>-4.23</TD><TD>GSE7768_OVA_ALONE_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_UP</TD><TD>MSigDB lists</TD><TD>GSE7768_OVA_ALONE_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_UP</TD><TD>172</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>VCP,JOSD1,OTUD7B,FBXO31</TD></TR>
<TR><TD>1.459e-02</TD><TD>-4.23</TD><TD>VG_K_chnl</TD><TD>interpro domains</TD><TD>IPR028325</TD><TD>33</TD><TD>2</TD><TD>18428</TD><TD>103</TD>
<TD>KCNA2,KCNG3</TD></TR>
<TR><TD>1.465e-02</TD><TD>-4.22</TD><TD>IL17 signaling pathway</TD><TD>WikiPathways</TD><TD>WP2112</TD><TD>31</TD><TD>2</TD><TD>5314</TD><TD>32</TD>
<TD>MAP3K7,JAK2</TD></TR>
<TR><TD>1.470e-02</TD><TD>-4.22</TD><TD>MATTIOLI_MGUS_VS_PCL</TD><TD>MSigDB lists</TD><TD>MATTIOLI_MGUS_VS_PCL</TD><TD>94</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>SMARCA4,EEF1A1,EPAS1</TD></TR>
<TR><TD>1.470e-02</TD><TD>-4.22</TD><TD>chr22q12</TD><TD>MSigDB lists</TD><TD>chr22q12</TD><TD>94</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>SLC35E4,LGALS2,MAFF</TD></TR>
<TR><TD>1.471e-02</TD><TD>-4.22</TD><TD>chr2p21</TD><TD>MSigDB lists</TD><TD>chr2p21</TD><TD>34</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>EPAS1,KCNG3</TD></TR>
<TR><TD>1.471e-02</TD><TD>-4.22</TD><TD>HIF1AN (hypoxia inducible factor 1 alpha subunit inhibitor)</TD><TD>protein interactions</TD><TD>55662</TD><TD>34</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>OTUD7B,UBE3A</TD></TR>
<TR><TD>1.471e-02</TD><TD>-4.22</TD><TD>ISYNA1 (inositol-3-phosphate synthase 1)</TD><TD>protein interactions</TD><TD>51477</TD><TD>34</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>VCP,ERN2</TD></TR>
<TR><TD>1.481e-02</TD><TD>-4.21</TD><TD>Export of Viral Ribonucleoproteins from Nucleus</TD><TD>REACTOME pathways</TD><TD>R-HSA-168274</TD><TD>32</TD><TD>2</TD><TD>10293</TD><TD>60</TD>
<TD>NUP37,POM121C</TD></TR>
<TR><TD>1.487e-02</TD><TD>-4.21</TD><TD>leg</TD><TD>COSMIC cancer mutations</TD><TD>leg</TD><TD>989</TD><TD>11</TD><TD>17630</TD><TD>93</TD>
<TD>PPP1R3F,JAK2,SMARCA4,MAP3K7,HEATR6,RGSL1,VARS2,SCARB2,PTPN3,BNC1,CDH7</TD></TR>
<TR><TD>1.500e-02</TD><TD>-4.20</TD><TD>Atopic dermatitis(PMID:22197932)</TD><TD>GWAS genes</TD><TD>Atopic dermatitis(PMID:22197932)</TD><TD>4</TD><TD>1</TD><TD>2388</TD><TD>9</TD>
<TD>OVOL1</TD></TR>
<TR><TD>1.508e-02</TD><TD>-4.19</TD><TD>NR3C1 (nuclear receptor subfamily 3 group C member 1)</TD><TD>protein interactions</TD><TD>2908</TD><TD>174</TD><TD>4</TD><TD>16330</TD><TD>89</TD>
<TD>MAFF,NR4A1,SMARCA4,FTH1</TD></TR>
<TR><TD>1.510e-02</TD><TD>-4.19</TD><TD>GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_UP</TD><TD>174</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>ENC1,MAFF,DTD1,GRAMD1B</TD></TR>
<TR><TD>1.510e-02</TD><TD>-4.19</TD><TD>GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_DN</TD><TD>MSigDB lists</TD><TD>GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_DN</TD><TD>174</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>MFSD6,EPAS1,FTH1,ATP2B4</TD></TR>
<TR><TD>1.511e-02</TD><TD>-4.19</TD><TD>regulation of proteolysis</TD><TD>biological process</TD><TD>GO:0030162</TD><TD>695</TD><TD>9</TD><TD>16543</TD><TD>92</TD>
<TD>VCP,SERPINB10,JAK2,UBE3A,ARIH2,TANK,AURKAIP1,OSBPL7,PTPN3</TD></TR>
<TR><TD>1.529e-02</TD><TD>-4.18</TD><TD>tRNA transport</TD><TD>biological process</TD><TD>GO:0051031</TD><TD>34</TD><TD>2</TD><TD>16543</TD><TD>92</TD>
<TD>POM121C,NUP37</TD></TR>
<TR><TD>1.537e-02</TD><TD>-4.18</TD><TD>RAF1 (Raf-1 proto-oncogene, serine/threonine kinase)</TD><TD>protein interactions</TD><TD>5894</TD><TD>175</TD><TD>4</TD><TD>16330</TD><TD>89</TD>
<TD>VCP,EEF1A1,GPRASP2,JAK2</TD></TR>
<TR><TD>1.538e-02</TD><TD>-4.17</TD><TD>anatomical structure development</TD><TD>biological process</TD><TD>GO:0048856</TD><TD>4835</TD><TD>37</TD><TD>16543</TD><TD>92</TD>
<TD>GJB2,TMEM198,EHMT1,OVOL1,MYPN,BNC1,SCARB2,RAB17,IFT27,CHODL,CHL1,CASP6,MNX1,PTPN3,SLC40A1,ONECUT3,EPAS1,EMX1,NANOG,ARIH2,KCNA2,TACC2,RFX2,ZNF683,MAFF,SMARCA4,SHB,PLK5,JAK2,ADAMTSL2,ENC1,NR4A1,ADAR,ATP2B4,ALAS2,GART,UBE3A</TD></TR>
<TR><TD>1.545e-02</TD><TD>-4.17</TD><TD>Znf_FYVE-rel</TD><TD>interpro domains</TD><TD>IPR017455</TD><TD>34</TD><TD>2</TD><TD>18428</TD><TD>103</TD>
<TD>ZFYVE1,FGD5</TD></TR>
<TR><TD>1.547e-02</TD><TD>-4.17</TD><TD>ZF_FYVE</TD><TD>prosite domains</TD><TD>PS50178</TD><TD>34</TD><TD>2</TD><TD>11955</TD><TD>67</TD>
<TD>ZFYVE1,FGD5</TD></TR>
<TR><TD>1.555e-02</TD><TD>-4.16</TD><TD>COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP</TD><TD>MSigDB lists</TD><TD>COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP</TD><TD>35</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>EEF1A1,FTH1</TD></TR>
<TR><TD>1.555e-02</TD><TD>-4.16</TD><TD>GO_DELAYED_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY</TD><TD>MSigDB lists</TD><TD>GO_DELAYED_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY</TD><TD>35</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>KCNG3,KCNA2</TD></TR>
<TR><TD>1.555e-02</TD><TD>-4.16</TD><TD>HOUSTIS_ROS</TD><TD>MSigDB lists</TD><TD>HOUSTIS_ROS</TD><TD>35</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>FTH1,FTL</TD></TR>
<TR><TD>1.555e-02</TD><TD>-4.16</TD><TD>H2AFV (H2A histone family member V)</TD><TD>protein interactions</TD><TD>94239</TD><TD>35</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>VCP,HEXA</TD></TR>
<TR><TD>1.555e-02</TD><TD>-4.16</TD><TD>AKAP8L (A-kinase anchoring protein 8 like)</TD><TD>protein interactions</TD><TD>26993</TD><TD>35</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>NANOG,EPAS1</TD></TR>
<TR><TD>1.555e-02</TD><TD>-4.16</TD><TD>MAFF (MAF bZIP transcription factor F)</TD><TD>protein interactions</TD><TD>23764</TD><TD>35</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>MAFF,OVOL1</TD></TR>
<TR><TD>1.557e-02</TD><TD>-4.16</TD><TD>TRAF6 (TNF receptor associated factor 6)</TD><TD>protein interactions</TD><TD>7189</TD><TD>268</TD><TD>5</TD><TD>16330</TD><TD>89</TD>
<TD>JAK2,TANK,MAP3K7,OTUD7B,VCP</TD></TR>
<TR><TD>1.562e-02</TD><TD>-4.16</TD><TD>V$E4F1_Q6</TD><TD>MSigDB lists</TD><TD>V$E4F1_Q6</TD><TD>268</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>KDM2A,FOSB,KCNA2,NR4A1,MAFF</TD></TR>
<TR><TD>1.568e-02</TD><TD>-4.16</TD><TD>cation homeostasis</TD><TD>biological process</TD><TD>GO:0055080</TD><TD>582</TD><TD>8</TD><TD>16543</TD><TD>92</TD>
<TD>SLC40A1,FTH1,RMDN3,EPAS1,ATP2B4,ALAS2,FTL,JAK2</TD></TR>
<TR><TD>1.569e-02</TD><TD>-4.15</TD><TD>GSE37301_HEMATOPOIETIC_STEM_CELL_VS_RAG2_KO_NK_CELL_DN</TD><TD>MSigDB lists</TD><TD>GSE37301_HEMATOPOIETIC_STEM_CELL_VS_RAG2_KO_NK_CELL_DN</TD><TD>176</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>SLC35E4,FOSB,NR4A1,ATP2B4</TD></TR>
<TR><TD>1.571e-02</TD><TD>-4.15</TD><TD>Nuclear import of Rev protein</TD><TD>REACTOME pathways</TD><TD>R-HSA-180746</TD><TD>33</TD><TD>2</TD><TD>10293</TD><TD>60</TD>
<TD>NUP37,POM121C</TD></TR>
<TR><TD>1.571e-02</TD><TD>-4.15</TD><TD>Vpr-mediated nuclear import of PICs</TD><TD>REACTOME pathways</TD><TD>R-HSA-180910</TD><TD>33</TD><TD>2</TD><TD>10293</TD><TD>60</TD>
<TD>NUP37,POM121C</TD></TR>
<TR><TD>1.573e-02</TD><TD>-4.15</TD><TD>ADP binding</TD><TD>molecular function</TD><TD>GO:0043531</TD><TD>34</TD><TD>2</TD><TD>16652</TD><TD>94</TD>
<TD>COQ8A,VCP</TD></TR>
<TR><TD>1.573e-02</TD><TD>-4.15</TD><TD>sodium channel regulator activity</TD><TD>molecular function</TD><TD>GO:0017080</TD><TD>34</TD><TD>2</TD><TD>16652</TD><TD>94</TD>
<TD>PTPN3,ATP2B4</TD></TR>
<TR><TD>1.573e-02</TD><TD>-4.15</TD><TD>Cellular responses to stress</TD><TD>REACTOME pathways</TD><TD>R-HSA-2262752</TD><TD>453</TD><TD>7</TD><TD>10293</TD><TD>60</TD>
<TD>VCP,EPAS1,POM121C,NUP37,MAP1LC3B,EEF1A1,EHMT1</TD></TR>
<TR><TD>1.574e-02</TD><TD>-4.15</TD><TD>haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_leukaemic_transformation_of_myeloid_metaplasia</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_leukaemic_transformation_of_myeloid_metaplasia</TD><TD>3</TD><TD>1</TD><TD>17630</TD><TD>93</TD>
<TD>JAK2</TD></TR>
<TR><TD>1.574e-02</TD><TD>-4.15</TD><TD>acute_leukaemic_transformation_of_myeloid_metaplasia</TD><TD>COSMIC cancer mutations</TD><TD>acute_leukaemic_transformation_of_myeloid_metaplasia</TD><TD>3</TD><TD>1</TD><TD>17630</TD><TD>93</TD>
<TD>JAK2</TD></TR>
<TR><TD>1.574e-02</TD><TD>-4.15</TD><TD>haematopoietic_and_lymphoid_tissue-other-thrombocytosis</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-other-thrombocytosis</TD><TD>3</TD><TD>1</TD><TD>17630</TD><TD>93</TD>
<TD>JAK2</TD></TR>
<TR><TD>1.574e-02</TD><TD>-4.15</TD><TD>thrombocytosis</TD><TD>COSMIC cancer mutations</TD><TD>thrombocytosis</TD><TD>3</TD><TD>1</TD><TD>17630</TD><TD>93</TD>
<TD>JAK2</TD></TR>
<TR><TD>1.574e-02</TD><TD>-4.15</TD><TD>testis-other-carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>testis-other-carcinoma</TD><TD>3</TD><TD>1</TD><TD>17630</TD><TD>93</TD>
<TD>SMARCA4</TD></TR>
<TR><TD>1.574e-02</TD><TD>-4.15</TD><TD>genital_tract-germ_cell_tumour-seminoma</TD><TD>COSMIC cancer mutations</TD><TD>genital_tract-germ_cell_tumour-seminoma</TD><TD>3</TD><TD>1</TD><TD>17630</TD><TD>93</TD>
<TD>SMARCA4</TD></TR>
<TR><TD>1.574e-02</TD><TD>-4.15</TD><TD>stomach-other-choriocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>stomach-other-choriocarcinoma</TD><TD>3</TD><TD>1</TD><TD>17630</TD><TD>93</TD>
<TD>JAK2</TD></TR>
<TR><TD>1.574e-02</TD><TD>-4.15</TD><TD>haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-T_cell_large_granular_lymphocytic_leukaemia</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-T_cell_large_granular_lymphocytic_leukaemia</TD><TD>3</TD><TD>1</TD><TD>17630</TD><TD>93</TD>
<TD>JAK2</TD></TR>
<TR><TD>1.575e-02</TD><TD>-4.15</TD><TD>regulation of cellular amide metabolic process</TD><TD>biological process</TD><TD>GO:0034248</TD><TD>363</TD><TD>6</TD><TD>16543</TD><TD>92</TD>
<TD>DTD1,ENC1,NGDN,VARS2,TSFM,ADAR</TD></TR>
<TR><TD>1.597e-02</TD><TD>-4.14</TD><TD>GORASP2 (golgi reassembly stacking protein 2)</TD><TD>protein interactions</TD><TD>26003</TD><TD>97</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>MAP1LC3B,RMDN3,EEF1A1</TD></TR>
<TR><TD>1.598e-02</TD><TD>-4.14</TD><TD>GO_POSITIVE_REGULATION_OF_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS</TD><TD>MSigDB lists</TD><TD>GO_POSITIVE_REGULATION_OF_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS</TD><TD>97</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>OSBPL7,ARIH2,VCP</TD></TR>
<TR><TD>1.598e-02</TD><TD>-4.14</TD><TD>MORF_PPP6C</TD><TD>MSigDB lists</TD><TD>MORF_PPP6C</TD><TD>97</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>USP8,VCP,ADAR</TD></TR>
<TR><TD>1.599e-02</TD><TD>-4.14</TD><TD>GSE37301_CD4_TCELL_VS_RAG2_KO_NK_CELL_DN</TD><TD>MSigDB lists</TD><TD>GSE37301_CD4_TCELL_VS_RAG2_KO_NK_CELL_DN</TD><TD>177</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>CASP6,EHMT1,OSBPL7,PPP1R3F</TD></TR>
<TR><TD>1.613e-02</TD><TD>-4.13</TD><TD>immune system development</TD><TD>biological process</TD><TD>GO:0002520</TD><TD>585</TD><TD>8</TD><TD>16543</TD><TD>92</TD>
<TD>ZNF683,SLC40A1,ALAS2,JAK2,ARIH2,EPAS1,ADAR,SHB</TD></TR>
<TR><TD>1.613e-02</TD><TD>-4.13</TD><TD>hydrolase activity</TD><TD>molecular function</TD><TD>GO:0016787</TD><TD>2445</TD><TD>22</TD><TD>16652</TD><TD>94</TD>
<TD>CHID1,PTPN3,SMARCA4,ERN2,TANK,RAB17,ADAMTSL2,VARS2,USP8,HEXA,ADAR,USF3,F10,OTUD7B,EEF1A1,DTD1,ATP2B4,PXYLP1,JOSD1,VCP,CASP6,RNASEH2A</TD></TR>
<TR><TD>1.622e-02</TD><TD>-4.12</TD><TD>cellular developmental process</TD><TD>biological process</TD><TD>GO:0048869</TD><TD>3247</TD><TD>27</TD><TD>16543</TD><TD>92</TD>
<TD>RFX2,ZNF683,AP1G1,BNC1,RAB17,SCARB2,JAK2,MYPN,PLK5,MAFF,SHB,RMDN3,TPM4,ONECUT3,MNX1,ENC1,CASP6,IFT27,CHL1,CHODL,ARIH2,ALAS2,NANOG,NR4A1,EPAS1,ADAR,EMX1</TD></TR>
<TR><TD>1.626e-02</TD><TD>-4.12</TD><TD>MDM1 (Mdm1 nuclear protein)</TD><TD>protein interactions</TD><TD>56890</TD><TD>3</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>UBE3A</TD></TR>
<TR><TD>1.626e-02</TD><TD>-4.12</TD><TD>SERPINA10 (serpin family A member 10)</TD><TD>protein interactions</TD><TD>51156</TD><TD>3</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>F10</TD></TR>
<TR><TD>1.626e-02</TD><TD>-4.12</TD><TD>NT5C (5', 3'-nucleotidase, cytosolic)</TD><TD>protein interactions</TD><TD>30833</TD><TD>3</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>ARPC1B</TD></TR>
<TR><TD>1.626e-02</TD><TD>-4.12</TD><TD>BARHL1 (BarH like homeobox 1)</TD><TD>protein interactions</TD><TD>56751</TD><TD>3</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>MED7</TD></TR>
<TR><TD>1.626e-02</TD><TD>-4.12</TD><TD>KIAA1551 (KIAA1551)</TD><TD>protein interactions</TD><TD>55196</TD><TD>3</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>NANOG</TD></TR>
<TR><TD>1.626e-02</TD><TD>-4.12</TD><TD>STE11 (mitogen-activated protein kinase kinase kinase STE11)</TD><TD>protein interactions</TD><TD>851076</TD><TD>3</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>MAP3K7</TD></TR>
<TR><TD>1.626e-02</TD><TD>-4.12</TD><TD>Dlg1 (discs large MAGUK scaffold protein 1)</TD><TD>protein interactions</TD><TD>25252</TD><TD>3</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>ATP2B4</TD></TR>
<TR><TD>1.626e-02</TD><TD>-4.12</TD><TD>HAMP (hepcidin antimicrobial peptide)</TD><TD>protein interactions</TD><TD>57817</TD><TD>3</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>SLC40A1</TD></TR>
<TR><TD>1.626e-02</TD><TD>-4.12</TD><TD>MAFIP (MAFF interacting protein (pseudogene))</TD><TD>protein interactions</TD><TD>727764</TD><TD>3</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>MAFF</TD></TR>
<TR><TD>1.626e-02</TD><TD>-4.12</TD><TD>Ubox5 (U box domain containing 5)</TD><TD>protein interactions</TD><TD>140629</TD><TD>3</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>VCP</TD></TR>
<TR><TD>1.626e-02</TD><TD>-4.12</TD><TD>Trim30a (tripartite motif-containing 30A)</TD><TD>protein interactions</TD><TD>20128</TD><TD>3</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>MAP3K7</TD></TR>
<TR><TD>1.626e-02</TD><TD>-4.12</TD><TD>ZNF865 (zinc finger protein 865)</TD><TD>protein interactions</TD><TD>100507290</TD><TD>3</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>NANOG</TD></TR>
<TR><TD>1.626e-02</TD><TD>-4.12</TD><TD>ARC (activity regulated cytoskeleton associated protein)</TD><TD>protein interactions</TD><TD>23237</TD><TD>3</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>UBE3A</TD></TR>
<TR><TD>1.626e-02</TD><TD>-4.12</TD><TD>SOX21 (SRY-box 21)</TD><TD>protein interactions</TD><TD>11166</TD><TD>3</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>NANOG</TD></TR>
<TR><TD>1.626e-02</TD><TD>-4.12</TD><TD>Ywhae (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide)</TD><TD>protein interactions</TD><TD>22627</TD><TD>3</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>USP8</TD></TR>
<TR><TD>1.626e-02</TD><TD>-4.12</TD><TD>SGCE (sarcoglycan epsilon)</TD><TD>protein interactions</TD><TD>8910</TD><TD>3</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>ARIH2</TD></TR>
<TR><TD>1.626e-02</TD><TD>-4.12</TD><TD>PTPRCAP (protein tyrosine phosphatase, receptor type C associated protein)</TD><TD>protein interactions</TD><TD>5790</TD><TD>3</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>EEF1A1</TD></TR>
<TR><TD>1.626e-02</TD><TD>-4.12</TD><TD>NEUROG2 (neurogenin 2)</TD><TD>protein interactions</TD><TD>63973</TD><TD>3</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>SMARCA4</TD></TR>
<TR><TD>1.626e-02</TD><TD>-4.12</TD><TD>Tbk1 (TANK-binding kinase 1)</TD><TD>protein interactions</TD><TD>56480</TD><TD>3</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>TANK</TD></TR>
<TR><TD>1.626e-02</TD><TD>-4.12</TD><TD>SALL4 (spalt like transcription factor 4)</TD><TD>protein interactions</TD><TD>57167</TD><TD>3</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>NANOG</TD></TR>
<TR><TD>1.626e-02</TD><TD>-4.12</TD><TD>ALS2 (ALS2, alsin Rho guanine nucleotide exchange factor)</TD><TD>protein interactions</TD><TD>57679</TD><TD>3</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>VCP</TD></TR>
<TR><TD>1.626e-02</TD><TD>-4.12</TD><TD>Dnmt3a (DNA methyltransferase 3A)</TD><TD>protein interactions</TD><TD>13435</TD><TD>3</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>SMARCA4</TD></TR>
<TR><TD>1.626e-02</TD><TD>-4.12</TD><TD>CRLF2 (cytokine receptor-like factor 2)</TD><TD>protein interactions</TD><TD>64109</TD><TD>3</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>JAK2</TD></TR>
<TR><TD>1.629e-02</TD><TD>-4.12</TD><TD>GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_UP</TD><TD>MSigDB lists</TD><TD>GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_UP</TD><TD>178</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>AURKAIP1,KDM2A,TPM4,EMX1</TD></TR>
<TR><TD>1.640e-02</TD><TD>-4.11</TD><TD>p97-Ufd1-Npl4 complex</TD><TD>KEGG pathways</TD><TD>hsa_M00400</TD><TD>3</TD><TD>1</TD><TD>7094</TD><TD>39</TD>
<TD>VCP</TD></TR>
<TR><TD>1.640e-02</TD><TD>-4.11</TD><TD>p97-Ufd1-Npl4 complex</TD><TD>KEGG pathways</TD><TD>M00400</TD><TD>3</TD><TD>1</TD><TD>7094</TD><TD>39</TD>
<TD>VCP</TD></TR>
<TR><TD>1.641e-02</TD><TD>-4.11</TD><TD>VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN</TD><TD>MSigDB lists</TD><TD>VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN</TD><TD>36</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>ARIH2,EEF1A1</TD></TR>
<TR><TD>1.641e-02</TD><TD>-4.11</TD><TD>BAG2 (BCL2 associated athanogene 2)</TD><TD>protein interactions</TD><TD>9532</TD><TD>98</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>VCP,EPAS1,NANOG</TD></TR>
<TR><TD>1.641e-02</TD><TD>-4.11</TD><TD>WRNIP1 (Werner helicase interacting protein 1)</TD><TD>protein interactions</TD><TD>56897</TD><TD>36</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>VCP,EPAS1</TD></TR>
<TR><TD>1.641e-02</TD><TD>-4.11</TD><TD>TATDN1 (TatD DNase domain containing 1)</TD><TD>protein interactions</TD><TD>83940</TD><TD>36</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>GART,USP8</TD></TR>
<TR><TD>1.641e-02</TD><TD>-4.11</TD><TD>MPP6 (membrane palmitoylated protein 6)</TD><TD>protein interactions</TD><TD>51678</TD><TD>36</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>SMARCA4,FTL</TD></TR>
<TR><TD>1.641e-02</TD><TD>-4.11</TD><TD>CLGN (calmegin)</TD><TD>protein interactions</TD><TD>1047</TD><TD>36</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>VCP,ATP2B4</TD></TR>
<TR><TD>1.648e-02</TD><TD>-4.11</TD><TD>RZZ complex</TD><TD>cellular component</TD><TD>GO:1990423</TD><TD>3</TD><TD>1</TD><TD>17744</TD><TD>98</TD>
<TD>KNTC1</TD></TR>
<TR><TD>1.648e-02</TD><TD>-4.11</TD><TD>supraspliceosomal complex</TD><TD>cellular component</TD><TD>GO:0044530</TD><TD>3</TD><TD>1</TD><TD>17744</TD><TD>98</TD>
<TD>ADAR</TD></TR>
<TR><TD>1.648e-02</TD><TD>-4.11</TD><TD>extrinsic component of omegasome membrane</TD><TD>cellular component</TD><TD>GO:0097629</TD><TD>3</TD><TD>1</TD><TD>17744</TD><TD>98</TD>
<TD>ZFYVE1</TD></TR>
<TR><TD>1.648e-02</TD><TD>-4.11</TD><TD>ribonuclease H2 complex</TD><TD>cellular component</TD><TD>GO:0032299</TD><TD>3</TD><TD>1</TD><TD>17744</TD><TD>98</TD>
<TD>RNASEH2A</TD></TR>
<TR><TD>1.654e-02</TD><TD>-4.10</TD><TD>tetrapyrrole biosynthesis</TD><TD>BIOCYC pathways</TD><TD>HUMAN_PWY-5189</TD><TD>5</TD><TD>1</TD><TD>903</TD><TD>3</TD>
<TD>ALAS2</TD></TR>
<TR><TD>1.654e-02</TD><TD>-4.10</TD><TD>tetrapyrrole biosynthesis II (from glycine)</TD><TD>BIOCYC pathways</TD><TD>META_PWY-5189</TD><TD>5</TD><TD>1</TD><TD>903</TD><TD>3</TD>
<TD>ALAS2</TD></TR>
<TR><TD>1.659e-02</TD><TD>-4.10</TD><TD>GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TREG_DN</TD><TD>MSigDB lists</TD><TD>GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TREG_DN</TD><TD>179</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>FOSB,ADAMTSL2,NR4A1,MAFF</TD></TR>
<TR><TD>1.659e-02</TD><TD>-4.10</TD><TD>interleukin-12-mediated signaling pathway</TD><TD>biological process</TD><TD>GO:0035722</TD><TD>3</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>JAK2</TD></TR>
<TR><TD>1.659e-02</TD><TD>-4.10</TD><TD>activation of JAK2 kinase activity</TD><TD>biological process</TD><TD>GO:0042977</TD><TD>3</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>JAK2</TD></TR>
<TR><TD>1.659e-02</TD><TD>-4.10</TD><TD>cellular response to interleukin-12</TD><TD>biological process</TD><TD>GO:0071349</TD><TD>3</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>JAK2</TD></TR>
<TR><TD>1.659e-02</TD><TD>-4.10</TD><TD>positive regulation of proteoglycan biosynthetic process</TD><TD>biological process</TD><TD>GO:1902730</TD><TD>3</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>PXYLP1</TD></TR>
<TR><TD>1.659e-02</TD><TD>-4.10</TD><TD>negative regulation of cardiac muscle adaptation</TD><TD>biological process</TD><TD>GO:0010616</TD><TD>3</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ATP2B4</TD></TR>
<TR><TD>1.659e-02</TD><TD>-4.10</TD><TD>D-ribose metabolic process</TD><TD>biological process</TD><TD>GO:0006014</TD><TD>3</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>RBKS</TD></TR>
<TR><TD>1.659e-02</TD><TD>-4.10</TD><TD>regulation of RNA interference</TD><TD>biological process</TD><TD>GO:1900368</TD><TD>3</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ADAR</TD></TR>
<TR><TD>1.659e-02</TD><TD>-4.10</TD><TD>regulation of heparan sulfate proteoglycan biosynthetic process</TD><TD>biological process</TD><TD>GO:0010908</TD><TD>3</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>PXYLP1</TD></TR>
<TR><TD>1.659e-02</TD><TD>-4.10</TD><TD>negative regulation of nitric oxide mediated signal transduction</TD><TD>biological process</TD><TD>GO:0010751</TD><TD>3</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ATP2B4</TD></TR>
<TR><TD>1.659e-02</TD><TD>-4.10</TD><TD>valyl-tRNA aminoacylation</TD><TD>biological process</TD><TD>GO:0006438</TD><TD>3</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>VARS2</TD></TR>
<TR><TD>1.659e-02</TD><TD>-4.10</TD><TD>regulation of transcription from RNA polymerase II promoter during mitotic cell cycle</TD><TD>biological process</TD><TD>GO:0046021</TD><TD>3</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>SMARCA4</TD></TR>
<TR><TD>1.659e-02</TD><TD>-4.10</TD><TD>negative regulation of cardiac muscle hypertrophy in response to stress</TD><TD>biological process</TD><TD>GO:1903243</TD><TD>3</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ATP2B4</TD></TR>
<TR><TD>1.659e-02</TD><TD>-4.10</TD><TD>riboflavin transport</TD><TD>biological process</TD><TD>GO:0032218</TD><TD>3</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>SLC52A2</TD></TR>
<TR><TD>1.659e-02</TD><TD>-4.10</TD><TD>negative regulation of adrenergic receptor signaling pathway</TD><TD>biological process</TD><TD>GO:0071878</TD><TD>3</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ATP2B4</TD></TR>
<TR><TD>1.659e-02</TD><TD>-4.10</TD><TD>positive regulation of heparan sulfate proteoglycan biosynthetic process</TD><TD>biological process</TD><TD>GO:0010909</TD><TD>3</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>PXYLP1</TD></TR>
<TR><TD>1.659e-02</TD><TD>-4.10</TD><TD>response to human chorionic gonadotropin</TD><TD>biological process</TD><TD>GO:0044752</TD><TD>3</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>GJB2</TD></TR>
<TR><TD>1.659e-02</TD><TD>-4.10</TD><TD>regulation of transcription during mitotic cell cycle</TD><TD>biological process</TD><TD>GO:0045896</TD><TD>3</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>SMARCA4</TD></TR>
<TR><TD>1.659e-02</TD><TD>-4.10</TD><TD>tyrosine phosphorylation of Stat1 protein</TD><TD>biological process</TD><TD>GO:0042508</TD><TD>3</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>JAK2</TD></TR>
<TR><TD>1.659e-02</TD><TD>-4.10</TD><TD>positive regulation of growth hormone receptor signaling pathway</TD><TD>biological process</TD><TD>GO:0060399</TD><TD>3</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>JAK2</TD></TR>
<TR><TD>1.659e-02</TD><TD>-4.10</TD><TD>positive regulation of glucose mediated signaling pathway</TD><TD>biological process</TD><TD>GO:1902661</TD><TD>3</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>SMARCA4</TD></TR>
<TR><TD>1.659e-02</TD><TD>-4.10</TD><TD>ferrous iron transmembrane transport</TD><TD>biological process</TD><TD>GO:1903874</TD><TD>3</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>SLC40A1</TD></TR>
<TR><TD>1.662e-02</TD><TD>-4.10</TD><TD>kinesin binding</TD><TD>molecular function</TD><TD>GO:0019894</TD><TD>35</TD><TD>2</TD><TD>16652</TD><TD>94</TD>
<TD>AP1G1,KCNA2</TD></TR>
<TR><TD>1.663e-02</TD><TD>-4.10</TD><TD>Transport of the SLBP independent Mature mRNA</TD><TD>REACTOME pathways</TD><TD>R-HSA-159227</TD><TD>34</TD><TD>2</TD><TD>10293</TD><TD>60</TD>
<TD>POM121C,NUP37</TD></TR>
<TR><TD>1.663e-02</TD><TD>-4.10</TD><TD>Rev-mediated nuclear export of HIV RNA</TD><TD>REACTOME pathways</TD><TD>R-HSA-165054</TD><TD>34</TD><TD>2</TD><TD>10293</TD><TD>60</TD>
<TD>POM121C,NUP37</TD></TR>
<TR><TD>1.668e-02</TD><TD>-4.09</TD><TD>AUTS2</TD><TD>interpro domains</TD><TD>IPR023246</TD><TD>3</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>AUTS2</TD></TR>
<TR><TD>1.668e-02</TD><TD>-4.09</TD><TD>TF_Ovo-like</TD><TD>interpro domains</TD><TD>IPR027755</TD><TD>3</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>OVOL1</TD></TR>
<TR><TD>1.668e-02</TD><TD>-4.09</TD><TD>DUF4782</TD><TD>interpro domains</TD><TD>IPR031968</TD><TD>3</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>GRAMD1B</TD></TR>
<TR><TD>1.668e-02</TD><TD>-4.09</TD><TD>KEN_dom</TD><TD>interpro domains</TD><TD>IPR010513</TD><TD>3</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>ERN2</TD></TR>
<TR><TD>1.668e-02</TD><TD>-4.09</TD><TD>GART_AS</TD><TD>interpro domains</TD><TD>IPR001555</TD><TD>3</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>GART</TD></TR>
<TR><TD>1.668e-02</TD><TD>-4.09</TD><TD>HIF_alpha_subunit</TD><TD>interpro domains</TD><TD>IPR021537</TD><TD>3</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>EPAS1</TD></TR>
<TR><TD>1.668e-02</TD><TD>-4.09</TD><TD>Alpha-crystallin_N</TD><TD>interpro domains</TD><TD>IPR003090</TD><TD>3</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>HSPB6</TD></TR>
<TR><TD>1.668e-02</TD><TD>-4.09</TD><TD>TBD</TD><TD>interpro domains</TD><TD>IPR024581</TD><TD>3</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>TANK</TD></TR>
<TR><TD>1.668e-02</TD><TD>-4.09</TD><TD>CD36_fam</TD><TD>interpro domains</TD><TD>IPR002159</TD><TD>3</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>SCARB2</TD></TR>
<TR><TD>1.668e-02</TD><TD>-4.09</TD><TD>OMP_Iml2/TPR_39</TD><TD>interpro domains</TD><TD>IPR019412</TD><TD>3</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>TTC39A</TD></TR>
<TR><TD>1.668e-02</TD><TD>-4.09</TD><TD>Glyco_hydro_20_cat</TD><TD>interpro domains</TD><TD>IPR015883</TD><TD>3</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>HEXA</TD></TR>
<TR><TD>1.668e-02</TD><TD>-4.09</TD><TD>RFX1_trans_act</TD><TD>interpro domains</TD><TD>IPR007668</TD><TD>3</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>RFX2</TD></TR>
<TR><TD>1.668e-02</TD><TD>-4.09</TD><TD>TACC</TD><TD>interpro domains</TD><TD>IPR007707</TD><TD>3</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>TACC2</TD></TR>
<TR><TD>1.668e-02</TD><TD>-4.09</TD><TD>USP8_dimer</TD><TD>interpro domains</TD><TD>IPR015063</TD><TD>3</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>USP8</TD></TR>
<TR><TD>1.668e-02</TD><TD>-4.09</TD><TD>Nuc_orph_rcpt</TD><TD>interpro domains</TD><TD>IPR003070</TD><TD>3</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>NR4A1</TD></TR>
<TR><TD>1.668e-02</TD><TD>-4.09</TD><TD>Sas10/Utp3/C1D</TD><TD>interpro domains</TD><TD>IPR007146</TD><TD>3</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>NGDN</TD></TR>
<TR><TD>1.668e-02</TD><TD>-4.09</TD><TD>Riboflavin_transptr</TD><TD>interpro domains</TD><TD>IPR009357</TD><TD>3</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>SLC52A2</TD></TR>
<TR><TD>1.668e-02</TD><TD>-4.09</TD><TD>PfkB_dom</TD><TD>interpro domains</TD><TD>IPR011611</TD><TD>3</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>RBKS</TD></TR>
<TR><TD>1.668e-02</TD><TD>-4.09</TD><TD>DUF4713</TD><TD>interpro domains</TD><TD>IPR031671</TD><TD>3</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>SMIM5</TD></TR>
<TR><TD>1.668e-02</TD><TD>-4.09</TD><TD>CDC48_domain_2-like</TD><TD>interpro domains</TD><TD>IPR029067</TD><TD>3</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>VCP</TD></TR>
<TR><TD>1.672e-02</TD><TD>-4.09</TD><TD>GART</TD><TD>prosite domains</TD><TD>PS00373</TD><TD>3</TD><TD>1</TD><TD>11955</TD><TD>67</TD>
<TD>GART</TD></TR>
<TR><TD>1.672e-02</TD><TD>-4.09</TD><TD>VAST</TD><TD>prosite domains</TD><TD>PS51778</TD><TD>3</TD><TD>1</TD><TD>11955</TD><TD>67</TD>
<TD>GRAMD1B</TD></TR>
<TR><TD>1.672e-02</TD><TD>-4.09</TD><TD>KEN</TD><TD>prosite domains</TD><TD>PS51392</TD><TD>3</TD><TD>1</TD><TD>11955</TD><TD>67</TD>
<TD>ERN2</TD></TR>
<TR><TD>1.673e-02</TD><TD>-4.09</TD><TD>macromolecule catabolic process</TD><TD>biological process</TD><TD>GO:0009057</TD><TD>955</TD><TD>11</TD><TD>16543</TD><TD>92</TD>
<TD>ENC1,USP8,CHID1,ERN2,HEXA,RNASEH2A,UBE3A,OTUD7B,ARIH2,FBXO31,VCP</TD></TR>
<TR><TD>1.679e-02</TD><TD>-4.09</TD><TD>YWHAE (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon)</TD><TD>protein interactions</TD><TD>7531</TD><TD>376</TD><TD>6</TD><TD>16330</TD><TD>89</TD>
<TD>MAP3K7,TP53BP2,USP8,UBE3A,FTH1,VCP</TD></TR>
<TR><TD>1.681e-02</TD><TD>-4.09</TD><TD>ErbB2/ErbB3 signaling events</TD><TD>Pathway Interaction DB</TD><TD>erbb2erbb3pathway</TD><TD>35</TD><TD>2</TD><TD>2226</TD><TD>13</TD>
<TD>USP8,JAK2</TD></TR>
<TR><TD>1.684e-02</TD><TD>-4.08</TD><TD>histone methyltransferase activity (H3-K27 specific)</TD><TD>molecular function</TD><TD>GO:0046976</TD><TD>3</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>EHMT1</TD></TR>
<TR><TD>1.684e-02</TD><TD>-4.08</TD><TD>ferrous iron transmembrane transporter activity</TD><TD>molecular function</TD><TD>GO:0015093</TD><TD>3</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>SLC40A1</TD></TR>
<TR><TD>1.684e-02</TD><TD>-4.08</TD><TD>double-stranded RNA adenosine deaminase activity</TD><TD>molecular function</TD><TD>GO:0003726</TD><TD>3</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>ADAR</TD></TR>
<TR><TD>1.684e-02</TD><TD>-4.08</TD><TD>glycogen binding</TD><TD>molecular function</TD><TD>GO:2001069</TD><TD>3</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>PPP1R3F</TD></TR>
<TR><TD>1.684e-02</TD><TD>-4.08</TD><TD>valine-tRNA ligase activity</TD><TD>molecular function</TD><TD>GO:0004832</TD><TD>3</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>VARS2</TD></TR>
<TR><TD>1.684e-02</TD><TD>-4.08</TD><TD>riboflavin transporter activity</TD><TD>molecular function</TD><TD>GO:0032217</TD><TD>3</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>SLC52A2</TD></TR>
<TR><TD>1.684e-02</TD><TD>-4.08</TD><TD>cyclo-ligase activity</TD><TD>molecular function</TD><TD>GO:0016882</TD><TD>3</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>GART</TD></TR>
<TR><TD>1.685e-02</TD><TD>-4.08</TD><TD>human chr2p21</TD><TD>chromosome location</TD><TD>human chr2p21</TD><TD>50</TD><TD>2</TD><TD>26234</TD><TD>104</TD>
<TD>EPAS1,KCNG3</TD></TR>
<TR><TD>1.690e-02</TD><TD>-4.08</TD><TD>GO_CYSTEINE_TYPE_PEPTIDASE_ACTIVITY</TD><TD>MSigDB lists</TD><TD>GO_CYSTEINE_TYPE_PEPTIDASE_ACTIVITY</TD><TD>180</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>OTUD7B,CASP6,JOSD1,USP8</TD></TR>
<TR><TD>1.706e-02</TD><TD>-4.07</TD><TD>hydrolase activity, hydrolyzing O-glycosyl compounds</TD><TD>molecular function</TD><TD>GO:0004553</TD><TD>96</TD><TD>3</TD><TD>16652</TD><TD>94</TD>
<TD>CHID1,HEXA,USF3</TD></TR>
<TR><TD>1.707e-02</TD><TD>-4.07</TD><TD>KCHANNEL</TD><TD>prints domains</TD><TD>PR00169</TD><TD>33</TD><TD>2</TD><TD>4725</TD><TD>29</TD>
<TD>KCNA2,KCNG3</TD></TR>
<TR><TD>1.719e-02</TD><TD>-4.06</TD><TD>USP8_dimer</TD><TD>pfam domains</TD><TD>PF08969</TD><TD>3</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>USP8</TD></TR>
<TR><TD>1.719e-02</TD><TD>-4.06</TD><TD>Crystallin</TD><TD>pfam domains</TD><TD>PF00525</TD><TD>3</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>HSPB6</TD></TR>
<TR><TD>1.719e-02</TD><TD>-4.06</TD><TD>DUF4782</TD><TD>pfam domains</TD><TD>PF16016</TD><TD>3</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>GRAMD1B</TD></TR>
<TR><TD>1.719e-02</TD><TD>-4.06</TD><TD>DUF1011</TD><TD>pfam domains</TD><TD>PF06237</TD><TD>3</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>SLC52A2</TD></TR>
<TR><TD>1.719e-02</TD><TD>-4.06</TD><TD>DUF4713</TD><TD>pfam domains</TD><TD>PF15831</TD><TD>3</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>SMIM5</TD></TR>
<TR><TD>1.719e-02</TD><TD>-4.06</TD><TD>RFX1_trans_act</TD><TD>pfam domains</TD><TD>PF04589</TD><TD>3</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>RFX2</TD></TR>
<TR><TD>1.719e-02</TD><TD>-4.06</TD><TD>Sas10_Utp3</TD><TD>pfam domains</TD><TD>PF04000</TD><TD>3</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>NGDN</TD></TR>
<TR><TD>1.719e-02</TD><TD>-4.06</TD><TD>Glyco_hydro_20</TD><TD>pfam domains</TD><TD>PF00728</TD><TD>3</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>HEXA</TD></TR>
<TR><TD>1.719e-02</TD><TD>-4.06</TD><TD>AIRS</TD><TD>pfam domains</TD><TD>PF00586</TD><TD>3</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>GART</TD></TR>
<TR><TD>1.719e-02</TD><TD>-4.06</TD><TD>PHD_4</TD><TD>pfam domains</TD><TD>PF16866</TD><TD>3</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>KDM2A</TD></TR>
<TR><TD>1.719e-02</TD><TD>-4.06</TD><TD>TBD</TD><TD>pfam domains</TD><TD>PF12845</TD><TD>3</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>TANK</TD></TR>
<TR><TD>1.719e-02</TD><TD>-4.06</TD><TD>PfkB</TD><TD>pfam domains</TD><TD>PF00294</TD><TD>3</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>RBKS</TD></TR>
<TR><TD>1.719e-02</TD><TD>-4.06</TD><TD>HIF-1</TD><TD>pfam domains</TD><TD>PF11413</TD><TD>3</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>EPAS1</TD></TR>
<TR><TD>1.719e-02</TD><TD>-4.06</TD><TD>Ribonuc_2-5A</TD><TD>pfam domains</TD><TD>PF06479</TD><TD>3</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>ERN2</TD></TR>
<TR><TD>1.719e-02</TD><TD>-4.06</TD><TD>CD36</TD><TD>pfam domains</TD><TD>PF01130</TD><TD>3</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>SCARB2</TD></TR>
<TR><TD>1.719e-02</TD><TD>-4.06</TD><TD>TACC</TD><TD>pfam domains</TD><TD>PF05010</TD><TD>3</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>TACC2</TD></TR>
<TR><TD>1.719e-02</TD><TD>-4.06</TD><TD>DUF3808</TD><TD>pfam domains</TD><TD>PF10300</TD><TD>3</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>TTC39A</TD></TR>
<TR><TD>1.721e-02</TD><TD>-4.06</TD><TD>GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_UP</TD><TD>MSigDB lists</TD><TD>GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_UP</TD><TD>181</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>FOSB,TP53BP2,OSBPL7,ENC1</TD></TR>
<TR><TD>1.721e-02</TD><TD>-4.06</TD><TD>GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_DN</TD><TD>181</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>HEATR6,OSBPL7,EPAS1,HEXA</TD></TR>
<TR><TD>1.723e-02</TD><TD>-4.06</TD><TD>Glyco_hydro_catalytic_dom</TD><TD>interpro domains</TD><TD>IPR013781</TD><TD>36</TD><TD>2</TD><TD>18428</TD><TD>103</TD>
<TD>CHID1,HEXA</TD></TR>
<TR><TD>1.728e-02</TD><TD>-4.06</TD><TD>ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN</TD><TD>MSigDB lists</TD><TD>ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN</TD><TD>37</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>POM121C,ALAS2</TD></TR>
<TR><TD>1.728e-02</TD><TD>-4.06</TD><TD>CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP</TD><TD>MSigDB lists</TD><TD>CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP</TD><TD>37</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>ENC1,FOSB</TD></TR>
<TR><TD>1.729e-02</TD><TD>-4.06</TD><TD>SMARCA1 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1)</TD><TD>protein interactions</TD><TD>6594</TD><TD>37</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>SMARCA4,NANOG</TD></TR>
<TR><TD>1.729e-02</TD><TD>-4.06</TD><TD>AGTR1 (angiotensin II receptor type 1)</TD><TD>protein interactions</TD><TD>185</TD><TD>37</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>ATP2B4,JAK2</TD></TR>
<TR><TD>1.729e-02</TD><TD>-4.06</TD><TD>PTPN23 (protein tyrosine phosphatase, non-receptor type 23)</TD><TD>protein interactions</TD><TD>25930</TD><TD>37</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>VCP,USP8</TD></TR>
<TR><TD>1.729e-02</TD><TD>-4.06</TD><TD>LMNB2 (lamin B2)</TD><TD>protein interactions</TD><TD>84823</TD><TD>37</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>GPRASP2,VCP</TD></TR>
<TR><TD>1.729e-02</TD><TD>-4.06</TD><TD>STAG2 (stromal antigen 2)</TD><TD>protein interactions</TD><TD>10735</TD><TD>37</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>VCP,KDM2A</TD></TR>
<TR><TD>1.729e-02</TD><TD>-4.06</TD><TD>PABPN1 (poly(A) binding protein nuclear 1)</TD><TD>protein interactions</TD><TD>8106</TD><TD>37</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>ARIH2,SMARCA4</TD></TR>
<TR><TD>1.739e-02</TD><TD>-4.05</TD><TD>Breakdown of the nuclear lamina</TD><TD>REACTOME pathways</TD><TD>R-HSA-352238</TD><TD>3</TD><TD>1</TD><TD>10293</TD><TD>60</TD>
<TD>CASP6</TD></TR>
<TR><TD>1.739e-02</TD><TD>-4.05</TD><TD>Oligomerization of connexins into connexons</TD><TD>REACTOME pathways</TD><TD>R-HSA-190704</TD><TD>3</TD><TD>1</TD><TD>10293</TD><TD>60</TD>
<TD>GJB2</TD></TR>
<TR><TD>1.739e-02</TD><TD>-4.05</TD><TD>Transport of connexins along the secretory pathway</TD><TD>REACTOME pathways</TD><TD>R-HSA-190827</TD><TD>3</TD><TD>1</TD><TD>10293</TD><TD>60</TD>
<TD>GJB2</TD></TR>
<TR><TD>1.739e-02</TD><TD>-4.05</TD><TD>POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation</TD><TD>REACTOME pathways</TD><TD>R-HSA-2892245</TD><TD>3</TD><TD>1</TD><TD>10293</TD><TD>60</TD>
<TD>NANOG</TD></TR>
<TR><TD>1.739e-02</TD><TD>-4.05</TD><TD>Oxygen-dependent asparagine hydroxylation of Hypoxia-inducible Factor Alpha</TD><TD>REACTOME pathways</TD><TD>R-HSA-1234162</TD><TD>3</TD><TD>1</TD><TD>10293</TD><TD>60</TD>
<TD>EPAS1</TD></TR>
<TR><TD>1.746e-02</TD><TD>-4.05</TD><TD>EZH2 (enhancer of zeste 2 polycomb repressive complex 2 subunit)</TD><TD>protein interactions</TD><TD>2146</TD><TD>276</TD><TD>5</TD><TD>16330</TD><TD>89</TD>
<TD>EHMT1,VCP,MAP3K7,JAK2,ADAR</TD></TR>
<TR><TD>1.752e-02</TD><TD>-4.04</TD><TD>regulation of biological process</TD><TD>biological process</TD><TD>GO:0050789</TD><TD>10614</TD><TD>69</TD><TD>16543</TD><TD>92</TD>
<TD>VCP,ZFYVE1,KCNA2,FGD5,ARPC1B,CASP6,CHODL,IFT27,FTH1,ONECUT3,SLC40A1,PTPN3,MNX1,KCNG3,POM121C,SCARB2,NGDN,EHMT1,KNTC1,PPP1R3F,AP1G1,MAP3K7,SERPINB10,NR4A1,FBXO31,MED7,TSFM,ADAMTSL2,AURKAIP1,MAFF,KDM2A,EEF1A1,CHID1,ZNF683,ERN2,EPAS1,EMX1,COMMD7,ARIH2,NANOG,CHL1,OSBPL7,DTD1,FOSB,TP53BP2,RAB17,OTUD7B,BNC1,GCSAM,NUP37,TMEM198,OVOL1,HSPB6,USP8,ATP2B4,ADAR,UBE3A,TANK,ENC1,AUTS2,SHB,SMARCA4,VARS2,JAK2,PLK5,MAP1LC3B,RFX2,PXYLP1,F10</TD></TR>
<TR><TD>1.753e-02</TD><TD>-4.04</TD><TD>GO_MYELOID_CELL_DIFFERENTIATION</TD><TD>MSigDB lists</TD><TD>GO_MYELOID_CELL_DIFFERENTIATION</TD><TD>182</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>ADAR,JAK2,ALAS2,EPAS1</TD></TR>
<TR><TD>1.753e-02</TD><TD>-4.04</TD><TD>GSE3982_MAST_CELL_VS_MAC_DN</TD><TD>MSigDB lists</TD><TD>GSE3982_MAST_CELL_VS_MAC_DN</TD><TD>182</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>EPAS1,HEXA,GRAMD1B,RAB17</TD></TR>
<TR><TD>1.753e-02</TD><TD>-4.04</TD><TD>GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_UP</TD><TD>182</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>EPAS1,RBKS,ATP2B4,ZFYVE1</TD></TR>
<TR><TD>1.753e-02</TD><TD>-4.04</TD><TD>E2F1_UP.V1_DN</TD><TD>MSigDB lists</TD><TD>E2F1_UP.V1_DN</TD><TD>182</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>LGALS2,ALAS2,SLC35E4,TANK</TD></TR>
<TR><TD>1.753e-02</TD><TD>-4.04</TD><TD>GSE2128_C57BL6_VS_NOD_CD4CD8_DP_THYMOCYTE_DN</TD><TD>MSigDB lists</TD><TD>GSE2128_C57BL6_VS_NOD_CD4CD8_DP_THYMOCYTE_DN</TD><TD>182</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>CASP6,DTD1,JAK2,GRAMD1B</TD></TR>
<TR><TD>1.754e-02</TD><TD>-4.04</TD><TD>delayed rectifier potassium channel activity</TD><TD>molecular function</TD><TD>GO:0005251</TD><TD>36</TD><TD>2</TD><TD>16652</TD><TD>94</TD>
<TD>KCNA2,KCNG3</TD></TR>
<TR><TD>1.757e-02</TD><TD>-4.04</TD><TD>Transport of the SLBP Dependant Mature mRNA</TD><TD>REACTOME pathways</TD><TD>R-HSA-159230</TD><TD>35</TD><TD>2</TD><TD>10293</TD><TD>60</TD>
<TD>POM121C,NUP37</TD></TR>
<TR><TD>1.757e-02</TD><TD>-4.04</TD><TD>Nuclear Pore Complex (NPC) Disassembly</TD><TD>REACTOME pathways</TD><TD>R-HSA-3301854</TD><TD>35</TD><TD>2</TD><TD>10293</TD><TD>60</TD>
<TD>POM121C,NUP37</TD></TR>
<TR><TD>1.764e-02</TD><TD>-4.04</TD><TD>-</TD><TD>gene3d domains</TD><TD>3.90.650.10</TD><TD>3</TD><TD>1</TD><TD>10485</TD><TD>62</TD>
<TD>GART</TD></TR>
<TR><TD>1.764e-02</TD><TD>-4.04</TD><TD>-</TD><TD>gene3d domains</TD><TD>3.10.330.10</TD><TD>3</TD><TD>1</TD><TD>10485</TD><TD>62</TD>
<TD>VCP</TD></TR>
<TR><TD>1.777e-02</TD><TD>-4.03</TD><TD>TRAF4 (TNF receptor associated factor 4)</TD><TD>protein interactions</TD><TD>9618</TD><TD>101</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>MAP3K7,FTH1,TP53BP2</TD></TR>
<TR><TD>1.783e-02</TD><TD>-4.03</TD><TD>inorganic ion homeostasis</TD><TD>biological process</TD><TD>GO:0098771</TD><TD>596</TD><TD>8</TD><TD>16543</TD><TD>92</TD>
<TD>SLC40A1,FTH1,ALAS2,FTL,JAK2,EPAS1,ATP2B4,RMDN3</TD></TR>
<TR><TD>1.784e-02</TD><TD>-4.03</TD><TD>GSE19825_CD24LOW_VS_IL2RA_HIGH_DAY3_EFF_CD8_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE19825_CD24LOW_VS_IL2RA_HIGH_DAY3_EFF_CD8_TCELL_UP</TD><TD>183</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>GRAMD1B,NR4A1,ZFYVE1,MAP1LC3B</TD></TR>
<TR><TD>1.784e-02</TD><TD>-4.03</TD><TD>GSE39820_IL1B_IL6_VS_IL1B_IL6_IL23A_TREATED_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE39820_IL1B_IL6_VS_IL1B_IL6_IL23A_TREATED_CD4_TCELL_UP</TD><TD>183</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>ENC1,EPAS1,BNC1,ARIH2</TD></TR>
<TR><TD>1.809e-02</TD><TD>-4.01</TD><TD>membrane-bounded organelle</TD><TD>cellular component</TD><TD>GO:0043227</TD><TD>11956</TD><TD>76</TD><TD>17744</TD><TD>98</TD>
<TD>MAP3K7,FTL,POM121C,CHL1,SLC40A1,ENC1,NUP37,SCARB2,OSBPL7,VCP,CHID1,TSFM,RAB17,PXYLP1,MAP1LC3B,ZNF683,CASP6,RMDN3,TACC2,ADI1,ADAR,NGDN,AP1G1,TPM4,SERPINB10,KDM2A,JAK2,UBE3A,ATP2B4,DTD1,RBKS,OTUD7B,PLK5,ERN2,AUTS2,FTH1,EPAS1,TP53BP2,ZFYVE1,KCNG3,SMARCA4,MAFF,MYPN,ARIH2,VARS2,OVOL1,ALAS2,HSPB6,MED7,GJB2,C14orf159,KNTC1,USF3,ARPC1B,KCNA2,EEF1A1,BNC1,FOSB,RNASEH2A,EHMT1,RFX2,COMMD7,NR4A1,MNX1,ONECUT3,GART,HEXA,F10,UGT1A6,COQ8A,NANOG,USP8,EMX1,FGD5,TMEM198,AURKAIP1</TD></TR>
<TR><TD>1.817e-02</TD><TD>-4.01</TD><TD>central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma</TD><TD>COSMIC cancer mutations</TD><TD>central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma</TD><TD>7487</TD><TD>50</TD><TD>17630</TD><TD>93</TD>
<TD>NUP37,JAK2,F10,ALAS2,ADAR,RFX2,MYPN,IFT27,ENC1,RGSL1,EPAS1,COMMD7,MNX1,RBKS,ATP2B4,DTD1,GJB2,SMARCA4,MAP3K7,EMX1,UGT1A6,AUTS2,OSBPL7,VCP,HEXA,TACC2,C14orf159,FOSB,SLC27A6,POM121C,KCNG3,TANK,CHL1,USP8,KDM2A,ZFYVE1,PTPN3,MFSD6,SERPINB10,CEACAM19,CHID1,EHMT1,RNASEH2A,HEATR6,VARS2,SHB,OTUD7B,KNTC1,CDH7,CHODL</TD></TR>
<TR><TD>1.817e-02</TD><TD>-4.01</TD><TD>GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_IFNAR_KO_UP</TD><TD>MSigDB lists</TD><TD>GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_IFNAR_KO_UP</TD><TD>184</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>KNTC1,ARPC1B,ATP2B4,CHODL</TD></TR>
<TR><TD>1.817e-02</TD><TD>-4.01</TD><TD>GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_UP</TD><TD>MSigDB lists</TD><TD>GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_UP</TD><TD>184</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>ADI1,MFSD6,ENC1,EPAS1</TD></TR>
<TR><TD>1.817e-02</TD><TD>-4.01</TD><TD>GSE37416_0H_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_DN</TD><TD>MSigDB lists</TD><TD>GSE37416_0H_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_DN</TD><TD>184</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>FTH1,MAFF,HEXA,MAP1LC3B</TD></TR>
<TR><TD>1.818e-02</TD><TD>-4.01</TD><TD>REACTOME_GLUCOSE_TRANSPORT</TD><TD>MSigDB lists</TD><TD>REACTOME_GLUCOSE_TRANSPORT</TD><TD>38</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>NUP37,POM121C</TD></TR>
<TR><TD>1.818e-02</TD><TD>-4.01</TD><TD>POLR3C (RNA polymerase III subunit C)</TD><TD>protein interactions</TD><TD>10623</TD><TD>38</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>VCP,SMARCA4</TD></TR>
<TR><TD>1.818e-02</TD><TD>-4.01</TD><TD>MPHOSPH6 (M-phase phosphoprotein 6)</TD><TD>protein interactions</TD><TD>10200</TD><TD>38</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>SMARCA4,FTL</TD></TR>
<TR><TD>1.818e-02</TD><TD>-4.01</TD><TD>PACSIN1 (protein kinase C and casein kinase substrate in neurons 1)</TD><TD>protein interactions</TD><TD>29993</TD><TD>38</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>FTH1,TPM4</TD></TR>
<TR><TD>1.818e-02</TD><TD>-4.01</TD><TD>MED18 (mediator complex subunit 18)</TD><TD>protein interactions</TD><TD>54797</TD><TD>38</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>EPAS1,MED7</TD></TR>
<TR><TD>1.818e-02</TD><TD>-4.01</TD><TD>METTL1 (methyltransferase like 1)</TD><TD>protein interactions</TD><TD>4234</TD><TD>38</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>UBE3A,ARPC1B</TD></TR>
<TR><TD>1.818e-02</TD><TD>-4.01</TD><TD>EP400 (E1A binding protein p400)</TD><TD>protein interactions</TD><TD>57634</TD><TD>38</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>SMARCA4,NANOG</TD></TR>
<TR><TD>1.820e-02</TD><TD>-4.01</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_T_cell_leukaemia</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_T_cell_leukaemia</TD><TD>756</TD><TD>9</TD><TD>17630</TD><TD>93</TD>
<TD>SCARB2,USP8,VARS2,JAK2,AURKAIP1,SMARCA4,FOSB,RNASEH2A,TACC2</TD></TR>
<TR><TD>1.820e-02</TD><TD>-4.01</TD><TD>acute_lymphoblastic_T_cell_leukaemia</TD><TD>COSMIC cancer mutations</TD><TD>acute_lymphoblastic_T_cell_leukaemia</TD><TD>756</TD><TD>9</TD><TD>17630</TD><TD>93</TD>
<TD>USP8,VARS2,SCARB2,JAK2,SMARCA4,AURKAIP1,FOSB,RNASEH2A,TACC2</TD></TR>
<TR><TD>1.822e-02</TD><TD>-4.01</TD><TD>YWHAZ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta)</TD><TD>protein interactions</TD><TD>7534</TD><TD>383</TD><TD>6</TD><TD>16330</TD><TD>89</TD>
<TD>RMDN3,USP8,UBE3A,TP53BP2,VCP,NR4A1</TD></TR>
<TR><TD>1.825e-02</TD><TD>-4.00</TD><TD>GO_CEREBRAL_CORTEX_DEVELOPMENT</TD><TD>MSigDB lists</TD><TD>GO_CEREBRAL_CORTEX_DEVELOPMENT</TD><TD>102</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>GART,EMX1,TACC2</TD></TR>
<TR><TD>1.830e-02</TD><TD>-4.00</TD><TD>FIBROSIN1LPF</TD><TD>prints domains</TD><TD>PR02044</TD><TD>3</TD><TD>1</TD><TD>4725</TD><TD>29</TD>
<TD>AUTS2</TD></TR>
<TR><TD>1.830e-02</TD><TD>-4.00</TD><TD>NUCLEARECPTR</TD><TD>prints domains</TD><TD>PR01284</TD><TD>3</TD><TD>1</TD><TD>4725</TD><TD>29</TD>
<TD>NR4A1</TD></TR>
<TR><TD>1.830e-02</TD><TD>-4.00</TD><TD>CD36FAMILY</TD><TD>prints domains</TD><TD>PR01609</TD><TD>3</TD><TD>1</TD><TD>4725</TD><TD>29</TD>
<TD>SCARB2</TD></TR>
<TR><TD>1.835e-02</TD><TD>-4.00</TD><TD>TNF alpha Signaling Pathway</TD><TD>WikiPathways</TD><TD>WP231</TD><TD>94</TD><TD>3</TD><TD>5314</TD><TD>32</TD>
<TD>MAP3K7,TANK,OTUD7B</TD></TR>
<TR><TD>1.840e-02</TD><TD>-4.00</TD><TD>regulation of cellular catabolic process</TD><TD>biological process</TD><TD>GO:0031329</TD><TD>376</TD><TD>6</TD><TD>16543</TD><TD>92</TD>
<TD>PTPN3,UBE3A,ARIH2,ATP2B4,OSBPL7,VCP</TD></TR>
<TR><TD>1.845e-02</TD><TD>-3.99</TD><TD>GO_SEQUENCE_SPECIFIC_DNA_BINDING</TD><TD>MSigDB lists</TD><TD>GO_SEQUENCE_SPECIFIC_DNA_BINDING</TD><TD>988</TD><TD>11</TD><TD>17621</TD><TD>96</TD>
<TD>MNX1,EMX1,FOSB,RFX2,MAFF,NR4A1,SMARCA4,ONECUT3,EPAS1,NANOG,OVOL1</TD></TR>
<TR><TD>1.846e-02</TD><TD>-3.99</TD><TD>KPNA2 (karyopherin subunit alpha 2)</TD><TD>protein interactions</TD><TD>3838</TD><TD>185</TD><TD>4</TD><TD>16330</TD><TD>89</TD>
<TD>FTH1,SMARCA4,GART,TANK</TD></TR>
<TR><TD>1.849e-02</TD><TD>-3.99</TD><TD>GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_UP</TD><TD>MSigDB lists</TD><TD>GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_UP</TD><TD>185</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>NUP37,MAP3K7,SMARCA4,KDM2A</TD></TR>
<TR><TD>1.849e-02</TD><TD>-3.99</TD><TD>GSE34515_CD16_NEG_VS_POS_MONOCYTE_UP</TD><TD>MSigDB lists</TD><TD>GSE34515_CD16_NEG_VS_POS_MONOCYTE_UP</TD><TD>185</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>ADAMTSL2,CASP6,F10,JAK2</TD></TR>
<TR><TD>1.849e-02</TD><TD>-3.99</TD><TD>GSE13493_DP_VS_CD8POS_THYMOCYTE_UP</TD><TD>MSigDB lists</TD><TD>GSE13493_DP_VS_CD8POS_THYMOCYTE_UP</TD><TD>185</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>TP53BP2,CASP6,CHL1,FTL</TD></TR>
<TR><TD>1.849e-02</TD><TD>-3.99</TD><TD>GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_T425A_HEXON_INF_DN</TD><TD>MSigDB lists</TD><TD>GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_T425A_HEXON_INF_DN</TD><TD>185</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>MYPN,VCP,UBE3A,NR4A1</TD></TR>
<TR><TD>1.849e-02</TD><TD>-3.99</TD><TD>GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP</TD><TD>MSigDB lists</TD><TD>GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP</TD><TD>185</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>TTC39A,ARPC1B,SLC40A1,ENC1</TD></TR>
<TR><TD>1.849e-02</TD><TD>-3.99</TD><TD>GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP</TD><TD>MSigDB lists</TD><TD>GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP</TD><TD>185</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>ADI1,GJB2,EMX1,PTPN3</TD></TR>
<TR><TD>1.849e-02</TD><TD>-3.99</TD><TD>GSE360_L_MAJOR_VS_T_GONDII_DC_UP</TD><TD>MSigDB lists</TD><TD>GSE360_L_MAJOR_VS_T_GONDII_DC_UP</TD><TD>185</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>GRAMD1B,LGALS2,TPM4,EMX1</TD></TR>
<TR><TD>1.849e-02</TD><TD>-3.99</TD><TD>GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN</TD><TD>MSigDB lists</TD><TD>GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN</TD><TD>185</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>AUTS2,DTD1,MNX1,OSBPL7</TD></TR>
<TR><TD>1.854e-02</TD><TD>-3.99</TD><TD>Interactions of Vpr with host cellular proteins</TD><TD>REACTOME pathways</TD><TD>R-HSA-176033</TD><TD>36</TD><TD>2</TD><TD>10293</TD><TD>60</TD>
<TD>NUP37,POM121C</TD></TR>
<TR><TD>1.854e-02</TD><TD>-3.99</TD><TD>Transcriptional regulation of pluripotent stem cells</TD><TD>REACTOME pathways</TD><TD>R-HSA-452723</TD><TD>36</TD><TD>2</TD><TD>10293</TD><TD>60</TD>
<TD>NANOG,EPAS1</TD></TR>
<TR><TD>1.854e-02</TD><TD>-3.99</TD><TD>Interactions of Rev with host cellular proteins</TD><TD>REACTOME pathways</TD><TD>R-HSA-177243</TD><TD>36</TD><TD>2</TD><TD>10293</TD><TD>60</TD>
<TD>POM121C,NUP37</TD></TR>
<TR><TD>1.882e-02</TD><TD>-3.97</TD><TD>GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_DN</TD><TD>186</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>CHL1,USP8,MAFF,KDM2A</TD></TR>
<TR><TD>1.882e-02</TD><TD>-3.97</TD><TD>GSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_UP</TD><TD>186</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>JAK2,KCNA2,CHL1,MAFF</TD></TR>
<TR><TD>1.882e-02</TD><TD>-3.97</TD><TD>GSE11057_CD4_EFF_MEM_VS_PBMC_DN</TD><TD>MSigDB lists</TD><TD>GSE11057_CD4_EFF_MEM_VS_PBMC_DN</TD><TD>186</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>LGALS2,JAK2,FTL,FTH1</TD></TR>
<TR><TD>1.882e-02</TD><TD>-3.97</TD><TD>GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_DN</TD><TD>186</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>JAK2,RNASEH2A,GART,RBKS</TD></TR>
<TR><TD>1.882e-02</TD><TD>-3.97</TD><TD>GSE40655_FOXO1_KO_VS_WT_NTREG_UP</TD><TD>MSigDB lists</TD><TD>GSE40655_FOXO1_KO_VS_WT_NTREG_UP</TD><TD>186</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>FTH1,ATP2B4,OSBPL7,MFSD6</TD></TR>
<TR><TD>1.885e-02</TD><TD>-3.97</TD><TD>GO_CELLULAR_COMPONENT_DISASSEMBLY</TD><TD>MSigDB lists</TD><TD>GO_CELLULAR_COMPONENT_DISASSEMBLY</TD><TD>497</TD><TD>7</TD><TD>17621</TD><TD>96</TD>
<TD>NUP37,AURKAIP1,CASP6,SERPINB10,SMARCA4,POM121C,ERN2</TD></TR>
<TR><TD>1.905e-02</TD><TD>-3.96</TD><TD>-</TD><TD>gene3d domains</TD><TD>3.20.20.80</TD><TD>36</TD><TD>2</TD><TD>10485</TD><TD>62</TD>
<TD>HEXA,CHID1</TD></TR>
<TR><TD>1.910e-02</TD><TD>-3.96</TD><TD>GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP</TD><TD>MSigDB lists</TD><TD>GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP</TD><TD>39</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>MAFF,FTH1</TD></TR>
<TR><TD>1.910e-02</TD><TD>-3.96</TD><TD>TELO2 (telomere maintenance 2)</TD><TD>protein interactions</TD><TD>9894</TD><TD>39</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>VCP,TPM4</TD></TR>
<TR><TD>1.910e-02</TD><TD>-3.96</TD><TD>FARSB (phenylalanyl-tRNA synthetase beta subunit)</TD><TD>protein interactions</TD><TD>10056</TD><TD>39</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>USP8,GART</TD></TR>
<TR><TD>1.910e-02</TD><TD>-3.96</TD><TD>UBXN10 (UBX domain protein 10)</TD><TD>protein interactions</TD><TD>127733</TD><TD>39</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>VCP,IFT27</TD></TR>
<TR><TD>1.915e-02</TD><TD>-3.96</TD><TD>GSE22033_UNTREATED_VS_MRL24_TREATED_MEF_DN</TD><TD>MSigDB lists</TD><TD>GSE22033_UNTREATED_VS_MRL24_TREATED_MEF_DN</TD><TD>187</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>TPM4,TP53BP2,UBE3A,AUTS2</TD></TR>
<TR><TD>1.915e-02</TD><TD>-3.96</TD><TD>GSE22886_NAIVE_VS_IGG_IGA_MEMORY_BCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE22886_NAIVE_VS_IGG_IGA_MEMORY_BCELL_DN</TD><TD>187</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>TSFM,ATP2B4,ARPC1B,C14orf159</TD></TR>
<TR><TD>1.915e-02</TD><TD>-3.96</TD><TD>GSE14308_TH1_VS_INDUCED_TREG_UP</TD><TD>MSigDB lists</TD><TD>GSE14308_TH1_VS_INDUCED_TREG_UP</TD><TD>187</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>FGD5,ENC1,HEXA,ARIH2</TD></TR>
<TR><TD>1.915e-02</TD><TD>-3.96</TD><TD>GSE40274_XBP1_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE40274_XBP1_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN</TD><TD>187</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>JAK2,ADAMTSL2,NR4A1,EHMT1</TD></TR>
<TR><TD>1.915e-02</TD><TD>-3.96</TD><TD>GSE41867_NAIVE_VS_DAY30_LCMV_ARMSTRONG_MEMORY_CD8_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE41867_NAIVE_VS_DAY30_LCMV_ARMSTRONG_MEMORY_CD8_TCELL_UP</TD><TD>187</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>AP1G1,JAK2,CASP6,IFT27</TD></TR>
<TR><TD>1.915e-02</TD><TD>-3.96</TD><TD>GSE3039_CD4_TCELL_VS_ALPHABETA_CD8_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE3039_CD4_TCELL_VS_ALPHABETA_CD8_TCELL_UP</TD><TD>187</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>EPAS1,FOSB,OTUD7B,NR4A1</TD></TR>
<TR><TD>1.915e-02</TD><TD>-3.96</TD><TD>GSE43863_TH1_VS_TFH_MEMORY_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE43863_TH1_VS_TFH_MEMORY_CD4_TCELL_DN</TD><TD>187</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>JAK2,EPAS1,SCARB2,KDM2A</TD></TR>
<TR><TD>1.915e-02</TD><TD>-3.96</TD><TD>GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_16H_DN</TD><TD>MSigDB lists</TD><TD>GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_16H_DN</TD><TD>187</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>AUTS2,GRAMD1B,MAP1LC3B,SCARB2</TD></TR>
<TR><TD>1.919e-02</TD><TD>-3.95</TD><TD>MED1 (mediator complex subunit 1)</TD><TD>protein interactions</TD><TD>5469</TD><TD>104</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>EPAS1,MED7,NR4A1</TD></TR>
<TR><TD>1.943e-02</TD><TD>-3.94</TD><TD>peptidase activator activity</TD><TD>molecular function</TD><TD>GO:0016504</TD><TD>38</TD><TD>2</TD><TD>16652</TD><TD>94</TD>
<TD>VCP,TANK</TD></TR>
<TR><TD>1.949e-02</TD><TD>-3.94</TD><TD>GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_LN_DN</TD><TD>MSigDB lists</TD><TD>GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_LN_DN</TD><TD>188</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>FTL,NR4A1,CASP6,TANK</TD></TR>
<TR><TD>1.949e-02</TD><TD>-3.94</TD><TD>GSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_DN</TD><TD>188</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>KDM2A,FTH1,JOSD1,AUTS2</TD></TR>
<TR><TD>1.949e-02</TD><TD>-3.94</TD><TD>GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_UP</TD><TD>MSigDB lists</TD><TD>GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_UP</TD><TD>188</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>GRAMD1B,RNASEH2A,GART,KNTC1</TD></TR>
<TR><TD>1.949e-02</TD><TD>-3.94</TD><TD>GSE13738_RESTING_VS_TCR_ACTIVATED_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE13738_RESTING_VS_TCR_ACTIVATED_CD4_TCELL_DN</TD><TD>188</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>TPM4,EPAS1,ZFYVE1,GRAMD1B</TD></TR>
<TR><TD>1.949e-02</TD><TD>-3.94</TD><TD>GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_2H_UP</TD><TD>MSigDB lists</TD><TD>GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_2H_UP</TD><TD>188</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>HEXA,SHB,EPAS1,C14orf159</TD></TR>
<TR><TD>1.949e-02</TD><TD>-3.94</TD><TD>GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP</TD><TD>MSigDB lists</TD><TD>GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP</TD><TD>188</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>JOSD1,AUTS2,VCP,FTH1</TD></TR>
<TR><TD>1.950e-02</TD><TD>-3.94</TD><TD>TP53 (tumor protein p53)</TD><TD>protein interactions</TD><TD>7157</TD><TD>998</TD><TD>11</TD><TD>16330</TD><TD>89</TD>
<TD>TP53BP2,UBE3A,VCP,EHMT1,NR4A1,FTH1,EEF1A1,ARIH2,TPM4,MAP1LC3B,SMARCA4</TD></TR>
<TR><TD>1.953e-02</TD><TD>-3.94</TD><TD>Ovarian tumor domain proteases</TD><TD>REACTOME pathways</TD><TD>R-HSA-5689896</TD><TD>37</TD><TD>2</TD><TD>10293</TD><TD>60</TD>
<TD>OTUD7B,VCP</TD></TR>
<TR><TD>1.964e-02</TD><TD>-3.93</TD><TD>enzyme binding</TD><TD>molecular function</TD><TD>GO:0019899</TD><TD>1769</TD><TD>17</TD><TD>16652</TD><TD>94</TD>
<TD>TANK,SMARCA4,PTPN3,ARIH2,SCARB2,AP1G1,FGD5,JAK2,GCSAM,EEF1A1,EPAS1,MAP1LC3B,VCP,ATP2B4,PPP1R3F,CHL1,PPP1R32</TD></TR>
<TR><TD>1.968e-02</TD><TD>-3.93</TD><TD>KEAP1 (kelch like ECH associated protein 1)</TD><TD>protein interactions</TD><TD>9817</TD><TD>105</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>GPRASP2,MAP1LC3B,ENC1</TD></TR>
<TR><TD>1.968e-02</TD><TD>-3.93</TD><TD>EPAS1 (endothelial PAS domain protein 1)</TD><TD>protein interactions</TD><TD>2034</TD><TD>105</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>MED7,EPAS1,SMARCA4</TD></TR>
<TR><TD>1.969e-02</TD><TD>-3.93</TD><TD>GO_TRANSITION_METAL_ION_TRANSPORT</TD><TD>MSigDB lists</TD><TD>GO_TRANSITION_METAL_ION_TRANSPORT</TD><TD>105</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>FTL,FTH1,SLC40A1</TD></TR>
<TR><TD>1.983e-02</TD><TD>-3.92</TD><TD>GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_DN</TD><TD>MSigDB lists</TD><TD>GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_DN</TD><TD>189</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>ENC1,GAPT,ARPC1B,KDM2A</TD></TR>
<TR><TD>1.983e-02</TD><TD>-3.92</TD><TD>GSE10239_NAIVE_VS_KLRG1HIGH_EFF_CD8_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE10239_NAIVE_VS_KLRG1HIGH_EFF_CD8_TCELL_DN</TD><TD>189</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>NUP37,EPAS1,PTPN3,KNTC1</TD></TR>
<TR><TD>1.983e-02</TD><TD>-3.92</TD><TD>GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_1H_UP</TD><TD>MSigDB lists</TD><TD>GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_1H_UP</TD><TD>189</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>SLC35E4,ADAR,JAK2,UBE3A</TD></TR>
<TR><TD>1.983e-02</TD><TD>-3.92</TD><TD>GSE17721_0.5H_VS_4H_PAM3CSK4_BMDC_DN</TD><TD>MSigDB lists</TD><TD>GSE17721_0.5H_VS_4H_PAM3CSK4_BMDC_DN</TD><TD>189</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>VCP,MAP3K7,F10,MNX1</TD></TR>
<TR><TD>1.983e-02</TD><TD>-3.92</TD><TD>GSE40666_WT_VS_STAT1_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN</TD><TD>MSigDB lists</TD><TD>GSE40666_WT_VS_STAT1_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN</TD><TD>189</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>TACC2,KNTC1,NR4A1,CHL1</TD></TR>
<TR><TD>1.983e-02</TD><TD>-3.92</TD><TD>GSE28783_ANTI_MIR33_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_UP</TD><TD>MSigDB lists</TD><TD>GSE28783_ANTI_MIR33_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_UP</TD><TD>189</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>UBE3A,IFT27,NR4A1,HSPB6</TD></TR>
<TR><TD>1.983e-02</TD><TD>-3.92</TD><TD>GSE10239_MEMORY_VS_KLRG1INT_EFF_CD8_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE10239_MEMORY_VS_KLRG1INT_EFF_CD8_TCELL_DN</TD><TD>189</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>MAP3K7,MED7,TACC2,AP1G1</TD></TR>
<TR><TD>1.983e-02</TD><TD>-3.92</TD><TD>GSE39382_IL3_VS_IL3_IL33_TREATED_MAST_CELL_DN</TD><TD>MSigDB lists</TD><TD>GSE39382_IL3_VS_IL3_IL33_TREATED_MAST_CELL_DN</TD><TD>189</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>GART,ATP2B4,JAK2,TSFM</TD></TR>
<TR><TD>1.983e-02</TD><TD>-3.92</TD><TD>GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_24H_IFNG_STIM_UP</TD><TD>MSigDB lists</TD><TD>GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_24H_IFNG_STIM_UP</TD><TD>189</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>NR4A1,CHL1,DTD1,ALAS2</TD></TR>
<TR><TD>1.983e-02</TD><TD>-3.92</TD><TD>GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP</TD><TD>MSigDB lists</TD><TD>GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP</TD><TD>189</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>TPM4,EPAS1,ENC1,AP1G1</TD></TR>
<TR><TD>1.983e-02</TD><TD>-3.92</TD><TD>GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_HET_MACROPHAGE_UP</TD><TD>MSigDB lists</TD><TD>GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_HET_MACROPHAGE_UP</TD><TD>189</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>ENC1,TACC2,PPP1R3F,SCARB2</TD></TR>
<TR><TD>1.983e-02</TD><TD>-3.92</TD><TD>GSE27786_CD4_TCELL_VS_MONO_MAC_UP</TD><TD>MSigDB lists</TD><TD>GSE27786_CD4_TCELL_VS_MONO_MAC_UP</TD><TD>189</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>COMMD7,UBE3A,ADI1,ARIH2</TD></TR>
<TR><TD>1.983e-02</TD><TD>-3.92</TD><TD>GSE13493_DP_VS_CD8POS_THYMOCYTE_DN</TD><TD>MSigDB lists</TD><TD>GSE13493_DP_VS_CD8POS_THYMOCYTE_DN</TD><TD>189</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>GJB2,ENC1,ADAR,TSFM</TD></TR>
<TR><TD>1.985e-02</TD><TD>-3.92</TD><TD>GO_PROTEOLYSIS</TD><TD>MSigDB lists</TD><TD>GO_PROTEOLYSIS</TD><TD>1132</TD><TD>12</TD><TD>17621</TD><TD>96</TD>
<TD>JAK2,F10,ARIH2,OTUD7B,JOSD1,VCP,UBE3A,FBXO31,ENC1,CASP6,ADAMTSL2,USP8</TD></TR>
<TR><TD>1.987e-02</TD><TD>-3.92</TD><TD>nucleolus</TD><TD>cellular component</TD><TD>GO:0005730</TD><TD>857</TD><TD>10</TD><TD>17744</TD><TD>98</TD>
<TD>KDM2A,NANOG,MNX1,NGDN,EEF1A1,PLK5,SMARCA4,ADAR,ENC1,TACC2</TD></TR>
<TR><TD>2.001e-02</TD><TD>-3.91</TD><TD>regulation of cell cycle</TD><TD>biological process</TD><TD>GO:0051726</TD><TD>981</TD><TD>11</TD><TD>16543</TD><TD>92</TD>
<TD>PLK5,NR4A1,FBXO31,ATP2B4,TP53BP2,SHB,SMARCA4,PTPN3,OVOL1,AURKAIP1,KNTC1</TD></TR>
<TR><TD>2.003e-02</TD><TD>-3.91</TD><TD>WINNEPENNINCKX_MELANOMA_METASTASIS_DN</TD><TD>MSigDB lists</TD><TD>WINNEPENNINCKX_MELANOMA_METASTASIS_DN</TD><TD>40</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>F10,LGALS2</TD></TR>
<TR><TD>2.003e-02</TD><TD>-3.91</TD><TD>JIANG_AGING_HYPOTHALAMUS_DN</TD><TD>MSigDB lists</TD><TD>JIANG_AGING_HYPOTHALAMUS_DN</TD><TD>40</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>EEF1A1,EPAS1</TD></TR>
<TR><TD>2.003e-02</TD><TD>-3.91</TD><TD>GO_POLYUBIQUITIN_BINDING</TD><TD>MSigDB lists</TD><TD>GO_POLYUBIQUITIN_BINDING</TD><TD>40</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>OTUD7B,VCP</TD></TR>
<TR><TD>2.003e-02</TD><TD>-3.91</TD><TD>chr2q32</TD><TD>MSigDB lists</TD><TD>chr2q32</TD><TD>40</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>MFSD6,SLC40A1</TD></TR>
<TR><TD>2.003e-02</TD><TD>-3.91</TD><TD>MYOG (myogenin)</TD><TD>protein interactions</TD><TD>4656</TD><TD>40</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>SMARCA4,FTL</TD></TR>
<TR><TD>2.003e-02</TD><TD>-3.91</TD><TD>MED25 (mediator complex subunit 25)</TD><TD>protein interactions</TD><TD>81857</TD><TD>40</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>EPAS1,MED7</TD></TR>
<TR><TD>2.006e-02</TD><TD>-3.91</TD><TD>regulation of cellular process</TD><TD>biological process</TD><TD>GO:0050794</TD><TD>10082</TD><TD>66</TD><TD>16543</TD><TD>92</TD>
<TD>DTD1,OSBPL7,CHL1,COMMD7,ARIH2,NANOG,EMX1,EPAS1,OVOL1,USP8,TMEM198,NUP37,BNC1,RAB17,OTUD7B,GCSAM,TP53BP2,FOSB,ENC1,TANK,UBE3A,ADAR,ATP2B4,PXYLP1,RFX2,F10,MAP1LC3B,JAK2,PLK5,AUTS2,SHB,VARS2,SMARCA4,FTH1,SLC40A1,ONECUT3,MNX1,PTPN3,ARPC1B,CASP6,FGD5,IFT27,CHODL,KCNA2,ZFYVE1,VCP,MAP3K7,PPP1R3F,KNTC1,EHMT1,AP1G1,SCARB2,NGDN,POM121C,TSFM,ADAMTSL2,AURKAIP1,MED7,NR4A1,FBXO31,SERPINB10,ERN2,ZNF683,EEF1A1,MAFF,KDM2A</TD></TR>
<TR><TD>2.018e-02</TD><TD>-3.90</TD><TD>GSE9650_NAIVE_VS_EXHAUSTED_CD8_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE9650_NAIVE_VS_EXHAUSTED_CD8_TCELL_UP</TD><TD>190</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>HEXA,AURKAIP1,RNASEH2A,MAP1LC3B</TD></TR>
<TR><TD>2.018e-02</TD><TD>-3.90</TD><TD>GSE11057_NAIVE_CD4_VS_PBMC_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE11057_NAIVE_CD4_VS_PBMC_CD4_TCELL_DN</TD><TD>190</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>JAK2,FTH1,EPAS1,ARPC1B</TD></TR>
<TR><TD>2.018e-02</TD><TD>-3.90</TD><TD>GSE16385_ROSIGLITAZONE_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_UP</TD><TD>MSigDB lists</TD><TD>GSE16385_ROSIGLITAZONE_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_UP</TD><TD>190</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>CHL1,NR4A1,MAFF,FOSB</TD></TR>
<TR><TD>2.018e-02</TD><TD>-3.90</TD><TD>GSE20500_RETINOIC_ACID_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE20500_RETINOIC_ACID_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_DN</TD><TD>190</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>TP53BP2,SCARB2,NR4A1,UBE3A</TD></TR>
<TR><TD>2.018e-02</TD><TD>-3.90</TD><TD>NCOA1 (nuclear receptor coactivator 1)</TD><TD>protein interactions</TD><TD>8648</TD><TD>106</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>VCP,NR4A1,SMARCA4</TD></TR>
<TR><TD>2.019e-02</TD><TD>-3.90</TD><TD>LINDGREN_BLADDER_CANCER_CLUSTER_1_UP</TD><TD>MSigDB lists</TD><TD>LINDGREN_BLADDER_CANCER_CLUSTER_1_UP</TD><TD>106</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>C14orf159,MED7,MAP3K7</TD></TR>
<TR><TD>2.052e-02</TD><TD>-3.89</TD><TD>GSE23925_DARK_ZONE_VS_NAIVE_BCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE23925_DARK_ZONE_VS_NAIVE_BCELL_DN</TD><TD>191</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>KDM2A,FOSB,MAFF,NR4A1</TD></TR>
<TR><TD>2.052e-02</TD><TD>-3.89</TD><TD>GSE17721_LPS_VS_POLYIC_12H_BMDC_UP</TD><TD>MSigDB lists</TD><TD>GSE17721_LPS_VS_POLYIC_12H_BMDC_UP</TD><TD>191</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>JAK2,CHID1,HEATR6,COMMD7</TD></TR>
<TR><TD>2.052e-02</TD><TD>-3.89</TD><TD>GSE24142_DN2_VS_DN3_THYMOCYTE_ADULT_UP</TD><TD>MSigDB lists</TD><TD>GSE24142_DN2_VS_DN3_THYMOCYTE_ADULT_UP</TD><TD>191</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>RAB17,AUTS2,ENC1,SLC35E4</TD></TR>
<TR><TD>2.052e-02</TD><TD>-3.89</TD><TD>GSE32128_INOS_DEPENDENT_VS_INOS_INDEPENDENT_ACTIVATED_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE32128_INOS_DEPENDENT_VS_INOS_INDEPENDENT_ACTIVATED_TCELL_UP</TD><TD>191</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>TACC2,MAP3K7,OTUD7B,ARIH2</TD></TR>
<TR><TD>2.052e-02</TD><TD>-3.89</TD><TD>GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TGFB_TREATED_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TGFB_TREATED_CD4_TCELL_UP</TD><TD>191</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>MED7,TACC2,MFSD6,GRAMD1B</TD></TR>
<TR><TD>2.052e-02</TD><TD>-3.89</TD><TD>GSE6674_PL2_3_VS_ANTI_IGM_AND_CPG_STIM_BCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE6674_PL2_3_VS_ANTI_IGM_AND_CPG_STIM_BCELL_UP</TD><TD>191</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>EPAS1,COMMD7,GRAMD1B,VCP</TD></TR>
<TR><TD>2.052e-02</TD><TD>-3.89</TD><TD>GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_STIM_DN</TD><TD>MSigDB lists</TD><TD>GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_STIM_DN</TD><TD>191</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>ATP2B4,PTPN3,GJB2,MED7</TD></TR>
<TR><TD>2.052e-02</TD><TD>-3.89</TD><TD>GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_DN</TD><TD>MSigDB lists</TD><TD>GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_DN</TD><TD>191</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>EPAS1,TPM4,ADAR,VCP</TD></TR>
<TR><TD>2.052e-02</TD><TD>-3.89</TD><TD>GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_DN</TD><TD>MSigDB lists</TD><TD>GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_DN</TD><TD>191</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>TACC2,NR4A1,LGALS2,ADI1</TD></TR>
<TR><TD>2.052e-02</TD><TD>-3.89</TD><TD>GSE3982_DC_VS_NKCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE3982_DC_VS_NKCELL_UP</TD><TD>191</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>SHB,ENC1,FTH1,CASP6</TD></TR>
<TR><TD>2.052e-02</TD><TD>-3.89</TD><TD>GSE27786_CD4_TCELL_VS_NKTCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE27786_CD4_TCELL_VS_NKTCELL_UP</TD><TD>191</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>MAP1LC3B,NR4A1,RNASEH2A,OTUD7B</TD></TR>
<TR><TD>2.052e-02</TD><TD>-3.89</TD><TD>GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_6H_UP</TD><TD>MSigDB lists</TD><TD>GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_6H_UP</TD><TD>191</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>MAFF,TTC39A,NGDN,MFSD6</TD></TR>
<TR><TD>2.052e-02</TD><TD>-3.89</TD><TD>GSE26030_UNSTIM_VS_RESTIM_TH17_DAY15_POST_POLARIZATION_DN</TD><TD>MSigDB lists</TD><TD>GSE26030_UNSTIM_VS_RESTIM_TH17_DAY15_POST_POLARIZATION_DN</TD><TD>191</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>ARIH2,ADAR,MAP1LC3B,SCARB2</TD></TR>
<TR><TD>2.069e-02</TD><TD>-3.88</TD><TD>WANG_HCP_PROSTATE_CANCER</TD><TD>MSigDB lists</TD><TD>WANG_HCP_PROSTATE_CANCER</TD><TD>107</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>TACC2,AUTS2,FTH1</TD></TR>
<TR><TD>2.076e-02</TD><TD>-3.87</TD><TD>medullary_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>medullary_carcinoma</TD><TD>298</TD><TD>5</TD><TD>17630</TD><TD>93</TD>
<TD>SMARCA4,FBXO31,JAK2,UBE3A,TTC39A</TD></TR>
<TR><TD>2.076e-02</TD><TD>-3.87</TD><TD>thyroid-carcinoma-medullary_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>thyroid-carcinoma-medullary_carcinoma</TD><TD>298</TD><TD>5</TD><TD>17630</TD><TD>93</TD>
<TD>SMARCA4,FBXO31,UBE3A,JAK2,TTC39A</TD></TR>
<TR><TD>2.076e-02</TD><TD>-3.87</TD><TD>cerebral cortex development</TD><TD>biological process</TD><TD>GO:0021987</TD><TD>105</TD><TD>3</TD><TD>16543</TD><TD>92</TD>
<TD>EMX1,GART,TACC2</TD></TR>
<TR><TD>2.081e-02</TD><TD>-3.87</TD><TD>B cell proliferation</TD><TD>biological process</TD><TD>GO:0042100</TD><TD>40</TD><TD>2</TD><TD>16543</TD><TD>92</TD>
<TD>SHB,GAPT</TD></TR>
<TR><TD>2.084e-02</TD><TD>-3.87</TD><TD>SKP1 (S-phase kinase associated protein 1)</TD><TD>protein interactions</TD><TD>6500</TD><TD>192</TD><TD>4</TD><TD>16330</TD><TD>89</TD>
<TD>FBXO31,KDM2A,GJB2,VCP</TD></TR>
<TR><TD>2.088e-02</TD><TD>-3.87</TD><TD>GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_UP</TD><TD>MSigDB lists</TD><TD>GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_UP</TD><TD>192</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>RBKS,TPM4,KNTC1,GRAMD1B</TD></TR>
<TR><TD>2.088e-02</TD><TD>-3.87</TD><TD>GSE22501_PERIPHERAL_BLOOD_VS_CORD_BLOOD_TREG_DN</TD><TD>MSigDB lists</TD><TD>GSE22501_PERIPHERAL_BLOOD_VS_CORD_BLOOD_TREG_DN</TD><TD>192</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>TP53BP2,EPAS1,CHL1,TTC39A</TD></TR>
<TR><TD>2.088e-02</TD><TD>-3.87</TD><TD>GSE40274_FOXP3_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE40274_FOXP3_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN</TD><TD>192</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>TACC2,EHMT1,FBXO31,NR4A1</TD></TR>
<TR><TD>2.088e-02</TD><TD>-3.87</TD><TD>GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_UP</TD><TD>MSigDB lists</TD><TD>GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_UP</TD><TD>192</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>OSBPL7,FTH1,JOSD1,ATP2B4</TD></TR>
<TR><TD>2.088e-02</TD><TD>-3.87</TD><TD>GSE27434_WT_VS_DNMT1_KO_TREG_DN</TD><TD>MSigDB lists</TD><TD>GSE27434_WT_VS_DNMT1_KO_TREG_DN</TD><TD>192</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>TANK,JAK2,ARIH2,NR4A1</TD></TR>
<TR><TD>2.088e-02</TD><TD>-3.87</TD><TD>GSE17721_LPS_VS_GARDIQUIMOD_8H_BMDC_DN</TD><TD>MSigDB lists</TD><TD>GSE17721_LPS_VS_GARDIQUIMOD_8H_BMDC_DN</TD><TD>192</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>MAP3K7,CHODL,POM121C,HEATR6</TD></TR>
<TR><TD>2.088e-02</TD><TD>-3.87</TD><TD>GSE24142_ADULT_VS_FETAL_DN2_THYMOCYTE_UP</TD><TD>MSigDB lists</TD><TD>GSE24142_ADULT_VS_FETAL_DN2_THYMOCYTE_UP</TD><TD>192</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>C14orf159,SCARB2,ENC1,NANOG</TD></TR>
<TR><TD>2.088e-02</TD><TD>-3.87</TD><TD>GSE7831_UNSTIM_VS_CPG_STIM_PDC_1H_UP</TD><TD>MSigDB lists</TD><TD>GSE7831_UNSTIM_VS_CPG_STIM_PDC_1H_UP</TD><TD>192</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>EPAS1,COMMD7,GRAMD1B,IFT27</TD></TR>
<TR><TD>2.088e-02</TD><TD>-3.87</TD><TD>GSE7852_THYMUS_VS_FAT_TCONV_DN</TD><TD>MSigDB lists</TD><TD>GSE7852_THYMUS_VS_FAT_TCONV_DN</TD><TD>192</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>FOSB,ALAS2,ATP2B4,MAFF</TD></TR>
<TR><TD>2.093e-02</TD><TD>-3.87</TD><TD>lung-carcinoma-mixed_adenosquamous_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>lung-carcinoma-mixed_adenosquamous_carcinoma</TD><TD>111</TD><TD>3</TD><TD>17630</TD><TD>93</TD>
<TD>SMARCA4,JAK2,GRAMD1B</TD></TR>
<TR><TD>2.094e-02</TD><TD>-3.87</TD><TD>haematopoietic_and_lymphoid_tissue-other-splanchnic_vein_thrombosis</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-other-splanchnic_vein_thrombosis</TD><TD>4</TD><TD>1</TD><TD>17630</TD><TD>93</TD>
<TD>JAK2</TD></TR>
<TR><TD>2.094e-02</TD><TD>-3.87</TD><TD>splanchnic_vein_thrombosis</TD><TD>COSMIC cancer mutations</TD><TD>splanchnic_vein_thrombosis</TD><TD>4</TD><TD>1</TD><TD>17630</TD><TD>93</TD>
<TD>JAK2</TD></TR>
<TR><TD>2.094e-02</TD><TD>-3.87</TD><TD>haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia_associated_with_mastocytosis</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia_associated_with_mastocytosis</TD><TD>4</TD><TD>1</TD><TD>17630</TD><TD>93</TD>
<TD>JAK2</TD></TR>
<TR><TD>2.094e-02</TD><TD>-3.87</TD><TD>secondary_thrombocythaemia</TD><TD>COSMIC cancer mutations</TD><TD>secondary_thrombocythaemia</TD><TD>4</TD><TD>1</TD><TD>17630</TD><TD>93</TD>
<TD>JAK2</TD></TR>
<TR><TD>2.094e-02</TD><TD>-3.87</TD><TD>large_intestine-colon-carcinoma-neuroendocrine_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>large_intestine-colon-carcinoma-neuroendocrine_carcinoma</TD><TD>4</TD><TD>1</TD><TD>17630</TD><TD>93</TD>
<TD>SMARCA4</TD></TR>
<TR><TD>2.094e-02</TD><TD>-3.87</TD><TD>haematopoietic_and_lymphoid_tissue-other-idiopathic_erythrocytosis</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-other-idiopathic_erythrocytosis</TD><TD>4</TD><TD>1</TD><TD>17630</TD><TD>93</TD>
<TD>JAK2</TD></TR>
<TR><TD>2.094e-02</TD><TD>-3.87</TD><TD>normal-like_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>normal-like_carcinoma</TD><TD>4</TD><TD>1</TD><TD>17630</TD><TD>93</TD>
<TD>JAK2</TD></TR>
<TR><TD>2.094e-02</TD><TD>-3.87</TD><TD>breast-carcinoma-normal-like_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>breast-carcinoma-normal-like_carcinoma</TD><TD>4</TD><TD>1</TD><TD>17630</TD><TD>93</TD>
<TD>JAK2</TD></TR>
<TR><TD>2.094e-02</TD><TD>-3.87</TD><TD>acute_myeloid_leukaemia_associated_with_mastocytosis</TD><TD>COSMIC cancer mutations</TD><TD>acute_myeloid_leukaemia_associated_with_mastocytosis</TD><TD>4</TD><TD>1</TD><TD>17630</TD><TD>93</TD>
<TD>JAK2</TD></TR>
<TR><TD>2.094e-02</TD><TD>-3.87</TD><TD>idiopathic_erythrocytosis</TD><TD>COSMIC cancer mutations</TD><TD>idiopathic_erythrocytosis</TD><TD>4</TD><TD>1</TD><TD>17630</TD><TD>93</TD>
<TD>JAK2</TD></TR>
<TR><TD>2.094e-02</TD><TD>-3.87</TD><TD>haematopoietic_and_lymphoid_tissue-other-secondary_thrombocythaemia</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-other-secondary_thrombocythaemia</TD><TD>4</TD><TD>1</TD><TD>17630</TD><TD>93</TD>
<TD>JAK2</TD></TR>
<TR><TD>2.094e-02</TD><TD>-3.87</TD><TD>skin-adnexal_tumour-other</TD><TD>COSMIC cancer mutations</TD><TD>skin-adnexal_tumour-other</TD><TD>4</TD><TD>1</TD><TD>17630</TD><TD>93</TD>
<TD>JAK2</TD></TR>
<TR><TD>2.098e-02</TD><TD>-3.86</TD><TD>AMIT_EGF_RESPONSE_120_MCF10A</TD><TD>MSigDB lists</TD><TD>AMIT_EGF_RESPONSE_120_MCF10A</TD><TD>41</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>MAFF,ENC1</TD></TR>
<TR><TD>2.098e-02</TD><TD>-3.86</TD><TD>GO_CELLULAR_COMPONENT_DISASSEMBLY_INVOLVED_IN_EXECUTION_PHASE_OF_APOPTOSIS</TD><TD>MSigDB lists</TD><TD>GO_CELLULAR_COMPONENT_DISASSEMBLY_INVOLVED_IN_EXECUTION_PHASE_OF_APOPTOSIS</TD><TD>41</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>ERN2,CASP6</TD></TR>
<TR><TD>2.099e-02</TD><TD>-3.86</TD><TD>PBRM1 (polybromo 1)</TD><TD>protein interactions</TD><TD>55193</TD><TD>41</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>NANOG,SMARCA4</TD></TR>
<TR><TD>2.099e-02</TD><TD>-3.86</TD><TD>MED27 (mediator complex subunit 27)</TD><TD>protein interactions</TD><TD>9442</TD><TD>41</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>EPAS1,MED7</TD></TR>
<TR><TD>2.099e-02</TD><TD>-3.86</TD><TD>DIABLO (diablo IAP-binding mitochondrial protein)</TD><TD>protein interactions</TD><TD>56616</TD><TD>41</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>EEF1A1,NR4A1</TD></TR>
<TR><TD>2.099e-02</TD><TD>-3.86</TD><TD>FTL (ferritin light chain)</TD><TD>protein interactions</TD><TD>2512</TD><TD>41</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>FTL,FTH1</TD></TR>
<TR><TD>2.120e-02</TD><TD>-3.85</TD><TD>ZHANG_TLX_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>ZHANG_TLX_TARGETS_UP</TD><TD>108</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>NR4A1,C14orf159,SCARB2</TD></TR>
<TR><TD>2.120e-02</TD><TD>-3.85</TD><TD>GO_TRANSLATIONAL_ELONGATION</TD><TD>MSigDB lists</TD><TD>GO_TRANSLATIONAL_ELONGATION</TD><TD>108</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>EEF1A1,TSFM,AURKAIP1</TD></TR>
<TR><TD>2.123e-02</TD><TD>-3.85</TD><TD>GSE15324_ELF4_KO_VS_WT_ACTIVATED_CD8_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE15324_ELF4_KO_VS_WT_ACTIVATED_CD8_TCELL_DN</TD><TD>193</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>OVOL1,ARPC1B,MED7,TACC2</TD></TR>
<TR><TD>2.123e-02</TD><TD>-3.85</TD><TD>GSE19401_UNSTIM_VS_PAM2CSK4_STIM_FOLLICULAR_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE19401_UNSTIM_VS_PAM2CSK4_STIM_FOLLICULAR_DC_DN</TD><TD>193</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>USP8,HEXA,ADAR,MED7</TD></TR>
<TR><TD>2.123e-02</TD><TD>-3.85</TD><TD>GSE1925_CTRL_VS_3H_IFNG_STIM_MACROPHAGE_UP</TD><TD>MSigDB lists</TD><TD>GSE1925_CTRL_VS_3H_IFNG_STIM_MACROPHAGE_UP</TD><TD>193</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>VCP,CHL1,NR4A1,GART</TD></TR>
<TR><TD>2.123e-02</TD><TD>-3.85</TD><TD>GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP</TD><TD>MSigDB lists</TD><TD>GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP</TD><TD>193</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>JAK2,ADAR,NGDN,RFX2</TD></TR>
<TR><TD>2.123e-02</TD><TD>-3.85</TD><TD>GSE28783_CTRL_ANTI_MIR_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_DN</TD><TD>MSigDB lists</TD><TD>GSE28783_CTRL_ANTI_MIR_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_DN</TD><TD>193</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>EPAS1,ALAS2,NR4A1,IFT27</TD></TR>
<TR><TD>2.123e-02</TD><TD>-3.85</TD><TD>GSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_DN</TD><TD>MSigDB lists</TD><TD>GSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_DN</TD><TD>193</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>ADAR,FBXO31,CHID1,KNTC1</TD></TR>
<TR><TD>2.140e-02</TD><TD>-3.84</TD><TD>polyubiquitin binding</TD><TD>molecular function</TD><TD>GO:0031593</TD><TD>40</TD><TD>2</TD><TD>16652</TD><TD>94</TD>
<TD>VCP,OTUD7B</TD></TR>
<TR><TD>2.143e-02</TD><TD>-3.84</TD><TD>mixed_adenosquamous_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>mixed_adenosquamous_carcinoma</TD><TD>112</TD><TD>3</TD><TD>17630</TD><TD>93</TD>
<TD>GRAMD1B,JAK2,SMARCA4</TD></TR>
<TR><TD>2.144e-02</TD><TD>-3.84</TD><TD>regulation of transcription from RNA polymerase II promoter</TD><TD>biological process</TD><TD>GO:0006357</TD><TD>1815</TD><TD>17</TD><TD>16543</TD><TD>92</TD>
<TD>RFX2,OVOL1,EHMT1,OTUD7B,MAFF,SMARCA4,FOSB,AUTS2,ONECUT3,SLC40A1,MNX1,UBE3A,MED7,NANOG,NR4A1,ATP2B4,EPAS1</TD></TR>
<TR><TD>2.153e-02</TD><TD>-3.84</TD><TD>myeloid cell differentiation</TD><TD>biological process</TD><TD>GO:0030099</TD><TD>190</TD><TD>4</TD><TD>16543</TD><TD>92</TD>
<TD>EPAS1,ADAR,ALAS2,JAK2</TD></TR>
<TR><TD>2.159e-02</TD><TD>-3.84</TD><TD>GSE360_CTRL_VS_L_DONOVANI_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE360_CTRL_VS_L_DONOVANI_DC_DN</TD><TD>194</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>CHL1,VCP,ALAS2,SCARB2</TD></TR>
<TR><TD>2.159e-02</TD><TD>-3.84</TD><TD>GSE42088_UNINF_VS_LEISHMANIA_INF_DC_4H_DN</TD><TD>MSigDB lists</TD><TD>GSE42088_UNINF_VS_LEISHMANIA_INF_DC_4H_DN</TD><TD>194</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>NR4A1,MAP1LC3B,FOSB,OSBPL7</TD></TR>
<TR><TD>2.159e-02</TD><TD>-3.84</TD><TD>GSE339_CD4POS_VS_CD4CD8DN_DC_IN_CULTURE_DN</TD><TD>MSigDB lists</TD><TD>GSE339_CD4POS_VS_CD4CD8DN_DC_IN_CULTURE_DN</TD><TD>194</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>ARIH2,KCNA2,CHL1,SLC35E4</TD></TR>
<TR><TD>2.159e-02</TD><TD>-3.84</TD><TD>GSE17721_CPG_VS_GARDIQUIMOD_2H_BMDC_DN</TD><TD>MSigDB lists</TD><TD>GSE17721_CPG_VS_GARDIQUIMOD_2H_BMDC_DN</TD><TD>194</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>UBE3A,POM121C,AP1G1,PPP1R3F</TD></TR>
<TR><TD>2.159e-02</TD><TD>-3.84</TD><TD>GSE7852_LN_VS_FAT_TCONV_DN</TD><TD>MSigDB lists</TD><TD>GSE7852_LN_VS_FAT_TCONV_DN</TD><TD>194</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>ATP2B4,ALAS2,NR4A1,FOSB</TD></TR>
<TR><TD>2.159e-02</TD><TD>-3.84</TD><TD>GSE20366_EX_VIVO_VS_DEC205_CONVERSION_NAIVE_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE20366_EX_VIVO_VS_DEC205_CONVERSION_NAIVE_CD4_TCELL_UP</TD><TD>194</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>EPAS1,KNTC1,NUP37,OTUD7B</TD></TR>
<TR><TD>2.162e-02</TD><TD>-3.83</TD><TD>OVOL1 (ovo like transcriptional repressor 1)</TD><TD>protein interactions</TD><TD>5017</TD><TD>4</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>MAFF</TD></TR>
<TR><TD>2.162e-02</TD><TD>-3.83</TD><TD>RHBDL3 (rhomboid like 3)</TD><TD>protein interactions</TD><TD>162494</TD><TD>4</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>VCP</TD></TR>
<TR><TD>2.162e-02</TD><TD>-3.83</TD><TD>Pebp1 (phosphatidylethanolamine binding protein 1)</TD><TD>protein interactions</TD><TD>29542</TD><TD>4</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>MAP3K7</TD></TR>
<TR><TD>2.162e-02</TD><TD>-3.83</TD><TD>gag-pol (gag-pol fusion polyprotein)</TD><TD>protein interactions</TD><TD>1490001</TD><TD>4</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>EEF1A1</TD></TR>
<TR><TD>2.162e-02</TD><TD>-3.83</TD><TD>TMPRSS3 (transmembrane protease, serine 3)</TD><TD>protein interactions</TD><TD>64699</TD><TD>4</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>EEF1A1</TD></TR>
<TR><TD>2.162e-02</TD><TD>-3.83</TD><TD>COMMD3-BMI1 (COMMD3-BMI1 readthrough)</TD><TD>protein interactions</TD><TD>100532731</TD><TD>4</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>NANOG</TD></TR>
<TR><TD>2.162e-02</TD><TD>-3.83</TD><TD>ZNF157 (zinc finger protein 157)</TD><TD>protein interactions</TD><TD>7712</TD><TD>4</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>NANOG</TD></TR>
<TR><TD>2.162e-02</TD><TD>-3.83</TD><TD>ZCCHC9 (zinc finger CCHC-type containing 9)</TD><TD>protein interactions</TD><TD>84240</TD><TD>4</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>FBXO31</TD></TR>
<TR><TD>2.162e-02</TD><TD>-3.83</TD><TD>RMDN2 (regulator of microtubule dynamics 2)</TD><TD>protein interactions</TD><TD>151393</TD><TD>4</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>RMDN3</TD></TR>
<TR><TD>2.162e-02</TD><TD>-3.83</TD><TD>TCF7L1 (transcription factor 7 like 1)</TD><TD>protein interactions</TD><TD>83439</TD><TD>4</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>NANOG</TD></TR>
<TR><TD>2.162e-02</TD><TD>-3.83</TD><TD>TAT (tyrosine aminotransferase)</TD><TD>protein interactions</TD><TD>6898</TD><TD>4</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>UBE3A</TD></TR>
<TR><TD>2.162e-02</TD><TD>-3.83</TD><TD>TRPM1 (transient receptor potential cation channel subfamily M member 1)</TD><TD>protein interactions</TD><TD>4308</TD><TD>4</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>NANOG</TD></TR>
<TR><TD>2.162e-02</TD><TD>-3.83</TD><TD>ANKIB1 (ankyrin repeat and IBR domain containing 1)</TD><TD>protein interactions</TD><TD>54467</TD><TD>4</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>NR4A1</TD></TR>
<TR><TD>2.162e-02</TD><TD>-3.83</TD><TD>AP1AR (adaptor related protein complex 1 associated regulatory protein)</TD><TD>protein interactions</TD><TD>55435</TD><TD>4</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>AP1G1</TD></TR>
<TR><TD>2.162e-02</TD><TD>-3.83</TD><TD>HSPB11 (heat shock protein family B (small) member 11)</TD><TD>protein interactions</TD><TD>51668</TD><TD>4</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>IFT27</TD></TR>
<TR><TD>2.162e-02</TD><TD>-3.83</TD><TD>ARHGEF10L (Rho guanine nucleotide exchange factor 10 like)</TD><TD>protein interactions</TD><TD>55160</TD><TD>4</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>NR4A1</TD></TR>
<TR><TD>2.162e-02</TD><TD>-3.83</TD><TD>TMPRSS13 (transmembrane protease, serine 13)</TD><TD>protein interactions</TD><TD>84000</TD><TD>4</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>VCP</TD></TR>
<TR><TD>2.162e-02</TD><TD>-3.83</TD><TD>CYSRT1 (cysteine rich tail 1)</TD><TD>protein interactions</TD><TD>375791</TD><TD>4</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>RMDN3</TD></TR>
<TR><TD>2.162e-02</TD><TD>-3.83</TD><TD>HDX (highly divergent homeobox)</TD><TD>protein interactions</TD><TD>139324</TD><TD>4</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>NANOG</TD></TR>
<TR><TD>2.162e-02</TD><TD>-3.83</TD><TD>FAM65A (family with sequence similarity 65 member A)</TD><TD>protein interactions</TD><TD>79567</TD><TD>4</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>MAP1LC3B</TD></TR>
<TR><TD>2.162e-02</TD><TD>-3.83</TD><TD>src (p60-SRC phosphoprotein)</TD><TD>protein interactions</TD><TD>1491925</TD><TD>4</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>SHB</TD></TR>
<TR><TD>2.162e-02</TD><TD>-3.83</TD><TD>PDE6A (phosphodiesterase 6A)</TD><TD>protein interactions</TD><TD>5145</TD><TD>4</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>NANOG</TD></TR>
<TR><TD>2.162e-02</TD><TD>-3.83</TD><TD>PCMTD1 (protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1)</TD><TD>protein interactions</TD><TD>115294</TD><TD>4</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>NANOG</TD></TR>
<TR><TD>2.162e-02</TD><TD>-3.83</TD><TD>HES5 (hes family bHLH transcription factor 5)</TD><TD>protein interactions</TD><TD>388585</TD><TD>4</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>JAK2</TD></TR>
<TR><TD>2.162e-02</TD><TD>-3.83</TD><TD>HTR7 (5-hydroxytryptamine receptor 7)</TD><TD>protein interactions</TD><TD>3363</TD><TD>4</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>GPRASP2</TD></TR>
<TR><TD>2.162e-02</TD><TD>-3.83</TD><TD>CHRM1 (cholinergic receptor muscarinic 1)</TD><TD>protein interactions</TD><TD>1128</TD><TD>4</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>GPRASP2</TD></TR>
<TR><TD>2.162e-02</TD><TD>-3.83</TD><TD>ANKRD24 (ankyrin repeat domain 24)</TD><TD>protein interactions</TD><TD>170961</TD><TD>4</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>EEF1A1</TD></TR>
<TR><TD>2.162e-02</TD><TD>-3.83</TD><TD>ABCB11 (ATP binding cassette subfamily B member 11)</TD><TD>protein interactions</TD><TD>8647</TD><TD>4</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>NR4A1</TD></TR>
<TR><TD>2.162e-02</TD><TD>-3.83</TD><TD>MAMDC2 (MAM domain containing 2)</TD><TD>protein interactions</TD><TD>256691</TD><TD>4</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>RNASEH2A</TD></TR>
<TR><TD>2.170e-02</TD><TD>-3.83</TD><TD>HNRNPDL (heterogeneous nuclear ribonucleoprotein D like)</TD><TD>protein interactions</TD><TD>9987</TD><TD>109</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>EEF1A1,RMDN3,NANOG</TD></TR>
<TR><TD>2.170e-02</TD><TD>-3.83</TD><TD>MTA2 (metastasis associated 1 family member 2)</TD><TD>protein interactions</TD><TD>9219</TD><TD>109</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>NR4A1,MYPN,NANOG</TD></TR>
<TR><TD>2.180e-02</TD><TD>-3.83</TD><TD>response to axon injury</TD><TD>biological process</TD><TD>GO:0048678</TD><TD>41</TD><TD>2</TD><TD>16543</TD><TD>92</TD>
<TD>JAK2,CHL1</TD></TR>
<TR><TD>2.180e-02</TD><TD>-3.83</TD><TD>response to progesterone</TD><TD>biological process</TD><TD>GO:0032570</TD><TD>41</TD><TD>2</TD><TD>16543</TD><TD>92</TD>
<TD>GJB2,FOSB</TD></TR>
<TR><TD>2.191e-02</TD><TD>-3.82</TD><TD>IRE1-TRAF2-ASK1 complex</TD><TD>cellular component</TD><TD>GO:1990604</TD><TD>4</TD><TD>1</TD><TD>17744</TD><TD>98</TD>
<TD>ERN2</TD></TR>
<TR><TD>2.191e-02</TD><TD>-3.82</TD><TD>eukaryotic translation elongation factor 1 complex</TD><TD>cellular component</TD><TD>GO:0005853</TD><TD>4</TD><TD>1</TD><TD>17744</TD><TD>98</TD>
<TD>EEF1A1</TD></TR>
<TR><TD>2.191e-02</TD><TD>-3.82</TD><TD>muscle thin filament tropomyosin</TD><TD>cellular component</TD><TD>GO:0005862</TD><TD>4</TD><TD>1</TD><TD>17744</TD><TD>98</TD>
<TD>TPM4</TD></TR>
<TR><TD>2.191e-02</TD><TD>-3.82</TD><TD>omegasome membrane</TD><TD>cellular component</TD><TD>GO:1903349</TD><TD>4</TD><TD>1</TD><TD>17744</TD><TD>98</TD>
<TD>ZFYVE1</TD></TR>
<TR><TD>2.191e-02</TD><TD>-3.82</TD><TD>cytoplasmic side of lysosomal membrane</TD><TD>cellular component</TD><TD>GO:0098574</TD><TD>4</TD><TD>1</TD><TD>17744</TD><TD>98</TD>
<TD>EEF1A1</TD></TR>
<TR><TD>2.195e-02</TD><TD>-3.82</TD><TD>GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN</TD><TD>195</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>HEATR6,TANK,OVOL1,MAFF</TD></TR>
<TR><TD>2.195e-02</TD><TD>-3.82</TD><TD>GSE7831_CPG_VS_INFLUENZA_STIM_PDC_1H_DN</TD><TD>MSigDB lists</TD><TD>GSE7831_CPG_VS_INFLUENZA_STIM_PDC_1H_DN</TD><TD>195</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>NANOG,JAK2,SLC35E4,ENC1</TD></TR>
<TR><TD>2.195e-02</TD><TD>-3.82</TD><TD>GSE17721_POLYIC_VS_PAM3CSK4_1H_BMDC_DN</TD><TD>MSigDB lists</TD><TD>GSE17721_POLYIC_VS_PAM3CSK4_1H_BMDC_DN</TD><TD>195</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>SMARCA4,ARIH2,AP1G1,FOSB</TD></TR>
<TR><TD>2.195e-02</TD><TD>-3.82</TD><TD>HALLMARK_COMPLEMENT</TD><TD>MSigDB lists</TD><TD>HALLMARK_COMPLEMENT</TD><TD>195</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>JAK2,F10,MAFF,USP8</TD></TR>
<TR><TD>2.196e-02</TD><TD>-3.82</TD><TD>RAD52 (RAD52 homolog, DNA repair protein)</TD><TD>protein interactions</TD><TD>5893</TD><TD>42</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>EEF1A1,NANOG</TD></TR>
<TR><TD>2.196e-02</TD><TD>-3.82</TD><TD>TRIM15 (tripartite motif containing 15)</TD><TD>protein interactions</TD><TD>89870</TD><TD>42</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>MED7,EHMT1</TD></TR>
<TR><TD>2.196e-02</TD><TD>-3.82</TD><TD>ERCC8 (ERCC excision repair 8, CSA ubiquitin ligase complex subunit)</TD><TD>protein interactions</TD><TD>1161</TD><TD>42</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>VCP,NANOG</TD></TR>
<TR><TD>2.196e-02</TD><TD>-3.82</TD><TD>MLF2 (myeloid leukemia factor 2)</TD><TD>protein interactions</TD><TD>8079</TD><TD>42</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>NANOG,GPRASP2</TD></TR>
<TR><TD>2.196e-02</TD><TD>-3.82</TD><TD>PHKG2 (phosphorylase kinase catalytic subunit gamma 2)</TD><TD>protein interactions</TD><TD>5261</TD><TD>42</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>VCP,UBE3A</TD></TR>
<TR><TD>2.196e-02</TD><TD>-3.82</TD><TD>REEP5 (receptor accessory protein 5)</TD><TD>protein interactions</TD><TD>7905</TD><TD>42</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>SMARCA4,KDM2A</TD></TR>
<TR><TD>2.196e-02</TD><TD>-3.82</TD><TD>NUP155 (nucleoporin 155)</TD><TD>protein interactions</TD><TD>9631</TD><TD>42</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>OTUD7B,TACC2</TD></TR>
<TR><TD>2.206e-02</TD><TD>-3.81</TD><TD>calcium ion export</TD><TD>biological process</TD><TD>GO:1901660</TD><TD>4</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ATP2B4</TD></TR>
<TR><TD>2.206e-02</TD><TD>-3.81</TD><TD>negative regulation of oocyte maturation</TD><TD>biological process</TD><TD>GO:1900194</TD><TD>4</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>SHB</TD></TR>
<TR><TD>2.206e-02</TD><TD>-3.81</TD><TD>positive regulation of cAMP-dependent protein kinase activity</TD><TD>biological process</TD><TD>GO:2000481</TD><TD>4</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ATP2B4</TD></TR>
<TR><TD>2.206e-02</TD><TD>-3.81</TD><TD>regulation of endosome organization</TD><TD>biological process</TD><TD>GO:1904978</TD><TD>4</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>SCARB2</TD></TR>
<TR><TD>2.206e-02</TD><TD>-3.81</TD><TD>negative regulation of calcineurin-NFAT signaling cascade</TD><TD>biological process</TD><TD>GO:0070885</TD><TD>4</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ATP2B4</TD></TR>
<TR><TD>2.206e-02</TD><TD>-3.81</TD><TD>negative regulation of cellular amine metabolic process</TD><TD>biological process</TD><TD>GO:0033239</TD><TD>4</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ATP2B4</TD></TR>
<TR><TD>2.206e-02</TD><TD>-3.81</TD><TD>adenosine to inosine editing</TD><TD>biological process</TD><TD>GO:0006382</TD><TD>4</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ADAR</TD></TR>
<TR><TD>2.206e-02</TD><TD>-3.81</TD><TD>tyrosine phosphorylation of Stat5 protein</TD><TD>biological process</TD><TD>GO:0042506</TD><TD>4</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>JAK2</TD></TR>
<TR><TD>2.206e-02</TD><TD>-3.81</TD><TD>positive regulation of mitochondrial membrane potential</TD><TD>biological process</TD><TD>GO:0010918</TD><TD>4</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>VCP</TD></TR>
<TR><TD>2.206e-02</TD><TD>-3.81</TD><TD>lobar bronchus epithelium development</TD><TD>biological process</TD><TD>GO:0060481</TD><TD>4</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ADAMTSL2</TD></TR>
<TR><TD>2.206e-02</TD><TD>-3.81</TD><TD>regulation of growth hormone receptor signaling pathway</TD><TD>biological process</TD><TD>GO:0060398</TD><TD>4</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>JAK2</TD></TR>
<TR><TD>2.206e-02</TD><TD>-3.81</TD><TD>proteasomal ubiquitin-independent protein catabolic process</TD><TD>biological process</TD><TD>GO:0010499</TD><TD>4</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ENC1</TD></TR>
<TR><TD>2.206e-02</TD><TD>-3.81</TD><TD>negative regulation of meiotic cell cycle phase transition</TD><TD>biological process</TD><TD>GO:1901994</TD><TD>4</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>OVOL1</TD></TR>
<TR><TD>2.206e-02</TD><TD>-3.81</TD><TD>regulation of natural killer cell differentiation involved in immune response</TD><TD>biological process</TD><TD>GO:0032826</TD><TD>4</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ZNF683</TD></TR>
<TR><TD>2.206e-02</TD><TD>-3.81</TD><TD>D-amino acid catabolic process</TD><TD>biological process</TD><TD>GO:0019478</TD><TD>4</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>DTD1</TD></TR>
<TR><TD>2.206e-02</TD><TD>-3.81</TD><TD>immunoglobulin transcytosis in epithelial cells</TD><TD>biological process</TD><TD>GO:0002414</TD><TD>4</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>RAB17</TD></TR>
<TR><TD>2.206e-02</TD><TD>-3.81</TD><TD>regulation of nitric oxide mediated signal transduction</TD><TD>biological process</TD><TD>GO:0010749</TD><TD>4</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ATP2B4</TD></TR>
<TR><TD>2.206e-02</TD><TD>-3.81</TD><TD>negative regulation of peptidyl-cysteine S-nitrosylation</TD><TD>biological process</TD><TD>GO:1902083</TD><TD>4</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ATP2B4</TD></TR>
<TR><TD>2.206e-02</TD><TD>-3.81</TD><TD>regulation of glucose mediated signaling pathway</TD><TD>biological process</TD><TD>GO:1902659</TD><TD>4</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>SMARCA4</TD></TR>
<TR><TD>2.206e-02</TD><TD>-3.81</TD><TD>DNA replication, removal of RNA primer</TD><TD>biological process</TD><TD>GO:0043137</TD><TD>4</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>RNASEH2A</TD></TR>
<TR><TD>2.206e-02</TD><TD>-3.81</TD><TD>protein deubiquitination involved in ubiquitin-dependent protein catabolic process</TD><TD>biological process</TD><TD>GO:0071947</TD><TD>4</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>OTUD7B</TD></TR>
<TR><TD>2.208e-02</TD><TD>-3.81</TD><TD>Porphyrin and chlorophyll metabolism</TD><TD>KEGG pathways</TD><TD>hsa00860</TD><TD>42</TD><TD>2</TD><TD>7094</TD><TD>39</TD>
<TD>UGT1A6,ALAS2</TD></TR>
<TR><TD>2.208e-02</TD><TD>-3.81</TD><TD>Porphyrin and chlorophyll metabolism</TD><TD>KEGG pathways</TD><TD>ko00860</TD><TD>42</TD><TD>2</TD><TD>7094</TD><TD>39</TD>
<TD>ALAS2,UGT1A6</TD></TR>
<TR><TD>2.217e-02</TD><TD>-3.81</TD><TD>HSA_dom</TD><TD>interpro domains</TD><TD>IPR014012</TD><TD>4</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>SMARCA4</TD></TR>
<TR><TD>2.217e-02</TD><TD>-3.81</TD><TD>ATP_Ca_trans_C</TD><TD>interpro domains</TD><TD>IPR022141</TD><TD>4</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>ATP2B4</TD></TR>
<TR><TD>2.217e-02</TD><TD>-3.81</TD><TD>Tropomyosin</TD><TD>interpro domains</TD><TD>IPR000533</TD><TD>4</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>TPM4</TD></TR>
<TR><TD>2.217e-02</TD><TD>-3.81</TD><TD>XPG_CS</TD><TD>interpro domains</TD><TD>IPR019974</TD><TD>4</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>BIVM-ERCC5</TD></TR>
<TR><TD>2.217e-02</TD><TD>-3.81</TD><TD>Neurofascin/L1/NrCAM_C</TD><TD>interpro domains</TD><TD>IPR026966</TD><TD>4</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>CHL1</TD></TR>
<TR><TD>2.217e-02</TD><TD>-3.81</TD><TD>P-type_ATPase_IIB</TD><TD>interpro domains</TD><TD>IPR006408</TD><TD>4</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>ATP2B4</TD></TR>
<TR><TD>2.217e-02</TD><TD>-3.81</TD><TD>PQQ_beta_propeller_repeat</TD><TD>interpro domains</TD><TD>IPR018391</TD><TD>4</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>ERN2</TD></TR>
<TR><TD>2.217e-02</TD><TD>-3.81</TD><TD>Asp_de-COase-like_dom</TD><TD>interpro domains</TD><TD>IPR009010</TD><TD>4</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>VCP</TD></TR>
<TR><TD>2.217e-02</TD><TD>-3.81</TD><TD>Formyl_transf_N</TD><TD>interpro domains</TD><TD>IPR002376</TD><TD>4</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>GART</TD></TR>
<TR><TD>2.217e-02</TD><TD>-3.81</TD><TD>PurM-like_N</TD><TD>interpro domains</TD><TD>IPR016188</TD><TD>4</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>GART</TD></TR>
<TR><TD>2.217e-02</TD><TD>-3.81</TD><TD>Tyr_kinase_non-rcpt_Jak/Tyk2</TD><TD>interpro domains</TD><TD>IPR016251</TD><TD>4</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>JAK2</TD></TR>
<TR><TD>2.217e-02</TD><TD>-3.81</TD><TD>POLO_box_1</TD><TD>interpro domains</TD><TD>IPR033701</TD><TD>4</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>PLK5</TD></TR>
<TR><TD>2.217e-02</TD><TD>-3.81</TD><TD>Josephin</TD><TD>interpro domains</TD><TD>IPR006155</TD><TD>4</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>JOSD1</TD></TR>
<TR><TD>2.217e-02</TD><TD>-3.81</TD><TD>AIR_synth_C_dom</TD><TD>interpro domains</TD><TD>IPR010918</TD><TD>4</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>GART</TD></TR>
<TR><TD>2.223e-02</TD><TD>-3.81</TD><TD>RAD23B (RAD23 homolog B, nucleotide excision repair protein)</TD><TD>protein interactions</TD><TD>5887</TD><TD>110</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>UBE3A,EEF1A1,NANOG</TD></TR>
<TR><TD>2.223e-02</TD><TD>-3.81</TD><TD>TROPOMYOSIN</TD><TD>prosite domains</TD><TD>PS00326</TD><TD>4</TD><TD>1</TD><TD>11955</TD><TD>67</TD>
<TD>TPM4</TD></TR>
<TR><TD>2.223e-02</TD><TD>-3.81</TD><TD>XPG_2</TD><TD>prosite domains</TD><TD>PS00842</TD><TD>4</TD><TD>1</TD><TD>11955</TD><TD>67</TD>
<TD>BIVM-ERCC5</TD></TR>
<TR><TD>2.223e-02</TD><TD>-3.81</TD><TD>XPG_1</TD><TD>prosite domains</TD><TD>PS00841</TD><TD>4</TD><TD>1</TD><TD>11955</TD><TD>67</TD>
<TD>BIVM-ERCC5</TD></TR>
<TR><TD>2.223e-02</TD><TD>-3.81</TD><TD>JOSEPHIN</TD><TD>prosite domains</TD><TD>PS50957</TD><TD>4</TD><TD>1</TD><TD>11955</TD><TD>67</TD>
<TD>JOSD1</TD></TR>
<TR><TD>2.223e-02</TD><TD>-3.81</TD><TD>HSA</TD><TD>prosite domains</TD><TD>PS51204</TD><TD>4</TD><TD>1</TD><TD>11955</TD><TD>67</TD>
<TD>SMARCA4</TD></TR>
<TR><TD>2.224e-02</TD><TD>-3.81</TD><TD>JUBAN_TARGETS_OF_SPI1_AND_FLI1_UP</TD><TD>MSigDB lists</TD><TD>JUBAN_TARGETS_OF_SPI1_AND_FLI1_UP</TD><TD>110</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>USP8,ALAS2,FTL</TD></TR>
<TR><TD>2.236e-02</TD><TD>-3.80</TD><TD>REACTOME_IMMUNE_SYSTEM</TD><TD>MSigDB lists</TD><TD>REACTOME_IMMUNE_SYSTEM</TD><TD>886</TD><TD>10</TD><TD>17621</TD><TD>96</TD>
<TD>AP1G1,TANK,NR4A1,NUP37,POM121C,JAK2,ARIH2,ADAR,UBE3A,MAP3K7</TD></TR>
<TR><TD>2.239e-02</TD><TD>-3.80</TD><TD>galactoside binding</TD><TD>molecular function</TD><TD>GO:0016936</TD><TD>4</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>LGALS2</TD></TR>
<TR><TD>2.239e-02</TD><TD>-3.80</TD><TD>K48-linked polyubiquitin binding</TD><TD>molecular function</TD><TD>GO:0036435</TD><TD>4</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>VCP</TD></TR>
<TR><TD>2.239e-02</TD><TD>-3.80</TD><TD>BAT3 complex binding</TD><TD>molecular function</TD><TD>GO:1904288</TD><TD>4</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>VCP</TD></TR>
<TR><TD>2.242e-02</TD><TD>-3.80</TD><TD>Myocardial infarction (early onset)(PMID:19198609)</TD><TD>GWAS genes</TD><TD>Myocardial infarction (early onset)(PMID:19198609)</TD><TD>6</TD><TD>1</TD><TD>2388</TD><TD>9</TD>
<TD>SMARCA4</TD></TR>
<TR><TD>2.259e-02</TD><TD>-3.79</TD><TD>Josephin</TD><TD>smart domains</TD><TD>SM01246</TD><TD>4</TD><TD>1</TD><TD>9480</TD><TD>54</TD>
<TD>JOSD1</TD></TR>
<TR><TD>2.259e-02</TD><TD>-3.79</TD><TD>PQQ</TD><TD>smart domains</TD><TD>SM00564</TD><TD>4</TD><TD>1</TD><TD>9480</TD><TD>54</TD>
<TD>ERN2</TD></TR>
<TR><TD>2.259e-02</TD><TD>-3.79</TD><TD>HSA</TD><TD>smart domains</TD><TD>SM00573</TD><TD>4</TD><TD>1</TD><TD>9480</TD><TD>54</TD>
<TD>SMARCA4</TD></TR>
<TR><TD>2.262e-02</TD><TD>-3.79</TD><TD>NS1 Mediated Effects on Host Pathways</TD><TD>REACTOME pathways</TD><TD>R-HSA-168276</TD><TD>40</TD><TD>2</TD><TD>10293</TD><TD>60</TD>
<TD>NUP37,POM121C</TD></TR>
<TR><TD>2.270e-02</TD><TD>-3.79</TD><TD>proteolysis</TD><TD>biological process</TD><TD>GO:0006508</TD><TD>1132</TD><TD>12</TD><TD>16543</TD><TD>92</TD>
<TD>ADAMTSL2,TANK,CASP6,F10,USP8,ENC1,JOSD1,FBXO31,VCP,OTUD7B,UBE3A,ARIH2</TD></TR>
<TR><TD>2.277e-02</TD><TD>-3.78</TD><TD>ion homeostasis</TD><TD>biological process</TD><TD>GO:0050801</TD><TD>624</TD><TD>8</TD><TD>16543</TD><TD>92</TD>
<TD>ATP2B4,EPAS1,RMDN3,FTL,ALAS2,JAK2,SLC40A1,FTH1</TD></TR>
<TR><TD>2.285e-02</TD><TD>-3.78</TD><TD>immune system process</TD><TD>biological process</TD><TD>GO:0002376</TD><TD>1973</TD><TD>18</TD><TD>16543</TD><TD>92</TD>
<TD>MNX1,SLC40A1,FTH1,GAPT,ARPC1B,TANK,ALAS2,ARIH2,ADAR,EPAS1,MAP3K7,ZNF683,CHID1,AP1G1,RAB17,JAK2,OTUD7B,SHB</TD></TR>
<TR><TD>2.285e-02</TD><TD>-3.78</TD><TD>Formyl_trans_N</TD><TD>pfam domains</TD><TD>PF00551</TD><TD>4</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>GART</TD></TR>
<TR><TD>2.285e-02</TD><TD>-3.78</TD><TD>Bravo_FIGEY</TD><TD>pfam domains</TD><TD>PF13882</TD><TD>4</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>CHL1</TD></TR>
<TR><TD>2.285e-02</TD><TD>-3.78</TD><TD>Josephin</TD><TD>pfam domains</TD><TD>PF02099</TD><TD>4</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>JOSD1</TD></TR>
<TR><TD>2.285e-02</TD><TD>-3.78</TD><TD>ATP_Ca_trans_C</TD><TD>pfam domains</TD><TD>PF12424</TD><TD>4</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>ATP2B4</TD></TR>
<TR><TD>2.285e-02</TD><TD>-3.78</TD><TD>Tropomyosin</TD><TD>pfam domains</TD><TD>PF00261</TD><TD>4</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>TPM4</TD></TR>
<TR><TD>2.285e-02</TD><TD>-3.78</TD><TD>AIRS_C</TD><TD>pfam domains</TD><TD>PF02769</TD><TD>4</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>GART</TD></TR>
<TR><TD>2.285e-02</TD><TD>-3.78</TD><TD>HSA</TD><TD>pfam domains</TD><TD>PF07529</TD><TD>4</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>SMARCA4</TD></TR>
<TR><TD>2.288e-02</TD><TD>-3.78</TD><TD>transition metal ion transport</TD><TD>biological process</TD><TD>GO:0000041</TD><TD>109</TD><TD>3</TD><TD>16543</TD><TD>92</TD>
<TD>FTH1,SLC40A1,FTL</TD></TR>
<TR><TD>2.295e-02</TD><TD>-3.77</TD><TD>REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS</TD><TD>MSigDB lists</TD><TD>REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS</TD><TD>43</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>KCNG3,KCNA2</TD></TR>
<TR><TD>2.295e-02</TD><TD>-3.77</TD><TD>ULE_SPLICING_VIA_NOVA2</TD><TD>MSigDB lists</TD><TD>ULE_SPLICING_VIA_NOVA2</TD><TD>43</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>CHL1,TACC2</TD></TR>
<TR><TD>2.295e-02</TD><TD>-3.77</TD><TD>LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN</TD><TD>MSigDB lists</TD><TD>LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN</TD><TD>43</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>MAP3K7,DTD1</TD></TR>
<TR><TD>2.295e-02</TD><TD>-3.77</TD><TD>GO_CELLULAR_PIGMENTATION</TD><TD>MSigDB lists</TD><TD>GO_CELLULAR_PIGMENTATION</TD><TD>43</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>AP1G1,RAB17</TD></TR>
<TR><TD>2.295e-02</TD><TD>-3.77</TD><TD>ATP6V1H (ATPase H+ transporting V1 subunit H)</TD><TD>protein interactions</TD><TD>51606</TD><TD>43</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>TANK,RMDN3</TD></TR>
<TR><TD>2.300e-02</TD><TD>-3.77</TD><TD>human chr1q21.2</TD><TD>chromosome location</TD><TD>human chr1q21.2</TD><TD>59</TD><TD>2</TD><TD>26234</TD><TD>104</TD>
<TD>NBPF9,OTUD7B</TD></TR>
<TR><TD>2.306e-02</TD><TD>-3.77</TD><TD>HALLMARK_TNFA_SIGNALING_VIA_NFKB</TD><TD>MSigDB lists</TD><TD>HALLMARK_TNFA_SIGNALING_VIA_NFKB</TD><TD>198</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>NR4A1,MAFF,TANK,FOSB</TD></TR>
<TR><TD>2.315e-02</TD><TD>-3.77</TD><TD>GO_IMMUNE_SYSTEM_PROCESS</TD><TD>MSigDB lists</TD><TD>GO_IMMUNE_SYSTEM_PROCESS</TD><TD>1866</TD><TD>17</TD><TD>17621</TD><TD>96</TD>
<TD>GAPT,AP1G1,CHID1,OTUD7B,ALAS2,ARIH2,RAB17,ARPC1B,SLC40A1,EPAS1,FTH1,TANK,MNX1,ZNF683,MAP3K7,JAK2,ADAR</TD></TR>
<TR><TD>2.327e-02</TD><TD>-3.76</TD><TD>hemopoiesis</TD><TD>biological process</TD><TD>GO:0030097</TD><TD>509</TD><TD>7</TD><TD>16543</TD><TD>92</TD>
<TD>SHB,EPAS1,ADAR,JAK2,ZNF683,ARIH2,ALAS2</TD></TR>
<TR><TD>2.329e-02</TD><TD>-3.76</TD><TD>SENP3 (SUMO1/sentrin/SMT3 specific peptidase 3)</TD><TD>protein interactions</TD><TD>26168</TD><TD>112</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>VCP,UBE3A,AP1G1</TD></TR>
<TR><TD>2.345e-02</TD><TD>-3.75</TD><TD>-</TD><TD>gene3d domains</TD><TD>3.30.1120.30</TD><TD>4</TD><TD>1</TD><TD>10485</TD><TD>62</TD>
<TD>PLK5</TD></TR>
<TR><TD>2.345e-02</TD><TD>-3.75</TD><TD>-</TD><TD>gene3d domains</TD><TD>3.30.1330.10</TD><TD>4</TD><TD>1</TD><TD>10485</TD><TD>62</TD>
<TD>GART</TD></TR>
<TR><TD>2.345e-02</TD><TD>-3.75</TD><TD>-</TD><TD>gene3d domains</TD><TD>3.40.50.170</TD><TD>4</TD><TD>1</TD><TD>10485</TD><TD>62</TD>
<TD>GART</TD></TR>
<TR><TD>2.353e-02</TD><TD>-3.75</TD><TD>anaplastic_large_cell_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>anaplastic_large_cell_lymphoma</TD><TD>45</TD><TD>2</TD><TD>17630</TD><TD>93</TD>
<TD>TPM4,JAK2</TD></TR>
<TR><TD>2.355e-02</TD><TD>-3.75</TD><TD>human chr3p26.3</TD><TD>chromosome location</TD><TD>human chr3p26.3</TD><TD>6</TD><TD>1</TD><TD>26234</TD><TD>104</TD>
<TD>CHL1</TD></TR>
<TR><TD>2.355e-02</TD><TD>-3.75</TD><TD>human chr9p13.1</TD><TD>chromosome location</TD><TD>human chr9p13.1</TD><TD>6</TD><TD>1</TD><TD>26234</TD><TD>104</TD>
<TD>SHB</TD></TR>
<TR><TD>2.379e-02</TD><TD>-3.74</TD><TD>TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN</TD><TD>MSigDB lists</TD><TD>TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN</TD><TD>299</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>PTPN3,ARPC1B,ENC1,MFSD6,GJB2</TD></TR>
<TR><TD>2.379e-02</TD><TD>-3.74</TD><TD>protein phosphatase binding</TD><TD>molecular function</TD><TD>GO:0019903</TD><TD>109</TD><TD>3</TD><TD>16652</TD><TD>94</TD>
<TD>VCP,PPP1R3F,ATP2B4</TD></TR>
<TR><TD>2.382e-02</TD><TD>-3.74</TD><TD>MITSIADES_RESPONSE_TO_APLIDIN_UP</TD><TD>MSigDB lists</TD><TD>MITSIADES_RESPONSE_TO_APLIDIN_UP</TD><TD>407</TD><TD>6</TD><TD>17621</TD><TD>96</TD>
<TD>MAP1LC3B,TPM4,FOSB,TACC2,MAFF,JOSD1</TD></TR>
<TR><TD>2.383e-02</TD><TD>-3.74</TD><TD>chondroitin sulfate proteoglycan metabolic process</TD><TD>biological process</TD><TD>GO:0050654</TD><TD>43</TD><TD>2</TD><TD>16543</TD><TD>92</TD>
<TD>PXYLP1,HEXA</TD></TR>
<TR><TD>2.385e-02</TD><TD>-3.74</TD><TD>GO_VACUOLAR_LUMEN</TD><TD>MSigDB lists</TD><TD>GO_VACUOLAR_LUMEN</TD><TD>113</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>SCARB2,HEXA,JAK2</TD></TR>
<TR><TD>2.388e-02</TD><TD>-3.73</TD><TD>Serotonin Receptor 2 and STAT3 Signaling</TD><TD>WikiPathways</TD><TD>WP733</TD><TD>4</TD><TD>1</TD><TD>5314</TD><TD>32</TD>
<TD>JAK2</TD></TR>
<TR><TD>2.395e-02</TD><TD>-3.73</TD><TD>regulation of nitrogen compound metabolic process</TD><TD>biological process</TD><TD>GO:0051171</TD><TD>4314</TD><TD>33</TD><TD>16543</TD><TD>92</TD>
<TD>VCP,EPAS1,EMX1,COMMD7,NANOG,SLC40A1,ONECUT3,DTD1,MNX1,FOSB,BNC1,OTUD7B,NGDN,EHMT1,MAP3K7,OVOL1,NR4A1,ADAR,ATP2B4,UBE3A,MED7,TSFM,ENC1,MAFF,VARS2,AUTS2,SMARCA4,KDM2A,JAK2,EEF1A1,RFX2,ERN2,ZNF683</TD></TR>
<TR><TD>2.396e-02</TD><TD>-3.73</TD><TD>GO_NUCLEAR_ENVELOPE_DISASSEMBLY</TD><TD>MSigDB lists</TD><TD>GO_NUCLEAR_ENVELOPE_DISASSEMBLY</TD><TD>44</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>NUP37,POM121C</TD></TR>
<TR><TD>2.396e-02</TD><TD>-3.73</TD><TD>PID_ERBB2_ERBB3_PATHWAY</TD><TD>MSigDB lists</TD><TD>PID_ERBB2_ERBB3_PATHWAY</TD><TD>44</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>USP8,JAK2</TD></TR>
<TR><TD>2.396e-02</TD><TD>-3.73</TD><TD>GO_MEMBRANE_DISASSEMBLY</TD><TD>MSigDB lists</TD><TD>GO_MEMBRANE_DISASSEMBLY</TD><TD>44</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>POM121C,NUP37</TD></TR>
<TR><TD>2.396e-02</TD><TD>-3.73</TD><TD>TIMM44 (translocase of inner mitochondrial membrane 44)</TD><TD>protein interactions</TD><TD>10469</TD><TD>44</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>COQ8A,VCP</TD></TR>
<TR><TD>2.396e-02</TD><TD>-3.73</TD><TD>NUP43 (nucleoporin 43)</TD><TD>protein interactions</TD><TD>348995</TD><TD>44</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>AURKAIP1,NUP37</TD></TR>
<TR><TD>2.396e-02</TD><TD>-3.73</TD><TD>ASPM (abnormal spindle microtubule assembly)</TD><TD>protein interactions</TD><TD>259266</TD><TD>44</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>GPRASP2,UBE3A</TD></TR>
<TR><TD>2.396e-02</TD><TD>-3.73</TD><TD>PSAP (prosaposin)</TD><TD>protein interactions</TD><TD>5660</TD><TD>44</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>MAFF,UBE3A</TD></TR>
<TR><TD>2.396e-02</TD><TD>-3.73</TD><TD>PPP6C (protein phosphatase 6 catalytic subunit)</TD><TD>protein interactions</TD><TD>5537</TD><TD>44</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>MAP3K7,VCP</TD></TR>
<TR><TD>2.399e-02</TD><TD>-3.73</TD><TD>translational elongation</TD><TD>biological process</TD><TD>GO:0006414</TD><TD>111</TD><TD>3</TD><TD>16543</TD><TD>92</TD>
<TD>AURKAIP1,TSFM,EEF1A1</TD></TR>
<TR><TD>2.407e-02</TD><TD>-3.73</TD><TD>REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES</TD><TD>MSigDB lists</TD><TD>REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES</TD><TD>408</TD><TD>6</TD><TD>17621</TD><TD>96</TD>
<TD>SLC27A6,SLC40A1,POM121C,FTL,NUP37,FTH1</TD></TR>
<TR><TD>2.421e-02</TD><TD>-3.72</TD><TD>GO_NEGATIVE_REGULATION_OF_CELL_CYCLE_PROCESS</TD><TD>MSigDB lists</TD><TD>GO_NEGATIVE_REGULATION_OF_CELL_CYCLE_PROCESS</TD><TD>201</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>SMARCA4,OVOL1,AURKAIP1,FBXO31</TD></TR>
<TR><TD>2.433e-02</TD><TD>-3.72</TD><TD>JANUSKINASE</TD><TD>prints domains</TD><TD>PR01823</TD><TD>4</TD><TD>1</TD><TD>4725</TD><TD>29</TD>
<TD>JAK2</TD></TR>
<TR><TD>2.433e-02</TD><TD>-3.72</TD><TD>TROPOMYOSIN</TD><TD>prints domains</TD><TD>PR00194</TD><TD>4</TD><TD>1</TD><TD>4725</TD><TD>29</TD>
<TD>TPM4</TD></TR>
<TR><TD>2.434e-02</TD><TD>-3.72</TD><TD>cellular component disassembly</TD><TD>biological process</TD><TD>GO:0022411</TD><TD>401</TD><TD>6</TD><TD>16543</TD><TD>92</TD>
<TD>ERN2,AURKAIP1,POM121C,NUP37,SMARCA4,CASP6</TD></TR>
<TR><TD>2.438e-02</TD><TD>-3.71</TD><TD>viral life cycle</TD><TD>biological process</TD><TD>GO:0019058</TD><TD>295</TD><TD>5</TD><TD>16543</TD><TD>92</TD>
<TD>VCP,NUP37,POM121C,SLC52A2,SCARB2</TD></TR>
<TR><TD>2.440e-02</TD><TD>-3.71</TD><TD>GO_SH3_DOMAIN_BINDING</TD><TD>MSigDB lists</TD><TD>GO_SH3_DOMAIN_BINDING</TD><TD>114</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>USP8,MYPN,TP53BP2</TD></TR>
<TR><TD>2.458e-02</TD><TD>-3.71</TD><TD>intracellular</TD><TD>cellular component</TD><TD>GO:0005622</TD><TD>13907</TD><TD>85</TD><TD>17744</TD><TD>98</TD>
<TD>COMMD7,RFX2,NR4A1,PTPN3,KCNA2,ARPC1B,TANK,EEF1A1,BNC1,FOSB,RNASEH2A,EHMT1,MED7,HSPB6,GJB2,C14orf159,KNTC1,USF3,MYPN,ARIH2,VARS2,ALAS2,OVOL1,JOSD1,EMX1,TMEM198,FGD5,SHB,AURKAIP1,COQ8A,UGT1A6,USP8,NANOG,RGSL1,F10,MNX1,ONECUT3,GART,HEXA,CASP6,RMDN3,TACC2,FBXO31,ADAR,ADI1,VCP,CHID1,TSFM,RAB17,PXYLP1,MAP1LC3B,ZNF683,GCSAM,SLC40A1,ENC1,NUP37,SCARB2,OSBPL7,FTL,MAP3K7,POM121C,CHODL,FTH1,EPAS1,ZFYVE1,KCNG3,TP53BP2,GPRASP2,SMARCA4,MAFF,PLK5,ERN2,AUTS2,UBE3A,ATP2B4,DTD1,OTUD7B,RBKS,TPM4,IFT27,NGDN,AP1G1,SERPINB10,KDM2A,JAK2</TD></TR>
<TR><TD>2.478e-02</TD><TD>-3.70</TD><TD>Host Interactions with Influenza Factors</TD><TD>REACTOME pathways</TD><TD>R-HSA-168253</TD><TD>42</TD><TD>2</TD><TD>10293</TD><TD>60</TD>
<TD>POM121C,NUP37</TD></TR>
<TR><TD>2.484e-02</TD><TD>-3.70</TD><TD>ROME_INSULIN_TARGETS_IN_MUSCLE_UP</TD><TD>MSigDB lists</TD><TD>ROME_INSULIN_TARGETS_IN_MUSCLE_UP</TD><TD>411</TD><TD>6</TD><TD>17621</TD><TD>96</TD>
<TD>VCP,UBE3A,ALAS2,MYPN,SCARB2,POM121C</TD></TR>
<TR><TD>2.488e-02</TD><TD>-3.69</TD><TD>mitotic nuclear envelope disassembly</TD><TD>biological process</TD><TD>GO:0007077</TD><TD>44</TD><TD>2</TD><TD>16543</TD><TD>92</TD>
<TD>NUP37,POM121C</TD></TR>
<TR><TD>2.488e-02</TD><TD>-3.69</TD><TD>cellular component disassembly involved in execution phase of apoptosis</TD><TD>biological process</TD><TD>GO:0006921</TD><TD>44</TD><TD>2</TD><TD>16543</TD><TD>92</TD>
<TD>CASP6,ERN2</TD></TR>
<TR><TD>2.494e-02</TD><TD>-3.69</TD><TD>MAP1LC3A (microtubule associated protein 1 light chain 3 alpha)</TD><TD>protein interactions</TD><TD>84557</TD><TD>115</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>VCP,MAP1LC3B,EPAS1</TD></TR>
<TR><TD>2.498e-02</TD><TD>-3.69</TD><TD>GO_SCAFFOLD_PROTEIN_BINDING</TD><TD>MSigDB lists</TD><TD>GO_SCAFFOLD_PROTEIN_BINDING</TD><TD>45</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>ATP2B4,MAP3K7</TD></TR>
<TR><TD>2.498e-02</TD><TD>-3.69</TD><TD>NCAPD3 (non-SMC condensin II complex subunit D3)</TD><TD>protein interactions</TD><TD>23310</TD><TD>45</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>NANOG,EPAS1</TD></TR>
<TR><TD>2.498e-02</TD><TD>-3.69</TD><TD>MYOC (myocilin)</TD><TD>protein interactions</TD><TD>4653</TD><TD>45</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>EEF1A1,FTL</TD></TR>
<TR><TD>2.498e-02</TD><TD>-3.69</TD><TD>DPF2 (double PHD fingers 2)</TD><TD>protein interactions</TD><TD>5977</TD><TD>45</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>SMARCA4,EPAS1</TD></TR>
<TR><TD>2.507e-02</TD><TD>-3.69</TD><TD>cellular cation homeostasis</TD><TD>biological process</TD><TD>GO:0030003</TD><TD>517</TD><TD>7</TD><TD>16543</TD><TD>92</TD>
<TD>RMDN3,ATP2B4,ALAS2,FTL,SLC40A1,FTH1,JAK2</TD></TR>
<TR><TD>2.513e-02</TD><TD>-3.68</TD><TD>Nuclear pore complex</TD><TD>KEGG pathways</TD><TD>M00427</TD><TD>45</TD><TD>2</TD><TD>7094</TD><TD>39</TD>
<TD>POM121C,NUP37</TD></TR>
<TR><TD>2.513e-02</TD><TD>-3.68</TD><TD>Nuclear pore complex</TD><TD>KEGG pathways</TD><TD>hsa_M00427</TD><TD>45</TD><TD>2</TD><TD>7094</TD><TD>39</TD>
<TD>NUP37,POM121C</TD></TR>
<TR><TD>2.522e-02</TD><TD>-3.68</TD><TD>MASSARWEH_TAMOXIFEN_RESISTANCE_UP</TD><TD>MSigDB lists</TD><TD>MASSARWEH_TAMOXIFEN_RESISTANCE_UP</TD><TD>528</TD><TD>7</TD><TD>17621</TD><TD>96</TD>
<TD>OTUD7B,RBKS,C14orf159,ENC1,MFSD6,EPAS1,TACC2</TD></TR>
<TR><TD>2.533e-02</TD><TD>-3.68</TD><TD>mesothelioma</TD><TD>COSMIC cancer mutations</TD><TD>mesothelioma</TD><TD>4563</TD><TD>33</TD><TD>17630</TD><TD>93</TD>
<TD>IFT27,NUP37,MAFF,JAK2,TP53BP2,F10,ALAS2,EPAS1,MNX1,ENC1,TPM4,RGSL1,FGD5,SMARCA4,MAP3K7,FBXO31,UBE3A,VCP,TACC2,FOSB,TANK,PPP1R3F,EEF1A1,SERPINB10,RAB17,CASP6,KDM2A,USP8,HSPB6,PTPN3,GPRASP2,HEATR6,KNTC1</TD></TR>
<TR><TD>2.538e-02</TD><TD>-3.67</TD><TD>V$CREB_Q4_01</TD><TD>MSigDB lists</TD><TD>V$CREB_Q4_01</TD><TD>204</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>FOSB,RBKS,MAFF,JOSD1</TD></TR>
<TR><TD>2.551e-02</TD><TD>-3.67</TD><TD>BCL6 (B-cell CLL/lymphoma 6)</TD><TD>protein interactions</TD><TD>604</TD><TD>116</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>SMARCA4,EHMT1,KDM2A</TD></TR>
<TR><TD>2.575e-02</TD><TD>-3.66</TD><TD>SUMO2 (small ubiquitin-like modifier 2)</TD><TD>protein interactions</TD><TD>6613</TD><TD>205</TD><TD>4</TD><TD>16330</TD><TD>89</TD>
<TD>TP53BP2,EEF1A1,VCP,TANK</TD></TR>
<TR><TD>2.589e-02</TD><TD>-3.65</TD><TD>Viral Messenger RNA Synthesis</TD><TD>REACTOME pathways</TD><TD>R-HSA-168325</TD><TD>43</TD><TD>2</TD><TD>10293</TD><TD>60</TD>
<TD>POM121C,NUP37</TD></TR>
<TR><TD>2.589e-02</TD><TD>-3.65</TD><TD>TNF signaling</TD><TD>REACTOME pathways</TD><TD>R-HSA-75893</TD><TD>43</TD><TD>2</TD><TD>10293</TD><TD>60</TD>
<TD>MAP3K7,OTUD7B</TD></TR>
<TR><TD>2.589e-02</TD><TD>-3.65</TD><TD>Binding and Uptake of Ligands by Scavenger Receptors</TD><TD>REACTOME pathways</TD><TD>R-HSA-2173782</TD><TD>43</TD><TD>2</TD><TD>10293</TD><TD>60</TD>
<TD>FTL,FTH1</TD></TR>
<TR><TD>2.603e-02</TD><TD>-3.65</TD><TD>IRITANI_MAD1_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>IRITANI_MAD1_TARGETS_DN</TD><TD>46</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>EEF1A1,DTD1</TD></TR>
<TR><TD>2.603e-02</TD><TD>-3.65</TD><TD>NUTT_GBM_VS_AO_GLIOMA_UP</TD><TD>MSigDB lists</TD><TD>NUTT_GBM_VS_AO_GLIOMA_UP</TD><TD>46</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>CHL1,TP53BP2</TD></TR>
<TR><TD>2.603e-02</TD><TD>-3.65</TD><TD>ZHAN_MULTIPLE_MYELOMA_CD2_DN</TD><TD>MSigDB lists</TD><TD>ZHAN_MULTIPLE_MYELOMA_CD2_DN</TD><TD>46</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>GJB2,GART</TD></TR>
<TR><TD>2.603e-02</TD><TD>-3.65</TD><TD>GO_RESPONSE_TO_AXON_INJURY</TD><TD>MSigDB lists</TD><TD>GO_RESPONSE_TO_AXON_INJURY</TD><TD>46</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>CHL1,JAK2</TD></TR>
<TR><TD>2.603e-02</TD><TD>-3.65</TD><TD>ADNP (activity dependent neuroprotector homeobox)</TD><TD>protein interactions</TD><TD>23394</TD><TD>46</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>SMARCA4,MAP1LC3B</TD></TR>
<TR><TD>2.603e-02</TD><TD>-3.65</TD><TD>UBE2L6 (ubiquitin conjugating enzyme E2 L6)</TD><TD>protein interactions</TD><TD>9246</TD><TD>46</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>UBE3A,ARIH2</TD></TR>
<TR><TD>2.603e-02</TD><TD>-3.65</TD><TD>AGO1 (argonaute 1, RISC catalytic component)</TD><TD>protein interactions</TD><TD>26523</TD><TD>46</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>GPRASP2,OTUD7B</TD></TR>
<TR><TD>2.603e-02</TD><TD>-3.65</TD><TD>BIRC6 (baculoviral IAP repeat containing 6)</TD><TD>protein interactions</TD><TD>57448</TD><TD>46</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>CASP6,USP8</TD></TR>
<TR><TD>2.603e-02</TD><TD>-3.65</TD><TD>HES1 (hes family bHLH transcription factor 1)</TD><TD>protein interactions</TD><TD>3280</TD><TD>46</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>JAK2,NR4A1</TD></TR>
<TR><TD>2.603e-02</TD><TD>-3.65</TD><TD>GMNN (geminin, DNA replication inhibitor)</TD><TD>protein interactions</TD><TD>51053</TD><TD>46</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>EHMT1,SMARCA4</TD></TR>
<TR><TD>2.608e-02</TD><TD>-3.65</TD><TD>UBE2E1 (ubiquitin conjugating enzyme E2 E1)</TD><TD>protein interactions</TD><TD>7324</TD><TD>117</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>UBE3A,USP8,ARIH2</TD></TR>
<TR><TD>2.608e-02</TD><TD>-3.65</TD><TD>PSMD1 (proteasome 26S subunit, non-ATPase 1)</TD><TD>protein interactions</TD><TD>5707</TD><TD>117</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>EPAS1,EEF1A1,TPM4</TD></TR>
<TR><TD>2.609e-02</TD><TD>-3.65</TD><TD>GO_PROTEIN_PHOSPHATASE_BINDING</TD><TD>MSigDB lists</TD><TD>GO_PROTEIN_PHOSPHATASE_BINDING</TD><TD>117</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>PPP1R3F,VCP,ATP2B4</TD></TR>
<TR><TD>2.610e-02</TD><TD>-3.65</TD><TD>monoclonal_gammopathy_of_undetermined_significance</TD><TD>COSMIC cancer mutations</TD><TD>monoclonal_gammopathy_of_undetermined_significance</TD><TD>5</TD><TD>1</TD><TD>17630</TD><TD>93</TD>
<TD>JAK2</TD></TR>
<TR><TD>2.610e-02</TD><TD>-3.65</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-malignant_histiocytosis</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-malignant_histiocytosis</TD><TD>5</TD><TD>1</TD><TD>17630</TD><TD>93</TD>
<TD>JAK2</TD></TR>
<TR><TD>2.610e-02</TD><TD>-3.65</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-monoclonal_gammopathy_of_undetermined_significance</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-monoclonal_gammopathy_of_undetermined_significance</TD><TD>5</TD><TD>1</TD><TD>17630</TD><TD>93</TD>
<TD>JAK2</TD></TR>
<TR><TD>2.610e-02</TD><TD>-3.65</TD><TD>malignant_histiocytosis</TD><TD>COSMIC cancer mutations</TD><TD>malignant_histiocytosis</TD><TD>5</TD><TD>1</TD><TD>17630</TD><TD>93</TD>
<TD>JAK2</TD></TR>
<TR><TD>2.630e-02</TD><TD>-3.64</TD><TD>GO_REGULATION_OF_CELL_CYCLE</TD><TD>MSigDB lists</TD><TD>GO_REGULATION_OF_CELL_CYCLE</TD><TD>910</TD><TD>10</TD><TD>17621</TD><TD>96</TD>
<TD>OVOL1,FBXO31,PLK5,PTPN3,KNTC1,ATP2B4,SMARCA4,NR4A1,AURKAIP1,TP53BP2</TD></TR>
<TR><TD>2.637e-02</TD><TD>-3.64</TD><TD>heme biosynthesis</TD><TD>BIOCYC pathways</TD><TD>HUMAN_PWY-5920</TD><TD>8</TD><TD>1</TD><TD>903</TD><TD>3</TD>
<TD>ALAS2</TD></TR>
<TR><TD>2.637e-02</TD><TD>-3.64</TD><TD>superpathway of heme biosynthesis from glycine</TD><TD>BIOCYC pathways</TD><TD>META_PWY-5920</TD><TD>8</TD><TD>1</TD><TD>903</TD><TD>3</TD>
<TD>ALAS2</TD></TR>
<TR><TD>2.661e-02</TD><TD>-3.63</TD><TD>GO_REGULATION_OF_CELL_CYCLE_PROCESS</TD><TD>MSigDB lists</TD><TD>GO_REGULATION_OF_CELL_CYCLE_PROCESS</TD><TD>534</TD><TD>7</TD><TD>17621</TD><TD>96</TD>
<TD>KNTC1,PLK5,FBXO31,AURKAIP1,OVOL1,SMARCA4,ATP2B4</TD></TR>
<TR><TD>2.667e-02</TD><TD>-3.62</TD><TD>REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS</TD><TD>MSigDB lists</TD><TD>REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS</TD><TD>118</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>NUP37,POM121C,AP1G1</TD></TR>
<TR><TD>2.667e-02</TD><TD>-3.62</TD><TD>GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD4_TCELL_DN</TD><TD>118</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>EPAS1,MNX1,OVOL1</TD></TR>
<TR><TD>2.670e-02</TD><TD>-3.62</TD><TD>head_neck</TD><TD>COSMIC cancer mutations</TD><TD>head_neck</TD><TD>16038</TD><TD>90</TD><TD>17630</TD><TD>93</TD>
<TD>KCNG3,TACC2,C14orf159,ZNF683,GRAMD1B,ARIH2,MFSD6,PTPN3,TMEM198,KDM2A,CASP6,ARPC1B,GPRASP2,JOSD1,EHMT1,CHID1,CEACAM19,KCNA2,TTC39A,MYPN,RFX2,NUP37,FGD5,AP1G1,RGSL1,NANOG,ENC1,SLC40A1,TSFM,UGT1A6,FBXO31,MAP3K7,GJB2,DTD1,RBKS,GAPT,OVOL1,C2orf81,BNC1,UBE3A,CHL1,MAP1LC3B,TANK,POM121C,SLC27A6,FOSB,NR4A1,HEXA,PPP1R3F,SERPINB10,EEF1A1,NGDN,HSPB6,USP8,GART,ZFYVE1,RAB17,HEATR6,RNASEH2A,FTL,CHODL,CDH7,KNTC1,OTUD7B,PLK5,SHB,SCARB2,VARS2,IFT27,AURKAIP1,MED7,ALAS2,F10,ADAR,TP53BP2,LGALS2,MAFF,JAK2,MNX1,COMMD7,EPAS1,SLC35E4,TPM4,AUTS2,SMARCA4,ADAMTSL2,ADI1,ATP2B4,VCP,OSBPL7</TD></TR>
<TR><TD>2.672e-02</TD><TD>-3.62</TD><TD>regulation of primary metabolic process</TD><TD>biological process</TD><TD>GO:0080090</TD><TD>5684</TD><TD>41</TD><TD>16543</TD><TD>92</TD>
<TD>SMARCA4,AUTS2,VARS2,SHB,MAFF,KDM2A,EEF1A1,JAK2,ZNF683,ERN2,RFX2,ADAR,ATP2B4,SERPINB10,NR4A1,UBE3A,MED7,TANK,TSFM,AURKAIP1,ENC1,FOSB,OTUD7B,BNC1,NGDN,EHMT1,PPP1R3F,OVOL1,MAP3K7,VCP,EPAS1,EMX1,ARIH2,COMMD7,NANOG,OSBPL7,DTD1,ONECUT3,SLC40A1,PTPN3,MNX1</TD></TR>
<TR><TD>2.678e-02</TD><TD>-3.62</TD><TD>Immune System</TD><TD>REACTOME pathways</TD><TD>R-HSA-168256</TD><TD>2103</TD><TD>19</TD><TD>10293</TD><TD>60</TD>
<TD>SERPINB10,MAP3K7,VCP,SMARCA4,FTL,FBXO31,TANK,NR4A1,UBE3A,FTH1,NANOG,NUP37,EEF1A1,AP1G1,JAK2,ARIH2,ADAR,ARPC1B,POM121C</TD></TR>
<TR><TD>2.695e-02</TD><TD>-3.61</TD><TD>ELVIDGE_HIF2A_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>ELVIDGE_HIF2A_TARGETS_UP</TD><TD>5</TD><TD>1</TD><TD>17621</TD><TD>96</TD>
<TD>JAK2</TD></TR>
<TR><TD>2.695e-02</TD><TD>-3.61</TD><TD>MIKKELSEN_IPS_LCP_WITH_H3K4ME3_AND_H3K27ME3</TD><TD>MSigDB lists</TD><TD>MIKKELSEN_IPS_LCP_WITH_H3K4ME3_AND_H3K27ME3</TD><TD>5</TD><TD>1</TD><TD>17621</TD><TD>96</TD>
<TD>CDH7</TD></TR>
<TR><TD>2.696e-02</TD><TD>-3.61</TD><TD>KCNB2 (potassium voltage-gated channel subfamily B member 2)</TD><TD>protein interactions</TD><TD>9312</TD><TD>5</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>KCNG3</TD></TR>
<TR><TD>2.696e-02</TD><TD>-3.61</TD><TD>LDOC1L (leucine zipper down-regulated in cancer 1 like)</TD><TD>protein interactions</TD><TD>84247</TD><TD>5</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>MAFF</TD></TR>
<TR><TD>2.696e-02</TD><TD>-3.61</TD><TD>IL23R (interleukin 23 receptor)</TD><TD>protein interactions</TD><TD>149233</TD><TD>5</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>JAK2</TD></TR>
<TR><TD>2.696e-02</TD><TD>-3.61</TD><TD>CCDC134 (coiled-coil domain containing 134)</TD><TD>protein interactions</TD><TD>79879</TD><TD>5</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>VCP</TD></TR>
<TR><TD>2.696e-02</TD><TD>-3.61</TD><TD>SPINK1 (serine peptidase inhibitor, Kazal type 1)</TD><TD>protein interactions</TD><TD>6690</TD><TD>5</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>UBE3A</TD></TR>
<TR><TD>2.696e-02</TD><TD>-3.61</TD><TD>KCNF1 (potassium voltage-gated channel modifier subfamily F member 1)</TD><TD>protein interactions</TD><TD>3754</TD><TD>5</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>KCNG3</TD></TR>
<TR><TD>2.696e-02</TD><TD>-3.61</TD><TD>RFX4 (regulatory factor X4)</TD><TD>protein interactions</TD><TD>5992</TD><TD>5</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>RFX2</TD></TR>
<TR><TD>2.696e-02</TD><TD>-3.61</TD><TD>TBC1D14 (TBC1 domain family member 14)</TD><TD>protein interactions</TD><TD>57533</TD><TD>5</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>UBE3A</TD></TR>
<TR><TD>2.696e-02</TD><TD>-3.61</TD><TD>KCNN4 (potassium calcium-activated channel subfamily N member 4)</TD><TD>protein interactions</TD><TD>3783</TD><TD>5</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>USP8</TD></TR>
<TR><TD>2.696e-02</TD><TD>-3.61</TD><TD>PRRX1 (paired related homeobox 1)</TD><TD>protein interactions</TD><TD>5396</TD><TD>5</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>MAFF</TD></TR>
<TR><TD>2.696e-02</TD><TD>-3.61</TD><TD>ABCC6 (ATP binding cassette subfamily C member 6)</TD><TD>protein interactions</TD><TD>368</TD><TD>5</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>NR4A1</TD></TR>
<TR><TD>2.696e-02</TD><TD>-3.61</TD><TD>SALL3 (spalt like transcription factor 3)</TD><TD>protein interactions</TD><TD>27164</TD><TD>5</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>NANOG</TD></TR>
<TR><TD>2.696e-02</TD><TD>-3.61</TD><TD>MYL3 (myosin light chain 3)</TD><TD>protein interactions</TD><TD>4634</TD><TD>5</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>FTH1</TD></TR>
<TR><TD>2.696e-02</TD><TD>-3.61</TD><TD>WISP3 (WNT1 inducible signaling pathway protein 3)</TD><TD>protein interactions</TD><TD>8838</TD><TD>5</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>SCARB2</TD></TR>
<TR><TD>2.696e-02</TD><TD>-3.61</TD><TD>MTMR14 (myotubularin related protein 14)</TD><TD>protein interactions</TD><TD>64419</TD><TD>5</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>TP53BP2</TD></TR>
<TR><TD>2.696e-02</TD><TD>-3.61</TD><TD>CLN6 (ceroid-lipofuscinosis, neuronal 6, late infantile, variant)</TD><TD>protein interactions</TD><TD>54982</TD><TD>5</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>VCP</TD></TR>
<TR><TD>2.696e-02</TD><TD>-3.61</TD><TD>KCNG3 (potassium voltage-gated channel modifier subfamily G member 3)</TD><TD>protein interactions</TD><TD>170850</TD><TD>5</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>KCNG3</TD></TR>
<TR><TD>2.702e-02</TD><TD>-3.61</TD><TD>Transport of Mature mRNA Derived from an Intronless Transcript</TD><TD>REACTOME pathways</TD><TD>R-HSA-159231</TD><TD>44</TD><TD>2</TD><TD>10293</TD><TD>60</TD>
<TD>NUP37,POM121C</TD></TR>
<TR><TD>2.702e-02</TD><TD>-3.61</TD><TD>Voltage gated Potassium channels</TD><TD>REACTOME pathways</TD><TD>R-HSA-1296072</TD><TD>44</TD><TD>2</TD><TD>10293</TD><TD>60</TD>
<TD>KCNA2,KCNG3</TD></TR>
<TR><TD>2.706e-02</TD><TD>-3.61</TD><TD>nucleus</TD><TD>cellular component</TD><TD>GO:0005634</TD><TD>6908</TD><TD>48</TD><TD>17744</TD><TD>98</TD>
<TD>ADAR,ADI1,NR4A1,RMDN3,RFX2,CASP6,TACC2,RNASEH2A,ZNF683,EHMT1,CHID1,EEF1A1,VCP,TSFM,FOSB,BNC1,KNTC1,USF3,HSPB6,MED7,ENC1,NUP37,OVOL1,ARIH2,MAP3K7,MYPN,POM121C,TP53BP2,EPAS1,MAFF,AURKAIP1,SMARCA4,EMX1,FTH1,AUTS2,PLK5,NANOG,USP8,DTD1,OTUD7B,RBKS,UBE3A,ONECUT3,JAK2,SERPINB10,NGDN,MNX1,KDM2A</TD></TR>
<TR><TD>2.709e-02</TD><TD>-3.61</TD><TD>GO_PROTEIN_K48_LINKED_UBIQUITINATION</TD><TD>MSigDB lists</TD><TD>GO_PROTEIN_K48_LINKED_UBIQUITINATION</TD><TD>47</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>ARIH2,UBE3A</TD></TR>
<TR><TD>2.709e-02</TD><TD>-3.61</TD><TD>GO_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORT</TD><TD>MSigDB lists</TD><TD>GO_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORT</TD><TD>47</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>ATP2B4,PTPN3</TD></TR>
<TR><TD>2.709e-02</TD><TD>-3.61</TD><TD>GO_PIGMENT_BIOSYNTHETIC_PROCESS</TD><TD>MSigDB lists</TD><TD>GO_PIGMENT_BIOSYNTHETIC_PROCESS</TD><TD>47</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>GART,ALAS2</TD></TR>
<TR><TD>2.709e-02</TD><TD>-3.61</TD><TD>BCAT.100_UP.V1_UP</TD><TD>MSigDB lists</TD><TD>BCAT.100_UP.V1_UP</TD><TD>47</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>ENC1,CHODL</TD></TR>
<TR><TD>2.709e-02</TD><TD>-3.61</TD><TD>HIP1R (huntingtin interacting protein 1 related)</TD><TD>protein interactions</TD><TD>9026</TD><TD>47</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>VCP,GART</TD></TR>
<TR><TD>2.720e-02</TD><TD>-3.60</TD><TD>Keratan sulfate degradation</TD><TD>KEGG pathways</TD><TD>M00079</TD><TD>5</TD><TD>1</TD><TD>7094</TD><TD>39</TD>
<TD>HEXA</TD></TR>
<TR><TD>2.720e-02</TD><TD>-3.60</TD><TD>Keratan sulfate degradation</TD><TD>KEGG pathways</TD><TD>hsa_M00079</TD><TD>5</TD><TD>1</TD><TD>7094</TD><TD>39</TD>
<TD>HEXA</TD></TR>
<TR><TD>2.721e-02</TD><TD>-3.60</TD><TD>IL-6 signaling pathway</TD><TD>WikiPathways</TD><TD>WP364</TD><TD>43</TD><TD>2</TD><TD>5314</TD><TD>32</TD>
<TD>JAK2,MAP3K7</TD></TR>
<TR><TD>2.724e-02</TD><TD>-3.60</TD><TD>NCOR2 (nuclear receptor corepressor 2)</TD><TD>protein interactions</TD><TD>9612</TD><TD>119</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>NANOG,SMARCA4,NR4A1</TD></TR>
<TR><TD>2.725e-02</TD><TD>-3.60</TD><TD>GO_UBIQUITIN_LIKE_PROTEIN_SPECIFIC_PROTEASE_ACTIVITY</TD><TD>MSigDB lists</TD><TD>GO_UBIQUITIN_LIKE_PROTEIN_SPECIFIC_PROTEASE_ACTIVITY</TD><TD>119</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>USP8,JOSD1,OTUD7B</TD></TR>
<TR><TD>2.725e-02</TD><TD>-3.60</TD><TD>KEGG_LYSOSOME</TD><TD>MSigDB lists</TD><TD>KEGG_LYSOSOME</TD><TD>119</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>HEXA,SCARB2,AP1G1</TD></TR>
<TR><TD>2.731e-02</TD><TD>-3.60</TD><TD>extrinsic component of endosome membrane</TD><TD>cellular component</TD><TD>GO:0031313</TD><TD>5</TD><TD>1</TD><TD>17744</TD><TD>98</TD>
<TD>USP8</TD></TR>
<TR><TD>2.742e-02</TD><TD>-3.60</TD><TD>KIM_WT1_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>KIM_WT1_TARGETS_UP</TD><TD>209</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>SHB,ENC1,NR4A1,MAFF</TD></TR>
<TR><TD>2.750e-02</TD><TD>-3.59</TD><TD>negative regulation of type I interferon-mediated signaling pathway</TD><TD>biological process</TD><TD>GO:0060339</TD><TD>5</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ADAR</TD></TR>
<TR><TD>2.750e-02</TD><TD>-3.59</TD><TD>blood coagulation, extrinsic pathway</TD><TD>biological process</TD><TD>GO:0007598</TD><TD>5</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>F10</TD></TR>
<TR><TD>2.750e-02</TD><TD>-3.59</TD><TD>aggresome assembly</TD><TD>biological process</TD><TD>GO:0070842</TD><TD>5</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>VCP</TD></TR>
<TR><TD>2.750e-02</TD><TD>-3.59</TD><TD>response to interleukin-12</TD><TD>biological process</TD><TD>GO:0070671</TD><TD>5</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>JAK2</TD></TR>
<TR><TD>2.750e-02</TD><TD>-3.59</TD><TD>calcium ion import across plasma membrane</TD><TD>biological process</TD><TD>GO:0098703</TD><TD>5</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ATP2B4</TD></TR>
<TR><TD>2.750e-02</TD><TD>-3.59</TD><TD>ferrous iron transport</TD><TD>biological process</TD><TD>GO:0015684</TD><TD>5</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>SLC40A1</TD></TR>
<TR><TD>2.750e-02</TD><TD>-3.59</TD><TD>lobar bronchus development</TD><TD>biological process</TD><TD>GO:0060482</TD><TD>5</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ADAMTSL2</TD></TR>
<TR><TD>2.750e-02</TD><TD>-3.59</TD><TD>negative regulation of oocyte development</TD><TD>biological process</TD><TD>GO:0060283</TD><TD>5</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>SHB</TD></TR>
<TR><TD>2.750e-02</TD><TD>-3.59</TD><TD>STAT protein import into nucleus</TD><TD>biological process</TD><TD>GO:0007262</TD><TD>5</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>JAK2</TD></TR>
<TR><TD>2.750e-02</TD><TD>-3.59</TD><TD>DNA replication, Okazaki fragment processing</TD><TD>biological process</TD><TD>GO:0033567</TD><TD>5</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>RNASEH2A</TD></TR>
<TR><TD>2.750e-02</TD><TD>-3.59</TD><TD>response to corticotropin-releasing hormone</TD><TD>biological process</TD><TD>GO:0043435</TD><TD>5</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>NR4A1</TD></TR>
<TR><TD>2.750e-02</TD><TD>-3.59</TD><TD>positive regulation of ATP biosynthetic process</TD><TD>biological process</TD><TD>GO:2001171</TD><TD>5</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>VCP</TD></TR>
<TR><TD>2.750e-02</TD><TD>-3.59</TD><TD>activation of Janus kinase activity</TD><TD>biological process</TD><TD>GO:0042976</TD><TD>5</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>JAK2</TD></TR>
<TR><TD>2.750e-02</TD><TD>-3.59</TD><TD>hemoglobin biosynthetic process</TD><TD>biological process</TD><TD>GO:0042541</TD><TD>5</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ALAS2</TD></TR>
<TR><TD>2.750e-02</TD><TD>-3.59</TD><TD>cellular response to corticotropin-releasing hormone stimulus</TD><TD>biological process</TD><TD>GO:0071376</TD><TD>5</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>NR4A1</TD></TR>
<TR><TD>2.750e-02</TD><TD>-3.59</TD><TD>regulation of glutamine family amino acid metabolic process</TD><TD>biological process</TD><TD>GO:0000820</TD><TD>5</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ATP2B4</TD></TR>
<TR><TD>2.750e-02</TD><TD>-3.59</TD><TD>B cell proliferation involved in immune response</TD><TD>biological process</TD><TD>GO:0002322</TD><TD>5</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>GAPT</TD></TR>
<TR><TD>2.750e-02</TD><TD>-3.59</TD><TD>regulation of histone H4-K16 acetylation</TD><TD>biological process</TD><TD>GO:2000618</TD><TD>5</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>AUTS2</TD></TR>
<TR><TD>2.750e-02</TD><TD>-3.59</TD><TD>regulation of meiotic cell cycle phase transition</TD><TD>biological process</TD><TD>GO:1901993</TD><TD>5</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>OVOL1</TD></TR>
<TR><TD>2.750e-02</TD><TD>-3.59</TD><TD>apoptotic chromosome condensation</TD><TD>biological process</TD><TD>GO:0030263</TD><TD>5</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ERN2</TD></TR>
<TR><TD>2.750e-02</TD><TD>-3.59</TD><TD>myoblast fate commitment</TD><TD>biological process</TD><TD>GO:0048625</TD><TD>5</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>EPAS1</TD></TR>
<TR><TD>2.750e-02</TD><TD>-3.59</TD><TD>optic nerve morphogenesis</TD><TD>biological process</TD><TD>GO:0021631</TD><TD>5</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>KCNA2</TD></TR>
<TR><TD>2.750e-02</TD><TD>-3.59</TD><TD>D-amino acid metabolic process</TD><TD>biological process</TD><TD>GO:0046416</TD><TD>5</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>DTD1</TD></TR>
<TR><TD>2.764e-02</TD><TD>-3.59</TD><TD>Pept_S1A_FX</TD><TD>interpro domains</TD><TD>IPR012224</TD><TD>5</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>F10</TD></TR>
<TR><TD>2.764e-02</TD><TD>-3.59</TD><TD>XPG/Rad2</TD><TD>interpro domains</TD><TD>IPR006084</TD><TD>5</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>BIVM-ERCC5</TD></TR>
<TR><TD>2.764e-02</TD><TD>-3.59</TD><TD>Aminotrans_II_pyridoxalP_BS</TD><TD>interpro domains</TD><TD>IPR001917</TD><TD>5</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>ALAS2</TD></TR>
<TR><TD>2.764e-02</TD><TD>-3.59</TD><TD>XPG-I_dom</TD><TD>interpro domains</TD><TD>IPR006086</TD><TD>5</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>BIVM-ERCC5</TD></TR>
<TR><TD>2.764e-02</TD><TD>-3.59</TD><TD>HhH2</TD><TD>interpro domains</TD><TD>IPR008918</TD><TD>5</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>BIVM-ERCC5</TD></TR>
<TR><TD>2.764e-02</TD><TD>-3.59</TD><TD>POLO_box_dom</TD><TD>interpro domains</TD><TD>IPR000959</TD><TD>5</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>PLK5</TD></TR>
<TR><TD>2.764e-02</TD><TD>-3.59</TD><TD>5-3_exonuclease_C</TD><TD>interpro domains</TD><TD>IPR020045</TD><TD>5</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>BIVM-ERCC5</TD></TR>
<TR><TD>2.764e-02</TD><TD>-3.59</TD><TD>UbiB_dom</TD><TD>interpro domains</TD><TD>IPR004147</TD><TD>5</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>COQ8A</TD></TR>
<TR><TD>2.771e-02</TD><TD>-3.59</TD><TD>AA_TRANSFER_CLASS_2</TD><TD>prosite domains</TD><TD>PS00599</TD><TD>5</TD><TD>1</TD><TD>11955</TD><TD>67</TD>
<TD>ALAS2</TD></TR>
<TR><TD>2.771e-02</TD><TD>-3.59</TD><TD>GAE</TD><TD>prosite domains</TD><TD>PS50180</TD><TD>5</TD><TD>1</TD><TD>11955</TD><TD>67</TD>
<TD>AP1G1</TD></TR>
<TR><TD>2.791e-02</TD><TD>-3.58</TD><TD>beta-N-acetylhexosaminidase activity</TD><TD>molecular function</TD><TD>GO:0004563</TD><TD>5</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>HEXA</TD></TR>
<TR><TD>2.791e-02</TD><TD>-3.58</TD><TD>histone methyltransferase activity (H3-K9 specific)</TD><TD>molecular function</TD><TD>GO:0046974</TD><TD>5</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>EHMT1</TD></TR>
<TR><TD>2.791e-02</TD><TD>-3.58</TD><TD>interleukin-12 receptor binding</TD><TD>molecular function</TD><TD>GO:0005143</TD><TD>5</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>JAK2</TD></TR>
<TR><TD>2.791e-02</TD><TD>-3.58</TD><TD>myosin II binding</TD><TD>molecular function</TD><TD>GO:0045159</TD><TD>5</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>GCSAM</TD></TR>
<TR><TD>2.791e-02</TD><TD>-3.58</TD><TD>growth hormone receptor binding</TD><TD>molecular function</TD><TD>GO:0005131</TD><TD>5</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>JAK2</TD></TR>
<TR><TD>2.791e-02</TD><TD>-3.58</TD><TD>GO_TRANSCRIPTIONAL_ACTIVATOR_ACTIVITY_RNA_POLYMERASE_II_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_BINDING</TD><TD>MSigDB lists</TD><TD>GO_TRANSCRIPTIONAL_ACTIVATOR_ACTIVITY_RNA_POLYMERASE_II_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_BINDING</TD><TD>312</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>NR4A1,MAFF,FOSB,ONECUT3,EPAS1</TD></TR>
<TR><TD>2.812e-02</TD><TD>-3.57</TD><TD>protein K48-linked ubiquitination</TD><TD>biological process</TD><TD>GO:0070936</TD><TD>47</TD><TD>2</TD><TD>16543</TD><TD>92</TD>
<TD>UBE3A,ARIH2</TD></TR>
<TR><TD>2.816e-02</TD><TD>-3.57</TD><TD>XPGI</TD><TD>smart domains</TD><TD>SM00484</TD><TD>5</TD><TD>1</TD><TD>9480</TD><TD>54</TD>
<TD>BIVM-ERCC5</TD></TR>
<TR><TD>2.816e-02</TD><TD>-3.57</TD><TD>XPGN</TD><TD>smart domains</TD><TD>SM00485</TD><TD>5</TD><TD>1</TD><TD>9480</TD><TD>54</TD>
<TD>BIVM-ERCC5</TD></TR>
<TR><TD>2.816e-02</TD><TD>-3.57</TD><TD>HhH2</TD><TD>smart domains</TD><TD>SM00279</TD><TD>5</TD><TD>1</TD><TD>9480</TD><TD>54</TD>
<TD>BIVM-ERCC5</TD></TR>
<TR><TD>2.816e-02</TD><TD>-3.57</TD><TD>PUG</TD><TD>smart domains</TD><TD>SM00580</TD><TD>5</TD><TD>1</TD><TD>9480</TD><TD>54</TD>
<TD>ERN2</TD></TR>
<TR><TD>2.817e-02</TD><TD>-3.57</TD><TD>TAVOR_CEBPA_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>TAVOR_CEBPA_TARGETS_UP</TD><TD>48</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>TANK,PTPN3</TD></TR>
<TR><TD>2.817e-02</TD><TD>-3.57</TD><TD>REACTOME_METABOLISM_OF_NON_CODING_RNA</TD><TD>MSigDB lists</TD><TD>REACTOME_METABOLISM_OF_NON_CODING_RNA</TD><TD>48</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>POM121C,NUP37</TD></TR>
<TR><TD>2.817e-02</TD><TD>-3.57</TD><TD>GO_RESPONSE_TO_PROGESTERONE</TD><TD>MSigDB lists</TD><TD>GO_RESPONSE_TO_PROGESTERONE</TD><TD>48</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>FOSB,GJB2</TD></TR>
<TR><TD>2.817e-02</TD><TD>-3.57</TD><TD>FOXA3 (forkhead box A3)</TD><TD>protein interactions</TD><TD>3171</TD><TD>48</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>RMDN3,ADAR</TD></TR>
<TR><TD>2.817e-02</TD><TD>-3.57</TD><TD>RAP2A (RAP2A, member of RAS oncogene family)</TD><TD>protein interactions</TD><TD>5911</TD><TD>48</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>EEF1A1,FTL</TD></TR>
<TR><TD>2.817e-02</TD><TD>-3.57</TD><TD>PATJ (PATJ, crumbs cell polarity complex component)</TD><TD>protein interactions</TD><TD>10207</TD><TD>48</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>GJB2,RNASEH2A</TD></TR>
<TR><TD>2.817e-02</TD><TD>-3.57</TD><TD>TANK (TRAF family member associated NFKB activator)</TD><TD>protein interactions</TD><TD>10010</TD><TD>48</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>TP53BP2,TANK</TD></TR>
<TR><TD>2.817e-02</TD><TD>-3.57</TD><TD>JUNB (JunB proto-oncogene, AP-1 transcription factor subunit)</TD><TD>protein interactions</TD><TD>3726</TD><TD>48</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>SMARCA4,FOSB</TD></TR>
<TR><TD>2.818e-02</TD><TD>-3.57</TD><TD>Transport of Mature mRNAs Derived from Intronless Transcripts</TD><TD>REACTOME pathways</TD><TD>R-HSA-159234</TD><TD>45</TD><TD>2</TD><TD>10293</TD><TD>60</TD>
<TD>NUP37,POM121C</TD></TR>
<TR><TD>2.818e-02</TD><TD>-3.57</TD><TD>TP53 Regulates Transcription of Cell Death Genes</TD><TD>REACTOME pathways</TD><TD>R-HSA-5633008</TD><TD>45</TD><TD>2</TD><TD>10293</TD><TD>60</TD>
<TD>CASP6,TP53BP2</TD></TR>
<TR><TD>2.823e-02</TD><TD>-3.57</TD><TD>HERC2 (HECT and RLD domain containing E3 ubiquitin protein ligase 2)</TD><TD>protein interactions</TD><TD>8924</TD><TD>211</TD><TD>4</TD><TD>16330</TD><TD>89</TD>
<TD>FTL,TANK,UBE3A,FTH1</TD></TR>
<TR><TD>2.835e-02</TD><TD>-3.56</TD><TD>negative regulation of cell cycle process</TD><TD>biological process</TD><TD>GO:0010948</TD><TD>207</TD><TD>4</TD><TD>16543</TD><TD>92</TD>
<TD>SMARCA4,AURKAIP1,FBXO31,OVOL1</TD></TR>
<TR><TD>2.840e-02</TD><TD>-3.56</TD><TD>Fas Ligand (FasL) pathway and Stress induction of Heat Shock Proteins (HSP) regulation</TD><TD>WikiPathways</TD><TD>WP314</TD><TD>44</TD><TD>2</TD><TD>5314</TD><TD>32</TD>
<TD>CASP6,MAP3K7</TD></TR>
<TR><TD>2.844e-02</TD><TD>-3.56</TD><TD>cellular ion homeostasis</TD><TD>biological process</TD><TD>GO:0006873</TD><TD>531</TD><TD>7</TD><TD>16543</TD><TD>92</TD>
<TD>JAK2,SLC40A1,FTH1,ALAS2,FTL,ATP2B4,RMDN3</TD></TR>
<TR><TD>2.849e-02</TD><TD>-3.56</TD><TD>ABC1</TD><TD>pfam domains</TD><TD>PF03109</TD><TD>5</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>COQ8A</TD></TR>
<TR><TD>2.849e-02</TD><TD>-3.56</TD><TD>XPG_I</TD><TD>pfam domains</TD><TD>PF00867</TD><TD>5</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>BIVM-ERCC5</TD></TR>
<TR><TD>2.849e-02</TD><TD>-3.56</TD><TD>BRK</TD><TD>pfam domains</TD><TD>PF07533</TD><TD>5</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>SMARCA4</TD></TR>
<TR><TD>2.852e-02</TD><TD>-3.56</TD><TD>AKT1 (AKT serine/threonine kinase 1)</TD><TD>protein interactions</TD><TD>207</TD><TD>314</TD><TD>5</TD><TD>16330</TD><TD>89</TD>
<TD>NR4A1,PTPN3,TPM4,VCP,USP8</TD></TR>
<TR><TD>2.869e-02</TD><TD>-3.55</TD><TD>CAIRO_LIVER_DEVELOPMENT_DN</TD><TD>MSigDB lists</TD><TD>CAIRO_LIVER_DEVELOPMENT_DN</TD><TD>212</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>KNTC1,F10,OVOL1,JAK2</TD></TR>
<TR><TD>2.869e-02</TD><TD>-3.55</TD><TD>AMUNDSON_RESPONSE_TO_ARSENITE</TD><TD>MSigDB lists</TD><TD>AMUNDSON_RESPONSE_TO_ARSENITE</TD><TD>212</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>KDM2A,TANK,MAFF,HEXA</TD></TR>
<TR><TD>2.881e-02</TD><TD>-3.55</TD><TD>Extrinsic Pathway of Fibrin Clot Formation</TD><TD>REACTOME pathways</TD><TD>R-HSA-140834</TD><TD>5</TD><TD>1</TD><TD>10293</TD><TD>60</TD>
<TD>F10</TD></TR>
<TR><TD>2.881e-02</TD><TD>-3.55</TD><TD>PTK6 Expression</TD><TD>REACTOME pathways</TD><TD>R-HSA-8849473</TD><TD>5</TD><TD>1</TD><TD>10293</TD><TD>60</TD>
<TD>EPAS1</TD></TR>
<TR><TD>2.904e-02</TD><TD>-3.54</TD><TD>GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_180MIN_UP</TD><TD>MSigDB lists</TD><TD>GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_180MIN_UP</TD><TD>122</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>JOSD1,PPP1R3F,HSPB6</TD></TR>
<TR><TD>2.912e-02</TD><TD>-3.54</TD><TD>RIGGINS_TAMOXIFEN_RESISTANCE_DN</TD><TD>MSigDB lists</TD><TD>RIGGINS_TAMOXIFEN_RESISTANCE_DN</TD><TD>213</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>MAP3K7,SCARB2,C14orf159,ENC1</TD></TR>
<TR><TD>2.915e-02</TD><TD>-3.54</TD><TD>GO_CELLULAR_RESPONSE_TO_STRESS</TD><TD>MSigDB lists</TD><TD>GO_CELLULAR_RESPONSE_TO_STRESS</TD><TD>1479</TD><TD>14</TD><TD>17621</TD><TD>96</TD>
<TD>KDM2A,MAP1LC3B,PLK5,EPAS1,VCP,MAP3K7,ZFYVE1,RNASEH2A,FBXO31,JAK2,ERN2,GJB2,CHL1,SERPINB10</TD></TR>
<TR><TD>2.924e-02</TD><TD>-3.53</TD><TD>pigment biosynthetic process</TD><TD>biological process</TD><TD>GO:0046148</TD><TD>48</TD><TD>2</TD><TD>16543</TD><TD>92</TD>
<TD>ALAS2,GART</TD></TR>
<TR><TD>2.924e-02</TD><TD>-3.53</TD><TD>nuclear envelope disassembly</TD><TD>biological process</TD><TD>GO:0051081</TD><TD>48</TD><TD>2</TD><TD>16543</TD><TD>92</TD>
<TD>POM121C,NUP37</TD></TR>
<TR><TD>2.924e-02</TD><TD>-3.53</TD><TD>membrane disassembly</TD><TD>biological process</TD><TD>GO:0030397</TD><TD>48</TD><TD>2</TD><TD>16543</TD><TD>92</TD>
<TD>NUP37,POM121C</TD></TR>
<TR><TD>2.926e-02</TD><TD>-3.53</TD><TD>WONG_PROTEASOME_GENE_MODULE</TD><TD>MSigDB lists</TD><TD>WONG_PROTEASOME_GENE_MODULE</TD><TD>49</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>USP8,UBE3A</TD></TR>
<TR><TD>2.926e-02</TD><TD>-3.53</TD><TD>GO_ACTIVATION_OF_MAPKK_ACTIVITY</TD><TD>MSigDB lists</TD><TD>GO_ACTIVATION_OF_MAPKK_ACTIVITY</TD><TD>49</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>JAK2,MAP3K7</TD></TR>
<TR><TD>2.926e-02</TD><TD>-3.53</TD><TD>GO_NEURAL_RETINA_DEVELOPMENT</TD><TD>MSigDB lists</TD><TD>GO_NEURAL_RETINA_DEVELOPMENT</TD><TD>49</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>ATP2B4,SMARCA4</TD></TR>
<TR><TD>2.927e-02</TD><TD>-3.53</TD><TD>MEX3C (mex-3 RNA binding family member C)</TD><TD>protein interactions</TD><TD>51320</TD><TD>49</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>ADAR,EEF1A1</TD></TR>
<TR><TD>2.927e-02</TD><TD>-3.53</TD><TD>COPE (coatomer protein complex subunit epsilon)</TD><TD>protein interactions</TD><TD>11316</TD><TD>49</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>GPRASP2,VCP</TD></TR>
<TR><TD>2.927e-02</TD><TD>-3.53</TD><TD>ING1 (inhibitor of growth family member 1)</TD><TD>protein interactions</TD><TD>3621</TD><TD>49</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>NANOG,SMARCA4</TD></TR>
<TR><TD>2.927e-02</TD><TD>-3.53</TD><TD>PPP1R2 (protein phosphatase 1 regulatory inhibitor subunit 2)</TD><TD>protein interactions</TD><TD>5504</TD><TD>49</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>KDM2A,TP53BP2</TD></TR>
<TR><TD>2.927e-02</TD><TD>-3.53</TD><TD>GBAS (glioblastoma amplified sequence)</TD><TD>protein interactions</TD><TD>2631</TD><TD>49</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>VCP,MAP1LC3B</TD></TR>
<TR><TD>2.927e-02</TD><TD>-3.53</TD><TD>ZGPAT (zinc finger CCCH-type and G-patch domain containing)</TD><TD>protein interactions</TD><TD>84619</TD><TD>49</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>TP53BP2,NANOG</TD></TR>
<TR><TD>2.931e-02</TD><TD>-3.53</TD><TD>protein deubiquitination</TD><TD>biological process</TD><TD>GO:0016579</TD><TD>120</TD><TD>3</TD><TD>16543</TD><TD>92</TD>
<TD>JOSD1,OTUD7B,USP8</TD></TR>
<TR><TD>2.935e-02</TD><TD>-3.53</TD><TD>SUMOylation of DNA replication proteins</TD><TD>REACTOME pathways</TD><TD>R-HSA-4615885</TD><TD>46</TD><TD>2</TD><TD>10293</TD><TD>60</TD>
<TD>NUP37,POM121C</TD></TR>
<TR><TD>2.935e-02</TD><TD>-3.53</TD><TD>Glucose transport</TD><TD>REACTOME pathways</TD><TD>R-HSA-70153</TD><TD>46</TD><TD>2</TD><TD>10293</TD><TD>60</TD>
<TD>NUP37,POM121C</TD></TR>
<TR><TD>2.944e-02</TD><TD>-3.53</TD><TD>Interferon Signaling</TD><TD>REACTOME pathways</TD><TD>R-HSA-913531</TD><TD>201</TD><TD>4</TD><TD>10293</TD><TD>60</TD>
<TD>NUP37,POM121C,ADAR,JAK2</TD></TR>
<TR><TD>2.945e-02</TD><TD>-3.52</TD><TD>system development</TD><TD>biological process</TD><TD>GO:0048731</TD><TD>3891</TD><TD>30</TD><TD>16543</TD><TD>92</TD>
<TD>CHL1,CHODL,IFT27,ADAMTSL2,PTPN3,MNX1,ENC1,ONECUT3,SLC40A1,EMX1,ADAR,EPAS1,ATP2B4,NR4A1,ALAS2,KCNA2,UBE3A,ARIH2,GART,GJB2,TACC2,ZNF683,OVOL1,SHB,SMARCA4,MAFF,PLK5,JAK2,SCARB2,RAB17</TD></TR>
<TR><TD>2.954e-02</TD><TD>-3.52</TD><TD>FERM_domain</TD><TD>interpro domains</TD><TD>IPR000299</TD><TD>48</TD><TD>2</TD><TD>18428</TD><TD>103</TD>
<TD>PTPN3,JAK2</TD></TR>
<TR><TD>2.955e-02</TD><TD>-3.52</TD><TD>Lysosome</TD><TD>KEGG pathways</TD><TD>hsa04142</TD><TD>123</TD><TD>3</TD><TD>7094</TD><TD>39</TD>
<TD>AP1G1,SCARB2,HEXA</TD></TR>
<TR><TD>2.955e-02</TD><TD>-3.52</TD><TD>Lysosome</TD><TD>KEGG pathways</TD><TD>ko04142</TD><TD>123</TD><TD>3</TD><TD>7094</TD><TD>39</TD>
<TD>HEXA,SCARB2,AP1G1</TD></TR>
<TR><TD>2.956e-02</TD><TD>-3.52</TD><TD>TIEN_INTESTINE_PROBIOTICS_24HR_DN</TD><TD>MSigDB lists</TD><TD>TIEN_INTESTINE_PROBIOTICS_24HR_DN</TD><TD>214</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>EEF1A1,TANK,FTL,FTH1</TD></TR>
<TR><TD>2.958e-02</TD><TD>-3.52</TD><TD>FERM_3</TD><TD>prosite domains</TD><TD>PS50057</TD><TD>48</TD><TD>2</TD><TD>11955</TD><TD>67</TD>
<TD>PTPN3,JAK2</TD></TR>
<TR><TD>2.964e-02</TD><TD>-3.52</TD><TD>methionine salvage cycle III</TD><TD>BIOCYC pathways</TD><TD>HUMAN_PWY-7527</TD><TD>9</TD><TD>1</TD><TD>903</TD><TD>3</TD>
<TD>ADI1</TD></TR>
<TR><TD>2.964e-02</TD><TD>-3.52</TD><TD>CALR (calreticulin)</TD><TD>protein interactions</TD><TD>811</TD><TD>123</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>UBE3A,VCP,ARPC1B</TD></TR>
<TR><TD>2.966e-02</TD><TD>-3.52</TD><TD>GO_STEROID_HORMONE_MEDIATED_SIGNALING_PATHWAY</TD><TD>MSigDB lists</TD><TD>GO_STEROID_HORMONE_MEDIATED_SIGNALING_PATHWAY</TD><TD>123</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>NR4A1,UBE3A,JAK2</TD></TR>
<TR><TD>2.969e-02</TD><TD>-3.52</TD><TD>central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma-desmoplastic</TD><TD>COSMIC cancer mutations</TD><TD>central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma-desmoplastic</TD><TD>51</TD><TD>2</TD><TD>17630</TD><TD>93</TD>
<TD>RFX2,SMARCA4</TD></TR>
<TR><TD>2.972e-02</TD><TD>-3.52</TD><TD>proteolysis involved in cellular protein catabolic process</TD><TD>biological process</TD><TD>GO:0051603</TD><TD>536</TD><TD>7</TD><TD>16543</TD><TD>92</TD>
<TD>VCP,FBXO31,OTUD7B,UBE3A,ARIH2,ENC1,USP8</TD></TR>
<TR><TD>2.980e-02</TD><TD>-3.51</TD><TD>Brain structure(PMID:20171287)</TD><TD>GWAS genes</TD><TD>Brain structure(PMID:20171287)</TD><TD>8</TD><TD>1</TD><TD>2388</TD><TD>9</TD>
<TD>SHB</TD></TR>
<TR><TD>2.980e-02</TD><TD>-3.51</TD><TD>Mean platelet volume(PMID:22423221)</TD><TD>GWAS genes</TD><TD>Mean platelet volume(PMID:22423221)</TD><TD>8</TD><TD>1</TD><TD>2388</TD><TD>9</TD>
<TD>TPM4</TD></TR>
<TR><TD>2.989e-02</TD><TD>-3.51</TD><TD>HSPA4 (heat shock protein family A (Hsp70) member 4)</TD><TD>protein interactions</TD><TD>3308</TD><TD>318</TD><TD>5</TD><TD>16330</TD><TD>89</TD>
<TD>EPAS1,GART,VCP,UBE3A,TP53BP2</TD></TR>
<TR><TD>2.995e-02</TD><TD>-3.51</TD><TD>lytic vacuole</TD><TD>cellular component</TD><TD>GO:0000323</TD><TD>540</TD><TD>7</TD><TD>17744</TD><TD>98</TD>
<TD>HEXA,SCARB2,FTH1,AP1G1,CHID1,FTL,EEF1A1</TD></TR>
<TR><TD>2.995e-02</TD><TD>-3.51</TD><TD>lysosome</TD><TD>cellular component</TD><TD>GO:0005764</TD><TD>540</TD><TD>7</TD><TD>17744</TD><TD>98</TD>
<TD>HEXA,AP1G1,FTH1,FTL,CHID1,EEF1A1,SCARB2</TD></TR>
<TR><TD>2.996e-02</TD><TD>-3.51</TD><TD>DBN1 (drebrin 1)</TD><TD>protein interactions</TD><TD>1627</TD><TD>215</TD><TD>4</TD><TD>16330</TD><TD>89</TD>
<TD>GART,ARPC1B,MAP1LC3B,TPM4</TD></TR>
<TR><TD>3.000e-02</TD><TD>-3.51</TD><TD>V$CREB_Q2_01</TD><TD>MSigDB lists</TD><TD>V$CREB_Q2_01</TD><TD>215</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>TPM4,FOSB,JOSD1,MAFF</TD></TR>
<TR><TD>3.006e-02</TD><TD>-3.50</TD><TD>scaffold protein binding</TD><TD>molecular function</TD><TD>GO:0097110</TD><TD>48</TD><TD>2</TD><TD>16652</TD><TD>94</TD>
<TD>ATP2B4,MAP3K7</TD></TR>
<TR><TD>3.026e-02</TD><TD>-3.50</TD><TD>TP63 (tumor protein p63)</TD><TD>protein interactions</TD><TD>8626</TD><TD>124</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>EMX1,EEF1A1,VCP</TD></TR>
<TR><TD>3.027e-02</TD><TD>-3.50</TD><TD>CTIP_DN.V1_UP</TD><TD>MSigDB lists</TD><TD>CTIP_DN.V1_UP</TD><TD>124</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>CHODL,RGSL1,NANOG</TD></TR>
<TR><TD>3.033e-02</TD><TD>-3.50</TD><TD>XPGRADSUPER</TD><TD>prints domains</TD><TD>PR00853</TD><TD>5</TD><TD>1</TD><TD>4725</TD><TD>29</TD>
<TD>BIVM-ERCC5</TD></TR>
<TR><TD>3.038e-02</TD><TD>-3.49</TD><TD>GTAAGAT,MIR-200A</TD><TD>MSigDB lists</TD><TD>GTAAGAT,MIR-200A</TD><TD>50</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>UBE3A,NR4A1</TD></TR>
<TR><TD>3.038e-02</TD><TD>-3.49</TD><TD>GO_LYMPHOCYTE_HOMEOSTASIS</TD><TD>MSigDB lists</TD><TD>GO_LYMPHOCYTE_HOMEOSTASIS</TD><TD>50</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>SLC40A1,GAPT</TD></TR>
<TR><TD>3.038e-02</TD><TD>-3.49</TD><TD>BURTON_ADIPOGENESIS_PEAK_AT_2HR</TD><TD>MSigDB lists</TD><TD>BURTON_ADIPOGENESIS_PEAK_AT_2HR</TD><TD>50</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>FOSB,NR4A1</TD></TR>
<TR><TD>3.038e-02</TD><TD>-3.49</TD><TD>cellular pigmentation</TD><TD>biological process</TD><TD>GO:0033059</TD><TD>49</TD><TD>2</TD><TD>16543</TD><TD>92</TD>
<TD>AP1G1,RAB17</TD></TR>
<TR><TD>3.038e-02</TD><TD>-3.49</TD><TD>FBLN1 (fibulin 1)</TD><TD>protein interactions</TD><TD>2192</TD><TD>50</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>ADAMTSL2,TANK</TD></TR>
<TR><TD>3.038e-02</TD><TD>-3.49</TD><TD>RPE (ribulose-5-phosphate-3-epimerase)</TD><TD>protein interactions</TD><TD>6120</TD><TD>50</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>RBKS,NANOG</TD></TR>
<TR><TD>3.038e-02</TD><TD>-3.49</TD><TD>USP28 (ubiquitin specific peptidase 28)</TD><TD>protein interactions</TD><TD>57646</TD><TD>50</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>JOSD1,USP8</TD></TR>
<TR><TD>3.046e-02</TD><TD>-3.49</TD><TD>SH3 domain binding</TD><TD>molecular function</TD><TD>GO:0017124</TD><TD>120</TD><TD>3</TD><TD>16652</TD><TD>94</TD>
<TD>USP8,TP53BP2,MYPN</TD></TR>
<TR><TD>3.078e-02</TD><TD>-3.48</TD><TD>teratoma</TD><TD>COSMIC cancer mutations</TD><TD>teratoma</TD><TD>52</TD><TD>2</TD><TD>17630</TD><TD>93</TD>
<TD>SMARCA4,JAK2</TD></TR>
<TR><TD>3.088e-02</TD><TD>-3.48</TD><TD>ZHANG_TLX_TARGETS_36HR_UP</TD><TD>MSigDB lists</TD><TD>ZHANG_TLX_TARGETS_36HR_UP</TD><TD>217</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>FTL,NR4A1,C14orf159,SCARB2</TD></TR>
<TR><TD>3.102e-02</TD><TD>-3.47</TD><TD>PEREZ_TP63_TARGETS</TD><TD>MSigDB lists</TD><TD>PEREZ_TP63_TARGETS</TD><TD>321</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>SLC35E4,ZFYVE1,AUTS2,LGALS2,OVOL1</TD></TR>
<TR><TD>3.124e-02</TD><TD>-3.47</TD><TD>haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-lymphoplasmacytic_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-lymphoplasmacytic_lymphoma</TD><TD>6</TD><TD>1</TD><TD>17630</TD><TD>93</TD>
<TD>JAK2</TD></TR>
<TR><TD>3.124e-02</TD><TD>-3.47</TD><TD>urinary_tract-ureter-carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>urinary_tract-ureter-carcinoma</TD><TD>6</TD><TD>1</TD><TD>17630</TD><TD>93</TD>
<TD>JAK2</TD></TR>
<TR><TD>3.124e-02</TD><TD>-3.47</TD><TD>bone-extraskeletal-chondrosarcoma</TD><TD>COSMIC cancer mutations</TD><TD>bone-extraskeletal-chondrosarcoma</TD><TD>6</TD><TD>1</TD><TD>17630</TD><TD>93</TD>
<TD>JAK2</TD></TR>
<TR><TD>3.124e-02</TD><TD>-3.47</TD><TD>genital_tract-germ_cell_tumour-teratoma</TD><TD>COSMIC cancer mutations</TD><TD>genital_tract-germ_cell_tumour-teratoma</TD><TD>6</TD><TD>1</TD><TD>17630</TD><TD>93</TD>
<TD>SMARCA4</TD></TR>
<TR><TD>3.128e-02</TD><TD>-3.46</TD><TD>Deubiquitination</TD><TD>REACTOME pathways</TD><TD>R-HSA-5688426</TD><TD>303</TD><TD>5</TD><TD>10293</TD><TD>60</TD>
<TD>VCP,MAP3K7,JOSD1,OTUD7B,USP8</TD></TR>
<TR><TD>3.128e-02</TD><TD>-3.46</TD><TD>human chr7q11.22</TD><TD>chromosome location</TD><TD>human chr7q11.22</TD><TD>8</TD><TD>1</TD><TD>26234</TD><TD>104</TD>
<TD>AUTS2</TD></TR>
<TR><TD>3.151e-02</TD><TD>-3.46</TD><TD>NATSUME_RESPONSE_TO_INTERFERON_BETA_DN</TD><TD>MSigDB lists</TD><TD>NATSUME_RESPONSE_TO_INTERFERON_BETA_DN</TD><TD>51</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>FTH1,FTL</TD></TR>
<TR><TD>3.151e-02</TD><TD>-3.46</TD><TD>GYORFFY_MITOXANTRONE_RESISTANCE</TD><TD>MSigDB lists</TD><TD>GYORFFY_MITOXANTRONE_RESISTANCE</TD><TD>51</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>PPP1R3F,MAFF</TD></TR>
<TR><TD>3.151e-02</TD><TD>-3.46</TD><TD>LUI_THYROID_CANCER_CLUSTER_1</TD><TD>MSigDB lists</TD><TD>LUI_THYROID_CANCER_CLUSTER_1</TD><TD>51</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>NR4A1,FOSB</TD></TR>
<TR><TD>3.151e-02</TD><TD>-3.46</TD><TD>HENDRICKS_SMARCA4_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>HENDRICKS_SMARCA4_TARGETS_UP</TD><TD>51</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>ATP2B4,SMARCA4</TD></TR>
<TR><TD>3.151e-02</TD><TD>-3.46</TD><TD>USP10 (ubiquitin specific peptidase 10)</TD><TD>protein interactions</TD><TD>9100</TD><TD>51</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>VCP,TANK</TD></TR>
<TR><TD>3.151e-02</TD><TD>-3.46</TD><TD>ZCCHC10 (zinc finger CCHC-type containing 10)</TD><TD>protein interactions</TD><TD>54819</TD><TD>51</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>PTPN3,EEF1A1</TD></TR>
<TR><TD>3.151e-02</TD><TD>-3.46</TD><TD>PDCD10 (programmed cell death 10)</TD><TD>protein interactions</TD><TD>11235</TD><TD>51</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>HEXA,VCP</TD></TR>
<TR><TD>3.151e-02</TD><TD>-3.46</TD><TD>CDK2AP1 (cyclin dependent kinase 2 associated protein 1)</TD><TD>protein interactions</TD><TD>8099</TD><TD>51</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>VCP,NANOG</TD></TR>
<TR><TD>3.152e-02</TD><TD>-3.46</TD><TD>RBPJ (recombination signal binding protein for immunoglobulin kappa J region)</TD><TD>protein interactions</TD><TD>3516</TD><TD>126</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>KDM2A,SMARCA4,ADAR</TD></TR>
<TR><TD>3.164e-02</TD><TD>-3.45</TD><TD>cellular response to stress</TD><TD>biological process</TD><TD>GO:0033554</TD><TD>1467</TD><TD>14</TD><TD>16543</TD><TD>92</TD>
<TD>KDM2A,FBXO31,EPAS1,VCP,PLK5,JAK2,ZFYVE1,MAP1LC3B,CHL1,RNASEH2A,GJB2,TANK,ERN2,MAP3K7</TD></TR>
<TR><TD>3.175e-02</TD><TD>-3.45</TD><TD>SUMOylation of RNA binding proteins</TD><TD>REACTOME pathways</TD><TD>R-HSA-4570464</TD><TD>48</TD><TD>2</TD><TD>10293</TD><TD>60</TD>
<TD>POM121C,NUP37</TD></TR>
<TR><TD>3.185e-02</TD><TD>-3.45</TD><TD>FERM_central</TD><TD>interpro domains</TD><TD>IPR019748</TD><TD>50</TD><TD>2</TD><TD>18428</TD><TD>103</TD>
<TD>PTPN3,JAK2</TD></TR>
<TR><TD>3.187e-02</TD><TD>-3.45</TD><TD>steroid hormone mediated signaling pathway</TD><TD>biological process</TD><TD>GO:0043401</TD><TD>124</TD><TD>3</TD><TD>16543</TD><TD>92</TD>
<TD>JAK2,UBE3A,NR4A1</TD></TR>
<TR><TD>3.216e-02</TD><TD>-3.44</TD><TD>FAF1 (Fas associated factor 1)</TD><TD>protein interactions</TD><TD>11124</TD><TD>127</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>NR4A1,GART,VCP</TD></TR>
<TR><TD>3.225e-02</TD><TD>-3.43</TD><TD>GGCGGCA,MIR-371</TD><TD>MSigDB lists</TD><TD>GGCGGCA,MIR-371</TD><TD>6</TD><TD>1</TD><TD>17621</TD><TD>96</TD>
<TD>POM121C</TD></TR>
<TR><TD>3.225e-02</TD><TD>-3.43</TD><TD>TESAR_ALK_TARGETS_HUMAN_ES_4D_DN</TD><TD>MSigDB lists</TD><TD>TESAR_ALK_TARGETS_HUMAN_ES_4D_DN</TD><TD>6</TD><TD>1</TD><TD>17621</TD><TD>96</TD>
<TD>NANOG</TD></TR>
<TR><TD>3.225e-02</TD><TD>-3.43</TD><TD>TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_DN</TD><TD>MSigDB lists</TD><TD>TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_DN</TD><TD>6</TD><TD>1</TD><TD>17621</TD><TD>96</TD>
<TD>NANOG</TD></TR>
<TR><TD>3.226e-02</TD><TD>-3.43</TD><TD>ANKRD1 (ankyrin repeat domain 1)</TD><TD>protein interactions</TD><TD>27063</TD><TD>6</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>MYPN</TD></TR>
<TR><TD>3.226e-02</TD><TD>-3.43</TD><TD>ABTB2 (ankyrin repeat and BTB domain containing 2)</TD><TD>protein interactions</TD><TD>25841</TD><TD>6</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>EEF1A1</TD></TR>
<TR><TD>3.226e-02</TD><TD>-3.43</TD><TD>PHKG1 (phosphorylase kinase catalytic subunit gamma 1)</TD><TD>protein interactions</TD><TD>5260</TD><TD>6</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>UBE3A</TD></TR>
<TR><TD>3.226e-02</TD><TD>-3.43</TD><TD>PRAG1 (PEAK1 related kinase activating pseudokinase 1)</TD><TD>protein interactions</TD><TD>157285</TD><TD>6</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>UBE3A</TD></TR>
<TR><TD>3.226e-02</TD><TD>-3.43</TD><TD>NREP (neuronal regeneration related protein)</TD><TD>protein interactions</TD><TD>9315</TD><TD>6</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>EEF1A1</TD></TR>
<TR><TD>3.226e-02</TD><TD>-3.43</TD><TD>GUSBP1 (glucuronidase, beta pseudogene 1)</TD><TD>protein interactions</TD><TD>728411</TD><TD>6</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>EEF1A1</TD></TR>
<TR><TD>3.226e-02</TD><TD>-3.43</TD><TD>CCL18 (C-C motif chemokine ligand 18)</TD><TD>protein interactions</TD><TD>6362</TD><TD>6</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>EEF1A1</TD></TR>
<TR><TD>3.226e-02</TD><TD>-3.43</TD><TD>CECR2 (CECR2, histone acetyl-lysine reader)</TD><TD>protein interactions</TD><TD>27443</TD><TD>6</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>NANOG</TD></TR>
<TR><TD>3.226e-02</TD><TD>-3.43</TD><TD>TMEM159 (transmembrane protein 159)</TD><TD>protein interactions</TD><TD>57146</TD><TD>6</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>COQ8A</TD></TR>
<TR><TD>3.226e-02</TD><TD>-3.43</TD><TD>IL5RA (interleukin 5 receptor subunit alpha)</TD><TD>protein interactions</TD><TD>3568</TD><TD>6</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>JAK2</TD></TR>
<TR><TD>3.226e-02</TD><TD>-3.43</TD><TD>ZNF26 (zinc finger protein 26)</TD><TD>protein interactions</TD><TD>7574</TD><TD>6</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>TP53BP2</TD></TR>
<TR><TD>3.226e-02</TD><TD>-3.43</TD><TD>TBX5 (T-box 5)</TD><TD>protein interactions</TD><TD>6910</TD><TD>6</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>SMARCA4</TD></TR>
<TR><TD>3.226e-02</TD><TD>-3.43</TD><TD>Mast3 (microtubule associated serine/threonine kinase 3)</TD><TD>protein interactions</TD><TD>546071</TD><TD>6</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>TPM4</TD></TR>
<TR><TD>3.226e-02</TD><TD>-3.43</TD><TD>DMXL1 (Dmx like 1)</TD><TD>protein interactions</TD><TD>1657</TD><TD>6</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>RNASEH2A</TD></TR>
<TR><TD>3.226e-02</TD><TD>-3.43</TD><TD>E6 (E6)</TD><TD>protein interactions</TD><TD>1489078</TD><TD>6</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>UBE3A</TD></TR>
<TR><TD>3.226e-02</TD><TD>-3.43</TD><TD>MOCS1 (molybdenum cofactor synthesis 1)</TD><TD>protein interactions</TD><TD>4337</TD><TD>6</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>RAB17</TD></TR>
<TR><TD>3.226e-02</TD><TD>-3.43</TD><TD>ORMDL3 (ORMDL sphingolipid biosynthesis regulator 3)</TD><TD>protein interactions</TD><TD>94103</TD><TD>6</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>EEF1A1</TD></TR>
<TR><TD>3.226e-02</TD><TD>-3.43</TD><TD>PAPD4 (poly(A) RNA polymerase D4, non-canonical)</TD><TD>protein interactions</TD><TD>167153</TD><TD>6</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>NANOG</TD></TR>
<TR><TD>3.226e-02</TD><TD>-3.43</TD><TD>KLHL5 (kelch like family member 5)</TD><TD>protein interactions</TD><TD>51088</TD><TD>6</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>MAP1LC3B</TD></TR>
<TR><TD>3.226e-02</TD><TD>-3.43</TD><TD>ZNF467 (zinc finger protein 467)</TD><TD>protein interactions</TD><TD>168544</TD><TD>6</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>NANOG</TD></TR>
<TR><TD>3.226e-02</TD><TD>-3.43</TD><TD>TCF19 (transcription factor 19)</TD><TD>protein interactions</TD><TD>6941</TD><TD>6</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>UBE3A</TD></TR>
<TR><TD>3.226e-02</TD><TD>-3.43</TD><TD>ALPL (alkaline phosphatase, liver/bone/kidney)</TD><TD>protein interactions</TD><TD>249</TD><TD>6</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>EEF1A1</TD></TR>
<TR><TD>3.226e-02</TD><TD>-3.43</TD><TD>GAS8 (growth arrest specific 8)</TD><TD>protein interactions</TD><TD>2622</TD><TD>6</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>HEATR6</TD></TR>
<TR><TD>3.226e-02</TD><TD>-3.43</TD><TD>FAM104A (family with sequence similarity 104 member A)</TD><TD>protein interactions</TD><TD>84923</TD><TD>6</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>VCP</TD></TR>
<TR><TD>3.226e-02</TD><TD>-3.43</TD><TD>H2AFJ (H2A histone family member J)</TD><TD>protein interactions</TD><TD>55766</TD><TD>6</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>VCP</TD></TR>
<TR><TD>3.226e-02</TD><TD>-3.43</TD><TD>IL12RB2 (interleukin 12 receptor subunit beta 2)</TD><TD>protein interactions</TD><TD>3595</TD><TD>6</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>JAK2</TD></TR>
<TR><TD>3.226e-02</TD><TD>-3.43</TD><TD>Cep250 (centrosomal protein 250)</TD><TD>protein interactions</TD><TD>16328</TD><TD>6</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>NUP37</TD></TR>
<TR><TD>3.241e-02</TD><TD>-3.43</TD><TD>GO_VACUOLAR_MEMBRANE</TD><TD>MSigDB lists</TD><TD>GO_VACUOLAR_MEMBRANE</TD><TD>557</TD><TD>7</TD><TD>17621</TD><TD>96</TD>
<TD>RAB17,USP8,MAP3K7,EEF1A1,AP1G1,MAP1LC3B,SCARB2</TD></TR>
<TR><TD>3.243e-02</TD><TD>-3.43</TD><TD>hydrolase activity, acting on glycosyl bonds</TD><TD>molecular function</TD><TD>GO:0016798</TD><TD>123</TD><TD>3</TD><TD>16652</TD><TD>94</TD>
<TD>HEXA,USF3,CHID1</TD></TR>
<TR><TD>3.246e-02</TD><TD>-3.43</TD><TD>GO_TRANSCRIPTION_FACTOR_ACTIVITY_RNA_POLYMERASE_II_CORE_PROMOTER_PROXIMAL_REGION_SEQUENCE_SPECIFIC_BINDING</TD><TD>MSigDB lists</TD><TD>GO_TRANSCRIPTION_FACTOR_ACTIVITY_RNA_POLYMERASE_II_CORE_PROMOTER_PROXIMAL_REGION_SEQUENCE_SPECIFIC_BINDING</TD><TD>325</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>NR4A1,OVOL1,ONECUT3,FOSB,EPAS1</TD></TR>
<TR><TD>3.255e-02</TD><TD>-3.43</TD><TD>Inosine monophosphate biosynthesis, PRPP + glutamine => IMP</TD><TD>KEGG pathways</TD><TD>hsa_M00048</TD><TD>6</TD><TD>1</TD><TD>7094</TD><TD>39</TD>
<TD>GART</TD></TR>
<TR><TD>3.255e-02</TD><TD>-3.43</TD><TD>Inosine monophosphate biosynthesis, PRPP + glutamine => IMP</TD><TD>KEGG pathways</TD><TD>M00048</TD><TD>6</TD><TD>1</TD><TD>7094</TD><TD>39</TD>
<TD>GART</TD></TR>
<TR><TD>3.265e-02</TD><TD>-3.42</TD><TD>GO_SH3_SH2_ADAPTOR_ACTIVITY</TD><TD>MSigDB lists</TD><TD>GO_SH3_SH2_ADAPTOR_ACTIVITY</TD><TD>52</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>TP53BP2,SHB</TD></TR>
<TR><TD>3.265e-02</TD><TD>-3.42</TD><TD>REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM</TD><TD>MSigDB lists</TD><TD>REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM</TD><TD>52</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>NUP37,POM121C</TD></TR>
<TR><TD>3.266e-02</TD><TD>-3.42</TD><TD>UGP2 (UDP-glucose pyrophosphorylase 2)</TD><TD>protein interactions</TD><TD>7360</TD><TD>52</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>GART,ARIH2</TD></TR>
<TR><TD>3.266e-02</TD><TD>-3.42</TD><TD>TNPO3 (transportin 3)</TD><TD>protein interactions</TD><TD>23534</TD><TD>52</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>UBE3A,VCP</TD></TR>
<TR><TD>3.266e-02</TD><TD>-3.42</TD><TD>FTH1 (ferritin heavy chain 1)</TD><TD>protein interactions</TD><TD>2495</TD><TD>52</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>FTH1,FTL</TD></TR>
<TR><TD>3.266e-02</TD><TD>-3.42</TD><TD>PDCD4 (programmed cell death 4)</TD><TD>protein interactions</TD><TD>27250</TD><TD>52</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>VCP,ARPC1B</TD></TR>
<TR><TD>3.266e-02</TD><TD>-3.42</TD><TD>BRD7 (bromodomain containing 7)</TD><TD>protein interactions</TD><TD>29117</TD><TD>52</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>FTH1,SMARCA4</TD></TR>
<TR><TD>3.266e-02</TD><TD>-3.42</TD><TD>ABCC1 (ATP binding cassette subfamily C member 1)</TD><TD>protein interactions</TD><TD>4363</TD><TD>52</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>EEF1A1,VCP</TD></TR>
<TR><TD>3.266e-02</TD><TD>-3.42</TD><TD>AP1G1 (adaptor related protein complex 1 gamma 1 subunit)</TD><TD>protein interactions</TD><TD>164</TD><TD>52</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>AP1G1,GPRASP2</TD></TR>
<TR><TD>3.266e-02</TD><TD>-3.42</TD><TD>TWF2 (twinfilin actin binding protein 2)</TD><TD>protein interactions</TD><TD>11344</TD><TD>52</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>ARIH2,NANOG</TD></TR>
<TR><TD>3.268e-02</TD><TD>-3.42</TD><TD>GO_ION_HOMEOSTASIS</TD><TD>MSigDB lists</TD><TD>GO_ION_HOMEOSTASIS</TD><TD>558</TD><TD>7</TD><TD>17621</TD><TD>96</TD>
<TD>ALAS2,JAK2,ATP2B4,FTL,FTH1,EPAS1,SLC40A1</TD></TR>
<TR><TD>3.269e-02</TD><TD>-3.42</TD><TD>kinetochore microtubule</TD><TD>cellular component</TD><TD>GO:0005828</TD><TD>6</TD><TD>1</TD><TD>17744</TD><TD>98</TD>
<TD>KNTC1</TD></TR>
<TR><TD>3.270e-02</TD><TD>-3.42</TD><TD>regulation of alpha-beta T cell differentiation</TD><TD>biological process</TD><TD>GO:0046637</TD><TD>51</TD><TD>2</TD><TD>16543</TD><TD>92</TD>
<TD>ZNF683,SHB</TD></TR>
<TR><TD>3.270e-02</TD><TD>-3.42</TD><TD>lymphocyte homeostasis</TD><TD>biological process</TD><TD>GO:0002260</TD><TD>51</TD><TD>2</TD><TD>16543</TD><TD>92</TD>
<TD>SLC40A1,GAPT</TD></TR>
<TR><TD>3.270e-02</TD><TD>-3.42</TD><TD>negative regulation of I-kappaB kinase/NF-kappaB signaling</TD><TD>biological process</TD><TD>GO:0043124</TD><TD>51</TD><TD>2</TD><TD>16543</TD><TD>92</TD>
<TD>OTUD7B,TANK</TD></TR>
<TR><TD>3.273e-02</TD><TD>-3.42</TD><TD>Homeobox</TD><TD>pfam domains</TD><TD>PF00046</TD><TD>209</TD><TD>4</TD><TD>16832</TD><TD>97</TD>
<TD>EMX1,ONECUT3,NANOG,MNX1</TD></TR>
<TR><TD>3.282e-02</TD><TD>-3.42</TD><TD>RB_P130_DN.V1_DN</TD><TD>MSigDB lists</TD><TD>RB_P130_DN.V1_DN</TD><TD>128</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>GJB2,CASP6,BNC1</TD></TR>
<TR><TD>3.291e-02</TD><TD>-3.41</TD><TD>endodermal cell fate specification</TD><TD>biological process</TD><TD>GO:0001714</TD><TD>6</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>NANOG</TD></TR>
<TR><TD>3.291e-02</TD><TD>-3.41</TD><TD>inclusion body assembly</TD><TD>biological process</TD><TD>GO:0070841</TD><TD>6</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>VCP</TD></TR>
<TR><TD>3.291e-02</TD><TD>-3.41</TD><TD>regulation of oligodendrocyte progenitor proliferation</TD><TD>biological process</TD><TD>GO:0070445</TD><TD>6</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>EMX1</TD></TR>
<TR><TD>3.291e-02</TD><TD>-3.41</TD><TD>oxygen homeostasis</TD><TD>biological process</TD><TD>GO:0032364</TD><TD>6</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ALAS2</TD></TR>
<TR><TD>3.291e-02</TD><TD>-3.41</TD><TD>positive regulation of oxidative phosphorylation</TD><TD>biological process</TD><TD>GO:1903862</TD><TD>6</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>VCP</TD></TR>
<TR><TD>3.291e-02</TD><TD>-3.41</TD><TD>regulation of cardiac muscle adaptation</TD><TD>biological process</TD><TD>GO:0010612</TD><TD>6</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ATP2B4</TD></TR>
<TR><TD>3.291e-02</TD><TD>-3.41</TD><TD>regulation of cardiac muscle hypertrophy in response to stress</TD><TD>biological process</TD><TD>GO:1903242</TD><TD>6</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ATP2B4</TD></TR>
<TR><TD>3.291e-02</TD><TD>-3.41</TD><TD>response to fungicide</TD><TD>biological process</TD><TD>GO:0060992</TD><TD>6</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>EHMT1</TD></TR>
<TR><TD>3.291e-02</TD><TD>-3.41</TD><TD>flavin-containing compound metabolic process</TD><TD>biological process</TD><TD>GO:0042726</TD><TD>6</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>VCP</TD></TR>
<TR><TD>3.291e-02</TD><TD>-3.41</TD><TD>response to tumor cell</TD><TD>biological process</TD><TD>GO:0002347</TD><TD>6</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>PLK5</TD></TR>
<TR><TD>3.291e-02</TD><TD>-3.41</TD><TD>pentose catabolic process</TD><TD>biological process</TD><TD>GO:0019323</TD><TD>6</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>RBKS</TD></TR>
<TR><TD>3.291e-02</TD><TD>-3.41</TD><TD>regulation of membrane depolarization during action potential</TD><TD>biological process</TD><TD>GO:0098902</TD><TD>6</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>PTPN3</TD></TR>
<TR><TD>3.291e-02</TD><TD>-3.41</TD><TD>hematopoietic stem cell homeostasis</TD><TD>biological process</TD><TD>GO:0061484</TD><TD>6</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ADAR</TD></TR>
<TR><TD>3.291e-02</TD><TD>-3.41</TD><TD>response to hydrostatic pressure</TD><TD>biological process</TD><TD>GO:0051599</TD><TD>6</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ATP2B4</TD></TR>
<TR><TD>3.291e-02</TD><TD>-3.41</TD><TD>regulation of adrenergic receptor signaling pathway</TD><TD>biological process</TD><TD>GO:0071877</TD><TD>6</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ATP2B4</TD></TR>
<TR><TD>3.291e-02</TD><TD>-3.41</TD><TD>'de novo' IMP biosynthetic process</TD><TD>biological process</TD><TD>GO:0006189</TD><TD>6</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>GART</TD></TR>
<TR><TD>3.291e-02</TD><TD>-3.41</TD><TD>positive regulation of histone H4 acetylation</TD><TD>biological process</TD><TD>GO:0090240</TD><TD>6</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>AUTS2</TD></TR>
<TR><TD>3.291e-02</TD><TD>-3.41</TD><TD>positive regulation of sulfur metabolic process</TD><TD>biological process</TD><TD>GO:0051176</TD><TD>6</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>PXYLP1</TD></TR>
<TR><TD>3.291e-02</TD><TD>-3.41</TD><TD>regulation of peptidyl-cysteine S-nitrosylation</TD><TD>biological process</TD><TD>GO:2000169</TD><TD>6</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ATP2B4</TD></TR>
<TR><TD>3.291e-02</TD><TD>-3.41</TD><TD>regulation of NK T cell differentiation</TD><TD>biological process</TD><TD>GO:0051136</TD><TD>6</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ZNF683</TD></TR>
<TR><TD>3.291e-02</TD><TD>-3.41</TD><TD>Golgi to lysosome transport</TD><TD>biological process</TD><TD>GO:0090160</TD><TD>6</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>AP1G1</TD></TR>
<TR><TD>3.291e-02</TD><TD>-3.41</TD><TD>tyrosine phosphorylation of Stat3 protein</TD><TD>biological process</TD><TD>GO:0042503</TD><TD>6</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>JAK2</TD></TR>
<TR><TD>3.303e-02</TD><TD>-3.41</TD><TD>Band_41_domain</TD><TD>interpro domains</TD><TD>IPR019749</TD><TD>51</TD><TD>2</TD><TD>18428</TD><TD>103</TD>
<TD>PTPN3,JAK2</TD></TR>
<TR><TD>3.303e-02</TD><TD>-3.41</TD><TD>T1-type_BTB</TD><TD>interpro domains</TD><TD>IPR003131</TD><TD>51</TD><TD>2</TD><TD>18428</TD><TD>103</TD>
<TD>KCNA2,KCNG3</TD></TR>
<TR><TD>3.308e-02</TD><TD>-3.41</TD><TD>XPG_DNA_repair_N</TD><TD>interpro domains</TD><TD>IPR006085</TD><TD>6</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>BIVM-ERCC5</TD></TR>
<TR><TD>3.308e-02</TD><TD>-3.41</TD><TD>A_deamin</TD><TD>interpro domains</TD><TD>IPR002466</TD><TD>6</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>ADAR</TD></TR>
<TR><TD>3.308e-02</TD><TD>-3.41</TD><TD>Rudment_hybrid_motif</TD><TD>interpro domains</TD><TD>IPR011054</TD><TD>6</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>GART</TD></TR>
<TR><TD>3.308e-02</TD><TD>-3.41</TD><TD>BRK_domain</TD><TD>interpro domains</TD><TD>IPR006576</TD><TD>6</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>SMARCA4</TD></TR>
<TR><TD>3.308e-02</TD><TD>-3.41</TD><TD>Ribokinase-like</TD><TD>interpro domains</TD><TD>IPR029056</TD><TD>6</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>RBKS</TD></TR>
<TR><TD>3.308e-02</TD><TD>-3.41</TD><TD>Clathrin_g-adaptin_app</TD><TD>interpro domains</TD><TD>IPR008153</TD><TD>6</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>AP1G1</TD></TR>
<TR><TD>3.308e-02</TD><TD>-3.41</TD><TD>Quinoprotein_ADH-like_fam</TD><TD>interpro domains</TD><TD>IPR027295</TD><TD>6</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>ERN2</TD></TR>
<TR><TD>3.308e-02</TD><TD>-3.41</TD><TD>Val/Leu/Ile-tRNA-synth_edit</TD><TD>interpro domains</TD><TD>IPR009008</TD><TD>6</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>VARS2</TD></TR>
<TR><TD>3.308e-02</TD><TD>-3.41</TD><TD>PUB_domain</TD><TD>interpro domains</TD><TD>IPR018997</TD><TD>6</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>ERN2</TD></TR>
<TR><TD>3.308e-02</TD><TD>-3.41</TD><TD>M/V/L/I-tRNA-synth_anticd-bd</TD><TD>interpro domains</TD><TD>IPR013155</TD><TD>6</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>VARS2</TD></TR>
<TR><TD>3.308e-02</TD><TD>-3.41</TD><TD>aa-tRNA-synth_Ia</TD><TD>interpro domains</TD><TD>IPR002300</TD><TD>6</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>VARS2</TD></TR>
<TR><TD>3.308e-02</TD><TD>-3.41</TD><TD>Transl_elong_EFTu/EF1A_C</TD><TD>interpro domains</TD><TD>IPR004160</TD><TD>6</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>EEF1A1</TD></TR>
<TR><TD>3.308e-02</TD><TD>-3.41</TD><TD>BZIP</TD><TD>prosite domains</TD><TD>PS50217</TD><TD>51</TD><TD>2</TD><TD>11955</TD><TD>67</TD>
<TD>MAFF,FOSB</TD></TR>
<TR><TD>3.317e-02</TD><TD>-3.41</TD><TD>A_DEAMIN_EDITASE</TD><TD>prosite domains</TD><TD>PS50141</TD><TD>6</TD><TD>1</TD><TD>11955</TD><TD>67</TD>
<TD>ADAR</TD></TR>
<TR><TD>3.317e-02</TD><TD>-3.41</TD><TD>stomach-carcinoma-mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable</TD><TD>COSMIC cancer mutations</TD><TD>stomach-carcinoma-mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable</TD><TD>978</TD><TD>10</TD><TD>17630</TD><TD>93</TD>
<TD>PTPN3,AP1G1,BNC1,OVOL1,ARIH2,GRAMD1B,ATP2B4,AUTS2,MAP3K7,MYPN</TD></TR>
<TR><TD>3.317e-02</TD><TD>-3.41</TD><TD>mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable</TD><TD>COSMIC cancer mutations</TD><TD>mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable</TD><TD>978</TD><TD>10</TD><TD>17630</TD><TD>93</TD>
<TD>ATP2B4,GRAMD1B,ARIH2,MAP3K7,MYPN,AUTS2,PTPN3,AP1G1,OVOL1,BNC1</TD></TR>
<TR><TD>3.340e-02</TD><TD>-3.40</TD><TD>protein phosphatase 2B binding</TD><TD>molecular function</TD><TD>GO:0030346</TD><TD>6</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>ATP2B4</TD></TR>
<TR><TD>3.340e-02</TD><TD>-3.40</TD><TD>ferroxidase activity</TD><TD>molecular function</TD><TD>GO:0004322</TD><TD>6</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>FTH1</TD></TR>
<TR><TD>3.340e-02</TD><TD>-3.40</TD><TD>oxidoreductase activity, oxidizing metal ions, oxygen as acceptor</TD><TD>molecular function</TD><TD>GO:0016724</TD><TD>6</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>FTH1</TD></TR>
<TR><TD>3.347e-02</TD><TD>-3.40</TD><TD>MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP</TD><TD>MSigDB lists</TD><TD>MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP</TD><TD>129</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>TANK,RGSL1,ARIH2</TD></TR>
<TR><TD>3.347e-02</TD><TD>-3.40</TD><TD>GO_LEADING_EDGE_MEMBRANE</TD><TD>MSigDB lists</TD><TD>GO_LEADING_EDGE_MEMBRANE</TD><TD>129</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>FGD5,EEF1A1,KCNA2</TD></TR>
<TR><TD>3.347e-02</TD><TD>-3.40</TD><TD>V$TAXCREB_01</TD><TD>MSigDB lists</TD><TD>V$TAXCREB_01</TD><TD>129</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>MAFF,KDM2A,FOSB</TD></TR>
<TR><TD>3.358e-02</TD><TD>-3.39</TD><TD>GO_REGULATION_OF_CELLULAR_AMIDE_METABOLIC_PROCESS</TD><TD>MSigDB lists</TD><TD>GO_REGULATION_OF_CELLULAR_AMIDE_METABOLIC_PROCESS</TD><TD>328</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>DTD1,ADAR,VARS2,ENC1,NGDN</TD></TR>
<TR><TD>3.365e-02</TD><TD>-3.39</TD><TD>YWHAQ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta)</TD><TD>protein interactions</TD><TD>10971</TD><TD>442</TD><TD>6</TD><TD>16330</TD><TD>89</TD>
<TD>PTPN3,RMDN3,VCP,USP8,EEF1A1,TP53BP2</TD></TR>
<TR><TD>3.370e-02</TD><TD>-3.39</TD><TD>ADEAMc</TD><TD>smart domains</TD><TD>SM00552</TD><TD>6</TD><TD>1</TD><TD>9480</TD><TD>54</TD>
<TD>ADAR</TD></TR>
<TR><TD>3.370e-02</TD><TD>-3.39</TD><TD>BRK</TD><TD>smart domains</TD><TD>SM00592</TD><TD>6</TD><TD>1</TD><TD>9480</TD><TD>54</TD>
<TD>SMARCA4</TD></TR>
<TR><TD>3.381e-02</TD><TD>-3.39</TD><TD>GO_REGULATION_OF_NITRIC_OXIDE_BIOSYNTHETIC_PROCESS</TD><TD>MSigDB lists</TD><TD>GO_REGULATION_OF_NITRIC_OXIDE_BIOSYNTHETIC_PROCESS</TD><TD>53</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>ATP2B4,JAK2</TD></TR>
<TR><TD>3.381e-02</TD><TD>-3.39</TD><TD>GO_EXECUTION_PHASE_OF_APOPTOSIS</TD><TD>MSigDB lists</TD><TD>GO_EXECUTION_PHASE_OF_APOPTOSIS</TD><TD>53</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>CASP6,ERN2</TD></TR>
<TR><TD>3.382e-02</TD><TD>-3.39</TD><TD>DPY30 (dpy-30, histone methyltransferase complex regulatory subunit)</TD><TD>protein interactions</TD><TD>84661</TD><TD>53</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>EPAS1,NANOG</TD></TR>
<TR><TD>3.382e-02</TD><TD>-3.39</TD><TD>Nup107 (nucleoporin 107)</TD><TD>protein interactions</TD><TD>103468</TD><TD>53</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>NUP37,POM121C</TD></TR>
<TR><TD>3.382e-02</TD><TD>-3.39</TD><TD>GGA1 (golgi associated, gamma adaptin ear containing, ARF binding protein 1)</TD><TD>protein interactions</TD><TD>26088</TD><TD>53</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>VCP,AP1G1</TD></TR>
<TR><TD>3.389e-02</TD><TD>-3.38</TD><TD>stem cell proliferation</TD><TD>biological process</TD><TD>GO:0072089</TD><TD>52</TD><TD>2</TD><TD>16543</TD><TD>92</TD>
<TD>SHB,ARIH2</TD></TR>
<TR><TD>3.389e-02</TD><TD>-3.38</TD><TD>neural retina development</TD><TD>biological process</TD><TD>GO:0003407</TD><TD>52</TD><TD>2</TD><TD>16543</TD><TD>92</TD>
<TD>ATP2B4,SMARCA4</TD></TR>
<TR><TD>3.389e-02</TD><TD>-3.38</TD><TD>activation of MAPKK activity</TD><TD>biological process</TD><TD>GO:0000186</TD><TD>52</TD><TD>2</TD><TD>16543</TD><TD>92</TD>
<TD>MAP3K7,JAK2</TD></TR>
<TR><TD>3.389e-02</TD><TD>-3.38</TD><TD>regulation of nitric oxide biosynthetic process</TD><TD>biological process</TD><TD>GO:0045428</TD><TD>52</TD><TD>2</TD><TD>16543</TD><TD>92</TD>
<TD>ATP2B4,JAK2</TD></TR>
<TR><TD>3.393e-02</TD><TD>-3.38</TD><TD>pleura</TD><TD>COSMIC cancer mutations</TD><TD>pleura</TD><TD>5011</TD><TD>35</TD><TD>17630</TD><TD>93</TD>
<TD>MAP3K7,SMARCA4,FBXO31,UBE3A,VCP,JAK2,MAFF,NUP37,TP53BP2,ALAS2,F10,MYPN,IFT27,TPM4,RGSL1,ENC1,FGD5,EPAS1,MNX1,FTH1,GPRASP2,HEATR6,KNTC1,PPP1R3F,TACC2,FOSB,TANK,KDM2A,USP8,CASP6,RAB17,PTPN3,HSPB6,SERPINB10,EEF1A1</TD></TR>
<TR><TD>3.399e-02</TD><TD>-3.38</TD><TD>BRLZ</TD><TD>smart domains</TD><TD>SM00338</TD><TD>51</TD><TD>2</TD><TD>9480</TD><TD>54</TD>
<TD>MAFF,FOSB</TD></TR>
<TR><TD>3.399e-02</TD><TD>-3.38</TD><TD>B41</TD><TD>smart domains</TD><TD>SM00295</TD><TD>51</TD><TD>2</TD><TD>9480</TD><TD>54</TD>
<TD>PTPN3,JAK2</TD></TR>
<TR><TD>3.402e-02</TD><TD>-3.38</TD><TD>GO_REGULATION_OF_PROTEOLYSIS</TD><TD>MSigDB lists</TD><TD>GO_REGULATION_OF_PROTEOLYSIS</TD><TD>688</TD><TD>8</TD><TD>17621</TD><TD>96</TD>
<TD>OSBPL7,AURKAIP1,SERPINB10,PTPN3,UBE3A,VCP,ARIH2,JAK2</TD></TR>
<TR><TD>3.409e-02</TD><TD>-3.38</TD><TD>GTP_EFTU_D3</TD><TD>pfam domains</TD><TD>PF03143</TD><TD>6</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>EEF1A1</TD></TR>
<TR><TD>3.409e-02</TD><TD>-3.38</TD><TD>A_deamin</TD><TD>pfam domains</TD><TD>PF02137</TD><TD>6</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>ADAR</TD></TR>
<TR><TD>3.409e-02</TD><TD>-3.38</TD><TD>tRNA-synt_1</TD><TD>pfam domains</TD><TD>PF00133</TD><TD>6</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>VARS2</TD></TR>
<TR><TD>3.409e-02</TD><TD>-3.38</TD><TD>XPG_N</TD><TD>pfam domains</TD><TD>PF00752</TD><TD>6</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>BIVM-ERCC5</TD></TR>
<TR><TD>3.409e-02</TD><TD>-3.38</TD><TD>Anticodon_1</TD><TD>pfam domains</TD><TD>PF08264</TD><TD>6</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>VARS2</TD></TR>
<TR><TD>3.412e-02</TD><TD>-3.38</TD><TD>V$ATF1_Q6</TD><TD>MSigDB lists</TD><TD>V$ATF1_Q6</TD><TD>224</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>RBKS,TPM4,FOSB,MAFF</TD></TR>
<TR><TD>3.413e-02</TD><TD>-3.38</TD><TD>GO_GENE_SILENCING_BY_RNA</TD><TD>MSigDB lists</TD><TD>GO_GENE_SILENCING_BY_RNA</TD><TD>130</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>ADAR,NUP37,POM121C</TD></TR>
<TR><TD>3.423e-02</TD><TD>-3.37</TD><TD>Death Receptor Signalling</TD><TD>REACTOME pathways</TD><TD>R-HSA-73887</TD><TD>50</TD><TD>2</TD><TD>10293</TD><TD>60</TD>
<TD>OTUD7B,MAP3K7</TD></TR>
<TR><TD>3.448e-02</TD><TD>-3.37</TD><TD>Methionine salvage pathway</TD><TD>REACTOME pathways</TD><TD>R-HSA-1237112</TD><TD>6</TD><TD>1</TD><TD>10293</TD><TD>60</TD>
<TD>ADI1</TD></TR>
<TR><TD>3.457e-02</TD><TD>-3.36</TD><TD>PUJANA_ATM_PCC_NETWORK</TD><TD>MSigDB lists</TD><TD>PUJANA_ATM_PCC_NETWORK</TD><TD>1370</TD><TD>13</TD><TD>17621</TD><TD>96</TD>
<TD>MAP1LC3B,POM121C,KNTC1,TSFM,HEXA,ADAR,ARIH2,JAK2,EMX1,TANK,NGDN,EEF1A1,TTC39A</TD></TR>
<TR><TD>3.459e-02</TD><TD>-3.36</TD><TD>GO_TRANSCRIPTIONAL_ACTIVATOR_ACTIVITY_RNA_POLYMERASE_II_CORE_PROMOTER_PROXIMAL_REGION_SEQUENCE_SPECIFIC_BINDING</TD><TD>MSigDB lists</TD><TD>GO_TRANSCRIPTIONAL_ACTIVATOR_ACTIVITY_RNA_POLYMERASE_II_CORE_PROMOTER_PROXIMAL_REGION_SEQUENCE_SPECIFIC_BINDING</TD><TD>225</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>NR4A1,EPAS1,ONECUT3,FOSB</TD></TR>
<TR><TD>3.459e-02</TD><TD>-3.36</TD><TD>GO_TELENCEPHALON_DEVELOPMENT</TD><TD>MSigDB lists</TD><TD>GO_TELENCEPHALON_DEVELOPMENT</TD><TD>225</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>ATP2B4,TACC2,GART,EMX1</TD></TR>
<TR><TD>3.462e-02</TD><TD>-3.36</TD><TD>GO_IMMUNE_SYSTEM_DEVELOPMENT</TD><TD>MSigDB lists</TD><TD>GO_IMMUNE_SYSTEM_DEVELOPMENT</TD><TD>565</TD><TD>7</TD><TD>17621</TD><TD>96</TD>
<TD>ZNF683,ARIH2,ADAR,ALAS2,JAK2,SLC40A1,EPAS1</TD></TR>
<TR><TD>3.464e-02</TD><TD>-3.36</TD><TD>cellular protein catabolic process</TD><TD>biological process</TD><TD>GO:0044257</TD><TD>554</TD><TD>7</TD><TD>16543</TD><TD>92</TD>
<TD>ENC1,USP8,OTUD7B,UBE3A,ARIH2,FBXO31,VCP</TD></TR>
<TR><TD>3.477e-02</TD><TD>-3.36</TD><TD>BENPORATH_SOX2_TARGETS</TD><TD>MSigDB lists</TD><TD>BENPORATH_SOX2_TARGETS</TD><TD>691</TD><TD>8</TD><TD>17621</TD><TD>96</TD>
<TD>C14orf159,KNTC1,PTPN3,RAB17,ADAR,NANOG,COMMD7,FTL</TD></TR>
<TR><TD>3.478e-02</TD><TD>-3.36</TD><TD>UBE2L3 (ubiquitin conjugating enzyme E2 L3)</TD><TD>protein interactions</TD><TD>7332</TD><TD>131</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>ARIH2,UBE3A,MAP1LC3B</TD></TR>
<TR><TD>3.491e-02</TD><TD>-3.36</TD><TD>BTB_2</TD><TD>pfam domains</TD><TD>PF02214</TD><TD>51</TD><TD>2</TD><TD>16832</TD><TD>97</TD>
<TD>KCNA2,KCNG3</TD></TR>
<TR><TD>3.497e-02</TD><TD>-3.35</TD><TD>-</TD><TD>gene3d domains</TD><TD>3.40.1190.20</TD><TD>6</TD><TD>1</TD><TD>10485</TD><TD>62</TD>
<TD>RBKS</TD></TR>
<TR><TD>3.497e-02</TD><TD>-3.35</TD><TD>-</TD><TD>gene3d domains</TD><TD>2.60.40.1230</TD><TD>6</TD><TD>1</TD><TD>10485</TD><TD>62</TD>
<TD>AP1G1</TD></TR>
<TR><TD>3.497e-02</TD><TD>-3.35</TD><TD>-</TD><TD>gene3d domains</TD><TD>2.140.10.10</TD><TD>6</TD><TD>1</TD><TD>10485</TD><TD>62</TD>
<TD>ERN2</TD></TR>
<TR><TD>3.497e-02</TD><TD>-3.35</TD><TD>-</TD><TD>gene3d domains</TD><TD>3.90.740.10</TD><TD>6</TD><TD>1</TD><TD>10485</TD><TD>62</TD>
<TD>VARS2</TD></TR>
<TR><TD>3.499e-02</TD><TD>-3.35</TD><TD>TIEN_INTESTINE_PROBIOTICS_6HR_UP</TD><TD>MSigDB lists</TD><TD>TIEN_INTESTINE_PROBIOTICS_6HR_UP</TD><TD>54</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>EEF1A1,FTL</TD></TR>
<TR><TD>3.499e-02</TD><TD>-3.35</TD><TD>GO_SPERM_FLAGELLUM</TD><TD>MSigDB lists</TD><TD>GO_SPERM_FLAGELLUM</TD><TD>54</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>ATP2B4,IFT27</TD></TR>
<TR><TD>3.500e-02</TD><TD>-3.35</TD><TD>PTPN12 (protein tyrosine phosphatase, non-receptor type 12)</TD><TD>protein interactions</TD><TD>5782</TD><TD>54</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>NANOG,JAK2</TD></TR>
<TR><TD>3.500e-02</TD><TD>-3.35</TD><TD>HNF1A (HNF1 homeobox A)</TD><TD>protein interactions</TD><TD>6927</TD><TD>54</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>SMARCA4,VCP</TD></TR>
<TR><TD>3.500e-02</TD><TD>-3.35</TD><TD>ARF6 (ADP ribosylation factor 6)</TD><TD>protein interactions</TD><TD>382</TD><TD>54</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>VCP,GART</TD></TR>
<TR><TD>3.500e-02</TD><TD>-3.35</TD><TD>PJA1 (praja ring finger ubiquitin ligase 1)</TD><TD>protein interactions</TD><TD>64219</TD><TD>54</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>USP8,JOSD1</TD></TR>
<TR><TD>3.509e-02</TD><TD>-3.35</TD><TD>organic substance biosynthetic process</TD><TD>biological process</TD><TD>GO:1901576</TD><TD>4602</TD><TD>34</TD><TD>16543</TD><TD>92</TD>
<TD>NR4A1,GART,ALAS2,MED7,TSFM,AURKAIP1,MAFF,VARS2,SMARCA4,KDM2A,USF3,EEF1A1,HEXA,RFX2,PXYLP1,ERN2,ZNF683,ADI1,VCP,COQ8A,EPAS1,COMMD7,NANOG,ONECUT3,DTD1,MNX1,FOSB,POM121C,BNC1,RNASEH2A,NUP37,MAP3K7,UGT1A6,OVOL1</TD></TR>
<TR><TD>3.521e-02</TD><TD>-3.35</TD><TD>macroautophagy</TD><TD>biological process</TD><TD>GO:0016236</TD><TD>129</TD><TD>3</TD><TD>16543</TD><TD>92</TD>
<TD>ZFYVE1,MAP1LC3B,VCP</TD></TR>
<TR><TD>3.526e-02</TD><TD>-3.34</TD><TD>salivary_gland-maxilla-carcinoma-adenoid_cystic_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>salivary_gland-maxilla-carcinoma-adenoid_cystic_carcinoma</TD><TD>56</TD><TD>2</TD><TD>17630</TD><TD>93</TD>
<TD>ATP2B4,MAP3K7</TD></TR>
<TR><TD>3.532e-02</TD><TD>-3.34</TD><TD>response to steroid hormone</TD><TD>biological process</TD><TD>GO:0048545</TD><TD>326</TD><TD>5</TD><TD>16543</TD><TD>92</TD>
<TD>FOSB,GJB2,NR4A1,UBE3A,JAK2</TD></TR>
<TR><TD>3.541e-02</TD><TD>-3.34</TD><TD>Post-translational protein modification</TD><TD>REACTOME pathways</TD><TD>R-HSA-597592</TD><TD>1037</TD><TD>11</TD><TD>10293</TD><TD>60</TD>
<TD>NUP37,EEF1A1,MAP3K7,VCP,JOSD1,OTUD7B,POM121C,USP8,RAB17,ADAMTSL2,F10</TD></TR>
<TR><TD>3.544e-02</TD><TD>-3.34</TD><TD>Glycoside_hydrolase_SF</TD><TD>interpro domains</TD><TD>IPR017853</TD><TD>53</TD><TD>2</TD><TD>18428</TD><TD>103</TD>
<TD>HEXA,CHID1</TD></TR>
<TR><TD>3.547e-02</TD><TD>-3.34</TD><TD>GO_MAINTENANCE_OF_CELL_NUMBER</TD><TD>MSigDB lists</TD><TD>GO_MAINTENANCE_OF_CELL_NUMBER</TD><TD>132</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>NANOG,EPAS1,MED7</TD></TR>
<TR><TD>3.547e-02</TD><TD>-3.34</TD><TD>GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP</TD><TD>MSigDB lists</TD><TD>GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP</TD><TD>132</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>HEXA,JAK2,CEACAM19</TD></TR>
<TR><TD>3.569e-02</TD><TD>-3.33</TD><TD>GO_CELLULAR_RESPONSE_TO_ORGANIC_CYCLIC_COMPOUND</TD><TD>MSigDB lists</TD><TD>GO_CELLULAR_RESPONSE_TO_ORGANIC_CYCLIC_COMPOUND</TD><TD>448</TD><TD>6</TD><TD>17621</TD><TD>96</TD>
<TD>NR4A1,UBE3A,ADAR,ATP2B4,JAK2,OSBPL7</TD></TR>
<TR><TD>3.597e-02</TD><TD>-3.33</TD><TD>Structural Pathway of Interleukin 1 (IL-1)</TD><TD>WikiPathways</TD><TD>WP2637</TD><TD>50</TD><TD>2</TD><TD>5314</TD><TD>32</TD>
<TD>MAP3K7,TANK</TD></TR>
<TR><TD>3.602e-02</TD><TD>-3.32</TD><TD>TCANNTGAY_V$SREBP1_01</TD><TD>MSigDB lists</TD><TD>TCANNTGAY_V$SREBP1_01</TD><TD>449</TD><TD>6</TD><TD>17621</TD><TD>96</TD>
<TD>KDM2A,MAFF,ZFYVE1,NR4A1,HEXA,JOSD1</TD></TR>
<TR><TD>3.609e-02</TD><TD>-3.32</TD><TD>transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding</TD><TD>molecular function</TD><TD>GO:0001228</TD><TD>323</TD><TD>5</TD><TD>16652</TD><TD>94</TD>
<TD>FOSB,MAFF,EPAS1,NR4A1,ONECUT3</TD></TR>
<TR><TD>3.610e-02</TD><TD>-3.32</TD><TD>regulation of cell cycle process</TD><TD>biological process</TD><TD>GO:0010564</TD><TD>559</TD><TD>7</TD><TD>16543</TD><TD>92</TD>
<TD>OVOL1,PLK5,SMARCA4,KNTC1,ATP2B4,AURKAIP1,FBXO31</TD></TR>
<TR><TD>3.614e-02</TD><TD>-3.32</TD><TD>GSE37319_WT_VS_RC3H1_KO_CD44LOW_CD8_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE37319_WT_VS_RC3H1_KO_CD44LOW_CD8_TCELL_UP</TD><TD>133</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>ENC1,NGDN,MAFF</TD></TR>
<TR><TD>3.619e-02</TD><TD>-3.32</TD><TD>MORF_BAG5</TD><TD>MSigDB lists</TD><TD>MORF_BAG5</TD><TD>55</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>ADAR,VCP</TD></TR>
<TR><TD>3.619e-02</TD><TD>-3.32</TD><TD>LUCAS_HNF4A_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>LUCAS_HNF4A_TARGETS_UP</TD><TD>55</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>RBKS,TACC2</TD></TR>
<TR><TD>3.619e-02</TD><TD>-3.32</TD><TD>TOPBP1 (topoisomerase (DNA) II binding protein 1)</TD><TD>protein interactions</TD><TD>11073</TD><TD>55</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>SMARCA4,DTD1</TD></TR>
<TR><TD>3.619e-02</TD><TD>-3.32</TD><TD>MED10 (mediator complex subunit 10)</TD><TD>protein interactions</TD><TD>84246</TD><TD>55</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>MED7,EPAS1</TD></TR>
<TR><TD>3.619e-02</TD><TD>-3.32</TD><TD>RFC5 (replication factor C subunit 5)</TD><TD>protein interactions</TD><TD>5985</TD><TD>55</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>EEF1A1,VCP</TD></TR>
<TR><TD>3.619e-02</TD><TD>-3.32</TD><TD>IPO11 (importin 11)</TD><TD>protein interactions</TD><TD>51194</TD><TD>55</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>UBE3A,ARPC1B</TD></TR>
<TR><TD>3.619e-02</TD><TD>-3.32</TD><TD>GRAP2 (GRB2-related adaptor protein 2)</TD><TD>protein interactions</TD><TD>9402</TD><TD>55</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>USP8,SHB</TD></TR>
<TR><TD>3.619e-02</TD><TD>-3.32</TD><TD>COMMD1 (copper metabolism domain containing 1)</TD><TD>protein interactions</TD><TD>150684</TD><TD>55</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>COMMD7,VCP</TD></TR>
<TR><TD>3.619e-02</TD><TD>-3.32</TD><TD>MED6 (mediator complex subunit 6)</TD><TD>protein interactions</TD><TD>10001</TD><TD>55</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>MED7,SMARCA4</TD></TR>
<TR><TD>3.623e-02</TD><TD>-3.32</TD><TD>lung-carcinoma-small_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>lung-carcinoma-small_cell_carcinoma</TD><TD>10247</TD><TD>63</TD><TD>17630</TD><TD>93</TD>
<TD>ZFYVE1,USP8,GART,KDM2A,RAB17,CASP6,PTPN3,NGDN,HSPB6,SERPINB10,EEF1A1,PPP1R3F,GRAMD1B,NR4A1,HEXA,ARIH2,SLC27A6,C14orf159,TACC2,FOSB,CHL1,TANK,VARS2,SHB,OTUD7B,KNTC1,CDH7,CEACAM19,EHMT1,GPRASP2,RNASEH2A,JOSD1,HEATR6,ARPC1B,RGSL1,TPM4,ENC1,SLC40A1,NANOG,FGD5,EPAS1,MNX1,JAK2,MAFF,NUP37,ALAS2,ADAR,TP53BP2,F10,AURKAIP1,MYPN,IFT27,OSBPL7,UBE3A,VCP,BNC1,ATP2B4,ADAMTSL2,MAP3K7,SMARCA4,UGT1A6,AUTS2,FBXO31</TD></TR>
<TR><TD>3.631e-02</TD><TD>-3.32</TD><TD>regulation of sodium ion transmembrane transport</TD><TD>biological process</TD><TD>GO:1902305</TD><TD>54</TD><TD>2</TD><TD>16543</TD><TD>92</TD>
<TD>ATP2B4,PTPN3</TD></TR>
<TR><TD>3.631e-02</TD><TD>-3.32</TD><TD>negative regulation of reproductive process</TD><TD>biological process</TD><TD>GO:2000242</TD><TD>54</TD><TD>2</TD><TD>16543</TD><TD>92</TD>
<TD>SHB,OVOL1</TD></TR>
<TR><TD>3.633e-02</TD><TD>-3.32</TD><TD>GO_PROTEIN_CATABOLIC_PROCESS</TD><TD>MSigDB lists</TD><TD>GO_PROTEIN_CATABOLIC_PROCESS</TD><TD>571</TD><TD>7</TD><TD>17621</TD><TD>96</TD>
<TD>VCP,UBE3A,OTUD7B,USP8,FBXO31,ARIH2,ENC1</TD></TR>
<TR><TD>3.635e-02</TD><TD>-3.31</TD><TD>parathyroid-adenoma-hyperplasia_NS</TD><TD>COSMIC cancer mutations</TD><TD>parathyroid-adenoma-hyperplasia_NS</TD><TD>7</TD><TD>1</TD><TD>17630</TD><TD>93</TD>
<TD>JAK2</TD></TR>
<TR><TD>3.635e-02</TD><TD>-3.31</TD><TD>adenoma-hyperplasia_NS</TD><TD>COSMIC cancer mutations</TD><TD>adenoma-hyperplasia_NS</TD><TD>7</TD><TD>1</TD><TD>17630</TD><TD>93</TD>
<TD>JAK2</TD></TR>
<TR><TD>3.642e-02</TD><TD>-3.31</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-Burkitt_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-Burkitt_lymphoma</TD><TD>2192</TD><TD>18</TD><TD>17630</TD><TD>93</TD>
<TD>SLC40A1,GART,RGSL1,ONECUT3,ADAR,NUP37,JAK2,TANK,CHL1,TACC2,SLC27A6,SHB,UBE3A,CDH7,BNC1,DTD1,AUTS2,SMARCA4</TD></TR>
<TR><TD>3.642e-02</TD><TD>-3.31</TD><TD>Burkitt_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>Burkitt_lymphoma</TD><TD>2192</TD><TD>18</TD><TD>17630</TD><TD>93</TD>
<TD>CHL1,TANK,SLC27A6,TACC2,ADAR,ONECUT3,JAK2,NUP37,GART,RGSL1,SLC40A1,AUTS2,SMARCA4,DTD1,CDH7,BNC1,SHB,UBE3A</TD></TR>
<TR><TD>3.642e-02</TD><TD>-3.31</TD><TD>Legionellosis</TD><TD>KEGG pathways</TD><TD>ko05134</TD><TD>55</TD><TD>2</TD><TD>7094</TD><TD>39</TD>
<TD>VCP,EEF1A1</TD></TR>
<TR><TD>3.642e-02</TD><TD>-3.31</TD><TD>Legionellosis</TD><TD>KEGG pathways</TD><TD>hsa05134</TD><TD>55</TD><TD>2</TD><TD>7094</TD><TD>39</TD>
<TD>EEF1A1,VCP</TD></TR>
<TR><TD>3.644e-02</TD><TD>-3.31</TD><TD>sequence-specific DNA binding</TD><TD>molecular function</TD><TD>GO:0043565</TD><TD>1061</TD><TD>11</TD><TD>16652</TD><TD>94</TD>
<TD>NR4A1,MNX1,RFX2,ONECUT3,SMARCA4,NANOG,OVOL1,EMX1,FOSB,MAFF,EPAS1</TD></TR>
<TR><TD>3.667e-02</TD><TD>-3.31</TD><TD>small_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>small_cell_carcinoma</TD><TD>10252</TD><TD>63</TD><TD>17630</TD><TD>93</TD>
<TD>HEATR6,ARPC1B,GPRASP2,RNASEH2A,JOSD1,EHMT1,CEACAM19,KNTC1,CDH7,OTUD7B,SHB,VARS2,CHL1,TANK,SLC27A6,TACC2,FOSB,C14orf159,GRAMD1B,NR4A1,ARIH2,HEXA,PPP1R3F,SERPINB10,EEF1A1,PTPN3,NGDN,HSPB6,GART,KDM2A,ZFYVE1,USP8,RAB17,CASP6,UGT1A6,AUTS2,FBXO31,MAP3K7,SMARCA4,ADAMTSL2,ATP2B4,BNC1,VCP,OSBPL7,UBE3A,IFT27,AURKAIP1,MYPN,TP53BP2,F10,ALAS2,ADAR,JAK2,MAFF,NUP37,MNX1,EPAS1,FGD5,RGSL1,TPM4,SLC40A1,ENC1,NANOG</TD></TR>
<TR><TD>3.667e-02</TD><TD>-3.31</TD><TD>bZIP</TD><TD>interpro domains</TD><TD>IPR004827</TD><TD>54</TD><TD>2</TD><TD>18428</TD><TD>103</TD>
<TD>MAFF,FOSB</TD></TR>
<TR><TD>3.678e-02</TD><TD>-3.30</TD><TD>Nuclear Envelope Breakdown</TD><TD>REACTOME pathways</TD><TD>R-HSA-2980766</TD><TD>52</TD><TD>2</TD><TD>10293</TD><TD>60</TD>
<TD>NUP37,POM121C</TD></TR>
<TR><TD>3.682e-02</TD><TD>-3.30</TD><TD>PHB (prohibitin)</TD><TD>protein interactions</TD><TD>5245</TD><TD>134</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>SMARCA4,EPAS1,VCP</TD></TR>
<TR><TD>3.683e-02</TD><TD>-3.30</TD><TD>GSE37605_TREG_VS_TCONV_NOD_FOXP3_FUSION_GFP_UP</TD><TD>MSigDB lists</TD><TD>GSE37605_TREG_VS_TCONV_NOD_FOXP3_FUSION_GFP_UP</TD><TD>134</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>MAFF,NR4A1,FOSB</TD></TR>
<TR><TD>3.683e-02</TD><TD>-3.30</TD><TD>PID_P53_DOWNSTREAM_PATHWAY</TD><TD>MSigDB lists</TD><TD>PID_P53_DOWNSTREAM_PATHWAY</TD><TD>134</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>TP53BP2,CASP6,SMARCA4</TD></TR>
<TR><TD>3.731e-02</TD><TD>-3.29</TD><TD>stem cell population maintenance</TD><TD>biological process</TD><TD>GO:0019827</TD><TD>132</TD><TD>3</TD><TD>16543</TD><TD>92</TD>
<TD>EPAS1,NANOG,MED7</TD></TR>
<TR><TD>3.733e-02</TD><TD>-3.29</TD><TD>regulation of proteolysis involved in cellular protein catabolic process</TD><TD>biological process</TD><TD>GO:1903050</TD><TD>226</TD><TD>4</TD><TD>16543</TD><TD>92</TD>
<TD>VCP,OSBPL7,ARIH2,UBE3A</TD></TR>
<TR><TD>3.740e-02</TD><TD>-3.29</TD><TD>USP22 (ubiquitin specific peptidase 22)</TD><TD>protein interactions</TD><TD>23326</TD><TD>56</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>USP8,HEXA</TD></TR>
<TR><TD>3.740e-02</TD><TD>-3.29</TD><TD>UBE2G2 (ubiquitin conjugating enzyme E2 G2)</TD><TD>protein interactions</TD><TD>7327</TD><TD>56</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>UBE3A,KDM2A</TD></TR>
<TR><TD>3.740e-02</TD><TD>-3.29</TD><TD>Ube2i (ubiquitin-conjugating enzyme E2I)</TD><TD>protein interactions</TD><TD>22196</TD><TD>56</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>NUP37,POM121C</TD></TR>
<TR><TD>3.740e-02</TD><TD>-3.29</TD><TD>LZTR1 (leucine zipper like transcription regulator 1)</TD><TD>protein interactions</TD><TD>8216</TD><TD>56</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>EHMT1,MED7</TD></TR>
<TR><TD>3.743e-02</TD><TD>-3.29</TD><TD>Measles</TD><TD>KEGG pathways</TD><TD>hsa05162</TD><TD>135</TD><TD>3</TD><TD>7094</TD><TD>39</TD>
<TD>MAP3K7,ADAR,JAK2</TD></TR>
<TR><TD>3.743e-02</TD><TD>-3.29</TD><TD>Measles</TD><TD>KEGG pathways</TD><TD>ko05162</TD><TD>135</TD><TD>3</TD><TD>7094</TD><TD>39</TD>
<TD>ADAR,MAP3K7,JAK2</TD></TR>
<TR><TD>3.751e-02</TD><TD>-3.28</TD><TD>KIAA0368 (KIAA0368)</TD><TD>protein interactions</TD><TD>23392</TD><TD>135</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>EEF1A1,KDM2A,NANOG</TD></TR>
<TR><TD>3.752e-02</TD><TD>-3.28</TD><TD>GO_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_REMOVAL</TD><TD>MSigDB lists</TD><TD>GO_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_REMOVAL</TD><TD>135</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>OTUD7B,JOSD1,USP8</TD></TR>
<TR><TD>3.752e-02</TD><TD>-3.28</TD><TD>LUDWICZEK_TREATING_IRON_OVERLOAD</TD><TD>MSigDB lists</TD><TD>LUDWICZEK_TREATING_IRON_OVERLOAD</TD><TD>7</TD><TD>1</TD><TD>17621</TD><TD>96</TD>
<TD>SLC40A1</TD></TR>
<TR><TD>3.752e-02</TD><TD>-3.28</TD><TD>chr7q</TD><TD>MSigDB lists</TD><TD>chr7q</TD><TD>7</TD><TD>1</TD><TD>17621</TD><TD>96</TD>
<TD>ARPC1B</TD></TR>
<TR><TD>3.752e-02</TD><TD>-3.28</TD><TD>GO_RNA_DNA_HYBRID_RIBONUCLEASE_ACTIVITY</TD><TD>MSigDB lists</TD><TD>GO_RNA_DNA_HYBRID_RIBONUCLEASE_ACTIVITY</TD><TD>7</TD><TD>1</TD><TD>17621</TD><TD>96</TD>
<TD>RNASEH2A</TD></TR>
<TR><TD>3.752e-02</TD><TD>-3.28</TD><TD>BUSA_SAM68_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>BUSA_SAM68_TARGETS_UP</TD><TD>7</TD><TD>1</TD><TD>17621</TD><TD>96</TD>
<TD>NR4A1</TD></TR>
<TR><TD>3.752e-02</TD><TD>-3.28</TD><TD>ST_IL_13_PATHWAY</TD><TD>MSigDB lists</TD><TD>ST_IL_13_PATHWAY</TD><TD>7</TD><TD>1</TD><TD>17621</TD><TD>96</TD>
<TD>JAK2</TD></TR>
<TR><TD>3.752e-02</TD><TD>-3.28</TD><TD>TESAR_ALK_TARGETS_HUMAN_ES_5D_DN</TD><TD>MSigDB lists</TD><TD>TESAR_ALK_TARGETS_HUMAN_ES_5D_DN</TD><TD>7</TD><TD>1</TD><TD>17621</TD><TD>96</TD>
<TD>NANOG</TD></TR>
<TR><TD>3.752e-02</TD><TD>-3.28</TD><TD>INGRAM_SHH_TARGETS</TD><TD>MSigDB lists</TD><TD>INGRAM_SHH_TARGETS</TD><TD>7</TD><TD>1</TD><TD>17621</TD><TD>96</TD>
<TD>NR4A1</TD></TR>
<TR><TD>3.754e-02</TD><TD>-3.28</TD><TD>TBC1D10B (TBC1 domain family member 10B)</TD><TD>protein interactions</TD><TD>26000</TD><TD>7</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>VCP</TD></TR>
<TR><TD>3.754e-02</TD><TD>-3.28</TD><TD>IL17RA (interleukin 17 receptor A)</TD><TD>protein interactions</TD><TD>23765</TD><TD>7</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>MAP3K7</TD></TR>
<TR><TD>3.754e-02</TD><TD>-3.28</TD><TD>PLPP3 (phospholipid phosphatase 3)</TD><TD>protein interactions</TD><TD>8613</TD><TD>7</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>VCP</TD></TR>
<TR><TD>3.754e-02</TD><TD>-3.28</TD><TD>CFAP20 (cilia and flagella associated protein 20)</TD><TD>protein interactions</TD><TD>29105</TD><TD>7</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>NANOG</TD></TR>
<TR><TD>3.754e-02</TD><TD>-3.28</TD><TD>LOC149950 (uncharacterized LOC149950)</TD><TD>protein interactions</TD><TD>149950</TD><TD>7</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>GPRASP2</TD></TR>
<TR><TD>3.754e-02</TD><TD>-3.28</TD><TD>STAB1 (stabilin 1)</TD><TD>protein interactions</TD><TD>23166</TD><TD>7</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>CHID1</TD></TR>
<TR><TD>3.754e-02</TD><TD>-3.28</TD><TD>Dlg4 (discs large MAGUK scaffold protein 4)</TD><TD>protein interactions</TD><TD>29495</TD><TD>7</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>ATP2B4</TD></TR>
<TR><TD>3.754e-02</TD><TD>-3.28</TD><TD>CDH6 (cadherin 6)</TD><TD>protein interactions</TD><TD>1004</TD><TD>7</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>CDH7</TD></TR>
<TR><TD>3.754e-02</TD><TD>-3.28</TD><TD>POGK (pogo transposable element with KRAB domain)</TD><TD>protein interactions</TD><TD>57645</TD><TD>7</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>ARPC1B</TD></TR>
<TR><TD>3.754e-02</TD><TD>-3.28</TD><TD>AHSP (alpha hemoglobin stabilizing protein)</TD><TD>protein interactions</TD><TD>51327</TD><TD>7</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>UBE3A</TD></TR>
<TR><TD>3.754e-02</TD><TD>-3.28</TD><TD>PTCRA (pre T-cell antigen receptor alpha)</TD><TD>protein interactions</TD><TD>171558</TD><TD>7</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>VCP</TD></TR>
<TR><TD>3.754e-02</TD><TD>-3.28</TD><TD>ZIC3 (Zic family member 3)</TD><TD>protein interactions</TD><TD>7547</TD><TD>7</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>NANOG</TD></TR>
<TR><TD>3.754e-02</TD><TD>-3.28</TD><TD>MSRB2 (methionine sulfoxide reductase B2)</TD><TD>protein interactions</TD><TD>22921</TD><TD>7</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>C14orf159</TD></TR>
<TR><TD>3.754e-02</TD><TD>-3.28</TD><TD>FXYD3 (FXYD domain containing ion transport regulator 3)</TD><TD>protein interactions</TD><TD>5349</TD><TD>7</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>NR4A1</TD></TR>
<TR><TD>3.754e-02</TD><TD>-3.28</TD><TD>STRADB (STE20-related kinase adaptor beta)</TD><TD>protein interactions</TD><TD>55437</TD><TD>7</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>MAP3K7</TD></TR>
<TR><TD>3.754e-02</TD><TD>-3.28</TD><TD>ZWILCH (zwilch kinetochore protein)</TD><TD>protein interactions</TD><TD>55055</TD><TD>7</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>KNTC1</TD></TR>
<TR><TD>3.754e-02</TD><TD>-3.28</TD><TD>KRTAP10-4 (keratin associated protein 10-4)</TD><TD>protein interactions</TD><TD>386672</TD><TD>7</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>JOSD1</TD></TR>
<TR><TD>3.754e-02</TD><TD>-3.28</TD><TD>HS1BP3 (HCLS1 binding protein 3)</TD><TD>protein interactions</TD><TD>64342</TD><TD>7</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>VCP</TD></TR>
<TR><TD>3.754e-02</TD><TD>-3.28</TD><TD>Tmsb4x (thymosin, beta 4, X chromosome)</TD><TD>protein interactions</TD><TD>19241</TD><TD>7</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>EEF1A1</TD></TR>
<TR><TD>3.754e-02</TD><TD>-3.28</TD><TD>ULK3 (unc-51 like kinase 3)</TD><TD>protein interactions</TD><TD>25989</TD><TD>7</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>VCP</TD></TR>
<TR><TD>3.754e-02</TD><TD>-3.28</TD><TD>CDH7 (cadherin 7)</TD><TD>protein interactions</TD><TD>1005</TD><TD>7</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>CDH7</TD></TR>
<TR><TD>3.754e-02</TD><TD>-3.28</TD><TD>Vcpip1 (valosin containing protein (p97)/p47 complex interacting protein 1)</TD><TD>protein interactions</TD><TD>70675</TD><TD>7</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>VCP</TD></TR>
<TR><TD>3.754e-02</TD><TD>-3.28</TD><TD>FGF21 (fibroblast growth factor 21)</TD><TD>protein interactions</TD><TD>26291</TD><TD>7</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>CDH7</TD></TR>
<TR><TD>3.755e-02</TD><TD>-3.28</TD><TD>execution phase of apoptosis</TD><TD>biological process</TD><TD>GO:0097194</TD><TD>55</TD><TD>2</TD><TD>16543</TD><TD>92</TD>
<TD>ERN2,CASP6</TD></TR>
<TR><TD>3.762e-02</TD><TD>-3.28</TD><TD>Direct p53 effectors</TD><TD>Pathway Interaction DB</TD><TD>p53downstreampathway</TD><TD>132</TD><TD>3</TD><TD>2226</TD><TD>13</TD>
<TD>TP53BP2,CASP6,SMARCA4</TD></TR>
<TR><TD>3.774e-02</TD><TD>-3.28</TD><TD>cellular macromolecule catabolic process</TD><TD>biological process</TD><TD>GO:0044265</TD><TD>817</TD><TD>9</TD><TD>16543</TD><TD>92</TD>
<TD>ERN2,ENC1,USP8,RNASEH2A,ARIH2,OTUD7B,UBE3A,VCP,FBXO31</TD></TR>
<TR><TD>3.803e-02</TD><TD>-3.27</TD><TD>Cul5-RING ubiquitin ligase complex</TD><TD>cellular component</TD><TD>GO:0031466</TD><TD>7</TD><TD>1</TD><TD>17744</TD><TD>98</TD>
<TD>ARIH2</TD></TR>
<TR><TD>3.804e-02</TD><TD>-3.27</TD><TD>ALFANO_MYC_TARGETS</TD><TD>MSigDB lists</TD><TD>ALFANO_MYC_TARGETS</TD><TD>232</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>TP53BP2,TACC2,EEF1A1,VCP</TD></TR>
<TR><TD>3.808e-02</TD><TD>-3.27</TD><TD>snRNP Assembly</TD><TD>REACTOME pathways</TD><TD>R-HSA-191859</TD><TD>53</TD><TD>2</TD><TD>10293</TD><TD>60</TD>
<TD>POM121C,NUP37</TD></TR>
<TR><TD>3.808e-02</TD><TD>-3.27</TD><TD>Metabolism of non-coding RNA</TD><TD>REACTOME pathways</TD><TD>R-HSA-194441</TD><TD>53</TD><TD>2</TD><TD>10293</TD><TD>60</TD>
<TD>NUP37,POM121C</TD></TR>
<TR><TD>3.822e-02</TD><TD>-3.26</TD><TD>AACATTC,MIR-409-3P</TD><TD>MSigDB lists</TD><TD>AACATTC,MIR-409-3P</TD><TD>136</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>EHMT1,FOSB,AP1G1</TD></TR>
<TR><TD>3.829e-02</TD><TD>-3.26</TD><TD>positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter</TD><TD>biological process</TD><TD>GO:1901838</TD><TD>7</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>SMARCA4</TD></TR>
<TR><TD>3.829e-02</TD><TD>-3.26</TD><TD>miRNA loading onto RISC involved in gene silencing by miRNA</TD><TD>biological process</TD><TD>GO:0035280</TD><TD>7</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ADAR</TD></TR>
<TR><TD>3.829e-02</TD><TD>-3.26</TD><TD>brainstem development</TD><TD>biological process</TD><TD>GO:0003360</TD><TD>7</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>GART</TD></TR>
<TR><TD>3.829e-02</TD><TD>-3.26</TD><TD>tetrahydrofolate biosynthetic process</TD><TD>biological process</TD><TD>GO:0046654</TD><TD>7</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>GART</TD></TR>
<TR><TD>3.829e-02</TD><TD>-3.26</TD><TD>regulation of oocyte maturation</TD><TD>biological process</TD><TD>GO:1900193</TD><TD>7</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>SHB</TD></TR>
<TR><TD>3.829e-02</TD><TD>-3.26</TD><TD>cerebral cortex regionalization</TD><TD>biological process</TD><TD>GO:0021796</TD><TD>7</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>EMX1</TD></TR>
<TR><TD>3.829e-02</TD><TD>-3.26</TD><TD>chitin catabolic process</TD><TD>biological process</TD><TD>GO:0006032</TD><TD>7</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>CHID1</TD></TR>
<TR><TD>3.829e-02</TD><TD>-3.26</TD><TD>iron ion transmembrane transport</TD><TD>biological process</TD><TD>GO:0034755</TD><TD>7</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>SLC40A1</TD></TR>
<TR><TD>3.829e-02</TD><TD>-3.26</TD><TD>negative regulation of lymphocyte migration</TD><TD>biological process</TD><TD>GO:2000402</TD><TD>7</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>GCSAM</TD></TR>
<TR><TD>3.829e-02</TD><TD>-3.26</TD><TD>negative regulation of cytokine production involved in inflammatory response</TD><TD>biological process</TD><TD>GO:1900016</TD><TD>7</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>CHID1</TD></TR>
<TR><TD>3.829e-02</TD><TD>-3.26</TD><TD>regulation of chaperone-mediated autophagy</TD><TD>biological process</TD><TD>GO:1904714</TD><TD>7</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>EEF1A1</TD></TR>
<TR><TD>3.829e-02</TD><TD>-3.26</TD><TD>histone H3-K36 demethylation</TD><TD>biological process</TD><TD>GO:0070544</TD><TD>7</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>KDM2A</TD></TR>
<TR><TD>3.829e-02</TD><TD>-3.26</TD><TD>chitin metabolic process</TD><TD>biological process</TD><TD>GO:0006030</TD><TD>7</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>CHID1</TD></TR>
<TR><TD>3.829e-02</TD><TD>-3.26</TD><TD>negative regulation of nitric-oxide synthase activity</TD><TD>biological process</TD><TD>GO:0051001</TD><TD>7</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ATP2B4</TD></TR>
<TR><TD>3.829e-02</TD><TD>-3.26</TD><TD>negative regulation of membrane protein ectodomain proteolysis</TD><TD>biological process</TD><TD>GO:0051045</TD><TD>7</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>PTPN3</TD></TR>
<TR><TD>3.829e-02</TD><TD>-3.26</TD><TD>regulation of ATP biosynthetic process</TD><TD>biological process</TD><TD>GO:2001169</TD><TD>7</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>VCP</TD></TR>
<TR><TD>3.829e-02</TD><TD>-3.26</TD><TD>regulation of aerobic respiration</TD><TD>biological process</TD><TD>GO:1903715</TD><TD>7</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>VCP</TD></TR>
<TR><TD>3.832e-02</TD><TD>-3.26</TD><TD>HOMEOBOX_2</TD><TD>prosite domains</TD><TD>PS50071</TD><TD>227</TD><TD>4</TD><TD>11955</TD><TD>67</TD>
<TD>NANOG,MNX1,EMX1,ONECUT3</TD></TR>
<TR><TD>3.848e-02</TD><TD>-3.26</TD><TD>Znf_A20</TD><TD>interpro domains</TD><TD>IPR002653</TD><TD>7</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>OTUD7B</TD></TR>
<TR><TD>3.848e-02</TD><TD>-3.26</TD><TD>K_chnl_volt-dep_Kv9</TD><TD>interpro domains</TD><TD>IPR003971</TD><TD>7</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>KCNG3</TD></TR>
<TR><TD>3.848e-02</TD><TD>-3.26</TD><TD>Atg8-like</TD><TD>interpro domains</TD><TD>IPR004241</TD><TD>7</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>MAP1LC3B</TD></TR>
<TR><TD>3.848e-02</TD><TD>-3.26</TD><TD>Pre-SET_dom</TD><TD>interpro domains</TD><TD>IPR007728</TD><TD>7</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>EHMT1</TD></TR>
<TR><TD>3.848e-02</TD><TD>-3.26</TD><TD>Chitinase_II</TD><TD>interpro domains</TD><TD>IPR011583</TD><TD>7</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>CHID1</TD></TR>
<TR><TD>3.848e-02</TD><TD>-3.26</TD><TD>CBM21_dom</TD><TD>interpro domains</TD><TD>IPR005036</TD><TD>7</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>PPP1R3F</TD></TR>
<TR><TD>3.848e-02</TD><TD>-3.26</TD><TD>Nuc_translocat</TD><TD>interpro domains</TD><TD>IPR001067</TD><TD>7</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>EPAS1</TD></TR>
<TR><TD>3.848e-02</TD><TD>-3.26</TD><TD>CUT_dom</TD><TD>interpro domains</TD><TD>IPR003350</TD><TD>7</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>ONECUT3</TD></TR>
<TR><TD>3.848e-02</TD><TD>-3.26</TD><TD>Glyco_hydro18_cat</TD><TD>interpro domains</TD><TD>IPR001223</TD><TD>7</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>CHID1</TD></TR>
<TR><TD>3.848e-02</TD><TD>-3.26</TD><TD>Transciption_factor_Maf_fam</TD><TD>interpro domains</TD><TD>IPR024874</TD><TD>7</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>MAFF</TD></TR>
<TR><TD>3.859e-02</TD><TD>-3.25</TD><TD>PRE_SET</TD><TD>prosite domains</TD><TD>PS50867</TD><TD>7</TD><TD>1</TD><TD>11955</TD><TD>67</TD>
<TD>EHMT1</TD></TR>
<TR><TD>3.859e-02</TD><TD>-3.25</TD><TD>CUT</TD><TD>prosite domains</TD><TD>PS51042</TD><TD>7</TD><TD>1</TD><TD>11955</TD><TD>67</TD>
<TD>ONECUT3</TD></TR>
<TR><TD>3.859e-02</TD><TD>-3.25</TD><TD>ZF_A20</TD><TD>prosite domains</TD><TD>PS51036</TD><TD>7</TD><TD>1</TD><TD>11955</TD><TD>67</TD>
<TD>OTUD7B</TD></TR>
<TR><TD>3.859e-02</TD><TD>-3.25</TD><TD>CBM21</TD><TD>prosite domains</TD><TD>PS51159</TD><TD>7</TD><TD>1</TD><TD>11955</TD><TD>67</TD>
<TD>PPP1R3F</TD></TR>
<TR><TD>3.862e-02</TD><TD>-3.25</TD><TD>SCHEIDEREIT_IKK_INTERACTING_PROTEINS</TD><TD>MSigDB lists</TD><TD>SCHEIDEREIT_IKK_INTERACTING_PROTEINS</TD><TD>57</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>TANK,EPAS1</TD></TR>
<TR><TD>3.863e-02</TD><TD>-3.25</TD><TD>MED29 (mediator complex subunit 29)</TD><TD>protein interactions</TD><TD>55588</TD><TD>57</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>EPAS1,MED7</TD></TR>
<TR><TD>3.863e-02</TD><TD>-3.25</TD><TD>CDK19 (cyclin dependent kinase 19)</TD><TD>protein interactions</TD><TD>23097</TD><TD>57</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>SMARCA4,MED7</TD></TR>
<TR><TD>3.863e-02</TD><TD>-3.25</TD><TD>TOM1L1 (target of myb1 like 1 membrane trafficking protein)</TD><TD>protein interactions</TD><TD>10040</TD><TD>57</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>VCP,ARPC1B</TD></TR>
<TR><TD>3.863e-02</TD><TD>-3.25</TD><TD>Nup98 (nucleoporin 98)</TD><TD>protein interactions</TD><TD>269966</TD><TD>57</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>POM121C,NUP37</TD></TR>
<TR><TD>3.863e-02</TD><TD>-3.25</TD><TD>FYTTD1 (forty-two-three domain containing 1)</TD><TD>protein interactions</TD><TD>84248</TD><TD>57</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>RNASEH2A,GPRASP2</TD></TR>
<TR><TD>3.874e-02</TD><TD>-3.25</TD><TD>maintenance of cell number</TD><TD>biological process</TD><TD>GO:0098727</TD><TD>134</TD><TD>3</TD><TD>16543</TD><TD>92</TD>
<TD>EPAS1,NANOG,MED7</TD></TR>
<TR><TD>3.881e-02</TD><TD>-3.25</TD><TD>HOX</TD><TD>smart domains</TD><TD>SM00389</TD><TD>225</TD><TD>4</TD><TD>9480</TD><TD>54</TD>
<TD>MNX1,ONECUT3,EMX1,NANOG</TD></TR>
<TR><TD>3.883e-02</TD><TD>-3.25</TD><TD>leading edge membrane</TD><TD>cellular component</TD><TD>GO:0031256</TD><TD>135</TD><TD>3</TD><TD>17744</TD><TD>98</TD>
<TD>KCNA2,EEF1A1,FGD5</TD></TR>
<TR><TD>3.886e-02</TD><TD>-3.25</TD><TD>RNA-DNA hybrid ribonuclease activity</TD><TD>molecular function</TD><TD>GO:0004523</TD><TD>7</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>RNASEH2A</TD></TR>
<TR><TD>3.886e-02</TD><TD>-3.25</TD><TD>chitinase activity</TD><TD>molecular function</TD><TD>GO:0004568</TD><TD>7</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>CHID1</TD></TR>
<TR><TD>3.886e-02</TD><TD>-3.25</TD><TD>histone demethylase activity (H3-K36 specific)</TD><TD>molecular function</TD><TD>GO:0051864</TD><TD>7</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>KDM2A</TD></TR>
<TR><TD>3.886e-02</TD><TD>-3.25</TD><TD>N-succinyltransferase activity</TD><TD>molecular function</TD><TD>GO:0016749</TD><TD>7</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>ALAS2</TD></TR>
<TR><TD>3.888e-02</TD><TD>-3.25</TD><TD>regulation of mitochondrion organization</TD><TD>biological process</TD><TD>GO:0010821</TD><TD>229</TD><TD>4</TD><TD>16543</TD><TD>92</TD>
<TD>ARIH2,TP53BP2,TSFM,MAP1LC3B</TD></TR>
<TR><TD>3.891e-02</TD><TD>-3.25</TD><TD>PSMA6 (proteasome subunit alpha 6)</TD><TD>protein interactions</TD><TD>5687</TD><TD>137</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>EEF1A1,TPM4,VCP</TD></TR>
<TR><TD>3.891e-02</TD><TD>-3.25</TD><TD>CHUK (conserved helix-loop-helix ubiquitous kinase)</TD><TD>protein interactions</TD><TD>1147</TD><TD>137</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>TANK,COMMD7,MAP3K7</TD></TR>
<TR><TD>3.893e-02</TD><TD>-3.25</TD><TD>GSE6674_UNSTIM_VS_PL2_3_STIM_BCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE6674_UNSTIM_VS_PL2_3_STIM_BCELL_UP</TD><TD>137</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>SERPINB10,RNASEH2A,GART</TD></TR>
<TR><TD>3.906e-02</TD><TD>-3.24</TD><TD>CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP</TD><TD>MSigDB lists</TD><TD>CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP</TD><TD>234</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>ATP2B4,MAFF,TTC39A,MAP1LC3B</TD></TR>
<TR><TD>3.921e-02</TD><TD>-3.24</TD><TD>PreSET</TD><TD>smart domains</TD><TD>SM00468</TD><TD>7</TD><TD>1</TD><TD>9480</TD><TD>54</TD>
<TD>EHMT1</TD></TR>
<TR><TD>3.921e-02</TD><TD>-3.24</TD><TD>CUT</TD><TD>smart domains</TD><TD>SM01109</TD><TD>7</TD><TD>1</TD><TD>9480</TD><TD>54</TD>
<TD>ONECUT3</TD></TR>
<TR><TD>3.921e-02</TD><TD>-3.24</TD><TD>ZnF_A20</TD><TD>smart domains</TD><TD>SM00259</TD><TD>7</TD><TD>1</TD><TD>9480</TD><TD>54</TD>
<TD>OTUD7B</TD></TR>
<TR><TD>3.921e-02</TD><TD>-3.24</TD><TD>Glyco_18</TD><TD>smart domains</TD><TD>SM00636</TD><TD>7</TD><TD>1</TD><TD>9480</TD><TD>54</TD>
<TD>CHID1</TD></TR>
<TR><TD>3.940e-02</TD><TD>-3.23</TD><TD>Hexose transport</TD><TD>REACTOME pathways</TD><TD>R-HSA-189200</TD><TD>54</TD><TD>2</TD><TD>10293</TD><TD>60</TD>
<TD>NUP37,POM121C</TD></TR>
<TR><TD>3.946e-02</TD><TD>-3.23</TD><TD>regulation of G1/S transition of mitotic cell cycle</TD><TD>biological process</TD><TD>GO:2000045</TD><TD>135</TD><TD>3</TD><TD>16543</TD><TD>92</TD>
<TD>PLK5,FBXO31,SMARCA4</TD></TR>
<TR><TD>3.966e-02</TD><TD>-3.23</TD><TD>Glyco_hydro_18</TD><TD>pfam domains</TD><TD>PF00704</TD><TD>7</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>CHID1</TD></TR>
<TR><TD>3.966e-02</TD><TD>-3.23</TD><TD>Pre-SET</TD><TD>pfam domains</TD><TD>PF05033</TD><TD>7</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>EHMT1</TD></TR>
<TR><TD>3.966e-02</TD><TD>-3.23</TD><TD>zf-A20</TD><TD>pfam domains</TD><TD>PF01754</TD><TD>7</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>OTUD7B</TD></TR>
<TR><TD>3.966e-02</TD><TD>-3.23</TD><TD>CUT</TD><TD>pfam domains</TD><TD>PF02376</TD><TD>7</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>ONECUT3</TD></TR>
<TR><TD>3.966e-02</TD><TD>-3.23</TD><TD>CBM_21</TD><TD>pfam domains</TD><TD>PF03370</TD><TD>7</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>PPP1R3F</TD></TR>
<TR><TD>3.966e-02</TD><TD>-3.23</TD><TD>Atg8</TD><TD>pfam domains</TD><TD>PF02991</TD><TD>7</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>MAP1LC3B</TD></TR>
<TR><TD>3.966e-02</TD><TD>-3.23</TD><TD>GO_POSITIVE_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER</TD><TD>MSigDB lists</TD><TD>GO_POSITIVE_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER</TD><TD>976</TD><TD>10</TD><TD>17621</TD><TD>96</TD>
<TD>EPAS1,ONECUT3,SLC40A1,AUTS2,UBE3A,NANOG,FOSB,SMARCA4,NR4A1,MAFF</TD></TR>
<TR><TD>3.986e-02</TD><TD>-3.22</TD><TD>BROWNE_HCMV_INFECTION_1HR_UP</TD><TD>MSigDB lists</TD><TD>BROWNE_HCMV_INFECTION_1HR_UP</TD><TD>58</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>ATP2B4,NR4A1</TD></TR>
<TR><TD>3.986e-02</TD><TD>-3.22</TD><TD>AMIT_EGF_RESPONSE_240_HELA</TD><TD>MSigDB lists</TD><TD>AMIT_EGF_RESPONSE_240_HELA</TD><TD>58</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>SHB,TPM4</TD></TR>
<TR><TD>3.987e-02</TD><TD>-3.22</TD><TD>POLR2D (RNA polymerase II subunit D)</TD><TD>protein interactions</TD><TD>5433</TD><TD>58</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>EMX1,FTL</TD></TR>
<TR><TD>3.987e-02</TD><TD>-3.22</TD><TD>TXNL1 (thioredoxin like 1)</TD><TD>protein interactions</TD><TD>9352</TD><TD>58</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>EEF1A1,UBE3A</TD></TR>
<TR><TD>3.987e-02</TD><TD>-3.22</TD><TD>SEH1L (SEH1 like nucleoporin)</TD><TD>protein interactions</TD><TD>81929</TD><TD>58</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>NUP37,POM121C</TD></TR>
<TR><TD>3.987e-02</TD><TD>-3.22</TD><TD>VBP1 (VHL binding protein 1)</TD><TD>protein interactions</TD><TD>7411</TD><TD>58</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>VCP,ARPC1B</TD></TR>
<TR><TD>3.987e-02</TD><TD>-3.22</TD><TD>PPM1B (protein phosphatase, Mg2+/Mn2+ dependent 1B)</TD><TD>protein interactions</TD><TD>5495</TD><TD>58</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>VCP,MAP3K7</TD></TR>
<TR><TD>3.987e-02</TD><TD>-3.22</TD><TD>SH3/SH2 adaptor activity</TD><TD>molecular function</TD><TD>GO:0005070</TD><TD>56</TD><TD>2</TD><TD>16652</TD><TD>94</TD>
<TD>SHB,TP53BP2</TD></TR>
<TR><TD>3.994e-02</TD><TD>-3.22</TD><TD>telencephalon development</TD><TD>biological process</TD><TD>GO:0021537</TD><TD>231</TD><TD>4</TD><TD>16543</TD><TD>92</TD>
<TD>TACC2,GART,EMX1,ATP2B4</TD></TR>
<TR><TD>4.007e-02</TD><TD>-3.22</TD><TD>GO_REGULATION_OF_CATABOLIC_PROCESS</TD><TD>MSigDB lists</TD><TD>GO_REGULATION_OF_CATABOLIC_PROCESS</TD><TD>711</TD><TD>8</TD><TD>17621</TD><TD>96</TD>
<TD>MAP1LC3B,PTPN3,ARIH2,VCP,UBE3A,EEF1A1,OSBPL7,ATP2B4</TD></TR>
<TR><TD>4.011e-02</TD><TD>-3.22</TD><TD>Vitamin B2 (riboflavin) metabolism</TD><TD>REACTOME pathways</TD><TD>R-HSA-196843</TD><TD>7</TD><TD>1</TD><TD>10293</TD><TD>60</TD>
<TD>SLC52A2</TD></TR>
<TR><TD>4.011e-02</TD><TD>-3.22</TD><TD>Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells</TD><TD>REACTOME pathways</TD><TD>R-HSA-210744</TD><TD>7</TD><TD>1</TD><TD>10293</TD><TD>60</TD>
<TD>ONECUT3</TD></TR>
<TR><TD>4.033e-02</TD><TD>-3.21</TD><TD>GO_NUCLEAR_TRANSPORT</TD><TD>MSigDB lists</TD><TD>GO_NUCLEAR_TRANSPORT</TD><TD>345</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>POM121C,NUP37,JAK2,RAB17,ADAR</TD></TR>
<TR><TD>4.035e-02</TD><TD>-3.21</TD><TD>PPARG (peroxisome proliferator activated receptor gamma)</TD><TD>protein interactions</TD><TD>5468</TD><TD>139</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>SMARCA4,NR4A1,MAFF</TD></TR>
<TR><TD>4.036e-02</TD><TD>-3.21</TD><TD>GO_NEGATIVE_REGULATION_OF_CELL_CYCLE_PHASE_TRANSITION</TD><TD>MSigDB lists</TD><TD>GO_NEGATIVE_REGULATION_OF_CELL_CYCLE_PHASE_TRANSITION</TD><TD>139</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>SMARCA4,OVOL1,FBXO31</TD></TR>
<TR><TD>4.036e-02</TD><TD>-3.21</TD><TD>BROWNE_HCMV_INFECTION_30MIN_DN</TD><TD>MSigDB lists</TD><TD>BROWNE_HCMV_INFECTION_30MIN_DN</TD><TD>139</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>EEF1A1,CHL1,CASP6</TD></TR>
<TR><TD>4.036e-02</TD><TD>-3.21</TD><TD>V$STAT3_02</TD><TD>MSigDB lists</TD><TD>V$STAT3_02</TD><TD>139</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>BNC1,NR4A1,FOSB</TD></TR>
<TR><TD>4.047e-02</TD><TD>-3.21</TD><TD>Channel_four-helix_dom</TD><TD>interpro domains</TD><TD>IPR027359</TD><TD>57</TD><TD>2</TD><TD>18428</TD><TD>103</TD>
<TD>KCNA2,KCNG3</TD></TR>
<TR><TD>4.049e-02</TD><TD>-3.21</TD><TD>mucosal</TD><TD>COSMIC cancer mutations</TD><TD>mucosal</TD><TD>2062</TD><TD>17</TD><TD>17630</TD><TD>93</TD>
<TD>SMARCA4,DTD1,CDH7,BNC1,VCP,OSBPL7,CHL1,TACC2,MYPN,HEXA,TP53BP2,ADAR,PPP1R3F,JAK2,SERPINB10,NGDN,ZFYVE1</TD></TR>
<TR><TD>4.049e-02</TD><TD>-3.21</TD><TD>skin-mucosal-malignant_melanoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-mucosal-malignant_melanoma</TD><TD>2062</TD><TD>17</TD><TD>17630</TD><TD>93</TD>
<TD>SMARCA4,DTD1,CDH7,BNC1,VCP,OSBPL7,CHL1,MYPN,TACC2,TP53BP2,ADAR,HEXA,JAK2,PPP1R3F,SERPINB10,NGDN,ZFYVE1</TD></TR>
<TR><TD>4.058e-02</TD><TD>-3.20</TD><TD>LNX1 (ligand of numb-protein X 1)</TD><TD>protein interactions</TD><TD>84708</TD><TD>237</TD><TD>4</TD><TD>16330</TD><TD>89</TD>
<TD>TPM4,VCP,NUP37,JOSD1</TD></TR>
<TR><TD>4.062e-02</TD><TD>-3.20</TD><TD>V$DR1_Q3</TD><TD>MSigDB lists</TD><TD>V$DR1_Q3</TD><TD>237</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>RBKS,OVOL1,OTUD7B,NR4A1</TD></TR>
<TR><TD>4.088e-02</TD><TD>-3.20</TD><TD>oesophagus</TD><TD>COSMIC cancer mutations</TD><TD>oesophagus</TD><TD>15639</TD><TD>88</TD><TD>17630</TD><TD>93</TD>
<TD>VCP,OSBPL7,EMX1,AUTS2,SMARCA4,ADI1,ADAMTSL2,ATP2B4,MNX1,EPAS1,SLC35E4,COMMD7,IFT27,AURKAIP1,LGALS2,TP53BP2,ALAS2,F10,ADAR,JAK2,CDH7,KNTC1,CHODL,PLK5,OTUD7B,SCARB2,SHB,VARS2,HEATR6,RNASEH2A,FTH1,FTL,EEF1A1,SERPINB10,HSPB6,NGDN,RAB17,ZFYVE1,USP8,GART,MAP1LC3B,TANK,CHL1,FOSB,SLC27A6,POM121C,NR4A1,HEXA,ONECUT3,PPP1R3F,BNC1,C2orf81,OVOL1,UBE3A,FBXO31,TSFM,UGT1A6,GJB2,MAP3K7,DTD1,RBKS,AP1G1,FGD5,NANOG,ENC1,SLC40A1,RGSL1,MYPN,RFX2,NUP37,KCNA2,TTC39A,ARPC1B,JOSD1,GPRASP2,EHMT1,CEACAM19,CHID1,MFSD6,TMEM198,PTPN3,KDM2A,KCNG3,TACC2,C14orf159,ARIH2,GRAMD1B,ZNF683</TD></TR>
<TR><TD>4.094e-02</TD><TD>-3.20</TD><TD>protein modification by small protein removal</TD><TD>biological process</TD><TD>GO:0070646</TD><TD>137</TD><TD>3</TD><TD>16543</TD><TD>92</TD>
<TD>OTUD7B,JOSD1,USP8</TD></TR>
<TR><TD>4.107e-02</TD><TD>-3.19</TD><TD>RAB5C (RAB5C, member RAS oncogene family)</TD><TD>protein interactions</TD><TD>5878</TD><TD>140</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>RMDN3,KDM2A,SMARCA4</TD></TR>
<TR><TD>4.109e-02</TD><TD>-3.19</TD><TD>single-organism organelle organization</TD><TD>biological process</TD><TD>GO:1902589</TD><TD>1378</TD><TD>13</TD><TD>16543</TD><TD>92</TD>
<TD>MYPN,JAK2,RAB17,TPM4,TP53BP2,VCP,TACC2,RFX2,IFT27,ARPC1B,KNTC1,NUP37,FGD5</TD></TR>
<TR><TD>4.112e-02</TD><TD>-3.19</TD><TD>chr1q25</TD><TD>MSigDB lists</TD><TD>chr1q25</TD><TD>59</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>RGSL1,ATP2B4</TD></TR>
<TR><TD>4.112e-02</TD><TD>-3.19</TD><TD>GTF3C4 (general transcription factor IIIC subunit 4)</TD><TD>protein interactions</TD><TD>9329</TD><TD>59</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>NANOG,HEXA</TD></TR>
<TR><TD>4.112e-02</TD><TD>-3.19</TD><TD>RHOXF2 (Rhox homeobox family member 2)</TD><TD>protein interactions</TD><TD>84528</TD><TD>59</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>NANOG,MED7</TD></TR>
<TR><TD>4.112e-02</TD><TD>-3.19</TD><TD>CLTA (clathrin light chain A)</TD><TD>protein interactions</TD><TD>1211</TD><TD>59</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>MAP1LC3B,VCP</TD></TR>
<TR><TD>4.112e-02</TD><TD>-3.19</TD><TD>STAM (signal transducing adaptor molecule)</TD><TD>protein interactions</TD><TD>8027</TD><TD>59</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>JAK2,USP8</TD></TR>
<TR><TD>4.123e-02</TD><TD>-3.19</TD><TD>Homeobox_dom</TD><TD>interpro domains</TD><TD>IPR001356</TD><TD>232</TD><TD>4</TD><TD>18428</TD><TD>103</TD>
<TD>NANOG,MNX1,EMX1,ONECUT3</TD></TR>
<TR><TD>4.127e-02</TD><TD>-3.19</TD><TD>kidney-carcinoma-clear_cell_renal_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>kidney-carcinoma-clear_cell_renal_cell_carcinoma</TD><TD>14471</TD><TD>83</TD><TD>17630</TD><TD>93</TD>
<TD>OTUD7B,KNTC1,CDH7,CHODL,VARS2,SCARB2,SHB,HEATR6,FTL,EEF1A1,SERPINB10,RAB17,ZFYVE1,GART,USP8,HSPB6,NGDN,FOSB,SLC27A6,POM121C,TANK,MAP1LC3B,CHL1,PPP1R3F,HEXA,NR4A1,OSBPL7,VCP,SMARCA4,EMX1,AUTS2,ATP2B4,ADI1,ADAMTSL2,EPAS1,COMMD7,MNX1,TPM4,MED7,AURKAIP1,IFT27,JAK2,MAFF,LGALS2,TP53BP2,ALAS2,ADAR,F10,KCNA2,TTC39A,GPRASP2,ARPC1B,CHID1,EHMT1,MFSD6,CASP6,KDM2A,TMEM198,PTPN3,TACC2,C14orf159,KCNG3,ARIH2,GRAMD1B,ZNF683,BNC1,C2orf81,OVOL1,UBE3A,MAP3K7,FBXO31,UGT1A6,TSFM,DTD1,ENC1,NANOG,SLC40A1,RGSL1,FGD5,AP1G1,MYPN,NUP37,RFX2</TD></TR>
<TR><TD>4.127e-02</TD><TD>-3.19</TD><TD>clear_cell_renal_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>clear_cell_renal_cell_carcinoma</TD><TD>14471</TD><TD>83</TD><TD>17630</TD><TD>93</TD>
<TD>SLC40A1,ENC1,NANOG,RGSL1,AP1G1,FGD5,NUP37,RFX2,MYPN,UBE3A,C2orf81,BNC1,OVOL1,DTD1,MAP3K7,FBXO31,TSFM,UGT1A6,CASP6,KDM2A,TMEM198,PTPN3,MFSD6,ARIH2,GRAMD1B,ZNF683,TACC2,C14orf159,KCNG3,TTC39A,KCNA2,CHID1,EHMT1,GPRASP2,ARPC1B,TPM4,EPAS1,COMMD7,MNX1,MAFF,JAK2,LGALS2,ALAS2,ADAR,TP53BP2,F10,MED7,AURKAIP1,IFT27,OSBPL7,VCP,ATP2B4,ADI1,ADAMTSL2,SMARCA4,EMX1,AUTS2,RAB17,GART,ZFYVE1,USP8,HSPB6,NGDN,EEF1A1,SERPINB10,PPP1R3F,NR4A1,HEXA,FOSB,SLC27A6,POM121C,TANK,MAP1LC3B,CHL1,VARS2,SCARB2,SHB,OTUD7B,KNTC1,CDH7,CHODL,FTL,HEATR6</TD></TR>
<TR><TD>4.144e-02</TD><TD>-3.18</TD><TD>haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-marginal_zone_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-marginal_zone_lymphoma</TD><TD>8</TD><TD>1</TD><TD>17630</TD><TD>93</TD>
<TD>JAK2</TD></TR>
<TR><TD>4.144e-02</TD><TD>-3.18</TD><TD>gastrointestinal_tract_(site_indeterminate)-carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>gastrointestinal_tract_(site_indeterminate)-carcinoma</TD><TD>8</TD><TD>1</TD><TD>17630</TD><TD>93</TD>
<TD>JAK2</TD></TR>
<TR><TD>4.144e-02</TD><TD>-3.18</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-lymphoplasmacytic_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-lymphoplasmacytic_lymphoma</TD><TD>8</TD><TD>1</TD><TD>17630</TD><TD>93</TD>
<TD>JAK2</TD></TR>
<TR><TD>4.144e-02</TD><TD>-3.18</TD><TD>haematopoietic_and_lymphoid_tissue-other-normal</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-other-normal</TD><TD>8</TD><TD>1</TD><TD>17630</TD><TD>93</TD>
<TD>JAK2</TD></TR>
<TR><TD>4.144e-02</TD><TD>-3.18</TD><TD>placenta-choriocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>placenta-choriocarcinoma</TD><TD>8</TD><TD>1</TD><TD>17630</TD><TD>93</TD>
<TD>JAK2</TD></TR>
<TR><TD>4.152e-02</TD><TD>-3.18</TD><TD>YWHAB (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta)</TD><TD>protein interactions</TD><TD>7529</TD><TD>348</TD><TD>5</TD><TD>16330</TD><TD>89</TD>
<TD>PTPN3,VCP,USP8,TP53BP2,RMDN3</TD></TR>
<TR><TD>4.163e-02</TD><TD>-3.18</TD><TD>posttranscriptional regulation of gene expression</TD><TD>biological process</TD><TD>GO:0010608</TD><TD>456</TD><TD>6</TD><TD>16543</TD><TD>92</TD>
<TD>ENC1,NGDN,DTD1,ADAR,VARS2,TSFM</TD></TR>
<TR><TD>4.163e-02</TD><TD>-3.18</TD><TD>multicellular organism development</TD><TD>biological process</TD><TD>GO:0007275</TD><TD>4495</TD><TD>33</TD><TD>16543</TD><TD>92</TD>
<TD>ALAS2,UBE3A,GART,ATP2B4,ADAR,NR4A1,ENC1,ADAMTSL2,PLK5,JAK2,SMARCA4,SHB,MAFF,TACC2,ZNF683,NANOG,KCNA2,ARIH2,EPAS1,EMX1,PTPN3,MNX1,ONECUT3,SLC40A1,CHL1,CHODL,IFT27,RAB17,SCARB2,OVOL1,EHMT1,GJB2,TMEM198</TD></TR>
<TR><TD>4.164e-02</TD><TD>-3.18</TD><TD>TUBB (tubulin beta class I)</TD><TD>protein interactions</TD><TD>203068</TD><TD>239</TD><TD>4</TD><TD>16330</TD><TD>89</TD>
<TD>NANOG,LGALS2,VCP,EEF1A1</TD></TR>
<TR><TD>4.168e-02</TD><TD>-3.18</TD><TD>REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT</TD><TD>MSigDB lists</TD><TD>REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT</TD><TD>239</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>SLC27A6,POM121C,SLC40A1,NUP37</TD></TR>
<TR><TD>4.180e-02</TD><TD>-3.17</TD><TD>HCVgp1 (polyprotein)</TD><TD>protein interactions</TD><TD>951475</TD><TD>141</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>FTH1,UBE3A,NR4A1</TD></TR>
<TR><TD>4.182e-02</TD><TD>-3.17</TD><TD>PODAR_RESPONSE_TO_ADAPHOSTIN_UP</TD><TD>MSigDB lists</TD><TD>PODAR_RESPONSE_TO_ADAPHOSTIN_UP</TD><TD>141</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>FTH1,MAFF,MAP1LC3B</TD></TR>
<TR><TD>4.182e-02</TD><TD>-3.17</TD><TD>GO_NUCLEAR_EXPORT</TD><TD>MSigDB lists</TD><TD>GO_NUCLEAR_EXPORT</TD><TD>141</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>ADAR,NUP37,POM121C</TD></TR>
<TR><TD>4.221e-02</TD><TD>-3.17</TD><TD>KV9CHANNEL</TD><TD>prints domains</TD><TD>PR01494</TD><TD>7</TD><TD>1</TD><TD>4725</TD><TD>29</TD>
<TD>KCNG3</TD></TR>
<TR><TD>4.221e-02</TD><TD>-3.17</TD><TD>NCTRNSLOCATR</TD><TD>prints domains</TD><TD>PR00785</TD><TD>7</TD><TD>1</TD><TD>4725</TD><TD>29</TD>
<TD>EPAS1</TD></TR>
<TR><TD>4.224e-02</TD><TD>-3.16</TD><TD>UBC (ubiquitin C)</TD><TD>protein interactions</TD><TD>7316</TD><TD>852</TD><TD>9</TD><TD>16330</TD><TD>89</TD>
<TD>UBE3A,USP8,VCP,NBPF9,NUP37,ARIH2,OTUD7B,EPAS1,JOSD1</TD></TR>
<TR><TD>4.228e-02</TD><TD>-3.16</TD><TD>Znf_FYVE_PHD</TD><TD>interpro domains</TD><TD>IPR011011</TD><TD>138</TD><TD>3</TD><TD>18428</TD><TD>103</TD>
<TD>FGD5,KDM2A,ZFYVE1</TD></TR>
<TR><TD>4.228e-02</TD><TD>-3.16</TD><TD>Transmembrane transport of small molecules</TD><TD>REACTOME pathways</TD><TD>R-HSA-382551</TD><TD>679</TD><TD>8</TD><TD>10293</TD><TD>60</TD>
<TD>FTH1,NUP37,ATP2B4,FTL,VCP,POM121C,SLC40A1,SLC27A6</TD></TR>
<TR><TD>4.229e-02</TD><TD>-3.16</TD><TD>SWEET_LUNG_CANCER_KRAS_UP</TD><TD>MSigDB lists</TD><TD>SWEET_LUNG_CANCER_KRAS_UP</TD><TD>467</TD><TD>6</TD><TD>17621</TD><TD>96</TD>
<TD>F10,CHL1,HEXA,GJB2,TPM4,TANK</TD></TR>
<TR><TD>4.239e-02</TD><TD>-3.16</TD><TD>GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN</TD><TD>MSigDB lists</TD><TD>GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN</TD><TD>60</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>CASP6,SMARCA4</TD></TR>
<TR><TD>4.239e-02</TD><TD>-3.16</TD><TD>GO_LEUKOCYTE_HOMEOSTASIS</TD><TD>MSigDB lists</TD><TD>GO_LEUKOCYTE_HOMEOSTASIS</TD><TD>60</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>SLC40A1,GAPT</TD></TR>
<TR><TD>4.239e-02</TD><TD>-3.16</TD><TD>GO_POSITIVE_REGULATION_OF_PHOSPHATIDYLINOSITOL_3_KINASE_SIGNALING</TD><TD>MSigDB lists</TD><TD>GO_POSITIVE_REGULATION_OF_PHOSPHATIDYLINOSITOL_3_KINASE_SIGNALING</TD><TD>60</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>UBE3A,JAK2</TD></TR>
<TR><TD>4.239e-02</TD><TD>-3.16</TD><TD>RAMASWAMY_METASTASIS_DN</TD><TD>MSigDB lists</TD><TD>RAMASWAMY_METASTASIS_DN</TD><TD>60</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>F10,NR4A1</TD></TR>
<TR><TD>4.239e-02</TD><TD>-3.16</TD><TD>HDAC9 (histone deacetylase 9)</TD><TD>protein interactions</TD><TD>9734</TD><TD>60</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>SMARCA4,ADAR</TD></TR>
<TR><TD>4.239e-02</TD><TD>-3.16</TD><TD>MED15 (mediator complex subunit 15)</TD><TD>protein interactions</TD><TD>51586</TD><TD>60</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>MED7,EPAS1</TD></TR>
<TR><TD>4.239e-02</TD><TD>-3.16</TD><TD>RRP12 (ribosomal RNA processing 12 homolog)</TD><TD>protein interactions</TD><TD>23223</TD><TD>60</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>VCP,NANOG</TD></TR>
<TR><TD>4.239e-02</TD><TD>-3.16</TD><TD>BID (BH3 interacting domain death agonist)</TD><TD>protein interactions</TD><TD>637</TD><TD>60</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>BNC1,VCP</TD></TR>
<TR><TD>4.239e-02</TD><TD>-3.16</TD><TD>GART (phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase)</TD><TD>protein interactions</TD><TD>2618</TD><TD>60</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>EEF1A1,GART</TD></TR>
<TR><TD>4.239e-02</TD><TD>-3.16</TD><TD>regulation of immune response</TD><TD>biological process</TD><TD>GO:0050776</TD><TD>835</TD><TD>9</TD><TD>16543</TD><TD>92</TD>
<TD>TANK,ARPC1B,AP1G1,ZNF683,MAP3K7,SHB,ADAR,JAK2,GCSAM</TD></TR>
<TR><TD>4.256e-02</TD><TD>-3.16</TD><TD>BROCKE_APOPTOSIS_REVERSED_BY_IL6</TD><TD>MSigDB lists</TD><TD>BROCKE_APOPTOSIS_REVERSED_BY_IL6</TD><TD>142</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>MAFF,ATP2B4,TPM4</TD></TR>
<TR><TD>4.256e-02</TD><TD>-3.16</TD><TD>PDGF_ERK_DN.V1_DN</TD><TD>MSigDB lists</TD><TD>PDGF_ERK_DN.V1_DN</TD><TD>142</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>MAFF,BNC1,KDM2A</TD></TR>
<TR><TD>4.262e-02</TD><TD>-3.16</TD><TD>superpathway of purine nucleotides de novo biosynthesis I</TD><TD>BIOCYC pathways</TD><TD>META_PWY-841</TD><TD>13</TD><TD>1</TD><TD>903</TD><TD>3</TD>
<TD>GART</TD></TR>
<TR><TD>4.275e-02</TD><TD>-3.15</TD><TD>cellular response to organic cyclic compound</TD><TD>biological process</TD><TD>GO:0071407</TD><TD>459</TD><TD>6</TD><TD>16543</TD><TD>92</TD>
<TD>JAK2,UBE3A,ATP2B4,ADAR,NR4A1,OSBPL7</TD></TR>
<TR><TD>4.276e-02</TD><TD>-3.15</TD><TD>V$CREBP1_Q2</TD><TD>MSigDB lists</TD><TD>V$CREBP1_Q2</TD><TD>241</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>JOSD1,MAFF,FOSB,TPM4</TD></TR>
<TR><TD>4.277e-02</TD><TD>-3.15</TD><TD>MIKKELSEN_PLURIPOTENT_STATE_DN</TD><TD>MSigDB lists</TD><TD>MIKKELSEN_PLURIPOTENT_STATE_DN</TD><TD>8</TD><TD>1</TD><TD>17621</TD><TD>96</TD>
<TD>JAK2</TD></TR>
<TR><TD>4.277e-02</TD><TD>-3.15</TD><TD>CHANG_POU5F1_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>CHANG_POU5F1_TARGETS_DN</TD><TD>8</TD><TD>1</TD><TD>17621</TD><TD>96</TD>
<TD>POM121C</TD></TR>
<TR><TD>4.277e-02</TD><TD>-3.15</TD><TD>MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_2</TD><TD>MSigDB lists</TD><TD>MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_2</TD><TD>8</TD><TD>1</TD><TD>17621</TD><TD>96</TD>
<TD>MAP1LC3B</TD></TR>
<TR><TD>4.277e-02</TD><TD>-3.15</TD><TD>ISHIKAWA_STING_SIGNALING</TD><TD>MSigDB lists</TD><TD>ISHIKAWA_STING_SIGNALING</TD><TD>8</TD><TD>1</TD><TD>17621</TD><TD>96</TD>
<TD>ADAR</TD></TR>
<TR><TD>4.277e-02</TD><TD>-3.15</TD><TD>GROSS_HYPOXIA_VIA_HIF1A_ONLY</TD><TD>MSigDB lists</TD><TD>GROSS_HYPOXIA_VIA_HIF1A_ONLY</TD><TD>8</TD><TD>1</TD><TD>17621</TD><TD>96</TD>
<TD>MAFF</TD></TR>
<TR><TD>4.277e-02</TD><TD>-3.15</TD><TD>RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_DN</TD><TD>MSigDB lists</TD><TD>RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_DN</TD><TD>8</TD><TD>1</TD><TD>17621</TD><TD>96</TD>
<TD>NR4A1</TD></TR>
<TR><TD>4.277e-02</TD><TD>-3.15</TD><TD>GO_POSITIVE_REGULATION_OF_NEURON_MIGRATION</TD><TD>MSigDB lists</TD><TD>GO_POSITIVE_REGULATION_OF_NEURON_MIGRATION</TD><TD>8</TD><TD>1</TD><TD>17621</TD><TD>96</TD>
<TD>FBXO31</TD></TR>
<TR><TD>4.277e-02</TD><TD>-3.15</TD><TD>REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX_UPON_TLR7_8_OR_9_STIMULATION</TD><TD>MSigDB lists</TD><TD>REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX_UPON_TLR7_8_OR_9_STIMULATION</TD><TD>8</TD><TD>1</TD><TD>17621</TD><TD>96</TD>
<TD>MAP3K7</TD></TR>
<TR><TD>4.277e-02</TD><TD>-3.15</TD><TD>TSUTSUMI_FBXW8_TARGETS</TD><TD>MSigDB lists</TD><TD>TSUTSUMI_FBXW8_TARGETS</TD><TD>8</TD><TD>1</TD><TD>17621</TD><TD>96</TD>
<TD>MYPN</TD></TR>
<TR><TD>4.279e-02</TD><TD>-3.15</TD><TD>EFR3A (EFR3 homolog A)</TD><TD>protein interactions</TD><TD>23167</TD><TD>8</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>FBXO31</TD></TR>
<TR><TD>4.279e-02</TD><TD>-3.15</TD><TD>BRSK2 (BR serine/threonine kinase 2)</TD><TD>protein interactions</TD><TD>9024</TD><TD>8</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>VCP</TD></TR>
<TR><TD>4.279e-02</TD><TD>-3.15</TD><TD>ANKRD13B (ankyrin repeat domain 13B)</TD><TD>protein interactions</TD><TD>124930</TD><TD>8</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>VCP</TD></TR>
<TR><TD>4.279e-02</TD><TD>-3.15</TD><TD>KIAA1468 (KIAA1468)</TD><TD>protein interactions</TD><TD>57614</TD><TD>8</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>VCP</TD></TR>
<TR><TD>4.279e-02</TD><TD>-3.15</TD><TD>Akap12 (A kinase (PRKA) anchor protein (gravin) 12)</TD><TD>protein interactions</TD><TD>83397</TD><TD>8</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>VCP</TD></TR>
<TR><TD>4.279e-02</TD><TD>-3.15</TD><TD>STIM2 (stromal interaction molecule 2)</TD><TD>protein interactions</TD><TD>57620</TD><TD>8</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>HEXA</TD></TR>
<TR><TD>4.279e-02</TD><TD>-3.15</TD><TD>CAAP1 (caspase activity and apoptosis inhibitor 1)</TD><TD>protein interactions</TD><TD>79886</TD><TD>8</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>VCP</TD></TR>
<TR><TD>4.279e-02</TD><TD>-3.15</TD><TD>BBC3 (BCL2 binding component 3)</TD><TD>protein interactions</TD><TD>27113</TD><TD>8</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>BNC1</TD></TR>
<TR><TD>4.279e-02</TD><TD>-3.15</TD><TD>C14orf159 (chromosome 14 open reading frame 159)</TD><TD>protein interactions</TD><TD>80017</TD><TD>8</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>C14orf159</TD></TR>
<TR><TD>4.279e-02</TD><TD>-3.15</TD><TD>Stmn1 (stathmin 1)</TD><TD>protein interactions</TD><TD>16765</TD><TD>8</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>VCP</TD></TR>
<TR><TD>4.279e-02</TD><TD>-3.15</TD><TD>PIEZO1 (piezo type mechanosensitive ion channel component 1)</TD><TD>protein interactions</TD><TD>9780</TD><TD>8</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>GJB2</TD></TR>
<TR><TD>4.279e-02</TD><TD>-3.15</TD><TD>KCNQ2 (potassium voltage-gated channel subfamily Q member 2)</TD><TD>protein interactions</TD><TD>3785</TD><TD>8</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>ARIH2</TD></TR>
<TR><TD>4.279e-02</TD><TD>-3.15</TD><TD>ASAP3 (ArfGAP with SH3 domain, ankyrin repeat and PH domain 3)</TD><TD>protein interactions</TD><TD>55616</TD><TD>8</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>UBE3A</TD></TR>
<TR><TD>4.279e-02</TD><TD>-3.15</TD><TD>LSS (lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase))</TD><TD>protein interactions</TD><TD>4047</TD><TD>8</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>NR4A1</TD></TR>
<TR><TD>4.279e-02</TD><TD>-3.15</TD><TD>ABCG8 (ATP binding cassette subfamily G member 8)</TD><TD>protein interactions</TD><TD>64241</TD><TD>8</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>NR4A1</TD></TR>
<TR><TD>4.279e-02</TD><TD>-3.15</TD><TD>MED12L (mediator complex subunit 12 like)</TD><TD>protein interactions</TD><TD>116931</TD><TD>8</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>MED7</TD></TR>
<TR><TD>4.279e-02</TD><TD>-3.15</TD><TD>TBC1D25 (TBC1 domain family member 25)</TD><TD>protein interactions</TD><TD>4943</TD><TD>8</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>MAP1LC3B</TD></TR>
<TR><TD>4.279e-02</TD><TD>-3.15</TD><TD>ZADH2 (zinc binding alcohol dehydrogenase domain containing 2)</TD><TD>protein interactions</TD><TD>284273</TD><TD>8</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>RBKS</TD></TR>
<TR><TD>4.279e-02</TD><TD>-3.15</TD><TD>HHV8GK18_gp80 (ORF71)</TD><TD>protein interactions</TD><TD>4961494</TD><TD>8</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>MAP3K7</TD></TR>
<TR><TD>4.279e-02</TD><TD>-3.15</TD><TD>HIST2H3D (histone cluster 2 H3 family member d)</TD><TD>protein interactions</TD><TD>653604</TD><TD>8</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>NANOG</TD></TR>
<TR><TD>4.279e-02</TD><TD>-3.15</TD><TD>KCNC1 (potassium voltage-gated channel subfamily C member 1)</TD><TD>protein interactions</TD><TD>3746</TD><TD>8</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>KCNG3</TD></TR>
<TR><TD>4.279e-02</TD><TD>-3.15</TD><TD>NOMO2 (NODAL modulator 2)</TD><TD>protein interactions</TD><TD>283820</TD><TD>8</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>UBE3A</TD></TR>
<TR><TD>4.279e-02</TD><TD>-3.15</TD><TD>HOXD12 (homeobox D12)</TD><TD>protein interactions</TD><TD>3238</TD><TD>8</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>MAFF</TD></TR>
<TR><TD>4.283e-02</TD><TD>-3.15</TD><TD>regulation of transcription, DNA-templated</TD><TD>biological process</TD><TD>GO:0006355</TD><TD>3525</TD><TD>27</TD><TD>16543</TD><TD>92</TD>
<TD>BNC1,OTUD7B,JAK2,EEF1A1,KDM2A,MAFF,FOSB,AUTS2,SMARCA4,RFX2,MAP3K7,ERN2,OVOL1,ZNF683,EHMT1,MED7,NANOG,COMMD7,UBE3A,NR4A1,EPAS1,ATP2B4,EMX1,MNX1,ONECUT3,SLC40A1,TSFM</TD></TR>
<TR><TD>4.290e-02</TD><TD>-3.15</TD><TD>GO_REGULATION_OF_INNATE_IMMUNE_RESPONSE</TD><TD>MSigDB lists</TD><TD>GO_REGULATION_OF_INNATE_IMMUNE_RESPONSE</TD><TD>351</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>TANK,AP1G1,MAP3K7,JAK2,ADAR</TD></TR>
<TR><TD>4.335e-02</TD><TD>-3.14</TD><TD>ER-mitochondrion membrane contact site</TD><TD>cellular component</TD><TD>GO:0044233</TD><TD>8</TD><TD>1</TD><TD>17744</TD><TD>98</TD>
<TD>ZFYVE1</TD></TR>
<TR><TD>4.350e-02</TD><TD>-3.14</TD><TD>animal organ development</TD><TD>biological process</TD><TD>GO:0048513</TD><TD>2738</TD><TD>22</TD><TD>16543</TD><TD>92</TD>
<TD>OVOL1,ZNF683,TACC2,GJB2,JAK2,SHB,SMARCA4,MAFF,SLC40A1,PTPN3,MNX1,ADAMTSL2,CHODL,IFT27,UBE3A,ARIH2,GART,ALAS2,ATP2B4,EMX1,EPAS1,ADAR</TD></TR>
<TR><TD>4.364e-02</TD><TD>-3.13</TD><TD>regulation of glycogen (starch) synthase activity</TD><TD>biological process</TD><TD>GO:2000465</TD><TD>8</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>PPP1R3F</TD></TR>
<TR><TD>4.364e-02</TD><TD>-3.13</TD><TD>L-methionine biosynthetic process from methylthioadenosine</TD><TD>biological process</TD><TD>GO:0019509</TD><TD>8</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ADI1</TD></TR>
<TR><TD>4.364e-02</TD><TD>-3.13</TD><TD>peptidyl-lysine monomethylation</TD><TD>biological process</TD><TD>GO:0018026</TD><TD>8</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>EHMT1</TD></TR>
<TR><TD>4.364e-02</TD><TD>-3.13</TD><TD>protoporphyrinogen IX biosynthetic process</TD><TD>biological process</TD><TD>GO:0006782</TD><TD>8</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ALAS2</TD></TR>
<TR><TD>4.364e-02</TD><TD>-3.13</TD><TD>negative regulation of muscle adaptation</TD><TD>biological process</TD><TD>GO:0014745</TD><TD>8</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ATP2B4</TD></TR>
<TR><TD>4.364e-02</TD><TD>-3.13</TD><TD>regulation of circadian sleep/wake cycle, non-REM sleep</TD><TD>biological process</TD><TD>GO:0045188</TD><TD>8</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>KCNA2</TD></TR>
<TR><TD>4.364e-02</TD><TD>-3.13</TD><TD>protein hexamerization</TD><TD>biological process</TD><TD>GO:0034214</TD><TD>8</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>VCP</TD></TR>
<TR><TD>4.364e-02</TD><TD>-3.13</TD><TD>gap junction assembly</TD><TD>biological process</TD><TD>GO:0016264</TD><TD>8</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>GJB2</TD></TR>
<TR><TD>4.364e-02</TD><TD>-3.13</TD><TD>negative regulation of protein kinase activity by regulation of protein phosphorylation</TD><TD>biological process</TD><TD>GO:0044387</TD><TD>8</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ADAR</TD></TR>
<TR><TD>4.364e-02</TD><TD>-3.13</TD><TD>radial glial cell differentiation</TD><TD>biological process</TD><TD>GO:0060019</TD><TD>8</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>EMX1</TD></TR>
<TR><TD>4.364e-02</TD><TD>-3.13</TD><TD>surfactant homeostasis</TD><TD>biological process</TD><TD>GO:0043129</TD><TD>8</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>EPAS1</TD></TR>
<TR><TD>4.364e-02</TD><TD>-3.13</TD><TD>small RNA loading onto RISC</TD><TD>biological process</TD><TD>GO:0070922</TD><TD>8</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ADAR</TD></TR>
<TR><TD>4.364e-02</TD><TD>-3.13</TD><TD>righting reflex</TD><TD>biological process</TD><TD>GO:0060013</TD><TD>8</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>AUTS2</TD></TR>
<TR><TD>4.367e-02</TD><TD>-3.13</TD><TD>TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP</TD><TD>MSigDB lists</TD><TD>TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP</TD><TD>61</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>FOSB,MAFF</TD></TR>
<TR><TD>4.368e-02</TD><TD>-3.13</TD><TD>ERC1 (ELKS/RAB6-interacting/CAST family member 1)</TD><TD>protein interactions</TD><TD>23085</TD><TD>61</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>NANOG,MAP3K7</TD></TR>
<TR><TD>4.368e-02</TD><TD>-3.13</TD><TD>ATF3 (activating transcription factor 3)</TD><TD>protein interactions</TD><TD>467</TD><TD>61</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>SMARCA4,MAFF</TD></TR>
<TR><TD>4.368e-02</TD><TD>-3.13</TD><TD>MED8 (mediator complex subunit 8)</TD><TD>protein interactions</TD><TD>112950</TD><TD>61</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>EPAS1,MED7</TD></TR>
<TR><TD>4.368e-02</TD><TD>-3.13</TD><TD>biosynthetic process</TD><TD>biological process</TD><TD>GO:0009058</TD><TD>4678</TD><TD>34</TD><TD>16543</TD><TD>92</TD>
<TD>NR4A1,GART,MED7,ALAS2,TSFM,AURKAIP1,VARS2,SMARCA4,MAFF,KDM2A,EEF1A1,USF3,HEXA,ZNF683,PXYLP1,ERN2,RFX2,ADI1,VCP,EPAS1,COQ8A,COMMD7,NANOG,DTD1,ONECUT3,MNX1,FOSB,POM121C,BNC1,NUP37,RNASEH2A,UGT1A6,OVOL1,MAP3K7</TD></TR>
<TR><TD>4.380e-02</TD><TD>-3.13</TD><TD>STUB1 (STIP1 homology and U-box containing protein 1)</TD><TD>protein interactions</TD><TD>10273</TD><TD>243</TD><TD>4</TD><TD>16330</TD><TD>89</TD>
<TD>EPAS1,JOSD1,VCP,MAP3K7</TD></TR>
<TR><TD>4.385e-02</TD><TD>-3.13</TD><TD>KAAB_HEART_ATRIUM_VS_VENTRICLE_UP</TD><TD>MSigDB lists</TD><TD>KAAB_HEART_ATRIUM_VS_VENTRICLE_UP</TD><TD>243</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>EEF1A1,CHL1,AUTS2,F10</TD></TR>
<TR><TD>4.386e-02</TD><TD>-3.13</TD><TD>K_chnl_volt-dep_Kv1</TD><TD>interpro domains</TD><TD>IPR003972</TD><TD>8</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>KCNA2</TD></TR>
<TR><TD>4.386e-02</TD><TD>-3.13</TD><TD>His_Pase_clade-2</TD><TD>interpro domains</TD><TD>IPR000560</TD><TD>8</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>PXYLP1</TD></TR>
<TR><TD>4.386e-02</TD><TD>-3.13</TD><TD>Alpha-crystallin/HSP</TD><TD>interpro domains</TD><TD>IPR001436</TD><TD>8</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>HSPB6</TD></TR>
<TR><TD>4.386e-02</TD><TD>-3.13</TD><TD>Vps4_C</TD><TD>interpro domains</TD><TD>IPR015415</TD><TD>8</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>VCP</TD></TR>
<TR><TD>4.406e-02</TD><TD>-3.12</TD><TD>RELA_DN.V1_UP</TD><TD>MSigDB lists</TD><TD>RELA_DN.V1_UP</TD><TD>144</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>SLC27A6,FOSB,TANK</TD></TR>
<TR><TD>4.408e-02</TD><TD>-3.12</TD><TD>transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding</TD><TD>molecular function</TD><TD>GO:0001077</TD><TD>235</TD><TD>4</TD><TD>16652</TD><TD>94</TD>
<TD>NR4A1,ONECUT3,EPAS1,FOSB</TD></TR>
<TR><TD>4.422e-02</TD><TD>-3.12</TD><TD>GO_POSITIVE_REGULATION_OF_PROTEOLYSIS</TD><TD>MSigDB lists</TD><TD>GO_POSITIVE_REGULATION_OF_PROTEOLYSIS</TD><TD>354</TD><TD>5</TD><TD>17621</TD><TD>96</TD>
<TD>OSBPL7,ARIH2,JAK2,AURKAIP1,VCP</TD></TR>
<TR><TD>4.429e-02</TD><TD>-3.12</TD><TD>chitin binding</TD><TD>molecular function</TD><TD>GO:0008061</TD><TD>8</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>CHID1</TD></TR>
<TR><TD>4.429e-02</TD><TD>-3.12</TD><TD>succinyltransferase activity</TD><TD>molecular function</TD><TD>GO:0016748</TD><TD>8</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>ALAS2</TD></TR>
<TR><TD>4.429e-02</TD><TD>-3.12</TD><TD>acetylcholine receptor binding</TD><TD>molecular function</TD><TD>GO:0033130</TD><TD>8</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>JAK2</TD></TR>
<TR><TD>4.429e-02</TD><TD>-3.12</TD><TD>hydroxymethyl-, formyl- and related transferase activity</TD><TD>molecular function</TD><TD>GO:0016742</TD><TD>8</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>GART</TD></TR>
<TR><TD>4.429e-02</TD><TD>-3.12</TD><TD>RNA polymerase I regulatory region DNA binding</TD><TD>molecular function</TD><TD>GO:0001013</TD><TD>8</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>SMARCA4</TD></TR>
<TR><TD>4.429e-02</TD><TD>-3.12</TD><TD>RNA polymerase I CORE element sequence-specific DNA binding</TD><TD>molecular function</TD><TD>GO:0001164</TD><TD>8</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>SMARCA4</TD></TR>
<TR><TD>4.429e-02</TD><TD>-3.12</TD><TD>mannosyl-oligosaccharide 1,2-alpha-mannosidase activity</TD><TD>molecular function</TD><TD>GO:0004571</TD><TD>8</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>USF3</TD></TR>
<TR><TD>4.429e-02</TD><TD>-3.12</TD><TD>iron ion transmembrane transporter activity</TD><TD>molecular function</TD><TD>GO:0005381</TD><TD>8</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>SLC40A1</TD></TR>
<TR><TD>4.429e-02</TD><TD>-3.12</TD><TD>RNA polymerase I regulatory region sequence-specific DNA binding</TD><TD>molecular function</TD><TD>GO:0001163</TD><TD>8</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>SMARCA4</TD></TR>
<TR><TD>4.429e-02</TD><TD>-3.12</TD><TD>muscle alpha-actinin binding</TD><TD>molecular function</TD><TD>GO:0051371</TD><TD>8</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>MYPN</TD></TR>
<TR><TD>4.432e-02</TD><TD>-3.12</TD><TD>transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding</TD><TD>molecular function</TD><TD>GO:0000982</TD><TD>342</TD><TD>5</TD><TD>16652</TD><TD>94</TD>
<TD>ONECUT3,NR4A1,OVOL1,FOSB,EPAS1</TD></TR>
<TR><TD>4.439e-02</TD><TD>-3.11</TD><TD>macromolecule metabolic process</TD><TD>biological process</TD><TD>GO:0043170</TD><TD>7264</TD><TD>49</TD><TD>16543</TD><TD>92</TD>
<TD>COQ8A,EPAS1,VCP,NANOG,ARIH2,COMMD7,CASP6,MNX1,PTPN3,ONECUT3,DTD1,JOSD1,POM121C,FOSB,NGDN,BNC1,OTUD7B,RNASEH2A,NUP37,EHMT1,USP8,MAP3K7,OVOL1,NR4A1,FBXO31,ADAR,MED7,ALAS2,UBE3A,AURKAIP1,TANK,TSFM,ADAMTSL2,ENC1,KDM2A,MAFF,VARS2,SMARCA4,PLK5,USF3,EEF1A1,JAK2,HEXA,F10,PXYLP1,RFX2,ERN2,CHID1,ZNF683</TD></TR>
<TR><TD>4.440e-02</TD><TD>-3.11</TD><TD>DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP</TD><TD>MSigDB lists</TD><TD>DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP</TD><TD>244</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>MAP1LC3B,TPM4,MAFF,AUTS2</TD></TR>
<TR><TD>4.440e-02</TD><TD>-3.11</TD><TD>DANG_REGULATED_BY_MYC_DN</TD><TD>MSigDB lists</TD><TD>DANG_REGULATED_BY_MYC_DN</TD><TD>244</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>UGT1A6,POM121C,FTL,FTH1</TD></TR>
<TR><TD>4.460e-02</TD><TD>-3.11</TD><TD>-</TD><TD>gene3d domains</TD><TD>1.20.120.350</TD><TD>57</TD><TD>2</TD><TD>10485</TD><TD>62</TD>
<TD>KCNG3,KCNA2</TD></TR>
<TR><TD>4.474e-02</TD><TD>-3.11</TD><TD>regeneration</TD><TD>biological process</TD><TD>GO:0031099</TD><TD>142</TD><TD>3</TD><TD>16543</TD><TD>92</TD>
<TD>JAK2,PTPN3,CHL1</TD></TR>
<TR><TD>4.474e-02</TD><TD>-3.11</TD><TD>gene silencing by RNA</TD><TD>biological process</TD><TD>GO:0031047</TD><TD>142</TD><TD>3</TD><TD>16543</TD><TD>92</TD>
<TD>POM121C,ADAR,NUP37</TD></TR>
<TR><TD>4.474e-02</TD><TD>-3.11</TD><TD>Host Interactions of HIV factors</TD><TD>REACTOME pathways</TD><TD>R-HSA-162909</TD><TD>136</TD><TD>3</TD><TD>10293</TD><TD>60</TD>
<TD>POM121C,NUP37,AP1G1</TD></TR>
<TR><TD>4.491e-02</TD><TD>-3.10</TD><TD>skin-trunk-malignant_melanoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-trunk-malignant_melanoma</TD><TD>2731</TD><TD>21</TD><TD>17630</TD><TD>93</TD>
<TD>EHMT1,HEATR6,SMARCA4,FTH1,GJB2,TTC39A,UBE3A,KNTC1,BNC1,ALAS2,TP53BP2,RFX2,ARIH2,CHL1,SLC27A6,MYPN,TACC2,TMEM198,USP8,SERPINB10,EEF1A1</TD></TR>
<TR><TD>4.497e-02</TD><TD>-3.10</TD><TD>GO_PIGMENT_METABOLIC_PROCESS</TD><TD>MSigDB lists</TD><TD>GO_PIGMENT_METABOLIC_PROCESS</TD><TD>62</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>ALAS2,GART</TD></TR>
<TR><TD>4.498e-02</TD><TD>-3.10</TD><TD>TTK (TTK protein kinase)</TD><TD>protein interactions</TD><TD>7272</TD><TD>62</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>TACC2,VCP</TD></TR>
<TR><TD>4.498e-02</TD><TD>-3.10</TD><TD>WARS (tryptophanyl-tRNA synthetase)</TD><TD>protein interactions</TD><TD>7453</TD><TD>62</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>EEF1A1,GART</TD></TR>
<TR><TD>4.498e-02</TD><TD>-3.10</TD><TD>SLAMF1 (signaling lymphocytic activation molecule family member 1)</TD><TD>protein interactions</TD><TD>6504</TD><TD>62</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>SLC27A6,HEATR6</TD></TR>
<TR><TD>4.498e-02</TD><TD>-3.10</TD><TD>TAX1BP1 (Tax1 binding protein 1)</TD><TD>protein interactions</TD><TD>8887</TD><TD>62</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>VCP,MAP1LC3B</TD></TR>
<TR><TD>4.515e-02</TD><TD>-3.10</TD><TD>response to organic cyclic compound</TD><TD>biological process</TD><TD>GO:0014070</TD><TD>845</TD><TD>9</TD><TD>16543</TD><TD>92</TD>
<TD>GJB2,ARPC1B,OSBPL7,FOSB,NR4A1,ADAR,ATP2B4,JAK2,UBE3A</TD></TR>
<TR><TD>4.519e-02</TD><TD>-3.10</TD><TD>His_Phos_2</TD><TD>pfam domains</TD><TD>PF00328</TD><TD>8</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>PXYLP1</TD></TR>
<TR><TD>4.519e-02</TD><TD>-3.10</TD><TD>Vps4_C</TD><TD>pfam domains</TD><TD>PF09336</TD><TD>8</TD><TD>1</TD><TD>16832</TD><TD>97</TD>
<TD>VCP</TD></TR>
<TR><TD>4.556e-02</TD><TD>-3.09</TD><TD>UBB (ubiquitin B)</TD><TD>protein interactions</TD><TD>7314</TD><TD>146</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>UBE3A,VCP,OTUD7B</TD></TR>
<TR><TD>4.556e-02</TD><TD>-3.09</TD><TD>IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta)</TD><TD>protein interactions</TD><TD>3551</TD><TD>146</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>COMMD7,MAP3K7,TANK</TD></TR>
<TR><TD>4.556e-02</TD><TD>-3.09</TD><TD>FBF1 (Fas binding factor 1)</TD><TD>protein interactions</TD><TD>85302</TD><TD>146</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>TSFM,VCP,TP53BP2</TD></TR>
<TR><TD>4.558e-02</TD><TD>-3.09</TD><TD>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP</TD><TD>MSigDB lists</TD><TD>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP</TD><TD>146</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>SLC40A1,SLC27A6,AUTS2</TD></TR>
<TR><TD>4.558e-02</TD><TD>-3.09</TD><TD>LIN_NPAS4_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>LIN_NPAS4_TARGETS_UP</TD><TD>146</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>CHODL,EPAS1,MFSD6</TD></TR>
<TR><TD>4.558e-02</TD><TD>-3.09</TD><TD>GAGCTGG,MIR-337</TD><TD>MSigDB lists</TD><TD>GAGCTGG,MIR-337</TD><TD>146</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>PPP1R3F,OVOL1,VCP</TD></TR>
<TR><TD>4.560e-02</TD><TD>-3.09</TD><TD>regulation of innate immune response</TD><TD>biological process</TD><TD>GO:0045088</TD><TD>350</TD><TD>5</TD><TD>16543</TD><TD>92</TD>
<TD>AP1G1,ADAR,TANK,MAP3K7,JAK2</TD></TR>
<TR><TD>4.571e-02</TD><TD>-3.09</TD><TD>Transport of fatty acids</TD><TD>REACTOME pathways</TD><TD>R-HSA-804914</TD><TD>8</TD><TD>1</TD><TD>10293</TD><TD>60</TD>
<TD>SLC27A6</TD></TR>
<TR><TD>4.571e-02</TD><TD>-3.09</TD><TD>Regulation of gene expression in early pancreatic precursor cells</TD><TD>REACTOME pathways</TD><TD>R-HSA-210747</TD><TD>8</TD><TD>1</TD><TD>10293</TD><TD>60</TD>
<TD>ONECUT3</TD></TR>
<TR><TD>4.573e-02</TD><TD>-3.09</TD><TD>foot</TD><TD>COSMIC cancer mutations</TD><TD>foot</TD><TD>151</TD><TD>3</TD><TD>17630</TD><TD>93</TD>
<TD>JAK2,RBKS,PPP1R3F</TD></TR>
<TR><TD>4.587e-02</TD><TD>-3.08</TD><TD>cellular macromolecule biosynthetic process</TD><TD>biological process</TD><TD>GO:0034645</TD><TD>3547</TD><TD>27</TD><TD>16543</TD><TD>92</TD>
<TD>BNC1,USF3,EEF1A1,KDM2A,MAFF,SMARCA4,VARS2,FOSB,MAP3K7,ERN2,RFX2,PXYLP1,ZNF683,OVOL1,RNASEH2A,MED7,ALAS2,NANOG,COMMD7,NR4A1,EPAS1,VCP,MNX1,ONECUT3,DTD1,AURKAIP1,TSFM</TD></TR>
<TR><TD>4.601e-02</TD><TD>-3.08</TD><TD>regulation of nucleic acid-templated transcription</TD><TD>biological process</TD><TD>GO:1903506</TD><TD>3548</TD><TD>27</TD><TD>16543</TD><TD>92</TD>
<TD>TSFM,ONECUT3,SLC40A1,MNX1,NR4A1,EPAS1,ATP2B4,EMX1,COMMD7,UBE3A,NANOG,MED7,EHMT1,MAP3K7,RFX2,ERN2,OVOL1,ZNF683,MAFF,FOSB,SMARCA4,AUTS2,KDM2A,BNC1,EEF1A1,JAK2,OTUD7B</TD></TR>
<TR><TD>4.603e-02</TD><TD>-3.08</TD><TD>RB1 (RB transcriptional corepressor 1)</TD><TD>protein interactions</TD><TD>5925</TD><TD>247</TD><TD>4</TD><TD>16330</TD><TD>89</TD>
<TD>SMARCA4,KDM2A,ENC1,CASP6</TD></TR>
<TR><TD>4.605e-02</TD><TD>-3.08</TD><TD>protein catabolic process</TD><TD>biological process</TD><TD>GO:0030163</TD><TD>590</TD><TD>7</TD><TD>16543</TD><TD>92</TD>
<TD>ENC1,USP8,ARIH2,UBE3A,OTUD7B,FBXO31,VCP</TD></TR>
<TR><TD>4.628e-02</TD><TD>-3.07</TD><TD>WYAAANNRNNNGCG_UNKNOWN</TD><TD>MSigDB lists</TD><TD>WYAAANNRNNNGCG_UNKNOWN</TD><TD>63</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>KDM2A,NR4A1</TD></TR>
<TR><TD>4.628e-02</TD><TD>-3.07</TD><TD>WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN</TD><TD>MSigDB lists</TD><TD>WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN</TD><TD>63</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>ATP2B4,EEF1A1</TD></TR>
<TR><TD>4.628e-02</TD><TD>-3.07</TD><TD>MIKKELSEN_MEF_LCP_WITH_H3K27ME3</TD><TD>MSigDB lists</TD><TD>MIKKELSEN_MEF_LCP_WITH_H3K27ME3</TD><TD>63</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>ADAMTSL2,CDH7</TD></TR>
<TR><TD>4.628e-02</TD><TD>-3.07</TD><TD>GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP</TD><TD>MSigDB lists</TD><TD>GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP</TD><TD>63</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>FTH1,MAFF</TD></TR>
<TR><TD>4.628e-02</TD><TD>-3.07</TD><TD>BYSTROEM_CORRELATED_WITH_IL5_DN</TD><TD>MSigDB lists</TD><TD>BYSTROEM_CORRELATED_WITH_IL5_DN</TD><TD>63</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>ADAR,AP1G1</TD></TR>
<TR><TD>4.629e-02</TD><TD>-3.07</TD><TD>UBE2S (ubiquitin conjugating enzyme E2 S)</TD><TD>protein interactions</TD><TD>27338</TD><TD>63</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>VCP,OTUD7B</TD></TR>
<TR><TD>4.629e-02</TD><TD>-3.07</TD><TD>PAFAH1B1 (platelet activating factor acetylhydrolase 1b regulatory subunit 1)</TD><TD>protein interactions</TD><TD>5048</TD><TD>63</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>AP1G1,CHID1</TD></TR>
<TR><TD>4.629e-02</TD><TD>-3.07</TD><TD>SHBG (sex hormone binding globulin)</TD><TD>protein interactions</TD><TD>6462</TD><TD>63</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>UBE3A,EEF1A1</TD></TR>
<TR><TD>4.629e-02</TD><TD>-3.07</TD><TD>TMOD3 (tropomodulin 3)</TD><TD>protein interactions</TD><TD>29766</TD><TD>63</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>MAP1LC3B,NR4A1</TD></TR>
<TR><TD>4.629e-02</TD><TD>-3.07</TD><TD>CYP1A1 (cytochrome P450 family 1 subfamily A member 1)</TD><TD>protein interactions</TD><TD>1543</TD><TD>63</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>TSFM,DTD1</TD></TR>
<TR><TD>4.629e-02</TD><TD>-3.07</TD><TD>MED16 (mediator complex subunit 16)</TD><TD>protein interactions</TD><TD>10025</TD><TD>63</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>MED7,EPAS1</TD></TR>
<TR><TD>4.630e-02</TD><TD>-3.07</TD><TD>regulation of proteasomal protein catabolic process</TD><TD>biological process</TD><TD>GO:0061136</TD><TD>144</TD><TD>3</TD><TD>16543</TD><TD>92</TD>
<TD>VCP,OSBPL7,ARIH2</TD></TR>
<TR><TD>4.634e-02</TD><TD>-3.07</TD><TD>NDUFS3 (NADH:ubiquinone oxidoreductase core subunit S3)</TD><TD>protein interactions</TD><TD>4722</TD><TD>147</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>COQ8A,TSFM,NANOG</TD></TR>
<TR><TD>4.635e-02</TD><TD>-3.07</TD><TD>TSAI_RESPONSE_TO_IONIZING_RADIATION</TD><TD>MSigDB lists</TD><TD>TSAI_RESPONSE_TO_IONIZING_RADIATION</TD><TD>147</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>JAK2,TANK,ENC1</TD></TR>
<TR><TD>4.650e-02</TD><TD>-3.07</TD><TD>acute_leukaemia_of_ambiguous_lineage_associated_with_MDS</TD><TD>COSMIC cancer mutations</TD><TD>acute_leukaemia_of_ambiguous_lineage_associated_with_MDS</TD><TD>9</TD><TD>1</TD><TD>17630</TD><TD>93</TD>
<TD>JAK2</TD></TR>
<TR><TD>4.650e-02</TD><TD>-3.07</TD><TD>haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_leukaemia_of_ambiguous_lineage_associated_with_MDS</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_leukaemia_of_ambiguous_lineage_associated_with_MDS</TD><TD>9</TD><TD>1</TD><TD>17630</TD><TD>93</TD>
<TD>JAK2</TD></TR>
<TR><TD>4.650e-02</TD><TD>-3.07</TD><TD>pancreas-other-chronic_pancreatitis</TD><TD>COSMIC cancer mutations</TD><TD>pancreas-other-chronic_pancreatitis</TD><TD>9</TD><TD>1</TD><TD>17630</TD><TD>93</TD>
<TD>JAK2</TD></TR>
<TR><TD>4.650e-02</TD><TD>-3.07</TD><TD>chronic_pancreatitis</TD><TD>COSMIC cancer mutations</TD><TD>chronic_pancreatitis</TD><TD>9</TD><TD>1</TD><TD>17630</TD><TD>93</TD>
<TD>JAK2</TD></TR>
<TR><TD>4.650e-02</TD><TD>-3.07</TD><TD>pancreas-ampulla_of_Vater-carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>pancreas-ampulla_of_Vater-carcinoma</TD><TD>9</TD><TD>1</TD><TD>17630</TD><TD>93</TD>
<TD>JAK2</TD></TR>
<TR><TD>4.656e-02</TD><TD>-3.07</TD><TD>human chr5q23.3</TD><TD>chromosome location</TD><TD>human chr5q23.3</TD><TD>12</TD><TD>1</TD><TD>26234</TD><TD>104</TD>
<TD>SLC27A6</TD></TR>
<TR><TD>4.665e-02</TD><TD>-3.07</TD><TD>V$ERR1_Q2</TD><TD>MSigDB lists</TD><TD>V$ERR1_Q2</TD><TD>248</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>GJB2,SHB,USP8,NR4A1</TD></TR>
<TR><TD>4.684e-02</TD><TD>-3.06</TD><TD>cytoskeletal protein binding</TD><TD>molecular function</TD><TD>GO:0008092</TD><TD>838</TD><TD>9</TD><TD>16652</TD><TD>94</TD>
<TD>ENC1,AP1G1,MAP1LC3B,TPM4,MYPN,PTPN3,ARPC1B,KCNA2,GCSAM</TD></TR>
<TR><TD>4.710e-02</TD><TD>-3.06</TD><TD>negative regulation of cell cycle phase transition</TD><TD>biological process</TD><TD>GO:1901988</TD><TD>145</TD><TD>3</TD><TD>16543</TD><TD>92</TD>
<TD>SMARCA4,FBXO31,OVOL1</TD></TR>
<TR><TD>4.711e-02</TD><TD>-3.06</TD><TD>CRY2 (cryptochrome circadian clock 2)</TD><TD>protein interactions</TD><TD>1408</TD><TD>148</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>VCP,EEF1A1,ADAR</TD></TR>
<TR><TD>4.717e-02</TD><TD>-3.05</TD><TD>EGFR (epidermal growth factor receptor)</TD><TD>protein interactions</TD><TD>1956</TD><TD>870</TD><TD>9</TD><TD>16330</TD><TD>89</TD>
<TD>TPM4,EEF1A1,AP1G1,OTUD7B,USP8,ATP2B4,JAK2,COQ8A,ADAR</TD></TR>
<TR><TD>4.717e-02</TD><TD>-3.05</TD><TD>PPP2R1A (protein phosphatase 2 scaffold subunit Aalpha)</TD><TD>protein interactions</TD><TD>5518</TD><TD>249</TD><TD>4</TD><TD>16330</TD><TD>89</TD>
<TD>MAP3K7,ARIH2,VCP,EEF1A1</TD></TR>
<TR><TD>4.749e-02</TD><TD>-3.05</TD><TD>maxilla</TD><TD>COSMIC cancer mutations</TD><TD>maxilla</TD><TD>66</TD><TD>2</TD><TD>17630</TD><TD>93</TD>
<TD>MAP3K7,ATP2B4</TD></TR>
<TR><TD>4.761e-02</TD><TD>-3.04</TD><TD>MORF_TERF1</TD><TD>MSigDB lists</TD><TD>MORF_TERF1</TD><TD>64</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>POM121C,ARIH2</TD></TR>
<TR><TD>4.761e-02</TD><TD>-3.04</TD><TD>DIRMEIER_LMP1_RESPONSE_EARLY</TD><TD>MSigDB lists</TD><TD>DIRMEIER_LMP1_RESPONSE_EARLY</TD><TD>64</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>FTH1,EEF1A1</TD></TR>
<TR><TD>4.761e-02</TD><TD>-3.04</TD><TD>YWATTWNNRGCT_UNKNOWN</TD><TD>MSigDB lists</TD><TD>YWATTWNNRGCT_UNKNOWN</TD><TD>64</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>NR4A1,TANK</TD></TR>
<TR><TD>4.762e-02</TD><TD>-3.04</TD><TD>ATL3 (atlastin GTPase 3)</TD><TD>protein interactions</TD><TD>25923</TD><TD>64</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>GART,RBKS</TD></TR>
<TR><TD>4.762e-02</TD><TD>-3.04</TD><TD>SAMHD1 (SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1)</TD><TD>protein interactions</TD><TD>25939</TD><TD>64</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>EEF1A1,GART</TD></TR>
<TR><TD>4.767e-02</TD><TD>-3.04</TD><TD>tRNA processing in the nucleus</TD><TD>REACTOME pathways</TD><TD>R-HSA-6784531</TD><TD>60</TD><TD>2</TD><TD>10293</TD><TD>60</TD>
<TD>NUP37,POM121C</TD></TR>
<TR><TD>4.790e-02</TD><TD>-3.04</TD><TD>RPL24 (ribosomal protein L24)</TD><TD>protein interactions</TD><TD>6152</TD><TD>149</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>GART,VCP,EEF1A1</TD></TR>
<TR><TD>4.791e-02</TD><TD>-3.04</TD><TD>GSE4590_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE4590_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_DN</TD><TD>149</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>PPP1R3F,HEATR6,SERPINB10</TD></TR>
<TR><TD>4.799e-02</TD><TD>-3.04</TD><TD>PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_5</TD><TD>MSigDB lists</TD><TD>PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_5</TD><TD>9</TD><TD>1</TD><TD>17621</TD><TD>96</TD>
<TD>NR4A1</TD></TR>
<TR><TD>4.799e-02</TD><TD>-3.04</TD><TD>GO_CELLULAR_RESPONSE_TO_NITROGEN_STARVATION</TD><TD>MSigDB lists</TD><TD>GO_CELLULAR_RESPONSE_TO_NITROGEN_STARVATION</TD><TD>9</TD><TD>1</TD><TD>17621</TD><TD>96</TD>
<TD>MAP1LC3B</TD></TR>
<TR><TD>4.799e-02</TD><TD>-3.04</TD><TD>ST_JAK_STAT_PATHWAY</TD><TD>MSigDB lists</TD><TD>ST_JAK_STAT_PATHWAY</TD><TD>9</TD><TD>1</TD><TD>17621</TD><TD>96</TD>
<TD>JAK2</TD></TR>
<TR><TD>4.799e-02</TD><TD>-3.04</TD><TD>BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FLI1</TD><TD>MSigDB lists</TD><TD>BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FLI1</TD><TD>9</TD><TD>1</TD><TD>17621</TD><TD>96</TD>
<TD>IFT27</TD></TR>
<TR><TD>4.799e-02</TD><TD>-3.04</TD><TD>GO_PRE_MIRNA_PROCESSING</TD><TD>MSigDB lists</TD><TD>GO_PRE_MIRNA_PROCESSING</TD><TD>9</TD><TD>1</TD><TD>17621</TD><TD>96</TD>
<TD>ADAR</TD></TR>
<TR><TD>4.799e-02</TD><TD>-3.04</TD><TD>GO_CELLULAR_RESPONSE_TO_NITROGEN_LEVELS</TD><TD>MSigDB lists</TD><TD>GO_CELLULAR_RESPONSE_TO_NITROGEN_LEVELS</TD><TD>9</TD><TD>1</TD><TD>17621</TD><TD>96</TD>
<TD>MAP1LC3B</TD></TR>
<TR><TD>4.799e-02</TD><TD>-3.04</TD><TD>GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN</TD><TD>MSigDB lists</TD><TD>GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN</TD><TD>9</TD><TD>1</TD><TD>17621</TD><TD>96</TD>
<TD>FOSB</TD></TR>
<TR><TD>4.799e-02</TD><TD>-3.04</TD><TD>OSAWA_TNF_TARGETS</TD><TD>MSigDB lists</TD><TD>OSAWA_TNF_TARGETS</TD><TD>9</TD><TD>1</TD><TD>17621</TD><TD>96</TD>
<TD>TP53BP2</TD></TR>
<TR><TD>4.799e-02</TD><TD>-3.04</TD><TD>REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION</TD><TD>MSigDB lists</TD><TD>REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION</TD><TD>9</TD><TD>1</TD><TD>17621</TD><TD>96</TD>
<TD>AP1G1</TD></TR>
<TR><TD>4.800e-02</TD><TD>-3.04</TD><TD>pigment metabolic process</TD><TD>biological process</TD><TD>GO:0042440</TD><TD>63</TD><TD>2</TD><TD>16543</TD><TD>92</TD>
<TD>ALAS2,GART</TD></TR>
<TR><TD>4.801e-02</TD><TD>-3.04</TD><TD>LGALS2 (galectin 2)</TD><TD>protein interactions</TD><TD>3957</TD><TD>9</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>LGALS2</TD></TR>
<TR><TD>4.801e-02</TD><TD>-3.04</TD><TD>GABRA1 (gamma-aminobutyric acid type A receptor alpha1 subunit)</TD><TD>protein interactions</TD><TD>2554</TD><TD>9</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>VCP</TD></TR>
<TR><TD>4.801e-02</TD><TD>-3.04</TD><TD>RNASEH2C (ribonuclease H2 subunit C)</TD><TD>protein interactions</TD><TD>84153</TD><TD>9</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>RNASEH2A</TD></TR>
<TR><TD>4.801e-02</TD><TD>-3.04</TD><TD>KCNA1 (potassium voltage-gated channel subfamily A member 1)</TD><TD>protein interactions</TD><TD>3736</TD><TD>9</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>KCNA2</TD></TR>
<TR><TD>4.801e-02</TD><TD>-3.04</TD><TD>MUC16 (mucin 16, cell surface associated)</TD><TD>protein interactions</TD><TD>94025</TD><TD>9</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>NANOG</TD></TR>
<TR><TD>4.801e-02</TD><TD>-3.04</TD><TD>C18orf21 (chromosome 18 open reading frame 21)</TD><TD>protein interactions</TD><TD>83608</TD><TD>9</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>FBXO31</TD></TR>
<TR><TD>4.801e-02</TD><TD>-3.04</TD><TD>CNTNAP2 (contactin associated protein-like 2)</TD><TD>protein interactions</TD><TD>26047</TD><TD>9</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>KCNA2</TD></TR>
<TR><TD>4.801e-02</TD><TD>-3.04</TD><TD>ARHGEF15 (Rho guanine nucleotide exchange factor 15)</TD><TD>protein interactions</TD><TD>22899</TD><TD>9</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>UBE3A</TD></TR>
<TR><TD>4.801e-02</TD><TD>-3.04</TD><TD>ZNF524 (zinc finger protein 524)</TD><TD>protein interactions</TD><TD>147807</TD><TD>9</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>NANOG</TD></TR>
<TR><TD>4.801e-02</TD><TD>-3.04</TD><TD>ZNF331 (zinc finger protein 331)</TD><TD>protein interactions</TD><TD>55422</TD><TD>9</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>NR4A1</TD></TR>
<TR><TD>4.801e-02</TD><TD>-3.04</TD><TD>KRT36 (keratin 36)</TD><TD>protein interactions</TD><TD>8689</TD><TD>9</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>USP8</TD></TR>
<TR><TD>4.801e-02</TD><TD>-3.04</TD><TD>RFX2 (regulatory factor X2)</TD><TD>protein interactions</TD><TD>5990</TD><TD>9</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>RFX2</TD></TR>
<TR><TD>4.801e-02</TD><TD>-3.04</TD><TD>OSMR (oncostatin M receptor)</TD><TD>protein interactions</TD><TD>9180</TD><TD>9</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>JAK2</TD></TR>
<TR><TD>4.801e-02</TD><TD>-3.04</TD><TD>HRK (harakiri, BCL2 interacting protein)</TD><TD>protein interactions</TD><TD>8739</TD><TD>9</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>BNC1</TD></TR>
<TR><TD>4.801e-02</TD><TD>-3.04</TD><TD>ABCC3 (ATP binding cassette subfamily C member 3)</TD><TD>protein interactions</TD><TD>8714</TD><TD>9</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>VCP</TD></TR>
<TR><TD>4.801e-02</TD><TD>-3.04</TD><TD>AGPAT1 (1-acylglycerol-3-phosphate O-acyltransferase 1)</TD><TD>protein interactions</TD><TD>10554</TD><TD>9</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>RNASEH2A</TD></TR>
<TR><TD>4.801e-02</TD><TD>-3.04</TD><TD>MRI1 (methylthioribose-1-phosphate isomerase 1)</TD><TD>protein interactions</TD><TD>84245</TD><TD>9</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>ADI1</TD></TR>
<TR><TD>4.801e-02</TD><TD>-3.04</TD><TD>IFNGR2 (interferon gamma receptor 2)</TD><TD>protein interactions</TD><TD>3460</TD><TD>9</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>JAK2</TD></TR>
<TR><TD>4.801e-02</TD><TD>-3.04</TD><TD>SPINK7 (serine peptidase inhibitor, Kazal type 7 (putative))</TD><TD>protein interactions</TD><TD>84651</TD><TD>9</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>FTL</TD></TR>
<TR><TD>4.801e-02</TD><TD>-3.04</TD><TD>DECR2 (2,4-dienoyl-CoA reductase 2)</TD><TD>protein interactions</TD><TD>26063</TD><TD>9</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>RNASEH2A</TD></TR>
<TR><TD>4.801e-02</TD><TD>-3.04</TD><TD>AKR1C1 (aldo-keto reductase family 1 member C1)</TD><TD>protein interactions</TD><TD>1645</TD><TD>9</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>PTPN3</TD></TR>
<TR><TD>4.801e-02</TD><TD>-3.04</TD><TD>EGFL8 (EGF like domain multiple 8)</TD><TD>protein interactions</TD><TD>80864</TD><TD>9</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>RMDN3</TD></TR>
<TR><TD>4.801e-02</TD><TD>-3.04</TD><TD>CDK10 (cyclin dependent kinase 10)</TD><TD>protein interactions</TD><TD>8558</TD><TD>9</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>RNASEH2A</TD></TR>
<TR><TD>4.801e-02</TD><TD>-3.04</TD><TD>ZIC2 (Zic family member 2)</TD><TD>protein interactions</TD><TD>7546</TD><TD>9</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>NANOG</TD></TR>
<TR><TD>4.801e-02</TD><TD>-3.04</TD><TD>CDH9 (cadherin 9)</TD><TD>protein interactions</TD><TD>1007</TD><TD>9</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>CDH7</TD></TR>
<TR><TD>4.801e-02</TD><TD>-3.04</TD><TD>MAGEA8 (MAGE family member A8)</TD><TD>protein interactions</TD><TD>4107</TD><TD>9</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>UBE3A</TD></TR>
<TR><TD>4.801e-02</TD><TD>-3.04</TD><TD>QSER1 (glutamine and serine rich 1)</TD><TD>protein interactions</TD><TD>79832</TD><TD>9</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>FBXO31</TD></TR>
<TR><TD>4.801e-02</TD><TD>-3.04</TD><TD>PCYT1A (phosphate cytidylyltransferase 1, choline, alpha)</TD><TD>protein interactions</TD><TD>5130</TD><TD>9</TD><TD>1</TD><TD>16330</TD><TD>89</TD>
<TD>CASP6</TD></TR>
<TR><TD>4.809e-02</TD><TD>-3.03</TD><TD>LEUZIPPRFOS</TD><TD>prints domains</TD><TD>PR00042</TD><TD>8</TD><TD>1</TD><TD>4725</TD><TD>29</TD>
<TD>FOSB</TD></TR>
<TR><TD>4.809e-02</TD><TD>-3.03</TD><TD>SHAKERCHANEL</TD><TD>prints domains</TD><TD>PR01496</TD><TD>8</TD><TD>1</TD><TD>4725</TD><TD>29</TD>
<TD>KCNA2</TD></TR>
<TR><TD>4.809e-02</TD><TD>-3.03</TD><TD>ACRYSTALLIN</TD><TD>prints domains</TD><TD>PR00299</TD><TD>8</TD><TD>1</TD><TD>4725</TD><TD>29</TD>
<TD>HSPB6</TD></TR>
<TR><TD>4.832e-02</TD><TD>-3.03</TD><TD>polycythaemia_vera</TD><TD>COSMIC cancer mutations</TD><TD>polycythaemia_vera</TD><TD>375</TD><TD>5</TD><TD>17630</TD><TD>93</TD>
<TD>JAK2,TMEM198,FGD5,PTPN3,TACC2</TD></TR>
<TR><TD>4.832e-02</TD><TD>-3.03</TD><TD>haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-polycythaemia_vera</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-polycythaemia_vera</TD><TD>375</TD><TD>5</TD><TD>17630</TD><TD>93</TD>
<TD>FGD5,PTPN3,TMEM198,JAK2,TACC2</TD></TR>
<TR><TD>4.847e-02</TD><TD>-3.03</TD><TD>multi-organism process</TD><TD>biological process</TD><TD>GO:0051704</TD><TD>1557</TD><TD>14</TD><TD>16543</TD><TD>92</TD>
<TD>BNC1,SCARB2,UBE3A,VCP,MAFF,FOSB,SMARCA4,POM121C,ATP2B4,RFX2,OVOL1,GJB2,NUP37,SLC52A2</TD></TR>
<TR><TD>4.863e-02</TD><TD>-3.02</TD><TD>VCP-NPL4-UFD1 AAA ATPase complex</TD><TD>cellular component</TD><TD>GO:0034098</TD><TD>9</TD><TD>1</TD><TD>17744</TD><TD>98</TD>
<TD>VCP</TD></TR>
<TR><TD>4.869e-02</TD><TD>-3.02</TD><TD>PLCG1 (phospholipase C gamma 1)</TD><TD>protein interactions</TD><TD>5335</TD><TD>150</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>SHB,JAK2,EEF1A1</TD></TR>
<TR><TD>4.869e-02</TD><TD>-3.02</TD><TD>CHD3 (chromodomain helicase DNA binding protein 3)</TD><TD>protein interactions</TD><TD>1107</TD><TD>150</TD><TD>3</TD><TD>16330</TD><TD>89</TD>
<TD>CASP6,SLC27A6,NR4A1</TD></TR>
<TR><TD>4.870e-02</TD><TD>-3.02</TD><TD>REACTOME_MRNA_PROCESSING</TD><TD>MSigDB lists</TD><TD>REACTOME_MRNA_PROCESSING</TD><TD>150</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>POM121C,ADAR,NUP37</TD></TR>
<TR><TD>4.878e-02</TD><TD>-3.02</TD><TD>regulation of RNA biosynthetic process</TD><TD>biological process</TD><TD>GO:2001141</TD><TD>3567</TD><TD>27</TD><TD>16543</TD><TD>92</TD>
<TD>MNX1,ONECUT3,SLC40A1,TSFM,MED7,NANOG,UBE3A,COMMD7,EMX1,EPAS1,ATP2B4,NR4A1,OVOL1,ZNF683,RFX2,MAP3K7,ERN2,EHMT1,EEF1A1,JAK2,OTUD7B,BNC1,KDM2A,AUTS2,SMARCA4,FOSB,MAFF</TD></TR>
<TR><TD>4.879e-02</TD><TD>-3.02</TD><TD>skin-foot-malignant_melanoma-acral_lentiginous</TD><TD>COSMIC cancer mutations</TD><TD>skin-foot-malignant_melanoma-acral_lentiginous</TD><TD>67</TD><TD>2</TD><TD>17630</TD><TD>93</TD>
<TD>PPP1R3F,RBKS</TD></TR>
<TR><TD>4.891e-02</TD><TD>-3.02</TD><TD>SP1 (Sp1 transcription factor)</TD><TD>protein interactions</TD><TD>6667</TD><TD>252</TD><TD>4</TD><TD>16330</TD><TD>89</TD>
<TD>EPAS1,SMARCA4,TPM4,CASP6</TD></TR>
<TR><TD>4.895e-02</TD><TD>-3.02</TD><TD>GO_MULTI_ORGANISM_TRANSPORT</TD><TD>MSigDB lists</TD><TD>GO_MULTI_ORGANISM_TRANSPORT</TD><TD>65</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>POM121C,NUP37</TD></TR>
<TR><TD>4.895e-02</TD><TD>-3.02</TD><TD>GO_MULTI_ORGANISM_LOCALIZATION</TD><TD>MSigDB lists</TD><TD>GO_MULTI_ORGANISM_LOCALIZATION</TD><TD>65</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>NUP37,POM121C</TD></TR>
<TR><TD>4.895e-02</TD><TD>-3.02</TD><TD>GO_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS</TD><TD>MSigDB lists</TD><TD>GO_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS</TD><TD>65</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>JAK2,ATP2B4</TD></TR>
<TR><TD>4.895e-02</TD><TD>-3.02</TD><TD>GO_LYSOSOMAL_TRANSPORT</TD><TD>MSigDB lists</TD><TD>GO_LYSOSOMAL_TRANSPORT</TD><TD>65</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>AP1G1,SCARB2</TD></TR>
<TR><TD>4.895e-02</TD><TD>-3.02</TD><TD>REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES</TD><TD>MSigDB lists</TD><TD>REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES</TD><TD>65</TD><TD>2</TD><TD>17621</TD><TD>96</TD>
<TD>POM121C,NUP37</TD></TR>
<TR><TD>4.896e-02</TD><TD>-3.02</TD><TD>HTRA2 (HtrA serine peptidase 2)</TD><TD>protein interactions</TD><TD>27429</TD><TD>65</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>EEF1A1,VCP</TD></TR>
<TR><TD>4.896e-02</TD><TD>-3.02</TD><TD>RABAC1 (Rab acceptor 1)</TD><TD>protein interactions</TD><TD>10567</TD><TD>65</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>RAB17,COQ8A</TD></TR>
<TR><TD>4.896e-02</TD><TD>-3.02</TD><TD>RABGGTB (Rab geranylgeranyltransferase beta subunit)</TD><TD>protein interactions</TD><TD>5876</TD><TD>65</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>RAB17,ALAS2</TD></TR>
<TR><TD>4.896e-02</TD><TD>-3.02</TD><TD>PPP3CA (protein phosphatase 3 catalytic subunit alpha)</TD><TD>protein interactions</TD><TD>5530</TD><TD>65</TD><TD>2</TD><TD>16330</TD><TD>89</TD>
<TD>ATP2B4,VCP</TD></TR>
<TR><TD>4.896e-02</TD><TD>-3.02</TD><TD>negative regulation of cell maturation</TD><TD>biological process</TD><TD>GO:1903430</TD><TD>9</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>SHB</TD></TR>
<TR><TD>4.896e-02</TD><TD>-3.02</TD><TD>xenobiotic glucuronidation</TD><TD>biological process</TD><TD>GO:0052697</TD><TD>9</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>UGT1A6</TD></TR>
<TR><TD>4.896e-02</TD><TD>-3.02</TD><TD>endothelial cell chemotaxis</TD><TD>biological process</TD><TD>GO:0035767</TD><TD>9</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>NR4A1</TD></TR>
<TR><TD>4.896e-02</TD><TD>-3.02</TD><TD>positive regulation of protein import into nucleus, translocation</TD><TD>biological process</TD><TD>GO:0033160</TD><TD>9</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>JAK2</TD></TR>
<TR><TD>4.896e-02</TD><TD>-3.02</TD><TD>cranial nerve structural organization</TD><TD>biological process</TD><TD>GO:0021604</TD><TD>9</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>KCNA2</TD></TR>
<TR><TD>4.896e-02</TD><TD>-3.02</TD><TD>positive regulation of membrane potential</TD><TD>biological process</TD><TD>GO:0045838</TD><TD>9</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>VCP</TD></TR>
<TR><TD>4.896e-02</TD><TD>-3.02</TD><TD>gas homeostasis</TD><TD>biological process</TD><TD>GO:0033483</TD><TD>9</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ALAS2</TD></TR>
<TR><TD>4.896e-02</TD><TD>-3.02</TD><TD>histone H3-K27 methylation</TD><TD>biological process</TD><TD>GO:0070734</TD><TD>9</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>EHMT1</TD></TR>
<TR><TD>4.896e-02</TD><TD>-3.02</TD><TD>corticosteroid receptor signaling pathway</TD><TD>biological process</TD><TD>GO:0031958</TD><TD>9</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>JAK2</TD></TR>
<TR><TD>4.896e-02</TD><TD>-3.02</TD><TD>multicellular organismal iron ion homeostasis</TD><TD>biological process</TD><TD>GO:0060586</TD><TD>9</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>SLC40A1</TD></TR>
<TR><TD>4.896e-02</TD><TD>-3.02</TD><TD>calcium ion import into cell</TD><TD>biological process</TD><TD>GO:1990035</TD><TD>9</TD><TD>1</TD><TD>16543</TD><TD>92</TD>
<TD>ATP2B4</TD></TR>
<TR><TD>4.920e-02</TD><TD>-3.01</TD><TD>DNA-bd_RFX</TD><TD>interpro domains</TD><TD>IPR003150</TD><TD>9</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>RFX2</TD></TR>
<TR><TD>4.920e-02</TD><TD>-3.01</TD><TD>RmlC_Cupin</TD><TD>interpro domains</TD><TD>IPR011051</TD><TD>9</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>ADI1</TD></TR>
<TR><TD>4.920e-02</TD><TD>-3.01</TD><TD>HSP20</TD><TD>interpro domains</TD><TD>IPR031107</TD><TD>9</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>HSPB6</TD></TR>
<TR><TD>4.920e-02</TD><TD>-3.01</TD><TD>Transl_elong_EF1A/Init_IF2_C</TD><TD>interpro domains</TD><TD>IPR009001</TD><TD>9</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>EEF1A1</TD></TR>
<TR><TD>4.920e-02</TD><TD>-3.01</TD><TD>Sugar_P_trans_dom</TD><TD>interpro domains</TD><TD>IPR004853</TD><TD>9</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>SLC35E4</TD></TR>
<TR><TD>4.920e-02</TD><TD>-3.01</TD><TD>G_TR_CS</TD><TD>interpro domains</TD><TD>IPR031157</TD><TD>9</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>EEF1A1</TD></TR>
<TR><TD>4.920e-02</TD><TD>-3.01</TD><TD>Clathrin_a/b/g-adaptin_app_Ig</TD><TD>interpro domains</TD><TD>IPR008152</TD><TD>9</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>AP1G1</TD></TR>
<TR><TD>4.920e-02</TD><TD>-3.01</TD><TD>AP-1</TD><TD>interpro domains</TD><TD>IPR000837</TD><TD>9</TD><TD>1</TD><TD>18428</TD><TD>103</TD>
<TD>FOSB</TD></TR>
<TR><TD>4.922e-02</TD><TD>-3.01</TD><TD>chr19p13</TD><TD>MSigDB lists</TD><TD>chr19p13</TD><TD>485</TD><TD>6</TD><TD>17621</TD><TD>96</TD>
<TD>PLK5,RFX2,TPM4,ONECUT3,SMARCA4,RNASEH2A</TD></TR>
<TR><TD>4.934e-02</TD><TD>-3.01</TD><TD>G_TR_1</TD><TD>prosite domains</TD><TD>PS00301</TD><TD>9</TD><TD>1</TD><TD>11955</TD><TD>67</TD>
<TD>EEF1A1</TD></TR>
<TR><TD>4.934e-02</TD><TD>-3.01</TD><TD>RFX_DBD</TD><TD>prosite domains</TD><TD>PS51526</TD><TD>9</TD><TD>1</TD><TD>11955</TD><TD>67</TD>
<TD>RFX2</TD></TR>
<TR><TD>4.934e-02</TD><TD>-3.01</TD><TD>HSP20</TD><TD>prosite domains</TD><TD>PS01031</TD><TD>9</TD><TD>1</TD><TD>11955</TD><TD>67</TD>
<TD>HSPB6</TD></TR>
<TR><TD>4.938e-02</TD><TD>-3.01</TD><TD>intracellular transport of virus</TD><TD>biological process</TD><TD>GO:0075733</TD><TD>64</TD><TD>2</TD><TD>16543</TD><TD>92</TD>
<TD>NUP37,POM121C</TD></TR>
<TR><TD>4.938e-02</TD><TD>-3.01</TD><TD>positive regulation of phosphatidylinositol 3-kinase signaling</TD><TD>biological process</TD><TD>GO:0014068</TD><TD>64</TD><TD>2</TD><TD>16543</TD><TD>92</TD>
<TD>JAK2,UBE3A</TD></TR>
<TR><TD>4.950e-02</TD><TD>-3.01</TD><TD>RODRIGUES_NTN1_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>RODRIGUES_NTN1_TARGETS_DN</TD><TD>151</TD><TD>3</TD><TD>17621</TD><TD>96</TD>
<TD>ENC1,SHB,NR4A1</TD></TR>
<TR><TD>4.954e-02</TD><TD>-3.00</TD><TD>V$NFY_Q6_01</TD><TD>MSigDB lists</TD><TD>V$NFY_Q6_01</TD><TD>253</TD><TD>4</TD><TD>17621</TD><TD>96</TD>
<TD>VCP,IFT27,FOSB,GART</TD></TR>
<TR><TD>4.968e-02</TD><TD>-3.00</TD><TD>nitric-oxide synthase regulator activity</TD><TD>molecular function</TD><TD>GO:0030235</TD><TD>9</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>ATP2B4</TD></TR>
<TR><TD>4.968e-02</TD><TD>-3.00</TD><TD>Tat protein binding</TD><TD>molecular function</TD><TD>GO:0030957</TD><TD>9</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>SMARCA4</TD></TR>
<TR><TD>4.968e-02</TD><TD>-3.00</TD><TD>calcium-transporting ATPase activity</TD><TD>molecular function</TD><TD>GO:0005388</TD><TD>9</TD><TD>1</TD><TD>16652</TD><TD>94</TD>
<TD>ATP2B4</TD></TR>
<TR><TD>4.979e-02</TD><TD>-3.00</TD><TD>regulation of cellular protein metabolic process</TD><TD>biological process</TD><TD>GO:0032268</TD><TD>2312</TD><TD>19</TD><TD>16543</TD><TD>92</TD>
<TD>AURKAIP1,OSBPL7,TANK,TSFM,PTPN3,ENC1,DTD1,SERPINB10,ATP2B4,ADAR,VCP,UBE3A,ARIH2,MAP3K7,AUTS2,VARS2,SHB,NGDN,JAK2</TD></TR>
</TABLE>
</BODY></HTML>
